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Observational studies have shown evidence for a positive association between maternal 
prenatal smoking, alcohol and caffeine consumption and attention-deficit hyperactivity 
disorder (ADHD) in offspring. However, it is still unclear whether these associations 
reflect a causal effect or are due to unmeasured and residual confounding. Although 
evidence from previous studies suggest that the association between maternal prenatal 
smoking and ADHD is unlikely to be causal, findings are still inconsistent regarding 
alcohol and caffeine exposure.  
In this thesis I used different epidemiological methods and triangulated findings across 
these methods to find evidence to support a causal effect of maternal prenatal 
substance use on offspring ADHD risk. The methods used in this thesis included a 
systematic review, a targeted Phenome-Wide Association Study (PheWAS) approach, a 
negative control design by using paternal substance use as a negative control, and 
polygenic risk score analyses. Throughout this thesis I used data from three longitudinal 
birth cohorts: the Avon Longitudinal Study of Parents and Children (ALSPAC), the 
Generation R (GenR), and the Norwegian Mother, Father and Child Cohort study 
(MoBa). A triangulation approach illustrated how important it is to apply different 
methods to infer causality as each method has its own sources of bias, but it is unlikely 
that different methods are biased in the same way. Therefore, comparing findings from 
various methods can provide more support on whether a causal relationship exists.  
My findings did not provide strong evidence for a causal effect of maternal prenatal 
substance use on offspring ADHD risk in any of the prenatal exposures. My findings on 
smoking exposure are in line with existing evidence indicating that the association is 
explained by genetic confounding. However, my results also suggest that future studies 
should focus on better phenotyping of ADHD and use bigger samples to detect whether 
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MR, & Zuccolo, L. (2021). Maternal and child genetic liability for smoking and caffeine 
consumption and child mental health: an intergenerational genetic risk score analysis in 
the alspac cohort. Addiction, 2021 Apr 23. https://doi.org/10.1111/add.15521 
*shared first authorship 
Preprints: 
Haan, E., Sallis, H. M., Zuccolo, L., Labrecque, J., Ystrom, E., Reichborn-Kjennerud, T., 
Havdahl, A., Munafò, M. R. (2021). Prenatal smoking, alcohol and caffeine exposure and 
ADHD risk in childhood: parental comparisons and polygenic risk score (PRS) analyses. 
Preprint available on medrXiv: https://doi.org/10.1101/2021.03.25.21254087  
Haan, E., Sallis, H. M., Ystrom, E., Njølstad, P. R., Andreassen, O. A., Reichborn-
Kjennerud, T., Munafò, M. R., Havdahl, A., Zuccolo, L. (2021). Maternal and 
child genetic risk score (GRS) analyses of fetal alcohol exposure and ADHD risk in 





TABLE OF CONTENTS 
Chapter 1 Introduction ................................................................................ 1 
1.1 Thesis overview ........................................................................................... 1 
1.2 Epidemiology of ADHD ................................................................................ 2 
1.2.1 Prevalence of ADHD .................................................................................... 2 
1.2.2 Gender effects of ADHD .............................................................................. 2 
1.2.3 Symptoms and diagnostic criteria of ADHD ................................................ 4 
1.2.4 Comorbidities and impairment ................................................................... 6 
1.2.5 Societal impact ............................................................................................ 7 
1.3 Genetic determinants of ADHD .................................................................... 9 
1.3.1 Heritability of ADHD .................................................................................... 9 
1.3.2 SNP-based heritability ............................................................................... 10 
1.3.3 Polygenic risk scores .................................................................................. 11 
1.4 Environmental determinants of ADHD ....................................................... 12 
1.4.1 Harms of prenatal substance use .............................................................. 13 
1.4.2 Comorbidity of prenatal substance use..................................................... 15 
1.4.3 Burden of maternal prenatal substance use ............................................. 16 
1.5 Causal inference research .......................................................................... 18 
1.5.1 Observational studies ................................................................................ 18 
1.5.2 Quasi-experimental designs ...................................................................... 19 
1.5.3 Mendelian Randomization (MR) ............................................................... 20 
1.5.4 Triangulation in causal inference research ............................................... 21 
1.6 Chapter summary ...................................................................................... 21 
1.7 Thesis focus ............................................................................................... 22 
1.7.1 Aims ........................................................................................................... 22 
1.7.2 Methods .................................................................................................... 22 
Chapter 2 Prenatal smoking, alcohol and caffeine exposure and 
offspring externalising disorders: A systematic review ................................... 24 
2.1 Introduction .............................................................................................. 24 




2.2.1 Search strategy .......................................................................................... 26 
2.2.2 Inclusion and exclusion criteria ................................................................. 27 
2.2.3 Study selection and data extraction .......................................................... 27 
2.2.4 Risk of bias assessment ............................................................................. 28 
2.3 Results...................................................................................................... 28 
2.3.1 Results of literature search ........................................................................ 28 
2.3.2 Characteristics of included studies ............................................................ 30 
2.3.3 Assessment of exposures ........................................................................... 30 
2.3.3.1 Smoking ................................................................................................. 30 
2.3.3.2 Alcohol ................................................................................................... 31 
2.3.3.3 Caffeine ................................................................................................. 32 
2.3.4 Assessment of outcomes ........................................................................... 32 
2.3.4.1 ADHD ..................................................................................................... 32 
2.3.4.2 CD and ODD ........................................................................................... 33 
2.3.5 Inclusion of confounding variables ............................................................ 33 
2.3.6 Summary of findings .................................................................................. 34 
2.3.6.1 Association between smoking during pregnancy and ADHD in 
offspring……. .......................................................................................................... 34 
2.3.6.2 Association between smoking during pregnancy and CD and ODD in 
offspring…… ........................................................................................................... 37 
2.3.6.3 Association between alcohol consumption during pregnancy and ADHD 
in offspring ............................................................................................................ 38 
2.3.6.4 Association between alcohol consumption during pregnancy and CD 
and ODD in offspring ............................................................................................. 39 
2.3.6.5 Association between caffeine consumption during pregnancy and ADHD 
and ODD in offspring ............................................................................................. 40 
2.4 Discussion................................................................................................. 41 
2.5 Chapter summary ..................................................................................... 44 
Chapter 3 Descriptions of cohorts ............................................................. 46 
3.1 Introduction ............................................................................................. 46 
3.2 The Avon Longitudinal Study of Parents and Children (ALSPAC) .................. 46 
3.2.1 Cohort profile ............................................................................................. 46 
3.2.2 Genome-wide data and quality control..................................................... 47 




3.2.3.1 The Development And Well-Being Assessment (DAWBA) ..................... 49 
3.2.3.2 The Strengths and Difficulties Questionnaire (SDQ) ............................. 50 
3.2.3.3 Descriptive statistics of ADHD measures .............................................. 50 
3.2.4 Assessment of parental prenatal substance use ....................................... 58 
3.2.4.1 Descriptive statistics of parental socio-demographic characteristics and 
prenatal substance use ......................................................................................... 60 
3.3 The Generation R (GenR) ........................................................................... 67 
3.3.1 Cohort profile ............................................................................................ 67 
3.3.2 Genome-wide data and quality control .................................................... 67 
3.3.3 Assessment of ADHD ................................................................................. 68 
3.3.3.1 The revised Conners’ Parent Rating Scale (CPRS-R) .............................. 68 
3.3.3.2 The Child Behavior Checklist (CBCL) ...................................................... 69 
3.3.3.3 Descriptive statistics of ADHD measures .............................................. 70 
3.3.4 Assessment of parental prenatal substance use ....................................... 75 
3.3.4.1 Descriptive statistics of parental socio-demographic characteristics and 
prenatal substance use ......................................................................................... 76 
3.4 The Norwegian Mother, Father and Child cohort study (MoBa) ................... 82 
3.4.1 Cohort profile ............................................................................................ 82 
3.4.2 Genome-wide data and quality control .................................................... 83 
3.4.3 Assessment of ADHD ................................................................................. 84 
3.4.3.1 The Parent/Teacher Rating Scale for Disruptive Behavior Disorders (RS-
DBD)…………. .......................................................................................................... 85 
3.4.3.2 Descriptive statistics of ADHD measure ................................................ 85 
3.4.4 Assessment of parental prenatal substance use ....................................... 89 
3.4.4.1 Descriptive statistics of parental socio-demographic statistics and 
prenatal substance use ......................................................................................... 91 
3.5 Cohort comparison .................................................................................... 97 
3.6 Selection of measures .............................................................................. 101 
3.7 Chapter summary .................................................................................... 102 
Chapter 4 Maternal and child genetic liability for smoking and caffeine 
consumption and child mental health: A Phenome-Wide Association 
Study in the ALSPAC cohort.......................................................................... 103 




4.2 Methods ................................................................................................. 109 
4.2.1 Study Population ..................................................................................... 109 
4.2.2 Phenotype selection ................................................................................ 109 
4.2.2.1 Maternal phenotypes during pregnancy ............................................. 110 
4.2.2.2 Maternal phenotypes outside of pregnancy ....................................... 114 
4.2.2.3 Offspring phenotypes in childhood ...................................................... 117 
4.2.2.4 Offspring phenotypes in adolescence .................................................. 119 
4.2.3 Polygenic risk scores (PRSs) ..................................................................... 122 
4.2.3.1 Smoking PRS ........................................................................................ 122 
4.2.3.2 Caffeine PRS......................................................................................... 122 
4.2.4 Statistical analysis ................................................................................... 122 
4.2.4.1 Sensitivity analyses .............................................................................. 123 
4.3 Results.................................................................................................... 124 
4.3.1 Aim 1: Validation of smoking and caffeine PRS....................................... 124 
4.3.2 Aim 2: Maternal and offspring PRS associations on offspring 
phenotypes in childhood ......................................................................................... 130 
4.3.2.1 Smoking Initiation PRS......................................................................... 130 
4.3.2.2 Caffeine PRS......................................................................................... 134 
4.3.3 Aim 3: Maternal and offspring PRS associations on their own 
outcomes during and outside of pregnancy and adolescence ................................ 137 
4.3.3.1 Smoking Initiation PRS......................................................................... 137 
4.3.3.2 Caffeine PRS......................................................................................... 141 
4.3.4 Sensitivity analyses .................................................................................. 144 
4.4 Discussion............................................................................................... 148 
4.5 Chapter summary ................................................................................... 152 
Chapter 5 Prenatal smoking, alcohol and caffeine exposure and ADHD 
risk in childhood: parental comparisons and polygenic risk score (PRS) 
analyses……… .............................................................................................. 153 
5.1 Introduction ........................................................................................... 153 
5.2 Methods ................................................................................................. 158 
5.2.1 Study Population ..................................................................................... 158 




5.2.3 Exposures ................................................................................................ 158 
5.2.4 Outcome .................................................................................................. 159 
5.2.4.1 Primary outcome measures ................................................................ 159 
5.2.4.2 Secondary outcome measures ............................................................ 160 
5.2.5 Polygenic risk scores (PRSs) ..................................................................... 160 
5.2.6 Statistical analysis ................................................................................... 162 
5.2.6.1 Negative control analyses ................................................................... 163 
5.2.6.2 Polygenic risk score analyses .............................................................. 164 
5.2.6.3 Sensitivity analyses ............................................................................. 165 
5.3 Results .................................................................................................... 167 
5.3.1 Smoking ................................................................................................... 171 
5.3.1.1 Negative control analyses ................................................................... 171 
5.3.1.2 Polygenic risk score analyses .............................................................. 178 
5.3.2 Alcohol ..................................................................................................... 183 
5.3.2.1 Negative control analyses ................................................................... 183 
5.3.2.2 Polygenic risk score analyses .............................................................. 190 
5.3.3 Caffeine ................................................................................................... 192 
5.3.3.1 Negative control analyses ................................................................... 192 
5.3.3.2 Polygenic risk score analyses .............................................................. 198 
5.3.4 Associations between PRS for substance use and participation at 
age 7-8 years ........................................................................................................... 200 
5.4 Discussion ............................................................................................... 201 
5.5 Chapter summary .................................................................................... 205 
Chapter 6 Maternal and offspring polygenic risk score (PRS) analyses of 
fetal alcohol exposure and ADHD risk in offspring ........................................ 206 
6.1 Introduction ............................................................................................ 206 
6.2 Methods ................................................................................................. 211 
6.2.1 Study Populations.................................................................................... 211 
6.2.2 Availability of genome-wide data ........................................................... 211 
6.2.3 Exposures ................................................................................................ 211 
6.2.3.1 Genetic variants .................................................................................. 211 




6.2.5 Harmonisation ......................................................................................... 214 
6.2.6 Polygenic risk scores ................................................................................ 220 
6.2.7 Statistical analysis ................................................................................... 220 
6.2.7.1 Primary analysis .................................................................................. 220 
6.2.7.2 Sensitivity analyses .............................................................................. 222 
6.2.7.3 Replication analysis of previous ALSPAC studies ................................. 223 
6.3 Results.................................................................................................... 223 
6.3.1 Maternal PRS analysis ............................................................................. 224 
6.3.2 Offspring PRS analysis ............................................................................. 229 
6.3.3 Sensitivity analyses .................................................................................. 239 
6.3.4 Replication analysis of previous ALSPAC studies ..................................... 239 
6.4 Discussion............................................................................................... 240 
6.4.1 Strengths and limitations ........................................................................ 242 
6.5 Chapter summary ................................................................................... 245 
Chapter 7 Discussion ............................................................................... 246 
7.1 Summary of findings ............................................................................... 246 
7.1.1 Prenatal smoking, alcohol and caffeine exposure and offspring 
externalising disorders: A systematic review .......................................................... 246 
7.1.2 Maternal and child genetic liability for smoking and caffeine 
consumption and child mental health: A Phenome-Wide Association Study in 
the ALSPAC cohort. .................................................................................................. 247 
7.1.3 Prenatal smoking, alcohol and caffeine exposure and ADHD risk in 
childhood: parental comparisons and polygenic risk score (PRS) analyses ............. 248 
7.1.4 Maternal and offspring polygenic risk score (PRS) analyses of fetal 
alcohol exposure and ADHD risk in offspring .......................................................... 249 
7.2 Overall findings ....................................................................................... 250 
7.3 Strengths and implications ...................................................................... 253 
7.3.1 Triangulation ........................................................................................... 253 
7.3.2 Multiple measures of ADHD .................................................................... 254 
7.3.3 Public health and clinical implications .................................................... 254 
7.4 Limitations ............................................................................................. 255 




7.4.2 Selection bias........................................................................................... 256 
7.4.3 Assessment of exposures ........................................................................ 256 
7.4.3.1 Self-reported exposures ...................................................................... 256 
7.4.3.2 Time-variation in exposures ................................................................ 257 
7.4.4 Assessment of ADHD ............................................................................... 258 
7.5 Future direction....................................................................................... 259 
7.5.1 Phenotyping of ADHD ............................................................................. 259 
7.5.2 Establishing stronger causal inference.................................................... 260 
7.5.2.1 Natural experiments and quasi-experimental designs ....................... 260 
7.5.2.2 Two-Sample Mendelian Randomization (MR) .................................... 261 
7.5.2.3 Multivariable MR ................................................................................ 262 
7.5.2.4 Transmitted and Non-Transmitted Alleles .......................................... 262 
7.5.2.5 Structural Equation Models (SEM) ...................................................... 263 
7.5.3 Evocative effects ..................................................................................... 263 
7.6 Thesis conclusions ................................................................................... 264 
References ......................................................................................................... 265 







List of Tables 
Table 3.1. Descriptive statistics of maternal reported ADHD symptoms scales in 
ALSPAC .............................................................................................................................. 53 
Table 3.2. Descriptive statistics of teacher reported ADHD symptoms scales in 
ALSPAC .............................................................................................................................. 54 
Table 3.3. Correlation matrix between maternal and teacher reported ADHD 
symptoms scales in ALSPAC .............................................................................................. 57 
Table 3.4. Maternal and paternal exposure assessment in ALSPAC ................................. 58 
Table 3.5. Maternal and paternal socio-demographic characteristics and substance 
use in the 1st pregnancy trimester in the full and analysis sample in ALSPAC .................. 63 
Table 3.6. Maternal and paternal substance use correlation matrix in the full 
sample in ALSPAC .............................................................................................................. 65 
Table 3.7. Maternal and paternal substance correlation matrix in the analysis 
sample in ALSPAC .............................................................................................................. 66 
Table 3.8. Descriptive statistics of ADHD symptoms scales in GenR ................................ 72 
Table 3.9. Correlation matrix between ADHD symptoms scales in GenR ......................... 74 
Table 3.10. Maternal and paternal exposure assessment in GenR .................................. 75 
Table 3.11. Maternal and paternal socio-demographic and substance use 
characteristics in the 1st pregnancy trimester in the full and analysis sample in 
GenR .................................................................................................................................. 79 
Table 3.12. Maternal and paternal substance use correlation matrix in the full 
sample in GenR ................................................................................................................. 81 
Table 3.13. Maternal and paternal substance use correlation matrix in the analysis 
sample in GenR ................................................................................................................. 81 
Table 3.14. Descriptive statistics of maternal reported ADHD symptoms scales in 
MoBa ................................................................................................................................. 87 
Table 3.15. Correlation matrix of ADHD subscales measured with the RS-DBD scale 
in MoBa ............................................................................................................................. 88 
Table 3.16. Maternal and paternal exposure assessment in MoBa .................................. 89 
Table 3.17. Maternal and paternal socio-demographic characteristics and 
substance use in the 1st pregnancy trimester in the full and analysis sample in 
MoBa ................................................................................................................................. 93 
Table 3.18. Maternal and paternal substance use correlation matrix in the full 




Table 3.19. Maternal and paternal substance use correlation matrix in the analysis 
sample in MoBa ................................................................................................................ 96 
Table 3.20. Comparison of cohorts’ parental socio-demographic characteristics 
and parental substance use during the 1st pregnancy trimester in the analysis 
sample ............................................................................................................................... 99 
Table 3.21. Comparison of cohorts’ child characteristics and maternal reported 
ADHD cases above the 85th percentile threshold ........................................................... 100 
Table 4.1. Maternal phenotypes during pregnancy........................................................ 112 
Table 4.2. Maternal phenotypes outside of pregnancy .................................................. 116 
Table 4.3. Offspring phenotypes in childhood ................................................................ 118 
Table 4.4. Offspring phenotypes in adolescence ............................................................ 120 
Table 4.5. Associations between maternal and offspring smoking initiation PRSs 
and smoking phenotypes in mothers and adolescence.................................................. 126 
Table 4.6. Associations between maternal and offspring caffeine PRSs and daily 
caffeine intake in mothers and offspring ........................................................................ 129 
Table 4.7. Associations between maternal and offspring smoking initiation PRSs 
and offspring phenotypes in childhood .......................................................................... 133 
Table 4.8. Associations between maternal and offspring caffeine PRSs and 
offspring phenotypes in childhood ................................................................................. 136 
Table 5.1. Phenotyping in genome-wide association studies ......................................... 161 
Table 5.2. The range of PRS in ALSPAC and MoBa .......................................................... 162 
Table 5.3. Correlation between PRSs in ALSPAC ............................................................. 162 
Table 5.4. Correlation between PRSs in MoBa ............................................................... 162 
Table 5.5. Associations between maternal and paternal prenatal smoking and high 
risk of maternal reported offspring ADHD symptoms in ALSPAC ................................... 172 
Table 5.6. Associations between maternal and paternal prenatal smoking and high 
risk of maternal and teacher reported offspring ADHD symptoms in GenR .................. 174 
Table 5.7. Associations between maternal and paternal prenatal smoking and high 
risk of maternal reported offspring ADHD symptoms in MoBa ...................................... 175 
Table 5.8. Associations between maternal weighted exposure PRSs and exposure 
phenotypes in ALSPAC .................................................................................................... 179 
Table 5.9. Associations between maternal weighted exposure PRSs and exposure 




Table 5.10. Associations between maternal smoking heaviness PRS and 
confounders in ALSPAC ................................................................................................... 180 
Table 5.11. Associations between maternal smoking heaviness PRS and 
confounders in MoBa ...................................................................................................... 180 
Table 5.12. Associations between maternal lifetime smoking PRS and confounders 
in ALSPAC ........................................................................................................................ 180 
Table 5.13. Associations between maternal lifetime smoking PRS and confounders 
in MoBa ........................................................................................................................... 181 
Table 5.14. Associations between maternal smoking heaviness PRS and high risk of 
maternal reported offspring ADHD symptoms in ALSPAC .............................................. 182 
Table 5.15. Associations between maternal smoking heaviness PRS and high risk of 
maternal reported offspring ADHD symptoms in MoBa ................................................. 182 
Table 5.16. Associations between maternal lifetime smoking PRS and high risk of 
maternal reported offspring ADHD symptoms in ALSPAC .............................................. 182 
Table 5.17. Associations between maternal lifetime smoking PRS and high risk of 
maternal reported offspring ADHD symptoms in MoBa ................................................. 182 
Table 5.18. Associations between maternal and paternal prenatal alcohol 
consumption and high risk of maternal reported offspring ADHD symptoms in 
ALSPAC ............................................................................................................................ 184 
Table 5.19. Associations between maternal and paternal prenatal alcohol 
consumption and high risk of maternal and teacher reported offspring ADHD 
symptoms in GenR .......................................................................................................... 186 
Table 5.20. Associations between maternal and paternal prenatal alcohol 
consumption and high risk of maternal reported offspring ADHD symptoms in 
MoBa ............................................................................................................................... 188 
Table 5.21. Associations between maternal alcohol PRS and confounders in 
ALSPAC ............................................................................................................................ 191 
Table 5.22. Associations between maternal alcohol PRS and confounders in MoBa ..... 191 
Table 5.23. Associations between maternal alcohol consumption PRS and high risk 
of maternal reported offspring ADHD symptoms in ALSPAC .......................................... 192 
Table 5.24. Associations between maternal alcohol consumption PRS and high risk 




Table 5.25. Associations between maternal and paternal daily prenatal caffeine 
consumption and high risk of maternal reported offspring ADHD symptoms in 
ALSPAC ............................................................................................................................ 193 
Table 5.26. Associations between maternal and paternal daily prenatal caffeine 
consumption and high risk of maternal reported offspring ADHD symptoms in 
MoBa ............................................................................................................................... 195 
Table 5.27. Associations between maternal daily prenatal caffeine consumption 
and high risk of maternal and teacher reported offspring ADHD symptoms in GenR ... 197 
Table 5.28. Associations between maternal caffeine PRS and confounders in 
ALSPAC ............................................................................................................................ 199 
Table 5.29. Associations between maternal caffeine PRS and confounders in MoBa ... 199 
Table 5.30. Associations between maternal caffeine consumption PRS and high 
risk of maternal reported offspring ADHD symptoms in ALSPAC ................................... 199 
Table 5.31. Associations between maternal caffeine consumption PRS and high 
risk of maternal reported offspring ADHD symptoms in MoBa ...................................... 200 
Table 5.32. Associations between maternal PRSs and participation in ALSPAC ............. 200 
Table 5.33. Associations between maternal PRSs and participation in MoBa ............... 200 
Table 6.1. Independent SNPs identified after clumping ................................................. 213 
Table 6.2. Harmonisation of SNPs in ALSPAC based on the GSCAN summary 
statistics .......................................................................................................................... 216 
Table 6.3. Harmonisation of SNPs in MoBa based on the GSCAN summary statistics ... 218 
Table 6.4. Overview of study sample characteristics ...................................................... 224 
Table 6.5. Associations between maternal PRS and high risk of maternal reported 
offspring ADHD symptoms in MoBa (primary analyses) ................................................. 227 
Table 6.6. Associations between maternal PRS and high risk of maternal reported 
offspring ADHD symptoms in ALSPAC (primary analyses) .............................................. 228 
Table 6.7. Associations between offspring PRS and high risk of maternal reported 
offspring ADHD symptoms in ALSPAC if mother drank during pregnancy (primary 
analyses) ......................................................................................................................... 233 
Table 6.8. Associations between offspring PRS and high risk of maternal reported 
offspring ADHD symptoms in ALSPAC if mother did not drink during pregnancy 




Table 6.9. Associations between offspring PRS and high risk of maternal reported 
offspring ADHD symptoms in MoBa if mother drank during pregnancy (primary 
analyses) .......................................................................................................................... 235 
Table 6.10. Associations between offspring PRS and high risk of maternal reported 
offspring ADHD symptoms in MoBa if mother did not drink during pregnancy 
(primary analyses) ........................................................................................................... 236 
Table 6.11. Associations between offspring PRS and high risk of maternal and 
teacher reported offspring ADHD symptoms in GenR (primary and secondary 
analyses) .......................................................................................................................... 238 
Table 6.12. Associations between maternal PRS and confounders in ALSPAC ............... 239 
Table 6.13. Associations between maternal PRS and confounders in MoBa ................. 239 




List of Figures 
Figure 1.1. ADHD incidence rates in UK per 10,000 person years at risk in the years 
2004-2013. Copyright Hire et al., 2018 ............................................................................... 3 
Figure 1.2. ADHD incidence rate by age of diagnosis. Copyright Hire et al., 2018. ............ 3 
Figure 1.3. Global years lived with disability: disability‐adjusted life years (DALYs) 
(in 1000 s) of attention‐deficit/hyperactivity disorder for males and females from 
ages 0 to 49 years. Copyright Erskine et al. 2014 ............................................................... 8 
Figure 1.4. Visual overview of the methodological approach .......................................... 23 
Figure 2.1. PRISMA Flowchart of search strategy ............................................................. 29 
Figure 3.1. Distribution of ADHD symptoms score with maternal reported DAWBA 
and SDQ scales in ALSPAC ................................................................................................. 55 
Figure 3.2. Distribution of ADHD symptoms score with teacher reported DAWBA 
and SDQ scales in ALSPAC ................................................................................................. 56 
Figure 3.3. Distribution of ADHD symptoms score measured with CPRS-R, CBCL 
and TRF scales in GenR ..................................................................................................... 73 
Figure 3.4. Distribution of ADHD symptoms score with the maternal reported RS-
DBD scale in MoBa ............................................................................................................ 88 
Figure 4.1.Comparison of GWAS and PheWAS ............................................................... 105 
Figure 4.2.Overview of study aims using directed acyclic graph (DAG) ......................... 108 
Figure 4.3. Median caffeine consumption in mg/day in mothers and offspring ............ 127 
Figure 4.4. Comparison of associations between maternal and offspring smoking 
initiation PRSs on offspring outcomes in childhood ....................................................... 132 
Figure 4.5. Comparison of associations between maternal and offspring caffeine 
PRSs on offspring outcomes in childhood ...................................................................... 135 
Figure 4.6. Associations between maternal smoking initiation PRS and maternal 
outcomes during pregnancy ........................................................................................... 138 
Figure 4.7. Associations between maternal smoking initiation PRS and maternal 
outcomes outside of pregnancy ..................................................................................... 138 
Figure 4.8. Associations between offspring smoking initiation PRS and offspring 
outcomes in adolescence ................................................................................................ 140 
Figure 4.9. Associations between maternal caffeine PRS and maternal outcomes 
during pregnancy ............................................................................................................ 142 
Figure 4.10. Associations between maternal caffeine PRS and maternal outcomes 




Figure 4.11. Associations between offspring caffeine PRS and offspring outcomes 
in adolescence. ................................................................................................................ 143 
Figure 4.12. Comparison of associations between maternal and offspring lifetime 
smoking PRSs on offspring outcomes in childhood ........................................................ 145 
Figure 4.13. Associations between maternal lifetime smoking PRS and maternal 
outcomes during pregnancy ........................................................................................... 146 
Figure 4.14. Associations between maternal lifetime smoking PRS and maternal 
outcomes outside of pregnancy ...................................................................................... 146 
Figure 4.15. Associations between offspring lifetime smoking PRS and offspring 
outcomes in adolescence ................................................................................................ 147 
Figure 5.1. Overview of Mendelian Randomization design and assumptions ................ 156 
Figure 5.2. Overview of study design .............................................................................. 157 
Figure 5.3. Meta-analysis of maternal and paternal prenatal smoking, alcohol, and 
caffeine consumption across the cohorts ....................................................................... 168 
Figure 6.1. Study design .................................................................................................. 210 
Figure 6.2. Collider bias in maternal PRS analyses .......................................................... 221 
Figure 6.3. Collider bias in offspring PRS analyses .......................................................... 222 
Figure 6.4. Meta-analysis of maternal PRS on high risk of maternal reported 
offspring ADHD symptoms in ALSPAC and MoBa ........................................................... 225 
Figure 6.5. Associations between maternal PRS and high risk of maternal reported 
offspring ADHD symptoms in ALSPAC and MoBa ........................................................... 226 
Figure 6.6. Meta-analysis of offspring PRS on high risk of maternal reported 
offspring ADHD symptoms across the cohorts ............................................................... 230 
Figure 6.7. Associations between offspring PRS and high risk of maternal reported 
offspring ADHD symptoms in ALSPAC stratified by maternal drinking status 
(primary analyses) ........................................................................................................... 231 
Figure 6.8. Associations between offspring PRS and high risk of maternal reported 
offspring ADHD symptoms in MoBa stratified by maternal drinking status (primary 
analyses) .......................................................................................................................... 232 
Figure 6.9. Associations between offspring PRS and high risk of maternal and 
teacher reported offspring ADHD symptoms in GenR stratified by maternal 





List of Appendices 
Appendix 2.1. Search performed in Medline (Ovid platform) including relevant 
MeSH Terms .................................................................................................................... 300 
Appendix 2.2. Risk of bias assessment ............................................................................ 302 
Appendix 2.3. Risk of bias assessment scores based on NOS scale of cohort, 
longitudinal and cross-sectional studies ......................................................................... 304 
Appendix 2.4. Risk of bias assessment scores based on NOS scale of case-control 
studies ............................................................................................................................. 305 
Appendix 2.5. List of studies excluded ............................................................................ 306 
Appendix 2.6. List of studies not reporting all the results .............................................. 333 
Appendix 2.7. Study characteristics and results of cohort, longitudinal and cross-
sectional studies ............................................................................................................. 334 
Appendix 2.8. Study characteristics and results of case-control studies ........................ 344 
Appendix 2.9. Confounders included in the cohort, longitudinal and cross-
sectional studies ............................................................................................................. 351 
Appendix 2.10. Confounders included in the case-control studies ................................ 352 
Appendix 3.1. Maternal and paternal daily smoking during the 1st pregnancy 
trimester in ALSPAC ........................................................................................................ 353 
Appendix 3.2. Maternal and paternal alcohol consumption during the 1st 
pregnancy trimester in ALSPAC ...................................................................................... 353 
Appendix 3.3. Maternal and paternal daily caffeine consumption during the 1st 
pregnancy trimester in ALSPAC ...................................................................................... 354 
Appendix 3.4. Maternal and paternal daily smoking during the 1st pregnancy 
trimester in GenR ............................................................................................................ 355 
Appendix 3.5. Maternal and paternal alcohol consumption during the 1st 
pregnancy trimester in GenR .......................................................................................... 355 
Appendix 3.6. Maternal and paternal daily smoking during the 1st pregnancy 
trimester in MoBa ........................................................................................................... 356 
Appendix 3.7. Maternal and paternal alcohol consumption during the 1st 
pregnancy trimester in MoBa ......................................................................................... 356 
Appendix 3.8. Maternal and paternal daily caffeine consumption during the 1st 
pregnancy trimester in MoBa ......................................................................................... 357 
Appendix 4.1. Associations between maternal and offspring lifetime smoking PRSs 




Appendix 4.2. Associations between maternal smoking initiation PRS and maternal 
outcomes during and outside of pregnancy ................................................................... 359 
Appendix 4.3. Associations between offspring smoking initiation PRS and offspring 
outcomes in adolescence ................................................................................................ 362 
Appendix 4.4. Associations between maternal caffeine PRS and maternal 
outcomes during and outside of pregnancy ................................................................... 364 
Appendix 4.5. Associations between offspring caffeine PRS and offspring 
outcomes in adolescence ................................................................................................ 367 
Appendix 4.6. Associations between maternal and offspring lifetime smoking PRSs 
and offspring phenotypes in childhood .......................................................................... 369 
Appendix 4.7. Associations between maternal lifetime smoking PRS and maternal 
outcomes during and outside of pregnancy ................................................................... 370 
Appendix 4.8. Associations between offspring lifetime smoking PRS and offspring 
outcomes in adolescence ................................................................................................ 373 
Appendix 4.9. Correlation between maternal smoking, caffeine and alcohol PRSs ....... 375 
Appendix 5.1. Associations between maternal prenatal smoking and high risk of 
maternal reported offspring ADHD symptoms in MoBa (adjusted for maternal 
ADHD) .............................................................................................................................. 376 
Appendix 5.2. Associations between maternal smoking before pregnancy and high 
risk of maternal reported offspring ADHD symptoms in MoBa ...................................... 377 
Appendix 5.3. Associations between maternal and paternal prenatal smoking and 
high risk of teacher reported offspring ADHD symptoms in ALSPAC .............................. 378 
Appendix 5.4. Associations between maternal smoking before pregnancy and high 
risk of maternal and teacher reported offspring ADHD symptoms in GenR .................. 380 
Appendix 5.5. Associations between maternal and paternal prenatal smoking and 
high risk of maternal reported offspring ADHD symptoms in ALSPAC (complete 
cases) ............................................................................................................................... 381 
Appendix 5.6. Associations between maternal and paternal prenatal smoking and 
high risk of maternal reported offspring ADHD symptoms in GenR (complete 
cases) ............................................................................................................................... 383 
Appendix 5.7. Associations between maternal and paternal prenatal smoking and 
high risk of maternal reported offspring ADHD symptoms in MoBa (complete 




Appendix 5.8. Associations between maternal unweighted PRSs and maternal 
exposure phenotypes in ALSPAC .................................................................................... 387 
Appendix 5.9. Associations between maternal unweighted PRSs and maternal 
exposure phenotypes in MoBa ....................................................................................... 387 
Appendix 5.10. Associations between maternal smoking heaviness PRS and high 
risk of teacher reported offspring in ALSPAC.................................................................. 388 
Appendix 5.11. Associations between maternal lifetime smoking PRS and high risk 
of teacher reported offspring in ALSPAC ........................................................................ 388 
Appendix 5.12. Associations between maternal prenatal alcohol consumption and 
high risk of maternal reported offspring ADHD symptoms in MoBa (adjusted for 
maternal ADHD) .............................................................................................................. 389 
Appendix 5.13. Associations between maternal alcohol consumption before 
pregnancy and high risk of maternal reported offspring ADHD symptoms in MoBa ..... 390 
Appendix 5.14. Associations between maternal alcohol consumption before 
pregnancy and high risk of maternal reported offspring ADHD symptoms in 
ALSPAC ............................................................................................................................ 391 
Appendix 5.15. Associations between maternal and paternal prenatal alcohol 
consumption and high risk of teacher reported offspring ADHD symptoms in 
ALSPAC ............................................................................................................................ 392 
Appendix 5.16. Associations between maternal prenatal weekly alcohol 
consumption in grams and high risk of maternal reported offspring ADHD 
symptoms in ALSPAC ...................................................................................................... 394 
Appendix 5.17. Associations between maternal prenatal weekly alcohol 
consumption in grams and high risk of maternal reported offspring ADHD 
symptoms in MoBa ......................................................................................................... 394 
Appendix 5.18. Associations between maternal and paternal prenatal alcohol 
consumption and high risk of maternal reported offspring ADHD symptoms in 
ALSPAC (complete cases) ................................................................................................ 395 
Appendix 5.19. Associations between maternal and paternal prenatal alcohol 
consumption and high risk of maternal and teacher reported offspring ADHD 
symptoms in GenR (complete cases) .............................................................................. 397 
Appendix 5.20. Associations between maternal and paternal prenatal alcohol 
consumption and high risk of maternal reported offspring ADHD symptoms in 




Appendix 5.21. Associations between maternal alcohol consumption PRS and high 
risk of teacher reported offspring ADHD symptoms in ALSPAC ..................................... 401 
Appendix 5.22. Associations between maternal daily prenatal caffeine 
consumption and high risk of maternal reported offspring ADHD symptoms in 
MoBa (adjusted for maternal ADHD) .............................................................................. 402 
Appendix 5.23. Associations between maternal daily caffeine consumption before 
pregnancy and high risk of maternal reported offspring ADHD symptoms in MoBa ..... 403 
Appendix 5.24. Associations between maternal and paternal daily prenatal 
caffeine consumption and high risk of teacher reported offspring ADHD symptoms 
in ALSPAC ........................................................................................................................ 404 
Appendix 5.25. Associations between maternal and paternal daily prenatal 
caffeine consumption and high risk of maternal reported offspring ADHD 
symptoms in ALSPAC (complete cases) ........................................................................... 406 
Appendix 5.26. Associations between maternal daily prenatal caffeine 
consumption and high risk of maternal and teacher reported offspring ADHD 
symptoms in GenR (complete cases) .............................................................................. 408 
Appendix 5.27. Associations between maternal and paternal daily prenatal 
caffeine consumption and high risk of maternal reported offspring ADHD 
symptoms in MoBa (complete cases) ............................................................................. 409 
Appendix 5.28. Associations between maternal caffeine consumption PRS and 
high risk of teacher reported offspring ADHD symptoms in ALSPAC .............................. 411 
Appendix 6.1. SNPs positioned in chromosome 4 before clumping ............................... 412 
Appendix 6.2. SNPs positioned in chromosome 9 before clumping ............................... 412 
Appendix 6.3. SNPs positioned in chromosome 12 before clumping ............................. 412 
Appendix 6.4. Harmonisation of SNPs in GenR based on the GSCAN summary 
statistics ........................................................................................................................... 413 
Appendix 6.5. Leave-one-out analyses in ALSPAC between maternal PRS and high 
risk of maternal reported offspring ADHD symptoms .................................................... 415 
Appendix 6.6. Leave-one-out analyses in ALSPAC between maternal PRS and high 
risk of teacher reported offspring ADHD symptoms ....................................................... 416 
Appendix 6.7. Leave-one-out analyses in ALSPAC between offspring PRS and high 
risk of maternal reported offspring ADHD symptoms if mother drank during 




Appendix 6.8. Leave-one-out analyses in ALSPAC between offspring PRS and high 
risk of maternal reported offspring ADHD symptoms if mother did not drink during 
pregnancy........................................................................................................................ 418 
Appendix 6.9. Leave-one-out analyses in ALSPAC between offspring PRS and high 
risk of teacher reported offspring ADHD symptoms if mother drank during 
pregnancy........................................................................................................................ 419 
Appendix 6.10. Leave-one-out analyses in ALSPAC between offspring PRS and high 
risk of teacher reported offspring ADHD symptoms if mother did not drink during 
pregnancy........................................................................................................................ 420 
Appendix 6.11. Leave-one-out analyses in GenR between offspring PRS and high 
risk of maternal and teacher reported offspring ADHD symptoms if mother drank 
during pregnancy ............................................................................................................ 421 
Appendix 6.12. Leave-one-out analyses in GenR between offspring PRS and high 
risk of maternal and teacher reported offspring ADHD symptoms if mother did not 
drink during pregnancy ................................................................................................... 422 
Appendix 6.13. Leave-one-out analyses in MoBa between maternal PRS and 
maternal reported offspring ADHD symptoms ............................................................... 423 
Appendix 6.14. Leave-one-out analyses in MoBa between offspring PRS and high 
risk of maternal reported offspring ADHD symptoms if mother drank during 
pregnancy........................................................................................................................ 424 
Appendix 6.15. Leave-one-out analyses in MoBa between offspring PRS and high 
risk of maternal reported offspring ADHD symptoms if mother did not drink during 
pregnancy........................................................................................................................ 425 
Appendix 6.16. Associations between maternal PRS and high risk of teacher 
reported offspring ADHD symptoms in ALSPAC ............................................................. 426 
Appendix 6.17. Associations between maternal PRS and high risk of teacher 
reported offspring ADHD symptoms in ALSPAC ............................................................. 427 
Appendix 6.18. Associations between offspring PRS and high risk of teacher 
reported offspring ADHD symptoms in ALSPAC stratified by maternal drinking 
status ............................................................................................................................... 428 
Appendix 6.19. Associations between offspring PRS and high risk of teacher 




Appendix 6.20. Associations between offspring PRS and high risk of teacher 
reported offspring ADHD symptoms in ALSPAC if mother did not drink during 
pregnancy ........................................................................................................................ 430 
Appendix 6.21. Associations between offspring PRS and high risk of maternal and 
teacher reported offspring ADHD symptoms in GenR stratified by maternal 
drinking status ................................................................................................................. 431 
Appendix 6.22. Associations between offspring PRS and high risk of maternal 
reported offspring ADHD symptoms in ALSPAC stratified by maternal drinking 
status ............................................................................................................................... 432 
Appendix 6.23. Associations between offspring PRS and high risk of teacher 
reported offspring ADHD symptoms in ALSPAC stratified by maternal drinking 
status ............................................................................................................................... 433 
Appendix 6.24. Associations between offspring PRS and high risk of maternal 
reported offspring ADHD symptoms in MoBa stratified by maternal drinking status ... 434 
Appendix 6.25. Associations between offspring PRS and high risk of maternal and 
teacher reported offspring ADHD symptoms in GenR .................................................... 435 
Appendix 6.26. Associations between offspring PRS and high risk of maternal 
reported offspring ADHD symptoms in ALSPAC if mother drank during pregnancy ...... 436 
Appendix 6.27. Associations between offspring PRS and high risk of maternal 
reported offspring ADHD symptoms in ALSPAC if mother did not drink during 
pregnancy ........................................................................................................................ 436 
Appendix 6.28. Associations between offspring PRS and high risk of teacher 
reported offspring ADHD symptoms in ALSPAC if mother drank during pregnancy ...... 437 
Appendix 6.29. Associations between offspring PRS and high risk of teacher 
reported offspring ADHD symptoms in ALSPAC if mother did not drink during 
pregnancy ........................................................................................................................ 437 
Appendix 6.30. Associations between offspring PRS and high risk of maternal 
reported offspring ADHD symptoms in MoBa if mother drank during pregnancy ......... 438 
Appendix 6.31. Associations between offspring PRS and high risk of maternal 
reported offspring ADHD symptoms in MoBa if mother did not drink during 






List of Abbreviations 
ADHD Attention-deficit hyperactivity disorder 
ADH Alcohol dehydrogenase 
ALDH Aldehyde dehydrogenase 
ALSPAC Avon Longitudinal Study of Parents and Children 
ARND Alcohol-related neurodevelopmental disorder 
ASD Autism spectrum disorder 
ASRS Adult ADHD Self-Report Scale 
AUDIT Alcohol Use Disorders Identification Test 
BMI Body mass index 
CBCL Child Behavior Checklist 
CCEI Crown-Crisp Experiential Index 





CIDI Composite International Diagnostic Interview 
CIS-R Revised Clinical Interview Schedule 
CNV Copy number variants 
CPRS-R Revised Conners’ Parent Rating Scale 
CSE Certificate of Secondary Education 
DAG Directed acyclic graph 
DALY Disability-adjusted life years 
DAWBA Development And Well-Being Assessment 
DISC Diagnostic Interview Schedule for Children 
DNA Deoxyribonucleic acid 
DOHaD Developmental Origin of Health and Disease 
DSM Diagnostic and Statistical Manual of Mental Disorders 
EPDS Edinburgh Postnatal Depression Scale 
FAS Fetal alcohol syndrome 
FASD Fetal alcohol spectrum disorder 
GB Great Britain 
GCSE General Certificate of Secondary Education 




GSCAN GWAS and Sequencing Consortium of Alcohol and Nicotine use 




Haplotype Reference Consortium 
Centre National de Genotypage 
European descent 
IBD Identity by decent 
ICD International Classification of Disease 
ID Identity 
IPIP International Personality Item Pool 
IPSM Interpersonal Sensitivity Measure 
IQ Intelligence quotient 
K-SADS Schedule for Affective Disorders and Schizophrenia 
KSP Karolinska Scale of Personality 
MAF Minor allele frequency 
MAGIC Missouri Assessment of Genetics Interview for Children 
MEC Medical Ethical Committee 
MeSH Medical subject headings 
MoBa Den norske mor, far og barn-undersøkelsen (Norwegian Mother, Father and child 
Cohort) 
MOOSE Meta-analyses of observational studies in epidemiology 
MR Mendelian Randomization 
MRI Magnetic resonance imaging 
MZ Monozygotic twins 
NHS National Health Service 
NOS Newcastle-Ottawa Scale 
ODD Oppositional-defiant disorder 
OR Odds ratio 
PAE Prenatal alcohol exposure 
PAPA Preschool Age Psychiatric Assessment 
PC Principal components 
PCA Principal components analysis 
PheWAS Phenome-Wide Association Study 
PLIKS Psychosis-like symptoms 




PROSPERO International prospective register of systematic reviews 
PRS Polygenic risk score 
QC Quality control 
RS-DBD Rating Scale for Disruptive Behavior Disorders 
SCL Hopkins Symptoms Checklist 
SD Standard deviation 
SDQ Strengths and Difficulties Questionnaire 
SEM Structural equation models 
SMFQ Short Mood and Feelings Questionnaire 
SNiPA Single nucleotide polymorphisms annotator 
SNP Single nucleotide polymorphism 
SWAN Strengths and Weaknesses of ADHD symptoms and Normal Behavior Scale 
TR Teacher report 




United States of America 
WISC Wechsler Intelligence Scale 
YLD Years lived with disability 






Chapter 1 INTRODUCTION 
1.1 THESIS OVERVIEW 
In this thesis, my main aim is to investigate whether there is a causal effect 
of maternal smoking, alcohol and caffeine use during pregnancy on 
attention-deficit hyperactivity disorder (ADHD) risk in offspring. I used both 
observational and genetic analyses to examine this relationship using data 
from three longitudinal birth cohorts: the Avon Longitudinal Study of 
Parents and Children (ALSPAC), the Generation R (GenR) and the Norwegian 
Mother, Father and Child Birth Cohort (MoBa). 
 
My thesis presents first the epidemiology and genetics of ADHD, 
environmental risk factors associated with ADHD, an overview of maternal 
prenatal substance use, and approaches used in causal inference research 
(Chapter 1). In Chapter 2, I present my systematic review of associations 
between maternal smoking, alcohol and caffeine use during pregnancy and 
externalising disorders: ADHD, conduct disorder (CD) and oppositional-
defiant disorder (ODD) in offspring. Chapter 3 focuses on the ALSPAC, GenR 
and MoBa data, presenting a narrative overview, descriptive statistics and 
comparison of cohorts analysed. Chapter 4 presents the phenome-wide 
association study method in the context of my research questions, and 
presents results using this approach based on data from ALSPAC. Chapter 5 
focuses on ADHD phenotypes in more detail, and I present results using a 
negative control method and polygenic risk score (PRS) analyses based on 
Mendelian Randomization (MR) framework. Chapter 6 explores the 
association between maternal prenatal alcohol exposure and ADHD in 
offspring by using genetic variants from alcohol metabolising genes as 
proxies for fetal alcohol exposure. The thesis ends with a discussion 
(Chapter 7) summarising findings from the different studies included, 
interpreting them in light of their strengths and limitations and in the 





1.2 EPIDEMIOLOGY OF ADHD 
1.2.1 Prevalence of ADHD 
ADHD is a common neurodevelopmental disorder characterised by 
excessive levels of hyperactivity and inattention. Although prevalence 
estimates vary, it has been reported that on average ADHD affects 5-8% of 
school aged children (up to 18 years) across different countries (Faraone et 
al., 2003; Polanczyk et al., 2007; Polanczyk et al., 2014). Variation in the 
prevalence estimates is mostly dependent on which classification system 
and assessment methods were used for measuring ADHD symptoms. For 
example, studies that have used self-reported ratings have estimated the 
global prevalence among 3- to 18-year-olds to be 6-7% (Polanczyk et al., 
2007; Willcutt, 2012). Alternatively, studies using a multi-informant 
procedure have reported the global prevalence among 5-19-year olds to be 
2.2% (Erskine et al., 2013). ADHD is an early onset disorder, and the highest 
prevalence has been reported among preschool and elementary school 
samples (10-11 %) (Willcutt, 2012). Although ADHD symptoms decrease 
with age, approximately 15% of those diagnosed in childhood show 
persistent symptoms of ADHD also in adulthood (Faraone et al., 2006).  
1.2.2 Gender effects of ADHD 
Furthermore, it has been reported that ADHD is more prevalent among 
boys than girls (Gaub and Carlson, 1997).  A study in the UK found that boys 
were five times more likely to get an ADHD diagnosis than girls (O'Leary et 
al., 2014). Similarly, another study in the UK showed that between 2004 
and 2013 the ADHD incidence rate per 10,000 person years at risk was 
higher among boys up to the age of 15 years and the rate becomes more 
equal in late adolescence (16-18 years) (Hire et al., 2018). See Figures 1.1 
and 1.2.  
 
However, it has been suggested that girls may be underdiagnosed because 
of the way symptoms are expressed and due to referral bias (Biederman et 
al., 2002). Compared with boys, girls with ADHD present more inattention 




symptoms, and therefore ADHD diagnosis in girls may be underestimated 
(Biederman et al., 2005; Gershon, 2002). 
Figure 1.1. ADHD incidence rates in UK per 10,000 person 
years at risk in the years 2004-2013. Copyright Hire et al., 2018  
 
Figure 1.2. ADHD incidence rate by age of diagnosis.  






1.2.3 Symptoms and diagnostic criteria of ADHD 
According to the current Diagnostic and Statistical Manual of Mental 
Disorders, 5th edition (DSM-5) (American Psychiatric Association, 2013) at 
least six symptoms either in the inattention or hyperactive-impulsive 
domains must be present for six months in two or more settings to meet 
the diagnosis of ADHD (Levy, 2014). A key element in diagnosing children 
with ADHD is to assess symptoms in different settings, usually at home and 
school. Very often ADHD inattention symptoms are more visible in 
structured settings, such as schools and therefore information from 
teachers is essential for ADHD assessment (Willcutt, 2012).  
 
ADHD symptoms according to the DSM-5 (Gallo and Posner, 2016) include: 
 
Inattention symptoms 
• Fails to give close attention to details or makes careless mistakes in 
schoolwork, work or during other activities. 
• Has difficulty sustaining attention in tasks or play activities. 
• Does not seem to listen when spoken to directly. 
• Does not follow through on instructions and fails to finish 
schoolwork, chores, or duties in the workplace. 
• Has difficulty organising tasks and activities. 
• Avoids or is reluctant to engage in tasks that require sustained 
mental effort. 
• Often loses things necessary for tasks or activities. 
• Easily distracted by extraneous stimuli or thoughts. 
• Is often forgetful in daily activities. 
 
Hyperactive-impulsive symptoms 
• Fidgets with or taps hands or squirms in seat. 
• Leaves seat in situations when remaining seating is expected. 
• Runs about or climbs, or is restless in situations where it is 
inappropriate. 
• Unable to play or engage in leisure activities quietly. 




• Talks excessively. 
• Blurts out answers before questions have been completed. 
• Has difficulty awaiting turn. 
• Interrupts or intrudes on others. 
 
Compared with DSM-IV, the major changes in the DSM-5 ADHD 
classification relate to moving the diagnosis from a disruptive behaviour 
disorders group to neurodevelopmental disorders, expanding the 
symptoms descriptions for adolescents and adults, changing the age of 
onset from 7 years to 12 years, and lowering the threshold from six to five 
symptoms in adults (Doernberg and Hollander, 2016; Gallo and Posner, 
2016; Sibley and Kuriyan, 2016).  
 
In the UK, the International Classification of Disease, 11th Revision (ICD-11) 
is used for diagnosing mental health disorders. Compared with the previous 
version (ICD-10), ADHD has been moved from the hyperkinetic disorders to 
the grouping of neurodevelopmental disorders, as it is classified in the DSM 
diagnostic system in order to make the DSM and ICD classification systems 
more comparable (Doernberg and Hollander, 2016; Reed et al., 2019). Both 
disease classification systems describe ADHD by the most dominant 
symptom type: inattentive, hyperactive-impulsive or combined (Reed et al., 
2019).  
 
Studies have shown that the ADHD inattentive subtype is the most 
prevalent subtype in children, adolescents, and adults, but not pre-school 
children where the hyperactive-impulsive subtype is more common 
(Willcutt, 2012). Further, hyperactive-impulsive symptoms have been 
shown to decline with age (Biederman et al., 2000) and the inattention 
subtype is more likely to persist into adulthood (Kessler et al., 2010). The 
main difficulty in diagnosing children with ADHD is that inattention and 
hyperactive-impulsive symptoms are also somewhat age-appropriate 
behaviours. It can therefore be challenging to differentiate when these 





Several studies have also indicated that ADHD symptoms are continuously 
distributed, and ADHD diagnosis occurs at the extreme end of the 
continuum (Thapar and Lewis, 2009). It has been argued that a categorical 
approach, such as a clinical diagnosis, is useful when deciding whether a 
child should receive a medication or not. On the other hand, a dimensional 
approach would allow the course and severity of disorder symptoms to be 
tracked more closely (Rutter, 2003). For example, it has been shown that 
ADHD inattention symptoms exist on a severity continuum, and therefore 
treatment of ADHD should focus on decreasing the symptoms from a 
pathological level to a nonpathological level, rather than to the absence of 
the disorder (Lubke et al., 2009). In other words, ADHD can be defined 
either in a categorical or a dimensional way. In this thesis I used both a 
measure of diagnosis (Chapter 2) and dichotomised symptoms score 
(Chapter 5 and 6).  
1.2.4 Comorbidities and impairment 
ADHD has a high comorbidity with other psychiatric conditions (Angold et 
al., 1999). The most common comorbid disorders are ODD and CD 
(Biederman et al., 1991; Kadesjo and Gillberg, 2001), but internalising and 
other mental health conditions are also prevalent among children with 
ADHD (Gillberg et al., 2004). For example, Biederman and colleagues (1991) 
have shown that up to 50% of children with ADHD also meet criteria for CD 
or ODD. In addition, ADHD often co-occurs with autism spectrum disorders 
(ASD). One study showed that 13% of children diagnosed with ADHD also 
have accompanied ASD symptoms which is higher among young children 
aged 4 to 11 years (Zablotsky et al., 2020). Other studies have reported that 
co-occurrence of ADHD symptoms in individuals with ASD is between 30 to 
50% (Leitner, 2014).  
 
Importantly, children with ADHD are also more likely to experience 
difficulties at school. Several studies have indicated that children with 
ADHD have lower academic performance and lower grades (DuPaul et al., 
2016; Loe and Feldman, 2007), and therefore children with ADHD are at 




in the job market (Erskine et al., 2016; Fredriksen et al., 2014). It is also 
widely reported that ADHD is a risk factor for later substance use (Charach 
et al., 2011). Several studies have shown associations between ADHD, 
smoking initiation, alcohol, and other substance use (Biederman et al., 
2006; Osland et al., 2017). 
 
Besides mental health impairment, deficits have been noted in children 
with ADHD in their cognitive and social skills, as well as in emotion 
regulation (Gardner and Gerdes, 2015). For instance, studies have reported 
that children with ADHD face more difficulties in peer relationships and 
very often they fail to understand the social cues needed for reciprocal 
interaction (Hoza, 2007; Sibley et al., 2010). Additionally, impulsive 
behaviour can be aversive for peers and therefore children with ADHD are 
often left out from groups (Hoza et al., 2005). Although ADHD is more 
commonly diagnosed among boys, studies on girls with ADHD have shown 
that girls have at least a similar degree of social difficulties as boys 
(Blachman and Hinshaw, 2002; Ragnarsdottir et al., 2018). 
 
To conclude, ADHD is a complex disorder with a high comorbidity with 
other mental health conditions as well as impairments in various everyday 
life domains. 
1.2.5 Societal impact 
Besides the negative impact of ADHD on children’s mental health and 
quality of life, a large body of research has described a considerable 
economic burden of ADHD for society as a whole. Studies have shown that 
ADHD has both direct and indirect costs, affecting educational attainment, 
risk behaviours and usage of social and health care systems (Sayal et al., 
2018).   
 
In the UK, the National Health Service (NHS) costs for ADHD were an 
estimated £23 million for initial assessment and £14 million annually to 
further specialised care in 2006 (King et al., 2006). Another study reported 




were estimated at £670 million with the highest costs in the education 
system (Telford et al., 2013). Furthermore, a cohort study in the UK found 
that children with ADHD had a higher rate of contacts with police and 
criminal justice system (Ford et al., 2008). Additionally, longitudinal studies 
have shown that ADHD in childhood is associated with lower levels of 
employment and income at age 30 years (Gordon and Fabiano, 2019; Knapp 
et al., 2011). According to the Institute for Health Metrics & Evaluation 
report in 2012, the global burden of ADHD in disability-adjusted life years 
(DALYs) was 491,500 and ADHD was the 98th leading cause of years lived 
with disability (YLDs) for individuals across the age groups. The global 
burden was even higher for males and those with comorbid conduct 
disorder (Erskine et al., 2014). Figure 1.3 shows global DALYs of ADHD up to 
age 49 years in males and females with the highest burden in males at age 
10-14. 
Figure 1.3. Global years lived with disability: disability‐adjusted life years 
(DALYs) (in 1000 s) of attention‐deficit/hyperactivity disorder for males and 
females from ages 0 to 49 years. Copyright Erskine et al. 2014 
 
 
Costs are also high with another highly comorbid neurodevelopmental 
disorder – ASD. It has been reported that in 2010 global prevalence of ASD 
was 2.4 per 1000 (Baxter et al., 2015). A study in the UK based on the 




found that prevalence of ADHD among 6 to 8 years in 2008-2009 was 1.4% 
and in ASD 1.7% (Russell et al., 2014). Furthermore, in children age 5 to 14 
years ASD was the 4th leading cause of disability out of mental health 
disorders and accounted 7.7 million DALYs globally in 2010 (Baxter et al., 
2015). Considering that ADHD symptoms decrease within age, ASD has 
shown to be persistent over the life course (Baxter et al., 2015; Faraone et 
al., 2006) and therefore can cause higher burden than ADHD. However, 
given the high comorbidity between ADHD, risk taking behaviour and 
substance use, as well as higher risk of treatment discontinuation in 
adolescents and young adults (McCarthy et al., 2009; Zulauf et al., 2014), 
there may be substantial indirect costs of ADHD which may be difficult to 
estimate.  
1.3 GENETIC DETERMINANTS OF ADHD 
1.3.1 Heritability of ADHD 
Heritability is an estimate of the proportion of variation in a trait in the 
population that is explained by genetic variance (Visscher et al., 2008). 
Heritability can be defined as broad-sense which captures the proportion of 
a trait variation due to the additive and non-additive genetic effects (such 
as interactions between alleles at the same locus or different loci (called 
“epistasis”)), and narrow-sense which captures the proportion of a trait 
variation due to the additive genetic effects (Rijsdijk and Sham, 2002; Wray 
and Visscher, 2008).  
 
ADHD is a highly heritable disorder with a narrow-sense heritability 
estimate of around 76% in both children and adults in White European 
populations (Faraone et al., 2005). The evidence for these estimates comes 
mostly from twin studies, which rely on the difference in rates of ADHD 
between monozygotic twin pairs who are genetically identical and dizygotic 
twin pairs who share 50% of their  genotypes on average (Faraone and 
Larsson, 2019). Twin and family studies have shown that ADHD runs in 
families (Faraone and Doyle, 2001; Faraone and Larsson, 2019; Rietveld et 
al., 2003) and the genetic risk is higher for ADHD persistence into adulthood 




2017; Franke et al., 2012). Similarly, adoption studies have shown that 
ADHD rates are higher among biological relatives of ADHD probands than 
adoptive relatives of adopted ADHD probands (Alberts-Corush et al., 1986; 
Sprich et al., 2000).  
 
Evidence for strong additive genetic effects is consistent regardless of 
whether ADHD has been measured with maternal and/or teacher report or 
as a clinical diagnosis (Larsson et al., 2014; Saudino et al., 2005). 
Furthermore, twin studies have found that although there is a substantial 
genetic overlap between hyperactive-impulsive and inattention subtypes of 
ADHD, independent genetic effects also exist in these symptom domains 
(Larsson et al., 2006; McLoughlin et al., 2007). It has been reported that the 
narrow-sense heritability of the hyperactive-impulsive subtype is higher 
(about 71%) compared with the inattention subtype (about 56%) (Nikolas 
and Burt, 2010). 
1.3.2 SNP-based heritability 
Heritability can also be estimated based on single nucleotide 
polymorphisms (SNPs) that are captured by microarrays used in genome-
wide association studies (GWASs). Recent GWAS has shown the estimate to 
be about 22% (Demontis et al., 2019). SNP-based heritability comes from a 
GWAS where the entire genome is examined in individuals to discover 
common genetic risk variants associated with a trait or disease of interest 
(Grimm et al., 2020; Yang et al., 2017). Common genetic variants occur in 
more than 1% of the population but normally have a small effect on a trait. 
Genetic variants that occur in less than 1% of the population are sometimes 
called rare variants (e.g., copy number variants (CNV)); these can have a 
bigger effect on a trait and/or to gene function compared with a common 
genetic variant (Bomba et al., 2017; Palladino et al., 2019). 
 
The largest GWAS to date with 20,000 ADHD cases and 35,000 controls 
found 12 independent genome-wide significant (p<5x10-8) loci associated 
with ADHD diagnosis which explained 5.5% of ADHD trait variation. These 




and have been found to be associated with educational attainment, speech 
problems and depression (Demontis et al., 2019).  
 
One of the reasons why there is such a big gap in narrow-sense heritability 
estimates based on twin and GWAS could be that the narrow-sense 
heritability cannot be explained fully by common genetic variants captured 
by the GWAS arrays and also rare variants and other DNA variants may play 
a role in ADHD heritability (Manolio et al., 2009). A recent study on children 
with ADHD diagnosis identified some rare genetic variants (CNV) but none 
of these CNV overlapped with genes which were discovered in the recent 
GWAS of ADHD (Martin et al., 2020). Other studies have confirmed high 
CNV burden among individuals with ADHD, but also genetic overlap with 
other neurodevelopmental disorders (such as autism and Tourette 
syndrome) have been reported (Chawner et al., 2019; Palladino et al., 
2019).  
1.3.3 Polygenic risk scores 
The discovery of multiple signals in GWAS have made it possible to 
aggregate these genetic variants into polygenic risk scores (PRSs). PRSs are 
calculated by summing risk alleles carried by an individual and weighting by 
the effect estimates detected in the GWAS. PRSs identify individuals with 
higher genetic liability for the disorder and could be used as a tool for 
genetic risk prediction (Torkamani et al., 2018). For example, it has been 
reported that PRSs derived from a general population sample predicted 
ADHD diagnosis and symptom severity in a clinical sample (Stergiakouli et 
al., 2015). Additionally, PRSs derived from a clinically diagnosed ADHD 
population predicted ADHD traits in general population (Martin et al., 
2014). 
 
Moreover, GWASs have also revealed the high polygenic nature of 
psychiatric disorders (Geschwind and Flint, 2015). Several studies have 
reported genetic correlation between ADHD and autism spectrum 
disorders, as well as with schizophrenia, bipolar disorder and depression 




strong genetic correlation has been found between ADHD and educational 
outcomes, IQ, BMI and smoking behaviour (Demontis et al., 2019). These 
findings highlight the complex nature of ADHD and shared genetic basis 
with other psychiatric disorders and behavioural traits.  
 
In addition, studies have shown that although genetic liability for a disorder 
is fixed at conception, expression of genetic risk for a disorder depends on 
interaction with environmental exposures (Lewis and Vassos, 2020). It has 
been also shown that genetic nurturing, where genetic risk for a disorder 
could be mediated by the environment parents create for their children can 
affect offspring behavioural traits (Kong et al., 2018).   
1.4 ENVIRONMENTAL DETERMINANTS OF ADHD 
As described above, there is strong evidence for genetic factors playing a 
role in ADHD development, and the heritability of ADHD remains stable at 
different developmental stages (Chang et al., 2013). However, the role of 
environmental factors cannot be dismissed. Twin and adoption studies have 
shown that approximately 10-19% of the variance within childhood 
externalising disorders (CD, ODD, disruptive behaviour problems) could be 
accounted for by shared environmental influences among siblings (Burt, 
2009). However, in ADHD aetiology shared environmental factors between 
siblings seem to have a less substantial role, indicating that non-shared 
environmental factors and/or gene-environment interaction may 
contribute to the risk of ADHD (Burt, 2009; Faraone et al., 2015). For 
example, some studies have observed gene-environment interactions in 
children with ADHD whose mothers were smoking and consuming alcohol 
during pregnancy (Brookes et al., 2006; Neuman et al., 2007).  
 
There is a large body of research also reporting that maternal pregnancy 
and labour complications, as well as infancy complications, such as low 
birth weight and prematurity are risk factors for ADHD (Halmoy et al., 2012; 
Sciberras et al., 2017; Silva et al., 2014). In addition, maternal postnatal risk 




maltreatment and emotional trauma may affect the development of ADHD 
(Gonzalez et al., 2019; Mulraney et al., 2019; Russell et al., 2016). 
 
Several studies have identified many prenatal risk factors that have been 
found to be associated with ADHD, such as maternal prenatal exposure to 
environmental toxins, and antenatal stress (Banerjee et al., 2007; Talge et 
al., 2007). Further, recent systematic reviews and meta-analyses indicated 
that maternal prenatal smoking is associated with higher risk for ADHD (He 
et al., 2020; Huang et al., 2018) but research of the effects of prenatal 
alcohol and caffeine consumption is less conclusive (Del-Ponte et al., 2016; 
Porter et al., 2019). As prenatal smoking, alcohol and caffeine use are the 
focus of this thesis, I will describe studies investigating associations 
between these maternal prenatal substances and ADHD in offspring more 
in detail in the following chapters, starting with a comprehensive 
systematic review in Chapter 2.  
 
In terms of how robust the evidence base is, it is worth pointing out that it 
remains difficult to disentangle prenatal effects from postnatal effects (such 
as maternal postnatal mental health, substance use and parenting 
behaviour) and draw conclusions on the relative importance of each in 
contributing to ADHD development. 
1.4.1 Harms of prenatal substance use 
The Developmental Origin of Health and Disease (DOHaD) hypothesis 
suggests that early fetal life is a sensitive period and developmental risk 
factors during this time can cause negative health outcomes in later life 
(O'Donnell and Meaney, 2017). For example, it has been also suggested 
that maternal early life stress and nutrition can have a negative effect on 
offspring neurodevelopmental outcomes (Bale et al., 2010).  
 
Although the majority of research on the teratogenic effects of prenatal 
substance use comes from animal studies, human studies have also 
confirmed the harmful effects of nicotine and alcohol on the developing 




cortex is generated, and the majority of adult neurons are produced 
(Holbrook, 2016; Lambers and Clark, 1996; Rajesh, 2012). Early nicotine and 
alcohol exposure have been found to influence this maturation process, 
and can therefore cause various health risks for the fetus (Blood-Siegfried 
and Rende, 2010; Rajesh, 2012). The most vulnerable period to the fetus’s 
brain development is the third trimester as during this time brain 
development is the most rapid and the likelihood for damage is the greatest 
(Richter and Richter, 2001). Adverse effects of heavier prenatal smoking 
and alcohol use have been well documented for a range of birth outcomes, 
such as low birth weight, preterm birth, miscarriage, increased infant 
mortality, as well as on neurobehavioral deficits in later childhood 
development (Forray, 2016). However, evidence is inconsistent for the 
effects of low to moderate prenatal alcohol consumption on child health 
outcomes (Mamluk et al., 2016; Mamluk et al., 2020). Research also 
indicates that adverse effects are dependent on the frequency, quantity 
and timing of substance use (Brand et al., 2019; Cluver et al., 2019; Richter 
and Richter, 2001).  
 
Research on teratogenic effects of caffeine in humans is less conclusive but 
evidence from animal studies has shown that caffeine also affects fetal 
brain development (Silva et al., 2013). It has been reported that high 
maternal caffeine intake can have an effect on negative birth outcomes, but 
evidence is weaker for harmful effects of caffeine intake less than 300 
mg/day (Temple et al., 2017). Given that caffeine consumption is also 
associated with smoking it may be difficult to disentangle specific effects of 
caffeine from smoking (Treur et al., 2016).  
 
Therefore, it remains unclear whether low to moderate level prenatal 
substance use has a harmful effect on offspring mental health outcomes 
and in particular ADHD risk. Testing the DOHaD hypothesis is particularly 
difficult because it is not possible to use randomised control designs in 
pregnancy exposures (D'Onofrio et al., 2014). Furthermore, given the 




it is important to address both genetic and environmental factors which 
may confound the association between the exposure and outcome.  
1.4.2 Comorbidity of prenatal substance use 
Several studies have found that prenatal smoking and alcohol use often co-
occur (Lange et al., 2015; Stotts et al., 2003), and smoking behaviour 
(smoking initiation and smoking heaviness) is highly correlated with higher 
caffeine consumption (Treur et al., 2016).  
 
Furthermore, it has been shown that using multiple substances is more 
common among women who are younger and with more disadvantaged 
social backgrounds (in terms of social class, education, and income) (Liu and 
Mumford, 2017; Powers et al., 2013). Pirie and colleagues (Pirie et al., 2000) 
found that pregnant women with low-income who used multiple 
substances (tobacco smoking, alcohol, and caffeine) were less likely to quit 
substance use compared with women who used only one substance. The 
same study also found that pregnant women who continued smoking were 
eight times more likely to drink alcohol during pregnancy and consumed 
more caffeine comparing with non-smokers.  
 
Research suggests that there is a similarity between the withdrawal 
symptoms of caffeine and nicotine, as well as increases in fatigue and 
headaches among those stopping both substances simultaneously, which 
could be one of the reasons why some women may find it difficult to quit 
both of these substances at the same time (Swanson et al., 1994; Swanson 
et al., 1997). Furthermore, it has been reported that women who continue 
with substance use during pregnancy suffer more mental health problems 
like depression and anxiety and their perceived self-worth is lower (Massey 
et al., 2011). Therefore, failure to quit multiple substance use during 
pregnancy may be associated with environmental, physiological, and 
psychological factors. In addition, consumption of multiple substances 
during pregnancy may have a stronger effect on offspring health outcomes. 




and illicit drugs accounted for the association between prenatal alcohol 
exposure and offspring attention problems (D'Onofrio et al., 2007).  
 
However, because of co-occurrence of multiple substances confounding 
factors can differ between those individuals who use only one substance 
from those who use multiple substances. Therefore, it is difficult to 
disentangle specific effects of each substance. 
1.4.3 Burden of maternal prenatal substance use 
Current guidelines, both in the UK and internationally, advise pregnant 
women not to smoke and drink alcohol when trying to become pregnant, 
and to stop if pregnancy is confirmed (Department of Health, 2016; 
National Institute for Health and Care Excellence, 2010). The current 
guidelines on caffeine consumption recommend limiting daily caffeine 
consumption and keeping it less than 200 mg a day (Agostoni et al., 2015; 
Insitute of Medicine, 2014) which is equivalent to one cup of strong coffee, 
two cups of instant coffee or three cups of tea. 
 
Although there is substantial evidence of negative health outcomes of 
prenatal substance use on the developing fetus and later childhood 
outcomes, prenatal substance use continues to be one of the major public 
health problems. The global prevalence of smoking during pregnancy was 
estimated to be 1.7% and with the highest rate in the European Region 
(Lange et al., 2018). In the UK in 2018/2019, the prevalence of smoking in 
the general population was 15% and among pregnant women at the time of 
delivery it was 11%. Although comparing with the year 2008/2009 the rate 
has gone down by 4%, a substantial proportion of women continue smoking 
during pregnancy. 
 
The global prevalence of consuming any amount of alcohol during 
pregnancy in the general population was estimated to be 9-11%. However, 
the prevalence of alcohol use during pregnancy varies across countries and 
is reported to be higher in European countries compared with Middle 




UK has the fourth highest estimated prevalence (41%) of prenatal alcohol 
use worldwide. Another study found that 79% of women in the UK drink 
during pregnancy and 33% at binge levels (O'Keeffe et al., 2015). 
 
The prevalence of coffee consumption also varies worldwide (Temple et al., 
2017). Nordic countries, such as Finland and Sweden have one of the 
highest coffee consumption levels (reported on average as 205-236 
mg/day), whereas in the UK the average caffeine consumption per day is 
about 130 mg/day (DePaula and Farah, 2019; Fitt et al., 2013). Prenatal 
caffeine consumption is still an under-researched area and currently there 
are limited data about the prevalence of caffeine consumption during 
pregnancy. One cohort study in the USA reported that the majority of 
women stopped or decreased their caffeine consumption after pregnancy 
recognition (Chen et al., 2014). The same study also found that mothers 
who smoked were less likely to stop their caffeine consumption (from 
coffee, tea and soft drinks), whereas prenatal alcohol consumption did not 
have a similar effect.  
 
Negative health outcomes of prenatal substance use not only impact 
individuals; they are also costly for the social, health and education sector. 
A study in the UK found that maternal smoking in pregnancy was associated 
with increased health-care costs during the first five years of a child’s life 
(Vaz et al., 2018). Furthermore, according to Public Health England, in the 
general population alcohol was the leading risk factor for ill-health, early 
mortality and disability. The public health burden of alcohol is not only 
causing costs to health care, social and criminal justice sector but is also 
related to indirect costs such as lost or decreased productivity, 
unemployment and impact to other people (Public Health England, 2016).  
 
In addition, prenatal alcohol consumption increases the risk of fetal alcohol 
spectrum disorder (FASD). FASD is an umbrella diagnosis that includes 
several conditions affected by prenatal alcohol exposure, such as fetal 
alcohol syndrome (FAS), partial FAS and alcohol-related 




there is a high comorbidity and overlap in symptom presentation between 
FASD, ADHD and disruptive behaviours (Mattson et al., 2019; Popova et al., 
2016). This further complicates differential diagnoses of FASD and ADHD, 
and some have questioned whether we are in the presence of co-occurring 
separate symptomatology (comorbidity), as opposed to different aspects of 
the same neurodevelopmental spectrum (Peadon and Elliott, 2010).  
 
It has been reported that in the UK the prevalence of FASD in the general 
population was 61.3 cases per 10,000 and globally more than 11 million 
individuals up to age 18 years in the general population have FASD (Popova 
et al., 2017). This further indicates a high burden of prenatal alcohol 
exposure. However, given that FASD is largely undiagnosed in the UK health 
care system, actual costs related to FASD may be underestimated (Popova 
et al., 2012). 
1.5 CAUSAL INFERENCE RESEARCH 
1.5.1 Observational studies 
Observational studies (e.g., cross-sectional, case-control, longitudinal 
cohort studies) have shown associations between maternal prenatal 
smoking, alcohol and caffeine use and behavioural problems in offspring 
(Easey, Dyer, et al., 2019; Huang et al., 2018; Mikkelsen et al., 2017). 
However, observational study designs and methods are subject to 
limitations such as the difficulty in identifying all the possible confounders 
(unmeasured confounding), as well as how selected confounders were 
assessed (measurement error leading to residual confounding), meaning 
that observed results may be biased (Davey Smith and Ebrahim, 2002; Gage 
et al., 2016). In reality it is impossible to measure all the confounders and 
measurement error can never be ruled out. Furthermore, several studies 
have measured prenatal substance use retrospectively, which may 
introduce recall bias (Gorber et al., 2009; Leviton, 2018). In addition, studies 
based on small sample sizes may yield positive association because of 
chance, and publication bias in the literature may appear when the majority 





Another limitation in observational studies is reverse causation as in some 
instances it might be difficult to ascertain whether the outcome itself can 
have a direct effect on the exposure. However, availability of data from 
longitudinal birth cohorts can help to deal with the problems with reverse 
causation. Prospective data collection, where exposures have been 
measured before the outcome, can strengthen the evidence base for 
causality (Richmond et al., 2014). Still, the limitations with unmeasured 
confounding remain. Additionally, selection bias in how the study 
participants were selected, as well as differences in data collection and loss 
to follow-up can bias exposure-outcome associations (Munafò et al., 2018).  
 
Therefore, considering these limitations, observational studies cannot fully 
confirm causality but combined with multiple methods as part of a 
triangulation approach (see paragraph 1.5.4 “Triangulation in Causal 
Inference”), can provide more support as to whether a causal effect exists. 
It has been emphasised that data integration using multiple approaches is 
the key criterion for causal inference research (Fedak et al., 2015).  
1.5.2 Quasi-experimental designs 
Quasi-experimental designs (such as twin designs, negative control, and 
sibling comparison) have been suggested as useful approaches to establish 
stronger causal inference. This is because these studies strive to compare 
‘like with like’ groups of individuals by, at least to some extent, accounting 
for both environmental and genetic confounding (D'Onofrio et al., 2020). I 
will discuss these designs more in detail in Chapter 5. Studies based on 
negative control and sibling comparison designs have provided stronger 
evidence that the association between maternal smoking during pregnancy 
and ADHD in offspring is likely not to be causal and may instead be 
explained by confounding (Gustavson et al., 2017; Skoglund et al., 2014). 
Currently there are fewer quasi-experimental studies investigating the 
effects of prenatal alcohol exposure on ADHD in offspring and one such 
study did not find strong evidence for a causal effect, whereas the other 
study suggested a weak effect (D'Onofrio et al., 2007; Eilertsen et al., 2017). 




have examined the effects of prenatal caffeine exposure on ADHD in 
offspring.   
1.5.3 Mendelian Randomization (MR) 
As an alternative to the conventional observational study designs, and 
another example of a quasi-experimental design, is the use of proxy genetic 
variants. For example, genetic variants which have been found to be 
associated with an exposure of interest in a GWAS can be used as a non-
confounded proxy or predictor for measuring exposure-outcome 
associations (Richmond et al., 2014). Mendelian Randomization (MR) is one 
such method that uses genetic variants associated with the modifiable risk 
factor as a proxy for that exposure to test for a causal effect on the 
outcome (Davey Smith and Ebrahim, 2004). However, three main 
assumptions need to be met before conducting MR (Davies et al., 2018): 1) 
the relevance assumption states that genetic variants are associated with 
the exposure of interest; 2) the independence assumption states that there 
is no common cause with the outcome (e.g., no confounding); and 3) the 
exclusion restriction assumption states that genetic variants do not affect 
the outcome directly other than via the exposure.  
 
The advantages of MR compared with the observational study designs are 
that genetic variants should not be affected by confounders or reverse 
causation, are much less affected by measurement error and very rarely 
does reverse causation come into play (Davey Smith and Ebrahim, 2004).  
 
Although MR has become a popular method in many settings investigating 
population health and disease aetiology, including when investigating 
intrauterine exposures, some limitations should be acknowledged, mainly 
in the form of biases occurring whenever the three core assumptions are 
not satisfied. First, MR studies may suffer from low statistical power as 
genetic variants explain a small proportion of the variance in a trait. Second, 
disease risks may differ in different ethnic populations and therefore may 
induce confounding due to genetic ancestry. Third, pleiotropy may be 




directly and not via the exposure (Davey Smith and Ebrahim, 2004; 
Richmond et al., 2014).  
1.5.4 Triangulation in causal inference research 
It is widely acknowledged that there is no single method that can enable us 
to draw strong conclusions on causality as each method has their own 
limitations and different source of biases (Lawlor et al., 2016). However, 
combining different methods can help to gain stronger support for a causal 
effect. For example, if different methods are pointing towards results in the 
same direction then stronger conclusions can be made. This is because it is 
unlikely that different methods are biased in the same way. On the 
contrary, if the results differ between different methods used in the study, 
further investigations should be made.  
 
The concept of “triangulation” refers to the integration of different 
approaches within the single or in multiple studies addressing the same 
research question (Lawlor et al., 2016). This is particularly relevant when 
investigating the DOHaD hypothesis. Considering that both environmental 
and genetic confounding can affect the associations between prenatal 
exposures and child outcomes, it is important to address alternative 
hypotheses and apply multiple methods before drawing conclusions on 
causality (D'Onofrio et al., 2014). 
1.6 CHAPTER SUMMARY 
To summarise, even though ADHD is a well-researched topic, there is still 
inconsistency in findings regarding whether the association between 
maternal prenatal smoking, alcohol and caffeine use and ADHD risk in 
offspring is causal. Quasi-experimental studies have shown that the 
association between maternal prenatal smoking and ADHD is likely to be 
confounded, but many of these studies have not examined ADHD subtypes 
separately. In addition, findings are less conclusive on the effects of 
prenatal alcohol and caffeine exposure on ADHD in offspring. Given the 
high public health burden of ADHD, it is crucial to understand causal 




and caffeine consumption during pregnancy are causally associated with 
ADHD symptoms in offspring, these harmful behaviours could be potential 
targets for public health interventions. Moreover, this knowledge can help 
to target children at risk for ADHD and provide interventions at earlier 
stages, in order to reduce or prevent negative outcomes.    
1.7 THESIS FOCUS 
1.7.1 Aims 
The aim of this thesis is to investigate the causal effects of maternal 
smoking, alcohol and caffeine use during pregnancy on risk of ADHD total 
symptoms, as well as separately for hyperactive-impulsive and inattention 
symptom domains in offspring. Triangulating evidence by using systematic 
review method (Chapter 2), observational (Chapter 5) and genetic analyses 
(Chapter 4, 5 and 6) and replicating findings in different cohorts, is the 
essence of this work.  
1.7.2 Methods 
In this thesis, I use different research methods. A systematic review is used 
to find evidence whether a current research support a causal role of 
prenatal smoking, alcohol and caffeine exposures on offspring externalising 
disorders (Chapter 2). A targeted Phenome-Wide Association Study is used 
to observe potential causal and pleiotropic effects of maternal prenatal 
smoking and caffeine consumption on various mental health outcomes in 
offspring (Chapter 4). Negative control and polygenic risk score analyses are 
used to investigate whether there is a causal effect of maternal prenatal 
smoking, alcohol and caffeine use on ADHD risk in offspring (Chapters 5 and 
6). A visual overview of the methodological approach used in this thesis is 
given in Figure 1.4. More details about each method are given in the 




Figure 1.4. Visual overview of the methodological approach 
 
 
Research question: Is the association between maternal prenatal 



















Chapter 2  PRENATAL SMOKING, ALCOHOL AND CAFFEINE 
EXPOSURE AND OFFSPRING EXTERNALISING DISORDERS: A 
SYSTEMATIC REVIEW 
In Chapter 1, I gave an overview of the background and complexities of 
ADHD, as well as described prevalence and harms of prenatal substance 
use. Furthermore, as described in Chapter 1, there is more evidence that 
the association between maternal prenatal smoking and ADHD is likely to 
be confounded, but evidence is inconsistent for the associations with 
alcohol and caffeine exposure.  
 
For this chapter I conducted a systematic review to examine current 
research and evaluate whether existing research has found evidence for a 
causal relationship between maternal prenatal smoking, alcohol and 
caffeine consumption and externalising disorders in offspring. I further 
appraised published studies in terms of methods used and provided 
suggestions for future studies to improve causal interpretation.  
2.1 INTRODUCTION 
Several studies have indicated that maternal health behaviours during 
pregnancy, such as smoking, alcohol, and caffeine consumption, may 
contribute to offspring externalising problems (Keyes et al., 2014; 
Mikkelsen et al., 2017; Pagnin et al., 2019) (problems such as attention-
deficit hyperactivity disorder (ADHD), conduct disorder (CD) and 
oppositional-defiant disorder (ODD)). However, it remains unclear whether 
these reflect true causal effects or rather the associations are due to 
residual confounding in particular due to socioeconomic factors such as 
socioeconomic position, education, income and maternal age (Berglundh et 
al., 2020; Kelly et al., 2012; Loomans et al., 2012; Palmer et al., 2016; 
Robinson et al., 2010; Russell, Ford, et al., 2015). As discussed in Chapter 1, 
this is of considerable public health importance, since smoking, alcohol and 
caffeine consumption are all common exposures and although current 




consumption (Department of Health, 2016; National Institute for Health 
and Care Excellence, 2010) and limiting daily caffeine consumption to 
200mg during pregnancy (Agostoni et al., 2015), most women still use these 
substances at some point in pregnancy (Lange et al., 2018; O'Keeffe et al., 
2015).  
 
A recent systematic review (Easey, Dyer, et al., 2019) found evidence of an 
association between low to moderate level maternal alcohol use during 
pregnancy and offspring behavioural and conduct problems. Similarly, other 
systematic reviews and meta-analyses have reported an association 
between maternal smoking during pregnancy and offspring CD and ADHD 
(He et al., 2020; Huang et al., 2018; Ruisch et al., 2018). However, these 
reviews are based on conventional observational studies which do not 
provide strong evidence of causality, given well described limitations such 
as unmeasured and residual confounding. In fact, the only review to date to 
triangulate evidence from different study designs many of which robust to 
confounding, concluded that there was no robust evidence for an effect of 
maternal alcohol use during pregnancy on behavioural phenotypes 
including ADHD (Mamluk et al., 2020).  
 
As well as socioeconomic confounding, the observed associations could also 
be explained by shared genetic influences (i.e., genetic confounding). 
Several studies have reported shared genetic liability between ADHD, CD 
and substance use (Grant et al., 2015; Treur et al., 2021; Vilar-Ribo et al., 
2020) and in particular, maternal genetic risk for ADHD has been found to 
be associated with smoking during pregnancy (Leppert et al., 2019). 
Therefore, it is possible that the association between prenatal substance 
exposure and externalising disorders in offspring could be explained by 
genetic transmission from mothers to offspring. Furthermore, these recent 
reviews have also highlighted the need for further investigation into 
whether there is a causal effect of maternal substance use during 
pregnancy on externalising problems in offspring and use genetically 





I conducted an updated systematic review to synthesise and evaluate the 
evidence for a causal relationship between maternal smoking, alcohol and 
caffeine consumption during pregnancy and diagnosis of ADHD, CD and 
ODD in offspring to reduce the potential heterogeneity in outcome 
assessment with self-reported measures. My main focus was on 
establishing whether the literature supports a causal role for these 
exposures; therefore I chose to build on existing research but not limiting to 
any study designs and specifically including studies that account for genetic 
effects, in addition to conventional observational approaches. Although in 
the DSM-5 ADHD is classified as a neurodevelopmental disorder, there is a 
high comorbidity between ADHD, CD and ODD (Singh, 2008) and prenatal 
substance use may have somewhat different effect on these outcomes. 
Therefore, I was interested whether associations differed across these 
externalising disorders.  
2.2 METHODS 
I published the protocol for this systematic review on the Open Science 
Framework (10.17605/OSF.IO/D9WZK) and PROSPERO (ID: 
CRD42018094810). I followed PRISMA and MOOSE guidelines, as well as 
Cochrane methods, where applicable.  
2.2.1 Search strategy 
I performed electronic searches using Web of Science, Embase, PsycINFO 
and Medline databases from the Ovid platform. In addition, I checked the 
reference lists of all previous reviews that were identified. My search 
strategy included following search terms: 
1. Outcome terms: "attention deficit disorder" OR "hyperactiv*" OR 
"impulsiv*" OR "ADHD" OR "attention deficit hyperactivity" OR “ADD” 
OR "externali?ing" OR “conduct disorder” OR “behavio* disorders” OR 





2. Exposure terms: "alcohol*" OR "tobacco" OR "caffein*" OR "drink*" OR 
"ethanol" OR “drinking” OR "smoking" OR "cigarette*" OR "nicotine" OR 
"coffee" OR "tea" OR "energy drink*"OR “taurine”  
3. Population terms: “pregnan*” OR “perinatal” OR “prenatal” OR 
“intrauterine*” OR “utero” OR” f?etal” OR “gestation” OR “trimester”  
 
I included relevant MeSH terms when searching from the Ovid platform. An 
example search is shown in Appendix 2.1. The search was performed 
including studies up to 26th of April 2018. 
2.2.2 Inclusion and exclusion criteria 
Inclusion criteria were: 1) publication in a peer reviewed journal in English 
language, 2) observational studies (including cross-sectional, case-control, 
longitudinal, and cohort studies which also included negative control 
studies), 3) maternal smoking, alcohol and caffeine use measured during 
pregnancy, and 4) diagnosis of ADHD, CD and ODD in offspring.  
 
Exclusion criteria for the study were: 1) animal studies, 2) reviews, 3) 
conference and/or meeting abstracts, 4) studies with no comparison group, 
5) fetal alcohol spectrum disorder (FASD) studies, as several studies have 
shown an association between heavier drinking and FASD; and 6) studies 
with comorbid autism spectrum and tic disorders due to the somewhat 
different aetiology of coexistence of these disorders.   
2.2.3 Study selection and data extraction 
I carried out selection of studies in three stages: stage 1 included screening 
titles and abstracts, stage 2 included full text screening, and stage 3 
included data extraction and risk of bias assessment. Study selection and 
data extraction took place by three reviewers: I conducted 100% of study 
screening, data extraction and risk of bias assessment; 75% check was 
conducted by PhD student Kirsten Westmoreland, and 25% check by PhD 





If included studies measured multiple exposures and outcomes, I extracted 
data separately for each exposure and outcome. Additionally, if more than 
one follow-up period was reported, I extracted data from the latest follow-
up period as per Cochrane guidance (Higgins et al., 2020).   
2.2.4 Risk of bias assessment 
I assessed risk of bias using the Newcastle Ottawa Scale (NOS) for cohorts 
and case-control studies (Wells et al., 2013). I evaluated included studies 
based on three categories: 1) Selection, 2) Comparability, and 3) Outcome. I 
ranked studies as low, medium or high risk of bias based on a rating system 
(maximum of 9 points, see Appendix 2.2). I conducted a risk of bias 
assessment and a check of 100% was carried out by other PhD students. 
Points given to each study are shown in Appendices 2.3 and 2.4. 
2.3 RESULTS 
2.3.1 Results of literature search 
In total 4,699 articles were identified (after removing duplicates) of which 
351 were included in the full text screening. Of these, 295 were excluded 
mainly because of non-specific outcome measure (n=31), wrong exposure 
(n=35) or not meeting outcome criteria (i.e., single reporter measure) 
(n=116). The list of studies excluded, including a reason is shown in 
Appendix 2.5. One study could not be used as the results were not reported 
and the remaining 56 articles were included in the current review (see 
Figure 2.1).  
 
I further contacted study authors if relevant details were missing. The list of 
studies which could not be included due to missing data are listed in 
Appendix 2.6. No further articles were identified from the reference check 
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Additional records identified 
through other sources 
(n = 0) 
Records after duplicates removed 
(n = 4699) 
Records screened at title 
and abstract stage 
(n = 4699) 
Records excluded after screening 
titles and abstracts 
(n = 4348) 
Full-text articles assessed 
for eligibility 
(n = 351) 
Full-text articles excluded, with 
reasons (n = 295) 
- Do not meet outcome criteria 
(self-reported measure) (n=116) 
- Externalising disorder not 
specified (n=31) 
- No outcome of interest (n=18) 
- No exposure of interest (n=35) 
- FAS sample (n= 18) 
- Combined exposure (tobacco 
and alcohol) (n=1) 
- Combined outcome (ADHD and   
ODD) (n=1) 
- Conference abstract (n=26) 
- Dissertation (n=1) 
- Retracted study (n=1) 
- Wrong study design (n=1) 
- No comparison/control group 
(n=11) 
- Not testing the association 
between exposure and outcome 
(n=6) 
- Only unadjusted analyses (n=4) 
- Review studies (n=13) 
- Not English language (n=4) 
- Duplicate (n=7) 
- Results not reported (n=1) 
 
Studies included in 
narrative synthesis 
(n = 56) 
Additional records 
identified through 






When I registered the study protocol, I planned to conduct a meta-analysis. 
However, considering differences in study designs, methods, exposure 
assessments and age at outcome assessment, a meta-analysis was not 
conducted. I therefore conducted a narrative synthesis of the current 
research and emphasized limitations in existing studies and provided 
suggestions for future research.  
2.3.2 Characteristics of included studies 
Characteristics of included studies are shown in Appendices 2.7 and 2.8. Of 
the included studies, 26 were North American, 20 European of which 12 
were Scandinavian, 4 Australian, 4 South American and 2 Asian. Of the 
included studies, 50 measured smoking exposure, 13 measured alcohol 
exposure and 4 studies measured caffeine exposure. 
 
Of the included 28 cohort and longitudinal studies and 6 cross-sectional 
studies, 5 studies were based on selective populations, such as participants 
from indigenous culture, areas of lower socioeconomic status, as well as 
participants of depressed probands. Additionally, three studies were 
conducted in twins. Of the 22 case-control studies included, 6 studies 
selected cases and controls from clinical and/or hospital-based sample and 
2 studies were conducted in twins.   
 
Follow-up time ranged from 2 to 37 years in cohort and longitudinal 
studies. Out of the 56 included studies, eight studies reported results 
separately for boys and girls (N=147 to 968,665), two studies were 
conducted only in boys (N=177 to 400) and two studies only in girls (N=228 
to 1,936).  
2.3.3 Assessment of exposures 
2.3.3.1 Smoking 
Of the 50 studies on smoking exposure, 22 studies (44%) used cohort 
and/or longitudinal design, 6 studies (12%) used cross-sectional, and 22 
studies (44%) used case-control study design (see Appendices 2.7 and 2.8). 




of the included cohort studies used a binary exposure measure of which 
three studies used a cut-off <10 cigarettes per day. Of the cross-sectional 
studies, four studies used also a binary exposure measure. 16 (57%) studies 
used different categorical measures of which one study included occasional 
smokers to the group of no smokers.  
 
A total of 11 (50%) of the included cohort and longitudinal studies assessed 
smoking during pregnancy prospectively. Three of these studies measured 
smoking in each pregnancy trimester, three studies in two pregnancy 
trimesters and the remaining three studies measured smoking at one time 
point during pregnancy. 12 (56%) studies assessed smoking some years 
after child’s birth. Four cross-sectional studies assessed smoking 
retrospectively and two studies did not provide these details.  
 
Of the 22 included case-control studies, 4 studies (18%) assessed smoking 
prospectively and 18 (82%) studies retrospectively. Three studies (14%) 
assessed smoking in each pregnancy trimester, one study during the second 
pregnancy trimester and 18 (82%) studies did not provide details of the 
pregnancy trimester during which smoking was assessed.  
2.3.3.2 Alcohol 
Of the 13 studies on alcohol exposure, 7 (50%) were cohort and longitudinal 
studies, 2 (17%) used cross-sectional design and 4 (33%) were case-control 
studies (see Appendices 2.7 and 2.8). Total sample size ranged from 546 to 
34,283 participants. 
 
Of the 9 included cohort, longitudinal and cross-sectional studies, 6 studies 
(67%) used different categorical measures and 2 studies (22%) used a 
binary measure. One longitudinal cohort study measured alcohol exposure 
using the continuous score from the AUDIT scale. Of the 4 case-control 
studies included, 3 studies used a binary measure, and one study used a 
categorical measure.  
 
Out of these 13 studies, 3 studies (23%) assessed alcohol consumption 




these details. One study assessed alcohol consumption in each pregnancy 
trimester, one study during the 1st pregnancy trimester and other two 
during the 1st and 3rd pregnancy trimester or 1st trimester and beyond.  
2.3.3.3 Caffeine 
Of the 4 studies on caffeine exposure, 2 used a cohort study design, one 
study was cross-sectional and the other used a case-control design. The 
total sample size ranged from 2,419 to 24,068 participants (see Appendices 
2.7 and 2.8). 
 
Two studies used categorical measures of caffeine exposure, of which one 
study included ‘some’ caffeine consumption as a baseline. Two other 
studies used a binary measure of which one used none to less than one cup 
per day as a reference. Two studies derived daily caffeine consumption 
from coffee and tea/mate intake, one study only from coffee and one study 
did not specify the source of caffeine in their analyses. Two studies 
assessed caffeine consumption prospectively of which one during the 2nd 
pregnancy trimester. The other two studies measured caffeine 
consumption retrospectively, of which one study asked about caffeine 
consumption in each pregnancy trimester and the other study did not 
specify in which pregnancy trimester caffeine intake was assessed.  
2.3.4 Assessment of outcomes 
2.3.4.1 ADHD 
Of the 56 included studies, 47 studies measured ADHD. Of these studies, 
two focused only on ADHD inattentive subtype and three ADHD combined 
or hyperactive-impulsive and inattentive subtypes.  
 
Fourteen studies (30%) used hospital or national registry databases for 
ADHD diagnosis and/or ADHD medication use. 23 studies (49%) used 
diagnostic interviews and most commonly the Diagnostic Interview 
Schedule for Children (DISC) and the Schedule for Affective Disorders and 
Schizophrenia (K-SADS) were used. Additionally, the Missouri Assessment 




Psychiatric Assessment (PAPA) were also used. Furthermore, two studies 
used the Development And Well-Being Assessment (DAWBA) maternal and 
teacher reports for generating ADHD diagnosis called “DAWBA bands”, five 
studies (11%) derived ADHD diagnosis based on clinical assessment or by 
using multiple evaluations by mothers, teachers and clinicians. Three 
studies (6%) used parent report of whether their child had been diagnosed 
with ADHD.  
 
Offspring age at assessment varied from 4 to 37 years. 5 studies were 
assessed at offspring age below 6 years, 32 studies were assessed at 
offspring age between 6 to 13 years, 5 studies at offspring age 14 to 18 
years, 4 studies were assessed in adulthood (at age 20 to 37 years) and one 
study did not provide these details.  
2.3.4.2 CD and ODD 
Of the 56 studies, 12 studies measured conduct disorder and 6 studies 
measured ODD. All studies derived diagnosis using diagnostic interviews 
(either DISC, K-SADS or PAPA) and the World Health Organization’s 
Composite International Diagnostic Interview (CIDI). 
 
Offspring age at CD assessment varied from 6 to 21 years. Four studies 
were assessed at offspring age from 8 to 15 years, six studies from 6 to 17 
years, one study was assessed in adulthood and one other study did not 
provide these details. Offspring age at ODD assessment varied from 4 to 21 
years. Two studies assessed ODD when offspring were aged 4 years, three 
studies at offspring age 11 to 17 years, and one study in adulthood (21 
years).  
2.3.5 Inclusion of confounding variables 
The majority of studies adjusted for socio-economic variables (social class, 
education, income, marital status), as well as for maternal age, offspring 
age and gender. Only a few studies adjusted for maternal mental health 
during pregnancy and none of the studies considered partner’s substance 




included in the multivariable analyses are shown in Appendices 2.9 and 
2.10. 
2.3.6 Summary of findings 
An overview of results as reported in the studies is shown in Appendices 
2.7 and 2.8.  
2.3.6.1 Association between smoking during pregnancy and ADHD in offspring 
Out of the 56 studies, 43 assessed the association between maternal 
smoking during pregnancy and ADHD in offspring, of which 18 (42%) were 
cohort and longitudinal studies, 4 (9%) cross-sectional and 21 (52%) case-
control studies.  
Of the included cohort and longitudinal studies 12 (69%) found a positive 
association between maternal smoking during pregnancy and ADHD in offspring, 
whereas 6 studies (26%) did not observe evidence for any association (N=147 to 
2,243) (Ball et al., 2010; Fergusson et al., 1998; Nigg and Breslau, 2007; Sagiv et 
al., 2013; Weissman et al., 1999). However, three of these studies that did not 
report a positive association used a sample measured when offspring were in 
late adolescence (16-18 years) or adulthood (37 years) (Ball et al., 2010; 
Fergusson et al., 1998; Weissman et al., 1999). 
 
Seven studies which found a positive association used samples from prospective 
longitudinal cohorts and large registries (N=5,758 to 986,046) (Gustavson et al., 
2017; Langley et al., 2012; Lindblad and Hjern, 2010; Obel et al., 2011; Obel et 
al., 2016; Skoglund et al., 2014; Zhu et al., 2014). These studies enabled the 
authors to take into account environmental and/or genetic confounding by 
using quasi-experimental designs, such as parental and sibling comparison 
designs. Six of these studies concluded that the association is most likely 
explained by confounding (Gustavson et al., 2017; Langley et al., 2012; Lindblad 
and Hjern, 2010; Obel et al., 2011; Obel et al., 2016; Skoglund et al., 2014). Two 
studies claimed that the association was stronger with maternal smoking 
compared to paternal smoking indicating a potential causal intrauterine effect 




the Danish National Birth Cohort (N=86,812) and other was a longitudinal study 
in USA (N=209).  
Moreover, six studies that observed a positive association adjusted for birth 
weight or other perinatal factors that could be potential mediators or lead to 
spurious association because of collider bias (Braun et al., 2006; Froehlich et al., 
2009; Koshy et al., 2011; Pohlabeln et al., 2017; Schmitt and Romanos, 2012; 
Sciberras et al., 2011). In addition, two twin studies concluded that prenatal 
smoking was a common risk factor among MZ (monozygotic) twins concordant 
for ADHD (Knopik et al., 2005; Lehn et al., 2007).  
 
All four included cross-sectional studies and of the included case-control studies, 
18 studies (86%) found a positive association between maternal smoking during 
pregnancy and ADHD in offspring, whereas three studies (14%) did not (Ketzer 
et al., 2012; Wiggs et al., 2016; Yoshimasu et al., 2009) and two of these studies  
were conducted in small samples (N=372 to 450) (Ketzer et al., 2012; Yoshimasu 
et al., 2009). Eight of these studies that observed a positive association adjusted 
for parental ADHD to account for potential genetic liability, but the association 
remained (Altink et al., 2009; Arnold et al., 2005; Biederman et al., 2009; Gard et 
al., 2016; Mick et al., 2002; Milberger et al., 1996; Milberger et al., 1998; 
Schmitz et al., 2006). However, another case-control study found that maternal 
smoking during pregnancy was shared between affected and unaffected siblings 
indicating that prenatal smoking is a weak risk factor for ADHD (Oerlemans et 
al., 2016).  
 
Six studies examined the association with ADHD subtypes (Gard et al., 2016; 
Ketzer et al., 2012; Neuman et al., 2007; Schmitz et al., 2006; Todd and Neuman, 
2007; Wiggs et al., 2016). One of these studies was conducted in girls only and 
observed an association with hyperactive-impulsive symptoms but not with 
inattention symptoms (Gard et al., 2016). In contrast, one study observed an 
indirect effect of prenatal smoking on inattention symptoms via memory span 
deficits (Wiggs et al., 2016). Two other studies focused only on the inattention 
subtype and were based on the same sample (Ketzer et al., 2012; Schmitz et al., 
2006), however only one study found an association (Schmitz et al., 2006). Two 




same sample of twins and found a positive effect between maternal smoking 
during pregnancy and child genotype in children with the combined ADHD 
subtype (Neuman et al., 2007; Todd and Neuman, 2007). However, two other 
studies that also investigated gene-environment interaction – but focused on 
overall ADHD and used a sample of singletons – did not find an interaction effect 
(Altink et al., 2008; Altink et al., 2009).  
 
Of the six studies which investigated gender differences (Braun et al., 
2006; Obel et al., 2011; Obel et al., 2016; Silva et al., 2014; Talati et al., 
2017; Weissman et al., 1999), one study found a stronger association 
between maternal smoking during pregnancy and ADHD in girls (Braun et 
al., 2006) and another study in boys (Talati et al., 2017), but there was no 
evidence of a gender difference in the remaining four studies. 
Furthermore, of all the included studies on smoking exposure, 14 studies 
(33%) also examined dose-response relationship of which 11 studies 
observed a dose-dependent association (Gustafsson and Kallen, 2011; 
Knopik et al., 2006; Koshy et al., 2011; Lindblad and Hjern, 2010; Obel et 
al., 2011; Obel et al., 2016; Pineda et al., 2007; Pohlabeln et al., 2017; 
Schmitz et al., 2006; Sciberras et al., 2011; Skoglund et al., 2014).  
2.3.6.1.1 Strength of evidence based on NOS score 
In total eight longitudinal and cohort studies were rated as low risk of bias 
(7-9 points). Six of these studies were based on quasi-experimental 
designs (Gustavson et al., 2017; Lindblad and Hjern, 2010; Obel et al., 
2011; Obel et al., 2016; Skoglund et al., 2014; Zhu et al., 2014), one study 
used a twin sample (Lehn et al., 2007) and another study was based on  a 
prospective cohort (Sagiv et al., 2013). Seven studies concluded that the 
association between maternal smoking during pregnancy and ADHD in 
offspring is unlikely to be a causal. This was in contrast with two studies 
rated as very high risk of bias (0-3 points) (Koshy et al., 2011; Nomura et 
al., 2010) and three other studies rated as high risk of bias (4-5 points) (all 
cross-sectional designs) (Braun et al., 2006; Froehlich et al., 2009; Schmitt 





In total eight case-control studies were rated as low risk of bias and seven 
of these studies found a positive association (Altink et al., 2009; Arnold et 
al., 2005; Gustafsson and Kallen, 2011; Joelsson et al., 2016; Linnet et al., 
2005; Schmitz et al., 2006; Silva et al., 2014; Yoshimasu et al., 2009), but 
these studies do not account for genetic effects and some of these are 
prone to recall bias, therefore conclusions about causality should be 
interpreted with caution.   
2.3.6.2 Association between smoking during pregnancy and CD and ODD in 
offspring 
Out of the 56 included studies, 10 investigated the association between 
maternal smoking during pregnancy and CD in offspring of which 5 were 
cohort and longitudinal studies, 2 cross-sectional studies and 3 case-
control studies. Six studies (60%) found an association between maternal 
smoking during pregnancy and CD in offspring (Biederman et al., 2017; 
Biederman et al., 2009; Braun et al., 2008; Nigg and Breslau, 2007; Talati 
et al., 2016; Wakschlag et al., 1997). However, four of these studies used 
a clinical or hospital referred sample (Biederman et al., 2017; Biederman 
et al., 2009; Talati et al., 2016; Weissman et al., 1999). One study 
observed an interaction effect between maternal prenatal smoking and 
child genotype (Talati et al., 2016). In the three studies that did not find 
evidence of an association, two studies used a sample of offspring in late 
adolescence (16-18 years) (Fergusson et al., 1998; Weissman et al., 1999) 
and one study found an indirect effect via neuropsychological functioning 
(Wiggs et al., 2016).  
 
Out of the 56 studies, six studies (11%) investigated the association 
between maternal smoking during pregnancy and ODD in offspring of 
which three were cohort and longitudinal studies, one cross-sectional 
study and two were case-control studies. Two studies (N=798 to 995) 
found an association with maternal smoking during pregnancy (Ellis et al., 
2012; Nigg and Breslau, 2007) and four studies did not (N=215 to 5,924) 
(Biederman et al., 2017; Nomura et al., 2010; Russell, Johnson, et al., 
2015; Wiggs et al., 2016). Among the studies that did not observe the 




functioning similarly to the effect observed for ADHD and CD (Wiggs et al., 
2016). Two studies measured ODD in adolescence (15 years) and 
adulthood (21 years) where disorder manifestation could differ from 
childhood (Biederman et al., 2017; Russell, Johnson, et al., 2015). One 
other study was conducted in a small sample (N=215) and may be 
influenced by low power to detect an effect (Nomura et al., 2010).  
2.3.6.2.1 Strength of evidence based on NOS score 
Only one study based on smoking and CD was rated as low risk of bias (8 
points) and this study did not find evidence for an association between 
prenatal smoking and CD (Fergusson et al., 1998). Two studies rated as 
very high risk of bias (2-3 points) did not find an association between 
prenatal smoking and ODD (Nomura et al., 2010; Russell, Johnson, et al., 
2015). Other studies rated as high risk of bias (4-6 points) found an 
association between prenatal smoking and CD and ODD in offspring 
(Biederman et al., 2009; Braun et al., 2008; Ellis et al., 2012; Nigg and 
Breslau, 2007; Talati et al., 2016; Talati et al., 2017; Wakschlag et al., 
1997; Weissman et al., 1999), but two studies were based on cross-
sectional or case-control design which cannot prove causality (Biederman 
et al., 2009; Braun et al., 2008) and other four studies used a clinical or 
hospital referred sample (Talati et al., 2016; Talati et al., 2017; Wakschlag 
et al., 1997; Weissman et al., 1999).  
2.3.6.3 Association between alcohol consumption during pregnancy and ADHD 
in offspring 
Out of the 56 studies, 9 investigated the association between maternal prenatal 
alcohol consumption and ADHD in offspring of which 4 were cohort and cross-
sectional studies (N=679 to 34,503), 1 was longitudinal twin study (N=1,936) and 
4 were case-control studies (N=372 to 2,419). The longitudinal twin study found 
a positive association only with heavier alcohol use (Knopik et al., 2005).Three 
(33%) case-control studies found a positive association with maternal alcohol 
consumption during pregnancy (Kim et al., 2009; Mick et al., 2002; Pineda et al., 
2007) of which one used heavier drinking (drunkenness during the first 2 




conducted in a hospital referred sample (Mick et al., 2002) and the other failed 
to adjust for many relevant confounders (Kim et al., 2009).  
 
2.3.6.3.1 Strength of evidence based on NOS score 
Only one study based on alcohol exposure and ADHD was rated as low risk of 
bias (9 points) and this study did not find evidence for an association between 
prenatal alcohol exposure and ADHD (Sagiv et al., 2013). Two other longitudinal 
cohort studies rated as high risk of bias (5-6 points) also did not find evidence 
for an association (Eilertsen et al., 2017; Pohlabeln et al., 2017). Out of four 
case-control studies rated as high risk of bias (5-6 points), three studies reported 
an association between prenatal alcohol exposure and ADHD in offspring (Kim et 
al., 2009; Mick et al., 2002; Pineda et al., 2007)  and one study did not (Ketzer et 
al., 2012).  
 
2.3.6.4 Association between alcohol consumption during pregnancy and CD and 
ODD in offspring 
Out of the 56 studies, 4 cohort and cross-sectional studies investigated the 
association between maternal alcohol consumption and CD and ODD in 
offspring (N=546 to 5,924). Three studies were on CD (Fergusson et al., 1998; 
Larkby et al., 2011; Whitbeck and Crawford, 2009) and one in ODD (Russell, 
Johnson, et al., 2015). No association was observed with ODD, but two studies 
found an association between maternal alcohol consumption during pregnancy 
and CD in offspring (Larkby et al., 2011; Whitbeck and Crawford, 2009). 
However, both of these studies found the association with heavier alcohol 
consumption and binge drinking, and one study used a sample based on 
indigenous culture (Whitbeck and Crawford, 2009). The study that did not 
observe an association with CD was a prospective longitudinal cohort in New 
Zealand and CD was assessed when offspring were aged 16-18 years (Fergusson 
et al., 1998).  
 
2.3.6.4.1 Strength of evidence based on NOS score 
Two studies based on alcohol exposure and CD were rated as low risk of 
bias (8 points). One of these studies did not find evidence for an 




for an association with heavier alcohol use (Larkby et al., 2011). Both of 
these studies were based on prospective longitudinal birth cohorts. Of the 
two other studies rated as very high risk of bias (2 points), one study on 
CD found a positive association with binge drinking (Whitbeck and 
Crawford, 2009) and other study based on ODD and using cross-sectional 
design did not find evidence for an association (Russell, Johnson, et al., 
2015).  
2.3.6.5 Association between caffeine consumption during pregnancy and ADHD 
and ODD in offspring 
Out of the 56 studies, 3 investigated the association between maternal caffeine 
consumption during pregnancy and ADHD in offspring (N=3,627 to 24,156) (Del-
Ponte et al., 2016; Kim et al., 2009; Linnet et al., 2009). Additionally, one study 
examined the association with ODD in offspring (N=5,924) (Russell, Johnson, et 
al., 2015). No evidence for a positive association was observed between 
maternal caffeine consumption during pregnancy and ADHD in offspring. Two of 
these studies used a longitudinal cohort design (Pelotas birth cohort in Brazil 
and the Aarhus birth cohort in Denmark) (Del-Ponte et al., 2016; Linnet et al., 
2009) and one study used a case-control design in a Korean sample (Kim et al., 
2009). A study of ODD based on a cross-sectional sample found a weak 
indication for an association with maternal prenatal caffeine use only in girls 
(Russell, Johnson, et al., 2015).  
 
2.3.6.5.1 Strength of evidence based on NOS score 
Two studies based on caffeine exposure and ADHD were rated as low risk 
of bias (8-9 points) (Del-Ponte et al., 2016; Linnet et al., 2009). Both studies 
did not find evidence for an association. One case-control study rated as 
high risk of bias (4 points) also did not find evidence for an association (Kim 
et al., 2009). Only one study on ODD rated as very high risk of bias (2 
points) found a weak suggestive evidence for an association only in girls 





In this systematic review I examined whether there is evidence to support a 
causal effect of maternal smoking, alcohol and caffeine use during 
pregnancy on ADHD, CD and ODD risk in offspring by synthesising the 
results of existing research based on risk of bias assessment. Overall, my 
findings support stronger associations between prenatal smoking and 
ADHD and CD. However, evidence was less clear for the association with 
ODD and inconsistent on alcohol exposure in all the outcomes. My findings 
on caffeine exposure were limited to ADHD and there was lack of evidence 
for other outcomes.  
 
My findings for smoking exposure indicate that maternal smoking during 
pregnancy is more strongly associated with ADHD and CD than with ODD. 
However, given that there are few studies on ODD, no strong conclusions 
can be drawn. Furthermore, some studies on ADHD with low risk of bias 
were able to take into account genetic effects, and indicate that shared 
genetics plays a substantial role in the association with prenatal smoking. 
This is supported by a previous study which used a genetically informed 
design and showed that the link between maternal prenatal smoking and 
offspring ADHD symptoms is likely to be inherited rather than due to 
intrauterine exposure (Thapar et al., 2009). Furthermore, another recent 
review concluded that besides ADHD, also the association between 
maternal prenatal smoking and CD symptoms could also be explained by 
familial confounding and shared genetics (Rice et al., 2018).  
 
I identified relatively few studies that investigated the association between 
prenatal alcohol exposure and diagnosis of ADHD, CD and ODD in offspring. 
Evidence from these studies indicates that a stronger association exists 
between heavier alcohol consumption and ADHD and CD. A recent review 
and meta-analysis which investigated the association between maternal 
low to moderate alcohol consumption during pregnancy and ADHD in 
offspring did not find evidence for an increased risk of ADHD symptoms 
(Porter et al., 2019), but studies on CD symptoms using quasi-experimental 




to moderate level alcohol consumption during pregnancy (D'Onofrio et al., 
2007; Murray et al., 2016). Similarly, to alcohol exposure, I only identified a 
few studies on prenatal caffeine exposure and these studies do not provide 
evidence for a causal effect with ADHD.  
 
However, several weaknesses and sources of heterogeneity between 
included studies emerged while I appraised the current research. First, 
included studies varied greatly on number of confounders adjusted in the 
multivariable analyses, thus raising the possibility of residual confounding. 
Although many studies adjusted for socioeconomic factors known to affect 
both exposures and outcomes, none of the studies adjusted for partner’s 
substance use during pregnancy. There is evidence that assortative mating 
affects parental smoking and alcohol consumption and failure to take into 
account partner’s substance use can lead to biased effect estimates 
(Madley-Dowd et al., 2020). Similarly, only a limited number of studies 
accounted for maternal mental health during pregnancy, which has also 
been found to be a potential risk factor. For example, it has been shown 
that maternal depressive and anxiety symptoms during pregnancy 
increased the risk for behavioural problems in offspring (Leis et al., 2014). In 
contrast, many studies on smoking exposure adjusted for perinatal factors, 
such as birth weight, gestational age or other pregnancy and birth 
complications, which could be potential mediators in the pathway between 
prenatal smoking and ADHD. Adjusting for mediators induces collider bias 
in unpredictable directions, as showed in previous studies (Schisterman et 
al., 2009). Therefore estimates adjusted for birth weight may result in 
spurious association if there is an unmeasured common cause between 
birth weight and outcome (Hernandez-Diaz et al., 2006).  
 
Second, maternal prenatal exposure assessment was based on self-reports 
and mothers may under report their prenatal substance use, due to social 
desirability, which may lead to biased effect estimates in the studies. 
Furthermore, many studies assessed exposures after child’s birth or 
retrospectively when the outcome was already present, which may lead to 




control studies). This means that from these studies causality should be 
interpreted cautiously. Third, studies also differed in terms of how prenatal 
smoking, alcohol and caffeine consumption were categorised. Many studies 
used a binary measure which does not adequately capture effects of 
substance use where these are dose-dependent. Some studies used a scale 
of low, moderate and high, but there is no clear definition what level of 
consumption each of these categories represent. Fourth, studies also varied 
on timing of substance use with the majority of studies using a single time 
point assuming that maternal substance use remains similar throughout 
pregnancy. One study on alcohol exposure reported that maternal prenatal 
alcohol consumption had a more harmful effect on offspring conduct 
disorder during the 1st trimester compared to the 3rd trimester indicating 
that prenatal alcohol exposure during the 1st pregnancy trimester may be 
more harmful (Larkby et al., 2011).  
 
Fifth, considering that there is a high comorbidity between externalising 
disorders, only a few studies took this into account. Although high rates of 
comorbidity are common among psychiatric disorders, it is also plausible 
that somewhat different aetiology may underlie externalising disorders 
with comorbidities. For example, two studies that observed the association 
between maternal prenatal smoking and ADHD with comorbid conditions 
found that ADHD with comorbid CD/ODD had a stronger association with 
maternal prenatal smoking than ADHD without comorbidities (Arnold et al., 
2005; Joelsson et al., 2016).  
 
Sixth, although externalising disorders are more prevalent among boys than 
girls (Merikangas et al., 2009) few studies investigated gender effects. Some 
studies have shown that boys exposed to prenatal smoking and alcohol 
consumption may be at higher risk for developing behavioural problems 
than girls (Hutchinson et al., 2010; Niclasen et al., 2014) and it is possible 
that prenatal substance use may have distinct effects on boys and girls 





Seventh, studies varied greatly on age when ADHD, CD and ODD were 
assessed. Although several studies have shown that childhood externalising 
disorder symptoms persist into adulthood (Kuja-Halkola et al., 2015; Reef et 
al., 2011), other studies have also found that childhood mental health 
problems change across development and persistence of externalising 
disorders also depends on severity and comorbidity of symptoms (Bunte et 
al., 2014; Caye et al., 2016). Furthermore, studies on ADHD have reported 
that presentation of hyperactive-impulsive and inattention symptoms 
varies from preschool to early adulthood and inattention symptoms tend to 
be more persistent (Dopfner et al., 2015). It is also suggested that child- and 
adulthood ADHD are two separate diagnoses and future studies should 
investigate which underlying mechanisms could explain these different 
developmental paths (Moffitt et al., 2015). 
 
One major strength of this systematic review is including multiple prenatal 
exposures (smoking, alcohol and caffeine) and outcomes (ADHD, CD and 
ODD) which enabled me to synthesise whether the associations would 
differ across different exposure-outcome combinations. Additionally, 
conducting risk of bias assessments enabled me to account for the relative 
weaknesses in study designs when interpreting the evidence supporting a 
causal relationship.  
 
However, this systematic review also has some limitations. First, I limited 
the searches to studies that used diagnosis as an outcome measure, and 
therefore I missed those studies reporting on symptoms scores or other 
continuous scales. Second, I only included English language studies. 
However, it has been shown that the exclusion of non-English studies has a 
little impact on overall findings (Morrison et al., 2012). Third, I was unable 
to quantitatively combine results into meta-analyses, due to the high 
degree of heterogeneity in exposure assessments, as well as study designs.  
2.5 CHAPTER SUMMARY 
My review showed that there is an association between maternal smoking 




shared genetic and environmental confounders suggest that this 
association is unlikely to be causal. Given that majority of the identified 
studies investigated the association between ADHD and smoking exposure, 
findings with alcohol and caffeine exposures and CD and ODD need more 
research, especially using more genetically sensitive designs. Future studies 
should also use more prospective and quantitative exposure measures 
during each pregnancy trimester, as well as take into account comorbidities 
between externalising disorders, gender differences and changes in 
presentation and manifestation of externalising disorder symptoms across 
development. 
 
In the next chapter, I describe cohorts used in my analyses to further 
investigate whether there is a causal effect of maternal smoking, alcohol 
and caffeine consumption during pregnancy on ADHD risk in offspring by 







Chapter 3  DESCRIPTIONS OF COHORTS 
3.1 INTRODUCTION 
In this thesis, I have used data from three longitudinal birth cohort studies: 
the Avon Longitudinal Study of Parents and Children (ALSPAC); the 
Generation R (GenR) and the Norwegian Mother, Father and Children 
Cohort Study (MoBa). In this chapter I will give an overview of each cohorts’ 
participants, availability, quality control of genome-wide data, and 
assessment of exposures and outcome. I will also provide a comparison of 
parental socio-economic and exposure characteristics, as well as 
characteristics of outcomes in the children, between the cohorts. This 
chapter will end by describing the measures selected for analyses described 
in this thesis.  
 
3.2 THE AVON LONGITUDINAL STUDY OF PARENTS AND CHILDREN (ALSPAC) 
3.2.1 Cohort profile 
ALSPAC is a prospective longitudinal cohort study designed to investigate 
genetic and environmental factors that influence health and development 
in parents and children (Fraser et al., 2013; Golding et al., 2001; Northstone 
et al., 2019). 
 
To be eligible for the study, pregnant women had to be resident in the 
former county of Avon and their expected date of delivery had to be 
between 1st April 1991 and 31st December 1992. Women who were 
residents but left shortly after enrolment were excluded from further 
follow-up, but women who left the study area after completing the 
questionnaire in the 3rd pregnancy trimester were retained even if the baby 
was born after the move (Golding et al., 2001). The eligible sample 
consisted of 20,248 pregnancies and 14,676 participants were recruited 
during 1990-1992. More participants were recruited during campaigns 
when the children were aged 7 years old and between ages 8 and 18 years 
old. These campaigns resulted in a further 913 children who were enrolled 




excluding triplets and quadruplets, the final baseline sample size was 
14,888 children (Northstone et al., 2019). 
 
The Avon population was considered to be representative of Great Britain 
(GB) in terms of parents’ ethnicity, marital status, higher education, and 
proportion of people living in rural areas. However, parents in ALSPAC were 
less likely to live in rented accommodation, and fathers were less likely to 
have a manual occupation compared with the rest of GB (Golding et al., 
2001).  
 
Data collection included self-reported questionnaires from mothers, their 
partners and their children from age 5 years; medical, educational and 
other records; interviews and examinations in the clinic, as well as 
measurements of biological and environmental samples (Boyd et al., 2013; 
Golding et al., 2001). 
 
The ALSPAC study was approved by the ALSPAC Ethics and Law Committee 
and the Local Research Ethics Committees and informed consent for the 
use of data collected via questionnaires and clinics was obtained from 
participants. The study website contains details of all the data that is 
available through a fully searchable data dictionary and variable search 
tool: http://www.bristol.ac.uk/alspac/researchers/our-data/    
3.2.2 Genome-wide data and quality control 
DNA samples were collected from 11,343 children and 10,015 mothers. 
ALSPAC children were genotyped using the Illumina HumanHap550 quad 
chip genotyping platforms. Individuals were excluded on the basis of 
gender mismatches, minimal or excessive heterozygosity, disproportionate 
levels of individual missingness (>3%) and insufficient sample replication 
(identity-by-descent (IBD) <0.8). SNPs with a minor allele frequency of < 1%, 
a call rate of < 95% or evidence for violations of Hardy-Weinberg 
equilibrium (p < 10-7) were removed. Related subjects that passed all other 




imputation. A total of 9,115 children and 500,527 SNPs passed these quality 
control filters. 
 
ALSPAC mothers were genotyped using the Illumina human660W-quad 
array at Centre National de Génotypage (CNG) and genotypes were called 
with Illumina GenomeStudio. SNPs were removed if they displayed more 
than 5% missingness or a Hardy-Weinberg equilibrium (p < 10-6). 
Additionally, SNPs with a minor allele frequency of less than 1% were 
removed. Samples were excluded if they displayed more than 5% 
missingness, had indeterminate X chromosome heterozygosity or extreme 
autosomal heterozygosity.  
 
Related subjects that passed all other quality control thresholds were 
retained during subsequent phasing and imputation. 9,048 mothers and 
526,688 SNPs passed these quality control filters. Population stratification 
in mothers and children were compared with Hapmap II (release 22) 
European descent (CEU), Han Chinese, Japanese and Yoruba reference 
populations; all individuals with non-European ancestry were removed. 
 
After combining genotype data in the mothers and the children, SNPs with 
genotype missingness above 1% were removed due to poor quality (11,396 
SNPs removed) and a further 321 subjects were removed due to potential 
ID mismatches. This resulted in a dataset of 17,842 subjects. Imputation of 
the target data was performed using Impute V2.2.2 against the 1000 
genomes reference panel (Phase 1, Version 3) (all polymorphic SNPs 
excluding singletons), using all 2,186 reference haplotypes (including non-
Europeans). After imputation and filtering on MAF > 0.01 and info > 0.8 
8,282,911 SNPs remained in the dataset. 
 
The final dataset included 8,237 children and 8,196 mothers.  
More details about the genotyping and quality control procedure can be 




3.2.3 Assessment of ADHD 
3.2.3.1 The Development And Well-Being Assessment (DAWBA) 
The DAWBA is a semi-structured interview administered to parents of 
children aged 4-16 years, to adolescents over 11 years, and a briefer 
questionnaire administered to teachers. The DAWBA was designed to bring 
together information from different sources (Goodman et al., 2000). 
Additionally, a computer algorithm is used to generate diagnoses called 
“DAWBA bands” which are based on the symptoms and impact reported in 
the DAWBA. The DAWBA bands can be generated for both informant-
specific and multi-informant measures, and these have been found to be a 
useful complement for clinician-rated diagnoses (Goodman et al., 2011).   
The DAWBA covers disorders such as separation anxiety, specific and social 
phobias, post-traumatic stress-disorder, obsessive compulsive disorder, 
generalised anxiety disorder, major depression, ADHD, conduct and 
oppositional-defiant disorder. However, teachers are not asked in detail 
about children’s internalising disorder symptoms and children are not 
asked in detail about their own externalising disorder symptoms (Loeber et 
al., 1991).  
 
The ADHD subscale consists of 18 items that measure total symptoms of 
ADHD and 9 items that separately measure inattentive and hyperactive-
impulsive symptom domains. The 18 items are made up of 9 items of 
inattentive symptoms and 9 items of hyperactive-impulsive symptoms. The 
items assess degree of symptom on Likert scales ranging from 0-2: 0 = no 
more than other; 1 = a little more than others; and 2 = a lot more than 
others. 
 
The DAWBA can be used either by a trained interviewer or it can be self-
completed online or via questionnaire (Goodman et al., 2011). The DAWBA 
has been found to be a reliable measure for distinguishing children with 
mental health problems both in clinical and community population 





In ALSPAC, ADHD was measured using the maternal report of DAWBA at 
age 7.5, 10, 13 and 15.5 years, and the teacher report is available at age 7 
and 10 years. The DAWBA bands are available at age 7.5 and 15.5 years. In 
the analyses I used maternal and teacher reported ADHD subscale at age 7 
years.  
3.2.3.2 The Strengths and Difficulties Questionnaire (SDQ) 
The SDQ is a brief behavioural screening questionnaire for children and 
adolescents at age 3-16 years completed by parents and teachers 
(Goodman, 1997). The questionnaire has 25 items which are divided into 
five subscales: emotional symptoms, conduct problems, hyperactivity 
problems, peer problems and prosocial behaviour. The hyperactivity 
subscale covers both hyperactivity and inattention symptoms. The items 
assess presence of symptoms on Likert scales ranging from 0-2: 0 = not 
true; 1 = somewhat true; and 2 = certainly true. The SDQ has been used in 
both clinical and community settings and has been found to be a good 
measure for identifying children with a higher risk of mental disorders 
(Goodman, 1997). Although the instrument is widely used, psychometric 
properties are poorer with respect to sensitivity than specificity, and when 
only a single-informant rater is used (Goodman, 1997; Goodman et al., 
2003). 
 
In ALSPAC, maternal reported SDQ is available at age 4, 7, 8, 10, 12, 13 and 
16.5 years and teacher reports at ages 7 and 10 years.  In this thesis I used 
the hyperactivity subscale at age 7 years. 
3.2.3.3 Descriptive statistics of ADHD measures 
Although data from multiple timepoints were available, descriptive 
statistics are shown at age around 7-8, as data at this timepoint were 
available across the cohorts. Analyses were conducted in the full sample 
without stratifying the sample by gender as there were few ADHD cases 
among girls after accounting for exposure and confounder data. In the 
analyses, both maternal and teacher reports were used. Descriptive 
statistics of ADHD measures with maternal and teacher report after 





The sample size varied depending on the instrument used and whether 
ADHD symptoms were assessed by parents or teachers. Children assessed 
with maternal reported DAWBA scale were on average 7.7 years old, 6.8 
years old when ADHD symptoms were assessed with SDQ scale and 8.3 
years old when ADHD symptoms were reported by teachers. The total 
available sample size where any items were answered was 8,005 when 
maternal reported DAWBA scale was used, 8,267 when SDQ scale was used 
and 6,222 when teacher reported DAWBA and SDQ scales were used. 
However, analyses were performed accounting for four missing items for 
total ADHD symptoms, two missing items for hyperactive-impulsive and 
inattentive symptoms and one missing item when SDQ scale was used. 
Missing items were accounted for by calculating row mean scores which 
was used as an outcome measure.  Accounting for missing items when 
questionnaire data has been used, has been applied before in psychology 
research (Forand and DeRubeis, 2013; Hazel et al., 2014). 
 
The distribution of maternal and teacher reported ADHD symptoms based 
on row mean scores are shown in Figures 3.1 and 3.2.  
 
Scores were zero-inflated and therefore binary variables were derived using 
85 percentile threshold of total symptoms and separately for hyperactive-
impulsive and inattentive symptoms to represent the children with the 
greatest number of symptoms. Although maternal reported ADHD 
symptoms score measured with SDQ was not zero-inflated and the 
distribution was right-skewed, a binary variable was derived using the same 
threshold for consistency.  
 
As shown in Table 3.1, in total there were 1,152 children above the 85th 
percentile threshold with higher risk for more severe ADHD symptoms, 
1,015 children with more severe hyperactivity symptoms and 1,088 children 
with more severe inattention symptoms rated with maternal reported 
DAWBA scale. 909 children were above the 85th percentile threshold with 




more severe ADHD, hyperactive-impulsive and inattention symptoms were 
similar with teacher reported DAWBA and SDQ scales (Table 3.2).  
 
Correlations between maternal and teacher reported ADHD symptom 
scales together with the sample sizes are shown in Table 3.3. The 
correlation between ADHD total symptoms and hyperactive-impulsive and 
inattention symptom domains with maternal reported DAWBA scale was 
similar for both symptom domains (r = 0.93) but somewhat higher with 
inattention symptom domain on the teacher reported DAWBA scale (rINA = 
0.94; rHYP = 0.87).  
The correlation between maternal reported DAWBA and SDQ scales was 
moderate (r = 0.63), but higher in teacher reported DAWBA and SDQ scales 
(r = 0.90). Furthermore, the correlation between maternal and teacher 
reported DAWBA and SDQ scales was low (rDAWBA = 0.47; rSDQ = 0.41) 



























(boys/gir ls)  




18 4 0.275 0.380 0.611 1,152 (14.56%) 
(787/365) 
HYPERACTIVE  7,996 7,933 4,069/3,864 7.5-9.3 years 
(7.7, 0.14) 
9 2 0.274 0.405 0.667 1,015 (12.79%) 
(688/327) 
INATTENTIVE 7,978 7,922 4,057/3,865 7.5-9.3 years 
(7.7, 0.14) 
9 2 0.277 0.413 0.667 1,088 (13.73%) 
(739/349) 
ADHD (SDQ) 8,267 8,148 4,186/3,962 6.7-8.4 years 
(6.8, 0.11) 
5 1 0.677 0.473 1.2 909 (11.16%) 
(606/303) 






























(boys/gir ls)  
ADHD (DAWBA) 6,214 6,210 3,132/3,078 7.7-9.5 years 
(8.3, 0.31) 
19 4 0.353 0.441 0.789 911 (14.67%) 
(717/194) 
HYPERACTIVE  6,213 6,209 3,131/3,078 7.7-9.5 years 
(8.3, 0.31) 
9 2 0.213 0.413 0.556 813 (13.09%) 
(656/157) 
INATTENTIVE 6,214 6,210 3,133/3,077 7.7-9.5 years 
(8.3, 0.31) 
10 2 0.479 0.546 1.1 807 (13%) 
(616/191) 
ADHD (SDQ) 6,222 6,207 3,131/3,076 7.7-9.5 years 
(8.3, 0.31) 
5 1 0.538 0.544 1.2 717 (11.55%) 
(569/148) 




Figure 3.1. Distribution of ADHD symptoms score with maternal reported 
DAWBA and SDQ scales in ALSPAC 
 






Figure 3.2. Distribution of ADHD symptoms score with teacher reported 
DAWBA and SDQ scales in ALSPAC 
 
























ADHD (DAWBA) 1.00 
(N=7,913)        
HYPERACTIVE (DAWBA) 0.928 
(N=7,900) 
1.00 
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3.2.4 Assessment of parental prenatal substance use 
Maternal and paternal smoking, alcohol and caffeine use during pregnancy 
were measured at 18 weeks of gestation. Additionally, mothers were asked 
about their consumption behaviour at 8 and 32 weeks of gestation. The 
questionnaire “Your Environment” was designed to collect measures 
around early pregnancy (approximately 8 weeks of gestation), this was 
administered at enrolment to pregnant women who joined the study 
before 23 weeks gestation. The range of gestational ages were from 6-28 
weeks. The 32 weeks gestation questionnaire (“Having a baby”) was sent 
out to mothers in the study at 32 weeks, for mother’s enrolling after 32 
weeks gestation the questionnaire was sent out at enrolment. The range of 
gestational ages covered by this questionnaire were from 32-40 weeks. 
 
An overview of exposure assessments in mothers and fathers is given in 
Table 3.4. 
Table 3.4. Maternal and paternal exposure assessment in ALSPAC 
MOTHER 
8 weeks of gestation 
Smoking 
Number of cigarettes currently smoked per day 
Alcohol consumption 
Alcoholic drinks consumed during the week and weekend 
Caffeine consumption 
Number of cups of tea and coffee consumed per day (caffeinated 
and decaffeinated) 
18 weeks of gestation 
Smoking 
Have ever been a smoker 
What age started smoking regularly 
Stopped smoking during pregnancy 
Number of cigarettes smoked before pregnancy, first 3 months of 
pregnancy and past 2 weeks 
Exposure to passive smoke at home and work 




Number of cigarettes partner smokes 
Alcohol consumption* 
Amount of alcohol consumption (in units) before current 
pregnancy, during first 3 months of pregnancy and at the time 
when they first felt the baby move, per day/week 
Number of days consumed at least 4 units of alcohol in one 
occasion 
Amount of partner’s average alcohol consumption (in units) per 
day/week 
Caffeine consumption** 
Number of cups of coffee, tea and cola consumed per day during 
the week and weekend 
Type of drink consumed (caffeinated, decaffeinated or both) 
FATHER 
Smoking 
Have ever been a smoker 
Age started smoking 
Stopped smoking during partner’s pregnancy 
Number of cigarettes smoked at the start of their partner’s 
pregnancy and in the last 2 weeks 
Alcohol consumption 
Amount of alcohol consumption before their partner’s pregnancy 
and first 3 months of their partner’s pregnancy, units per 
day/week 
Number of days had more than 4 units of alcohol in the past 
month 
Caffeine consumption 
Number of cups of caffeinated and decaffeinated coffee and tea 
consumption per day 
Number of cups of cola consumption per week 
32 weeks of gestation 
MOTHER 
Smoking 
Number of cigarettes per day currently smoking 
Time exposed to passive smoke 
Alcohol consumption 
Average alcohol consumption in units during week and weekend 






Number of cups of caffeinated and decaffeinated coffee, tea and 
cola drinking per day 
*1 unit or 1 drink of alcohol is equivalent to 8 grams of alcohol 
**caffeine consumption was transformed into milligrams of caffeine in a day. In 
ALSPAC, caffeine transformation has been used for a cup of coffee 75mg; a cup of 
tea 40mg and a can of cola 33mg 
 
3.2.4.1 Descriptive statistics of parental socio-demographic characteristics and 
prenatal substance use 
Overview of maternal and paternal socio-demographic characteristics and 
substance use during the 1st pregnancy trimester in the full and analysis 
sample is given in Table 3.5.  
 
Visual comparisons of maternal and paternal smoking, alcohol and caffeine 
consumption during the 1st pregnancy trimester in the full sample are 
presented in Appendices 3.1-3.3.  
 
The mean age of mothers at child’s birth in the full sample was 28 years and 
in fathers 30 years. In the analysis sample mothers were on average a year 
older (mean age at child’s birth 29 years). 
 
In the full sample, the majority of participants were Europeans (~97%) and 
married (75%), but the proportion of mothers who were married was even 
higher in the analysis sample (81%).  
 
Comparing maternal and paternal educational qualifications in the full 
sample, there were more fathers with the Certificate of Secondary 
Education (CSE) level and degree level education (22% and 21%) than 
mothers (20% and 13%). However, O-level qualification was more frequent 
in mothers (35%) compared to fathers (22%). Compared to the full sample, 
the proportion of mothers and fathers with degree level education was 
higher in the analysis sample (16% of mothers and 23% of fathers) and 
fewer parents with the CSE level education remained to the study (14% of 





In terms of social class distribution (based on the Office of Population 
Censuses and Surveys in the UK), in the full sample more fathers had a 
higher social class (47%) compared to mothers (37%) and this proportion 
was even higher in the analysis sample (51% of fathers and 41% of mothers 
with I and II level). Whereas more mothers had skilled non-manual 
occupation (43%) than fathers (11%). However, nearly 4,000 mothers did 
not report about their social class.  
 
Comparing parental mental health in the full and analysis sample, the 
proportion of mothers who screened positive for depression and anxiety 
was lower in the analysis sample. The proportion was more similar among 
fathers.  
 
Comparing maternal and paternal prenatal substance use in the full and 
analysis sample, there were more mothers and fathers who reported no 
smoking in the analysis sample (81% of mothers and 70% of fathers) than in 
the full sample (75% of mothers and 66% of fathers). As well as the 
proportion of mothers and fathers who reported smoking >10 cigarettes 
per day was smaller in the analysis sample (9% of mothers and 21% of 
fathers) than in the full sample (14% of mothers and 25% of fathers). 
Proportion of mothers and fathers consuming alcohol were similar in the 
full and analysis sample but proportion of mothers who reported higher 
caffeine consumption (>300mg/day) was a bit smaller in the analysis 
sample (21%) than in the full sample (24%). However, more than 2,000 
fathers did not report about their prenatal consumption behaviour. 
 
Overview of maternal and paternal smoking, alcohol and caffeine 
consumption correlations in the full and analysis sample is given in Tables 
3.6 and 3.7.  
 
Overall, correlations between maternal and paternal prenatal substance 
use in the full and analysis sample were similar. The highest correlation in 
the analysis sample was between maternal prenatal smoking and caffeine 




smoking and caffeine consumption was 0.12. The correlation between 
maternal prenatal smoking and alcohol consumption was 0.12 which in 
fathers was 0.01. The correlation between alcohol and caffeine 
consumption was similar in mothers (r = 0.09) and fathers (r = 0.07). 
The highest correlation between maternal and paternal substance use was 
in smoking (r = 0.37). Correlation between parental alcohol consumption 
was 0.22 and parental caffeine consumption 0.19. These correlations 
indicate that mothers smoke and consume less alcohol and caffeine during 















Sample size N=13,697 N=7,886 N=9,999 N=6,608 
Age (child’s birth) (15-44 years) 
Mean 28 years; SD 4.98 
(15-44 years) 
Mean 29 years; SD 4.61 
(16-75 years) 
Mean 30 years; SD 6.71 
(16-75 years) 
























































































































Mean 2.9; SD 3.53 
1871 
7,455  











































































<1 drink a week 
>1 drink a week 
























































*CSE reflects to the certificate of secondary education. O level is equivalent to grades D and E and A level is equivalent to grades A to C after GCSE examination. Degree level reflects to 

















Maternal smoking 1.00 
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Maternal smoking 1.00 
7,731      




    






   




































3.3 THE GENERATION R (GENR) 
3.3.1 Cohort profile 
The Generation R (GenR) is a population-based prospective cohort study 
in Rotterdam in the Netherlands designed to investigate environmental and 
genetic causes of health and development from fetal life until young 
adulthood. GenR recruited 9,778 pregnant women who were expected to 
give birth between April 2002 and January 2006 in Rotterdam. Of all eligible 
pregnant women, 61% agreed to participate in the study. The final baseline 
sample size included 9,749 children and 80% of the sample has been 
followed up until age 13 years. The GenR is a multi-ethnic cohort. Besides 
Dutch ethnicity, other largest ethnic groups making up the GenR cohort are 
Surinamese, Turkish and Moroccan. In terms of representativeness of the 
study population, parents in GenR had a higher socio-economic status 
compared with the general population in the Netherlands.   
 
Data collection in GenR included self-reported questionnaires, interviews, 
physical examinations, behavioural observations, as well as magnetic 
resonance imaging (MRI) and biological samples (Jaddoe et al., 2006; 
Kooijman et al., 2016).  
 
The GenR study was approved by the local Medical Ethical Committee (MEC 
198.782/2001/31). Written informed consent was obtained from all 
participating women. 
3.3.2 Genome-wide data and quality control 
Genotype data were either collected from cord blood at birth (Illumina 
610K Quad Chip)  for 5,908 children (Generation R-1) and for additional 320 
samples blood sample were collected by venipuncture (Illumina 660K Quad 
Chip) during a visit to the research centre at age 6 years (Generation R-2). 
Variants were filtered for minor allele frequency (MAF < 0.01), Hardy‐–




were additionally filtered on relatedness, sex mismatch and a total of 178 
samples with genotyping rates lower than 97.5 % were excluded from the 
final projects (Generation R-1 and Generation R-2 sets). The combined 
dataset, merged using only SNPs common to both platforms (n = 5,809), 
consisted of 549,511 SNPs. Imputation was based on two different 
reference panels: HapMap Project Phase II Release 22, build 36 phasing and 
1000 Genomes Project (phase III release version), build 37 phasing. After 
imputation and restricting on MAF < 0.01 18,804,120 SNPs were included. 
 
Individuals from European descent were selected within 4 standard 
deviations on the first four genetic principal components of the HapMap 
Phase II Northwestern European (CEU) population. The final genome-wide 
data is available for 5,732 children from different ethnic backgrounds and 
for 2,661 children from the European ethnicity.  
 
Currently (as of 2nd March 2020) maternal genotype data is not available yet 
and is going through quality control procedure. More details about the 
genotyping procedure and quality control can be found elsewhere (Medina-
Gomez et al., 2015). 
3.3.3 Assessment of ADHD 
3.3.3.1 The revised Conners’ Parent Rating Scale (CPRS-R) 
The CPRS-R was developed for screening and assessing child’s behavioural 
problems based on parental report (Conners et al., 1998). The CPRS-R has 
full and short versions. The full CPRS-R comprises seven subscales: 
cognitive, oppositional, hyperactive-impulsive, anxious-shy, perfectionism, 
psychosomatic and social problems. The hyperactive-impulsive subscale 
consists of nine items and the cognitive problems subscale twelve items 
which are rated on 4-point Likert scale (0 = not at all true to 3 = very much 
true). The short version comprises four subscales: oppositional, cognitive 
problems/inattention, hyperactivity and ADHD index, which was included to 





The CPRS-R has both maternal and teacher report and the instrument has 
been found to be good for distinguishing ADHD symptom domains 
(inattention and hyperactive-impulsive), identifying children with higher 
risk of ADHD diagnosis and monitoring treatment outcomes in clinical 
settings (Conners et al., 1998; Gianarris et al., 2001).  
 
In GenR, maternal report of the CPRS-R was used in the analyses at age 7.5 
years.  
3.3.3.2 The Child Behavior Checklist (CBCL) 
The CBCL (now called the Achenbach System of Empirically Based 
Assessment) provides information on child’s behavioural problems and 
social competencies (Achenbach, 1991). The CBCL has two versions: the 
preschool questionnaire for children at age 1.5 to 5 years and school-age 
questionnaire for children and adolescents at age 6 to 18 years. The CBCL 
has 8 subscales: anxious/depressed, withdrawn/depressed, somatic 
complaints, social problems, thought problems, attention problems, rule-
breaking behaviour and aggressive behaviour. These are further divided 
into two broader groups: internalising and externalising problems 
(Achenbach, 1991). Attention problems subscale consists of 5 items in the 
preschool version and 10 items in the school-age version. These are rated 
using a 3-point scale: 0 = not true; 1 = somewhat true; and 2 = very true. 
 
The CBCL also provides DSM-IV oriented scales associated with anxiety, 
oppositional defiant disorder, conduct problems, somatic problems, 
affective problems, and attention deficit disorder. The CBCL has parental, 
teacher (Teacher Report Form (TRF)) and children’s self-report version 
(Youth Self-Report (YSR)). The CBCL has been widely used in different 
cultural settings with good psychometric properties (Achenbach et al., 
2008). 
 
In GenR, maternal report has been used at age 1.5, 3, 6, 7.5, 9 and 14 years. 
Teacher report is available at age 7 years and children’s own self-report at 
age 9 and 14 years. In the analyses I used maternal and teacher report of 




3.3.3.3 Descriptive statistics of ADHD measures 
Descriptive statistics of ADHD measures with maternal and teacher report 
after excluding siblings and accounting for missing items is given in Table 
3.8. 
 
The mean age of children assessed with maternal reported CPRS-R scale 
was 8.2 years. Children were on average 6.1 years old when ADHD 
symptoms were assessed with CBCL and 6.7 years old when TRF was used. 
The total available sample size where any items were answered when 
assessed with the CPRS-R scale was 4,589, 6,142 when assessed with CBCL 
scale and 4,609 when TRF was used.  
 
However, I performed the analyses accounting for up to three missing items 
for total ADHD symptoms, two missing items for hyperactive-impulsive and 
inattention symptoms measured with CPRS-R, one missing item when CBCL 
scale was used and four missing items were allowed with TRF. Missing 
items were accounted for by calculating weighted sum scores for each 
scale. 
  
The distribution of ADHD symptoms measured with CPRS-R, CBCL and TRF 
is shown in Figure 3.3.  
 
Scores were mostly zero-inflated, except total ADHD symptoms score 
measured with CPRS-R which was right-skewed. Therefore, as in ALSPAC, I 
derived binary variables using 85 percentile threshold of total symptoms 
and separately for hyperactive-impulsive and inattentive symptoms to 
represent these children with the higher risk for ADHD symptoms.  
 
As shown in Table 3.8, there were 549 children above the 85th percentile 
threshold with higher risk for more severe ADHD symptoms, 477 children 
with more severe hyperactive-impulsive symptoms and 424 children with 
more severe inattention symptoms rated with CPRS-R scale. 750 children 





Correlations between the scales used for assessing ADHD symptoms 
together with the sample sizes are shown in Table 3.9.  
 
The correlation with ADHD total symptoms was higher for inattention 
symptoms domain (r = 0.89), compared to hyperactive-impulsive symptoms 
domain (r = 0.72). The correlation between maternal reported CPRS-R and 
CBCL scales was moderate (r = 0.55) but lower between CPRS-R and TRF (r = 
0.37). Furthermore, the correlation was even lower between TRF and CPRS-
R hyperactive-impulsive symptom domain (r = 0.30) and somewhat higher 
between TRF and CPRS-R inattention symptom domain and CBCL scale (r = 
0.36). This indicates differences depending on the instrument and rater 






























(boys/gir ls)  
ADHD (CPRS-R) 4,589 3,849 1,911/1,938 7.5-10.8 years 
 (8.2, 0.23) 
18 3 7.24 6.63 14 549 (13.9%) 
(345/204) 
HYPERACTIVE  4,587 3,853 1,913/1,940 7.5-10.8 years 
(8.2, 0.23) 
9 2 2.13 2.72 5 477 (10.6%) 
(300/177) 
INATTENTIVE 4,589 3,854 1,911/1,943 7.5-10.8 years 
(8.2, 0.23) 
9 2 3.15 3.38 7 424 (12.1%) 
(268/156) 
CBCL 6,142 5,183 2,601/2,582 4.9-9.1 years 
(6.1, 0.49) 
5 1 1.54 1.74 3 750 (13.5%) 
(464/286) 
TRF 4,609 3,952 2,003/1,949 4.2-9.97 years 
(6.7, 1.30) 
25 4 6.79 8.78 15 623 (15%) 
(464/159) 




Figure 3.3. Distribution of ADHD symptoms score measured with CPRS-R, 
CBCL and TRF scales in GenR 
 
Note: Revised Conners’ Parent Rating Scale (CPRS-R), Child Behavior Checklist 















ADHD (CPRS-R) 1.00 
3,849 
 
   
HYPERACTIVE (CPRS-R) 0.719 
3,847 
1.00 
3,854    
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3.3.4 Assessment of parental prenatal substance use 
Maternal smoking, alcohol and caffeine consumption during pregnancy 
were measured in each pregnancy trimester. Paternal smoking and alcohol 
consumption were assessed in the 2nd pregnancy trimester only. 
An overview of parental exposure assessment is given in Table 3.10.  
Table 3.10. Maternal and paternal exposure assessment in GenR 
MOTHER 
<18 weeks of gestation 
Smoking 
Stopped or continued smoking during pregnancy 
Number of cigarettes smoked before pregnancy and in the past 3 
months of pregnancy 
Time exposed to passive smoke at home and work 
Partner’s current smoking status before pregnancy 
Number of cigarettes partner smoked before pregnancy 
Alcohol consumption* 
Number of glasses of alcohol consumed before pregnancy and in 
the past 3 months of pregnancy (per week/day) 
Number of days consumed more than 6 glasses a day in the past 
3 months 
Number of glasses of alcohol partner consumed before 
pregnancy (per week/day) 
Caffeine consumption** 
Number of cups of coffee and tea consumed per day in the past 3 
months 
Type of drink consumed (caffeinated, decaffeinated or both) 
18-25 weeks of gestation 
MOTHER 
Smoking 
Number of cigarettes smoked in the past 2 months 
Time exposed to passive smoke at home and work 
Alcohol consumption 
Number of glasses of alcohol consumed in the past 2 months 
(per week/month) 






Number of cups of coffee and tea consumed daily before 
pregnancy and in the past 2 months of pregnancy 
Type of drink consumed (caffeinated, decaffeinated or both) 
FATHER 
Smoking 
Number of cigarettes smoked 2 months before their partner’s 
pregnancy  
Alcohol consumption 
Number of glasses of alcohol consumed per week or day 2 
months before their partner’s pregnancy 
Number of days consumed more than 6 glasses a day in the past 
6 months 
>25 weeks of gestation 
MOTHER 
Smoking 
Number of cigarettes smoked in the past 2 months 
Time exposed to passive smoke at home and work 
Alcohol consumption 
Number of classes of alcohol consumed in the past 2 months per 
week/month 
Number of days consumed more than 6 glasses a day in the past 
2 months 
Caffeine consumption 
Number of cups of coffee and tea consumed daily before 
pregnancy and in the past 2 months of pregnancy 
* A measure of alcoholic drink is based one glass containing 12g of pure alcohol 
**Paternal caffeine consumption was not assessed. Maternal caffeine  
consumption was assessed from coffee and tea and transformed into milligrams a 
day based on that 125ml coffee contains 90mg of caffeine, decaffeinated coffee 
3mg and a cup of tea 45mg 
 
3.3.4.1 Descriptive statistics of parental socio-demographic characteristics and 
prenatal substance use 
An overview of maternal and paternal socio-demographic characteristics 
and substance use during the 1st pregnancy trimester in the full and analysis 





Visual comparisons of maternal and paternal smoking and alcohol 
consumption during the 1st pregnancy trimester in the full sample is 
presented in Appendices 3.4 and 3.5.  
 
The mean age of mothers at study intake in the full sample was 30 years 
and in fathers 33 years. In the analysis sample mothers and fathers were a 
year older (mean age in mothers 31 years and in fathers 34 years). 
 
Nearly 60% of mothers and fathers in the full sample were Europeans. 
Other major ethnic groups were Moroccan, Surinamese and Turkish (nearly 
25% of mothers and fathers in these ethnic groups). However, the 
proportion of mothers and fathers with European ethnicity was bigger in 
the analysis sample (71% of mothers and 78% of fathers).  
 
86% of mothers were married or cohabiting and 14% were single in the full 
sample, but the proportion of mothers either married or cohabiting was 
higher in the analysis sample (91%). 
 
In terms of education, in the full sample, 43% of mothers and 51% of 
fathers had a higher education, 46% of mothers and 41% of fathers had a 
secondary education and 11% of mothers and 8% of fathers had a primary 
education. However, the proportion of mothers and fathers with higher 
education was larger in the analysis sample (54% mothers and 57% of 
fathers) and smaller with primary education (6% mothers and 5% fathers). 
Furthermore, mothers who reported having financial difficulties in the full 
sample (22%) were less likely to remain in the study (15% in the analysis 
sample).  
 
Comparing parental mental health in the full and analysis sample, the 
proportion of mothers who screened positive for depression and anxiety 
was lower in the analysis sample. The proportion was more similar among 
fathers. However, nearly 3,000 mothers and over 2,000 fathers did not 





The proportion of mothers and fathers who reported no smoking was 
similar in the full and analysis sample (analysis sample: 79% of mothers and 
59% of fathers; full sample: 75% of mothers and 56% of fathers). However, 
mothers and fathers who reported smoking were less likely to remain in the 
study (25% of mothers in the full sample compared to 20% in the analysis 
sample and 44% of fathers in the full sample compared to 41% in the 
analysis sample).  
 
The proportion of mothers and fathers who reported no drinking was 
slightly lower in the analysis sample compared to the full sample (57% of 
mothers in the full sample and 49% in the analysis sample and 17% of 
fathers in the full sample and 12% in the analysis sample). Similarly, the 
proportion of mothers who reported lower caffeine consumption 
(<49mg/day) was smaller in the analysis sample (19%) compared to the full 
sample (23%). More than 2,000 mothers and fathers did not report their 
smoking and alcohol consumption.  
 
An overview of maternal and paternal smoking, alcohol and caffeine 
consumption correlations in the full and analysis sample is given in Tables 
3.12 and 3.13.  
 
Overall, correlations between maternal and paternal prenatal substance 
use in the full and analysis sample were similar. The highest correlation in 
the analysis sample were between maternal prenatal alcohol and caffeine 
consumption (r = 0.21) and maternal smoking and caffeine consumption (r 
= 0.16). The correlation between maternal prenatal smoking and alcohol 
consumption was 0.14. The correlation between maternal and paternal 
alcohol consumption was 0.39 and maternal and paternal smoking 0.36. 






Table 3.11. Maternal and paternal socio-demographic characteristics and substance use in the 1st pregnancy trimester in the full and analysis 
sample in GenR 
 Mothers  
(full sample)  
Mothers  
(analysis sample)  
Fathers  
(full sample)  
Fathers  
(analysis sample)  
 N=9,504 N=3,849 N=7,323 N=2,672 
Age (study intake)  15-46 years  
Mean  29.9; SD  5.4 
15-46 years 
Mean 31.4; SD 4.8 
14-68 years  
Mean  33; SD  6 
17-58 years 













































































Financial difficulties  
No difficulties 



























































1-4 cigarettes  
5-9 cigarettes 


























Alcohol consumption  
None 
<1 drink a week 
>1 drink a week 
































































Maternal smoking 1.00 
7,349 
    




   






































Maternal smoking 1.00 
2,446 
    




   






























3.4 THE NORWEGIAN MOTHER, FATHER AND CHILD COHORT STUDY (MOBA) 
3.4.1 Cohort profile 
The Norwegian Mother, Father and Child Cohort Study (MoBa) is a 
prospective population-based pregnancy cohort study in Norway with an 
aim to investigate factors influencing health and disease exposures and 
outcomes throughout the life course. MoBa study began in July 1999 where 
pregnant women were invited to participate until December 2008. After 
the initial recruitment phase, fathers were also invited to participate in the 
study. All pregnant women in Norway were eligible to participate and out 
of 277,702 pregnancies, the participation rate was 41% (Magnus et al., 
2016). The cohort includes more than 114,000 children, 95,000 mothers 
and 75,000 fathers across Norway. Additionally, about 16,400 families with 
two or more pregnancies were included. However, it has been reported 
that women <25 years, those living alone, and smokers were 
underrepresented indicating selection bias in the MoBa study (Nilsen et al., 
2009).  
 
Data collection included self-reported questionnaires, biological and 
environmental samples. Furthermore, all residents in Norway have a 
unique identification number that enables researchers to link the collected 
data with various health registries, such as Medical Birth Registry, National 
Patient Registry and Prescription Database (Magnus et al., 2016).  
 
Informed consent was obtained from all study participants. The 
administrative board of the Norwegian Mother, Father, and Child Cohort 
Study led by the Norwegian Institute of Public Health approved the study 
protocol. The establishment of MoBa and initial data collection was based 
on a license from the Norwegian Data Protection Agency and approval from 
The Regional Committee for Medical Research Ethics. The MoBa cohort is 
currently regulated by the Norwegian Health Registry Act. The study was 





3.4.2 Genome-wide data and quality control 
Approximately 17,000 trios from the Norwegian Mother, Father and Child 
cohort were genotyped in three batches. The first batch, comprising 20,664 
individuals and 542,585 SNPs, was genotyped at the Genomics Core Facility 
(Iceland) using the Illumina HumanCoreExome (Illumina, San Diego, USA) 
genotyping array, version 12 1.1. The second batch, comprising 12,874 
individuals and 547,644 SNPs was genotyped at the Genomics Core Facility 
(Iceland) using the Illumina HumanCoreExome (Illumina, San Diego, USA) 
genotyping array, version 24 1.0. The third batch, comprising 17,949 
individuals and 692,367 SNPs, was genotyped at ERASMUS MC (the 
Netherlands) using the Illumina Global Screening Array (Illumina, San Diego, 
USA) version 24 1. 
 
Individuals were excluded if they had a genotyping call rate below 95% or 
autosomal heterozygosity greater than four standard deviations from the 
sample mean. SNPs were excluded if they were ambiguous (A/T and C/G), 
had a genotyping call rate below 98%, minor allele frequency of less than 
1%, or Hardy-Weinberg equilibrium P-value less than 1 × 10-6. Relatedness 
was assessed by flagging one individual from each pairwise comparison of 
IBD with a pi-hat greater than 0.1. 
 
Population stratification was assessed, using the HapMap phase 3 release 3 
as a reference by principal component analysis using EIGENSTRAT version 
6.1.4. Visual inspection identified a homogenous population of European 
ethnicity and individuals of non-European ethnicity were removed.  
 
Duplicate samples were removed, and each genotyping batch was split into 
parents and offspring. Quality control (QC) was then conducted by 
genotyping array in parents and offspring separately. 
 
The parents and offspring datasets were then merged into one dataset per 
genotyping batch, keeping only the SNPs that passed quality control in both 
datasets. All individuals passing the genotyping call rate and autosomal 




the merged datasets included individuals previously excluded or flagged as 
a duplicate, ethnic outlier, having a sex discrepancy, or high level of 
relatedness. Concordance checks were then conducted on validated 
duplicates. Duplicate, tri-allelic and discordant (any discordance between 
the validated duplicates) SNPs were excluded. Individuals and SNPs with a 
genotyping call rate below 98% in the merged datasets were excluded. The 
duplicate sample that was removed before the start of the quality control 
was then excluded. Mendelian errors identified by the assessment of duos 
and trios were then recoded to missing. Insertions and deletions were also 
excluded. 
 
After QC the Human Core Exome 12 batch comprised 20,231 individuals 
and 384,855 SNPs, the Human Core Exome 24 batch comprised 12,757 
individuals and 396,189 SNPs, and the Global Screening Array batch 
comprised 17,742 individuals and 568,275 SNPs. Imputation was conducted 
separately for each genotyping batch by using the Haplotype reference 
consortium (HRC) release 1-1 as the genetic reference panel.  
 
Post imputation quality control was performed by removing individuals if 
they had a genotyping call rate less than 99% or were of non-European 
ethnicity. After quality control, a core homogeneous sample of European 
ethnicity (based on principal components analysis (PCA) of markers 
overlapping with available HapMap markers, unrelated (within generation, 
defined as accumulated IBD <0.015 and overall IBD PI_HAT <10%) 
individuals across all batches and arrays were available for use in analysis 
(Nchildren = 15,208; Nmothers = 14,804; Nfathers = 15,198) and in total 5,003,747 
SNPs were included after post imputation.  
 
More details about the genotyping and quality control procedure have 
been reported elsewhere (Helgeland et al., 2019). 
3.4.3 Assessment of ADHD 
Selected items from the shorter form of CBCL was used at age 1.5, 3 and 5 




of the instruments can be found in the section 3.3.3 (“Assessment of ADHD 
in GenR”).  
3.4.3.1 The Parent/Teacher Rating Scale for Disruptive Behavior Disorders (RS-
DBD) 
The RS-DBD was developed to assess oppositional-defiant disorder, conduct 
disorder and ADHD using both parental and teacher ratings. The scale 
consists of 41 DSM-IV oriented items for measuring these three distinctive 
externalising disorders. The ADHD subscale consists of 18 items which are 
rated on a 4-point Likert scale: 1 = not at all; 2 = just a little; 3 = pretty 
much; and 4 = very much (Silva et al., 2005).  
 
In MoBa, currently maternal report is available at age 8 years. In this thesis I 
used only RS-DBD scale as other scales were used at the younger age. 
3.4.3.2 Descriptive statistics of ADHD measure 
Descriptive statistics of ADHD measure are given in Table 3.14. The mean 
age of children assessed with maternal reported RS-DBD scale was 8.2 
years. The total available sample size where any items were answered was 
43,512. The maximum sample size used in analyses was 43,451. As in 
ALSPAC, analyses were performed accounting for four missing items for 
total ADHD symptoms, two missing items for hyperactive-impulsive and 
inattentive symptoms by calculating row mean scores.  
 
The distribution of ADHD symptoms based on row mean scores is shown in 
Figure 3.4.  
 
The distribution of ADHD symptoms was right-skewed and to keep 
consistency with ALSPAC and GenR cohorts, I derived binary variables  by 
using 85 percentile threshold of total symptoms and separately for 
hyperactive-impulsive and inattentive symptoms. There were 5,808 
children with higher risk for more severe ADHD symptoms, 5,738 children 
with more severe hyperactivity symptoms and 5,082 children with more 
severe inattention symptoms.  




The correlation matrix between ADHD symptom domains is given in Table 
3.15.  
 
The correlation was high between ADHD total symptoms and hyperactive-
impulsive (r = 0.89) and inattention symptom domains (r = 0.90) but was 
lower between hyperactive-impulsive and inattention symptom domains (r 
= 0.61). This indicates that RS-DBD scale is capturing different symptom 
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18 4 1.474 0.401 1.833 5,808 (13.37%) 
(3,870/1,938) 
HYPERACTIVE  43,500 43,433 22,109/21,247 7.9-10.3 years 
 (8.2, 0.17) 
9 2 1.396 0.434 1.777 5,738 (13.21%) 
(3,683/2,055) 
INATTENTIVE 43,467 43,451 22,127/21,247 7.9-10.3 years 
(8.2, 0.17) 
9 2 1.553 0.460 2 5,082 (11.70%) 
(3,369/1,713) 




Figure 3.4. Distribution of ADHD symptoms score with the maternal 
reported RS-DBD scale in MoBa 
 
 Note: Rating Scale for Disruptive Behavior Disorders (RS-DBD) 
 
Table 3.15. Correlation matrix of ADHD subscales measured with the RS-
DBD scale in MoBa  
 ADHD HYPERACTIVE INATTENTIVE 





















3.4.4 Assessment of parental prenatal substance use 
Maternal smoking and alcohol consumption during pregnancy were 
measured at 17 and 30 weeks of gestation and 6 months after the child’s 
birth. Caffeine consumption during pregnancy was measured at 17 and 30 
weeks of gestation.   
 
Paternal smoking, alcohol and caffeine consumption was assessed at 17 
weeks of gestation.  
 
Overview of maternal and paternal exposure assessment is given in Table 
3.16. 
 
Table 3.16. Maternal and paternal exposure assessment in MoBa  
MOTHER 
17 weeks of gestation 
Smoking 
Have ever been a smoker 
Stopped smoking after becoming pregnant 
Number of cigarettes smoked per day and week before 
pregnancy and after pregnancy was known 
Exposure to passive smoke at home and work 
Partner’s current smoking status 
Alcohol consumption* 
Frequency and number of units of alcohol consumed 3 months 
before pregnancy and during pregnancy per week/month  
Frequency of drinking 5 alcohol units or more at least once in the 
last 3 months before pregnancy and during pregnancy 
Caffeine consumption** 
Number of cups/glasses of caffeinated and decaffeinated coffee, 
tea and cola consumption per day  
FATHER 
Smoking 
Have ever been a smoker 
Number of cigarettes smoked 6 months before their partner’s 





Ever drunk alcohol 
Frequency and number of units of alcohol consumed 6 months 
before partner’s pregnancy and after partner become pregnant 
per week/month 
Frequency of drinking 5 alcohol units or more at least one 
occasion 6 months before partner’s pregnancy and after partner 
become pregnant  
Caffeine consumption 
How often consumed coffee, tea and cola weekly and daily 
30 weeks of gestation 
MOTHER 
Smoking 
Number of cigarettes per day currently smoking 
Exposure to passive smoke at home and work 
Partner’s smoking status 
Number of cigarettes partner smokes per day 
Alcohol consumption 
Frequency and number of units of alcohol consumed 3 months 
before pregnancy, 0-12 weeks of pregnancy, 13-24 weeks of 
pregnancy and 25+ weeks of pregnancy per week/month 
Frequency of drinking 5 alcohol units or more at least once 3 
months before pregnancy, 0-12 weeks of pregnancy, 13-24 weeks 
of pregnancy and 25+ weeks of pregnancy 
Caffeine consumption 
Number of cups/glasses of caffeinated and decaffeinated coffee, 
tea and cola drinking per day after the 13th week of pregnancy 
6 months after the child’s birth 
MOTHER 
Smoking 
Number of cigarettes per day smoked last 3 months of pregnancy 
Number of cigarettes per day partner smoked last 3 months of 
pregnancy 
Alcohol consumption 
Frequency and number of units of alcohol consumed last 3 
months of pregnancy per week/month 
*A measure of alcoholic unit and 1 drink was equivalent to 12.8 grams of pure 
alcohol; **Caffeine consumption into milligrams a day was transformed based  
on a cup of boiled/filtered coffee contains 85mg of caffeine, instant/espresso coffee 





3.4.4.1 Descriptive statistics of parental socio-demographic statistics and 
prenatal substance use 
An overview of maternal and paternal socio-demographic characteristics 
and substance use during the 1st pregnancy trimester in the full and analysis 
sample is given in Table 3.17.  
 
Visual comparisons of maternal and paternal smoking, alcohol and caffeine 
consumption during the 1st pregnancy trimester in the full sample are 
presented in Appendices 3.6-3.8.  
 
The mean age of mothers at child’s birth in the full sample was 30 years and 
in fathers 33 years, whereas in the analysis sample mothers were a year 
older (mean age at child’s birth 31 years). The majority of participants were 
married or cohabiting (96%).  
 
Comparing maternal and paternal education in the full sample, mothers 
were more highly educated (64%) than fathers (51%). The proportion of 
mothers and fathers with higher education was even higher in the analysis 
sample (72% of mothers and 56% of fathers). Further, 17% of mothers 
reported having financial difficulties in the full sample comparing with 14% 
in the analysis sample, but more than 22,000 mothers did not report 
financial difficulties at the initial assessment.   
 
In terms of parental mental health, 8% of mothers screened positive for 
depression and anxiety problems in the full sample and 6% in the analysis 
sample. Among fathers the proportion who screened positive for 
depression and anxiety problems was similar in the full and analysis sample 
(3%). The proportion of mothers and fathers who screened positive for 
more severe ADHD symptoms was similar in the full and analysis sample 
(3% in mothers and 5% in fathers). However, there is a substantial degree 






Comparing maternal and paternal prenatal substance use in the full and 
analysis sample, the proportion of mothers and fathers who reported no 
smoking was similar in the analysis sample (94% of mothers and 79% of 
fathers) and in the full sample (92% of mothers and 77% of fathers).  
Likewise, proportions in the maternal and paternal alcohol and caffeine 
consumption were similar in the full and analysis sample although more 
than 21,000 mothers and nearly 50,000 fathers did not report their alcohol 
consumption.  
 
An overview of maternal and paternal smoking, alcohol and caffeine 
consumption correlations in the full and analysis samples is given in Tables 
3.18 and 3.19.  
 
Overall, correlations between maternal and paternal prenatal substance 
use in the full and analysis samples were similar.  
 
In the analysis sample, the highest correlations were between maternal 
prenatal smoking and caffeine consumption (r = 0.19) and maternal 
prenatal alcohol and caffeine consumption (r = 0.17). Whereas correlation 
between maternal prenatal smoking and alcohol consumption was 0.04. 
 
In fathers, the correlation between prenatal alcohol and caffeine 
consumption was higher (r = 0.24) than between prenatal smoking and 
caffeine consumption (r = 0.13) and prenatal smoking and alcohol 
consumption (r = 0.05). The highest correlation between maternal and 
paternal prenatal substance use was in smoking (r = 0.29) and was more 






Table 3.17. Maternal and paternal socio-demographic characteristics and substance use in the 1st pregnancy trimester in the full and analysis 
sample in MoBa 
 Mothers  
(full sample) 
Mothers  
(analysis sample)  
Fathers 
 (full sample)  
Fathers 
 (analysis sample)  
 N=114,143 N=43,364 N=77,648 N=35,376 
Age (child’s birth)*  16-46 years  
(Mean 30; SD 4.65)  
16-46 years 
(Mean 31; SD 4.41) 
17-60 years  
(Mean 33; SD 5.32)  
17-60 years 





















































































































1-4 cigarettes  
5-9 cigarettes 






















Alcohol consumption  
None 
<1 drink a week 
>1 drink a week 










































































Maternal smoking 1.00 
103,119      




    






   


















































Maternal smoking 1.00 
42,740      




    






   






































3.5 COHORT COMPARISON 
A comparison of the cohorts’ parental socio-demographic characteristics 
and substance use during the 1st pregnancy trimester in the analysis 
sample is given in Table 3.20. The comparison of the cohorts’ child 
characteristics is given in Table 3.21. 
 
In general, the majority of participants were married but mothers and 
fathers in GenR and MoBa were somewhat older at their child’s birth than 
in ALSPAC.  
 
In terms of ethnicity, parents in ALSPAC and MoBa were mostly Europeans 
but in GenR, 29% of mothers and 22% of fathers were Non-Europeans. 
Likewise, in GenR and MoBa parents were more highly educated comparing 
with parents in ALSPAC.  
 
However, mothers in ALSPAC reported having more financial difficulties 
(60%) compared to mothers in GenR (15%) and MoBa (14%). Furthermore, 
mothers and fathers in ALSPAC had more depression and anxiety symptoms 
compared to mothers and fathers in GenR and MoBa.  
 
In terms of parental prenatal substance use, mothers in MoBa smoked and 
consumed less alcohol and caffeine during pregnancy compared to mothers 
in ALSPAC and GenR.  
 
Maternal smoking during pregnancy was more similar in ALSPAC (19%) and 
GenR (20%) but mothers in ALSPAC reported drinking more alcohol during 
pregnancy (56%) than mothers in GenR (51%). Similarly, 21% of mothers in 
ALSPAC consumed more than 300mg of caffeine per day, compared to 
mothers in GenR (16%).  
 
Among children, gender distribution was similar in all the cohorts but in 




children in ALSPAC (7.6 years) when ADHD symptoms were assessed using a 
scale that measures hyperactive-impulsive and inattention symptom 
domains.  
 
Furthermore, the proportion of first-born children was higher in GenR 





Table 3.20. Comparison of cohorts’ parental socio-demographic characteristics and parental substance use during the 1st pregnancy trimester in the 
analysis sample 
 ALSPAC GenR MoBA 
Characteristics Mothers Fathers Mothers Father Mothers Fathers 
N 

































































































































































<1 unit per week 
1-6 units per week 




















0-49mg per day 
50-199mg per day 
200-299mg per day 




























* In MoBa, participants are 95% Scandinavians and 5% non-scandinavians; **In ALSPAC, financial difficulties were measured with 5 items questionnaire: 1) Difficulty 
in affording food; 2) Difficulty in affording clothing; 3) Difficulty in affording heating 4) Difficulty in affording accommodation 5) Difficulty in affording things for baby. 
In GenR, financial difficulties were assessed with single item question: Difficulty in paying food, rent, bills and suchlike. In MoBa, financial difficulties were assessed 
with single item question: Have you experienced financial problems?; In MoBa, depression and anxiety symptoms were assessed together 
 
 
Table 3.21. Comparison of cohorts’ child characteristics and maternal reported ADHD cases above the 85th percentile threshold 




7.5 – 9 years 
(Mean = 7.6, SD 0.14) 
3,849 
7.5-11 years 
(Mean = 8.2, SD 0.23) 
43,512 
8-10 years, 

































Proportion of children with 
ADHD symptoms above the 
85th percentile threshold 





3.6 SELECTION OF MEASURES 
The main criterion for selecting outcome measure was availability of the 
instrument that enabled separation of ADHD hyperactive-impulsive and 
inattention symptom domains. In each cohort, this type of instrument was 
available at child age 7.5 - 8 years. In ALSPAC, both maternal and teacher 
report were available (DAWBA), whereas in GenR and MoBa only a 
maternal reported instrument (CPRS-R and RS-DBD) was available. 
Correlations between ADHD total symptoms and hyperactive-impulsive and 
inattention symptom domains were more similar measured with DAWBA (r 
= 0.93) and RS-DBD (r = 0.90) compared to CPRS-R (rHYP = 0.72; rINA = 0.89). 
Moreover, in ALSPAC and GenR additional measures were included for 
ADHD subscale (SDQ, CBCL, TRF) as previous studies have reported 
different findings depending on whether child’s ADHD symptoms were 
reported by mother or teacher, and which assessment instrument was used 
(Narad et al., 2015).  
 
Given that paternal prenatal smoking, alcohol and caffeine use were 
assessed only during the partner’s 2nd pregnancy trimester in each cohort 
(except in GenR where paternal caffeine consumption was not assessed and 
smoking and alcohol consumption were assessed 2 months prior their 
partner’s pregnancy), exposures included in the analyses were based on the 
assessment during the 2nd pregnancy trimester.  
 
Overall, correlations between maternal and paternal substance use were 
similar across the cohorts with a few exceptions. In ALSPAC and MoBa, the 
highest correlation of maternal prenatal substance use was with smoking 
and caffeine consumption (rALSPAC = 0.24; rMOBA = 0.19) whereas in GenR it 
was between alcohol and caffeine consumption (rGENR = 0.21). Furthermore, 
the highest correlation between maternal and paternal substance in 
ALSPAC and MoBa was in smoking (rALSPAC = 0.37; rMOBA = 0.29) but in GenR it 





More detailed information about the measures and coding used in the 
analyses are described in the beginning of each study chapter.  
3.7 CHAPTER SUMMARY 
In this chapter, I have described the cohorts used in this thesis (ALSPAC, 
GenR and MoBa) and provided details about cohorts’ participants, data 
availability, quality control of genome-wide data, and assessment of 
exposures and outcomes. Although availability of data varied between the 
cohorts, socio-demographic characteristics, and the assessment of 





Chapter 4 MATERNAL AND CHILD GENETIC LIABILITY FOR 
SMOKING AND CAFFEINE CONSUMPTION AND CHILD MENTAL 
HEALTH: A PHENOME-WIDE ASSOCIATION STUDY IN THE 
ALSPAC COHORT 
This chapter is based on the manuscript “Maternal and child genetic liability 
for smoking and caffeine consumption and child mental health: An 
intergenerational genetic risk score analysis in the ALSPAC cohort.” The 
manuscript is published in Addiction journal 
https://doi.org/10.1111/add.15521 
 
This study was a collaborative project undertaken by a group of PhD 
students and post-doctoral researchers. Given the ambitious nature of the 
project, we initially allocated tasks by exposures and outcomes. Polygenic 
risk scores were created by a post-doctoral researcher, Dr. Robyn Wootton, 
and a script for running the analyses was written by Dr. Kayleigh Easey. I 
extracted all the variables for maternal exposure and outcome phenotypes 
outside of pregnancy, as well as offspring externalising disorder phenotypes 
in childhood and adolescence and life events phenotype for all the 
subpopulations. Each of us prepared a dataset with their extracted 
variables and a final dataset was merged together. We cross-checked each 
other’s work and the analyses for smoking were run by myself and checked 
by fellow PhD-student Laura Schellhas. I created all the figures and tables 
presented in this chapter. I drafted the discussion and interpretation of the 
results, in particular relative to smoking and offspring externalising 
disorders and sought comments from supervisors before revising for 
publication. Two manuscripts were written as a result of this work: the one 
presented in this chapter, on smoking and caffeine exposure, led by myself 
and Laura Schellhas and published as a joint first-authored paper, and a 
separate manuscript led by Dr Kayleigh Easey, on alcohol exposure, entitled 
“Characterization of alcohol polygenic risk scores in the context of mental 
health outcomes: Within-individual and intergenerational analyses in the 





This chapter investigates associations between genetic risk scores 
predictive of smoking and caffeine consumption and mental health 
outcomes in mothers during and outside of pregnancy, and in offspring in 
childhood and adolescence, by using a targeted Phenome-Wide Association 
Study design.  
4.1 INTRODUCTION 
A large body of research has found that smoking and caffeine consumption 
are often comorbid, and associated with mental health problems and other 
substance use behaviours (Kendler et al., 2008; Lara, 2010; Treur et al., 
2016).  
However, by using observational methods it is difficult to ascertain whether 
these associations are causal, as they may be affected by unmeasured 
environmental confounders and/or explained by shared genetics, or due to 
evocative effects (reverse causation). Evocative effects reflect gene-
environment correlations where parental behaviour is affected by 
children’s genetically determined behaviour and there is evidence that the 
relationship between negative parenting behaviour and children’s 
behavioural problems is bidirectional (Marceau et al., 2013). One approach 
to overcome biased associations because of unmeasured confounding or 
reverse causation is to use genetic variants as proxies for (environmental, 
modifiable) exposures (Davey Smith and Ebrahim, 2003). This approach is 
especially powerful in epidemiological studies where it is not feasible or 
ethical to conduct a randomised controlled trial, such as investigating 
effects of prenatal substance use on child health outcomes. 
 
Large-scale genome-wide association studies (GWASs) have led to the 
discovery of thousands of genetic variants (single nucleotide 
polymorphisms, SNPs) associated with health outcomes and behavioural 
traits. These GWASs have revealed the polygenic nature of psychiatric 
disorders and traits (Maier et al., 2018; Visscher et al., 2012), although SNPs 
identified in GWASs explain only a small proportion of the trait variation, 




2012). These SNPs can be aggregated into genetic risk scores and can help 
to predict genetic risk for a disease (Maier et al., 2018; Wray et al., 2014). 
The Phenome-Wide Association Study (PheWAS) method can be used to 
test associations between single genetic variants or genetic risk scores and 
a wide range of phenotypes (Figure 4.1).  
 




The availability of large-scale data resources, such as from electronic health 
records, longitudinal studies or biobanks has made it possible to test 
associations between genetic variants and a broad range of phenotypes in 
this hypothesis-free manner (Leppert et al., 2020; Verma et al., 2019). The 
PheWAS approach is useful for replicating exposure-outcome associations 
found in GWASs, discovering novel associations, and detecting pleiotropic 
effects where the same genetic variants are associated with multiple traits 
(Pendergrass et al., 2013; Pendergrass et al., 2015). 
 
For example, a PheWAS investigating alcohol and nicotine use in a sample 
of 26,394 women from different ethnicities replicated previously known 
genetic associations, such as the associations between smoking, lung 
cancer and asthma, as well as the associations between alcohol, education 
and income (Polimanti et al., 2016). However, this study also found 




(Polimanti et al., 2016). The same study concluded that genetic variations 
underpinning alcohol and nicotine use have much broader effects than 
previously known, and that PheWAS is a powerful approach to discover 
these new potential pathways (Polimanti et al., 2016). Another PheWAS 
investigated associations between polygenic risk scores (PRSs) of five 
common psychiatric disorders (ADHD, autism, schizophrenia, major 
depression and bipolar disorder) and various socio-demographic, lifestyle, 
physical and mental health outcomes in UK Biobank. The authors concluded 
that besides major genetic overlap across the disorders, disorder-specific 
effects also exist. For instance, the PRS for ADHD was associated with a 
history of physical maltreatment, while the PRS for bipolar disorder was 
associated with higher educational attainment (Leppert et al., 2020). 
 
Furthermore, PheWAS can be targeted, focusing on traits from specific 
domains such as psychopathology (Krapohl et al., 2016), or combined with 
other methods such as Mendelian Randomization (MR) to uncover which of 
the observed associations could be causal (Millard et al., 2015; Shen et al., 
2020). Overall, PheWAS is an important emerging method to explore the 
genome and phenome together in a hypothesis-free manner to discover 
the genetic architecture of complex traits, and identify potential causal 
pathways. 
 
In this study, we used a targeted PheWAS approach to investigate whether 
maternal smoking and caffeine consumption are associated with mental 
health outcomes in offspring. The study aims were to: 1) validate that the 
PRS of smoking and caffeine consumption are associated with consumption 
of these substances in pregnancy and in adolescence. This is important as 
often GWAS has been conducted in non-pregnant adult populations and 
genetic variants identified in GWAS may not predict consumption 
behaviour during pregnancy (Lawlor et al., 2017); 2) investigate 
intergenerational effects by testing associations between maternal and 
offspring PRS and offspring outcomes in childhood before children are likely 
to consume these substances themselves (under age 10 years). This is 




consumption may confound associations; and lastly 3) disentangle potential 
causal effects from pleiotropic effects, by testing associations between 
maternal PRS and mothers own mental health outcomes during and outside 
of pregnancy as well as between offspring PRS on offspring mental health 
outcomes in adolescence. A visual representation of study aims is shown in 
Figure 4.2.  
 
Comparing maternal PRS and offspring PRS analyses for offspring outcomes 
in childhood could give more indication whether some associations could 
be causal. As a child inherits 50% of their genetic variants from mother, a 
stronger maternal PRS and offspring outcome association could indicate 
effect through maternal environment (pre- and/or postnatal). Conversely, 
similar, associations between maternal PRS on maternal mental health 
outcomes during and outside of pregnancy, and offspring PRS on offspring 
mental health outcomes in adolescence, could give indications for potential 
pleiotropic effects. Conversely, similar associations across generations 
(childhood, adolescence, mothers during and outside of pregnancy) would 
reflect pleiotropic effects. Ideally maternal PRS analyses should be adjusted 
for offspring and paternal genetic data to avoid collider bias, but given the 
limited availability of paternal genetic data, often it is not possible. 
Therefore, we compared maternal and offspring PRS analyses on childhood 
outcomes to get more indication about potential causal effects.  
 
It is important to note that the PheWAS approach alone cannot confirm 
whether observed associations are due to the intrauterine exposure to 
caffeine and smoking. Even if we observed that the maternal PRS 
associations are stronger than the offspring PRS associations, the former 
could reflect the effect of the maternal postnatal environment, such as 
maternal mental health status and parenting behaviour. In addition, 
maternal PRS associations may be a result of genetic nurturing, where 
genetic effects are mediated by the environment parents create for their 





Figure 4.2.Overview of study aims using Directed acyclic graph (DAG) 
 
Note: Thick red arrows represent the main aim of the study: investigate intergenerational effects of maternal smoking and caffeine PRS on offspring mental health 
outcomes in childhood. To achieve this: 1) genetic variants of smoking and caffeine use were validated in pregnancy; 2) potential maternal environmental effects 
were disentangled from pleiotropic effects by testing associations between maternal and offspring PRS on offspring outcomes in childhood (<10 years). Childhood 
outcomes were selected under age 10 years as it is unlikely that in this age children are consuming these substances themselves. As child inherits 50% of genetic 
variants from mother, larger effect estimate with offspring PRS would reflect pleiotropic effect (red arrow); 3) to further disentangle causal effects from pleiotropic 
effects, associations were tested between maternal PRS on their own outcomes during and outside of pregnancy, as well as between offspring PRS on their own 
outcomes in adolescence (blue dashed arrows). Consistent associations across generations would reflect pleiotropic effects.   
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4.2.1 Study Population 
We used data from the Avon Longitudinal Study of Parents and Children 
(ALSPAC). More details about the ALSPAC cohort and genotype data can be 
found in Chapter 3 (see section 3.2 “The Avon Longitudinal Study of Parents 
and Children”).  
4.2.2 Phenotype selection 
The main focus of phenotype selection was mental health, but substance 
use and non-mental health phenotypes were also included based on the 
literature indicating high comorbidity with mental health (such as alcohol 
and cannabis use, personality traits, socioeconomic variables, body mass 
index, sleep, physical activity). Some variables were also included to check 
for confounding.  
 
ALSPAC provides data at multiple timepoints for both mothers and 
offspring. We chose to include maternal phenotypes assessed during 
pregnancy (8, 18 and 32 weeks of gestation) and outside of pregnancy (pre- 
and post-pregnancy). Offspring data included phenotypes assessed in 
childhood (age 7-11 years) and adolescence (age 12-18 years). Maternal 
phenotypes assessed before child age 4 years were excluded as the 
transition to parenthood may affect mother’s mental health and mothers 
may be more likely to be pregnant again. For phenotypes that correlated 
highly, we only included the one with the larger sample size. We 
transformed continuous phenotypes that were not normally distributed 
into quantiles and if validated cut-off score was available, we derived binary 
phenotypes. We accounted for zero inflation by transforming continuous 
phenotypes with more than 20% of zero values into 3 categories (0, 
<median, >median).  
 
We transformed caffeine phenotypes (coffee, tea, cola) based on their 
caffeine content. In ALSPAC, caffeine content for a cup of tea was 27mg, for 




et al., 1998). We computed total caffeine consumption per day by summing 
up each drink. We removed extreme outliers, such as consuming more than 
28 cups of coffee and tea per day.  
 
In total, we included 79 phenotypes for mothers during and outside of 
pregnancy and 71 phenotypes for offspring in childhood and adolescence. 
These are listed in Tables 4.1-4.4. The maximum sample size available in 
mothers during pregnancy was 7,269, outside of pregnancy 7,199, in 
offspring during childhood 6,156 and during adolescence 4,974.  
 
We restricted the sample to singletons or one individual from a twin pair 
and to individuals of European ancestry. However, to avoid limiting sample 
size further, we did not restrict analyses to only mother-offspring pairs with 
complete genotype data. Participants who withdrew consent at any stage 
were removed from the analyses. 
 
4.2.2.1 Maternal phenotypes during pregnancy 
Maternal phenotypes assessed during pregnancy are shown in Table 4.1.  
All phenotypes were based on self-report using either questionnaires or 
single item questions. 
 
Depression, anxiety, hypersensitivity to interpersonal rejection and number 
of life events were assessed using validated questionnaires.  
 
Depression was assessed using Edinburgh Postnatal Depressions Scale 
(EPDS) developed by Cox and colleagues (Cox et al., 1987). Cut-off score 
13 points was used as a threshold representing more severe depression 
symptoms (Cox et al., 1996).  
 
Anxiety was assessed with the anxiety sub-scale of the Crown-Crisp 
Experiential Index (CCEI). Cut-off score 85th percentile has been used in 
previous studies representing more severe anxiety symptoms (Capron et 





Hypersensitivity to interpersonal rejection was measured with 
Interpersonal Sensitivity Measure (IPSM) (Boyce and Parker, 1989) which 
has been found to be correlated with neuroticism personality trait (Boyce 
et al., 1990). The IPSM has 5 subscales: inter-personal awareness, need for 
approval, separation anxiety, timidity and fragile inner self. Total score of all 
the subscales was included in the analyses.   
 
Life events were measured with the Life Events Inventory which includes 42 





Table 4.1. Maternal phenotypes during pregnancy 
Mental health Timepoint Substance use Timepoint Non-mental health phenotypes Timepoint 
Binary phenotypes 
Depression symptoms 18 weeks Smoked first three months in 
pregnancy 
18 weeks Physical activity 32 weeks 
Depression symptoms 32 weeks Ever smoked during pregnancy 8 weeks Mother vomited first three months of 
pregnancy 
18 weeks 
Hypersensitivity to interpersonal 
rejection 
18 weeks Stopped smoking  8 weeks   
  Cut down smoking  8 weeks   
Anxiety symptoms 18 weeks Doing hard drugs 18 weeks   
  Cannabis use first three months in 
pregnancy 
8 weeks   
  Consumed more caffeine 8 weeks   
  Never been drinking caffeine 8 weeks   
  Did not change caffeine consumption  8 weeks   
  Reduced caffeine consumption  8 weeks   
  Never drank tea 8 weeks   
  Reduced tea consumption  8 weeks   
  Craved or had more tea 8 weeks   
  Never drank coffee 8 weeks   
  Stopped drinking coffee  8 weeks   
  Reduced coffee consumption 8 weeks   
  Craved or had more coffee 8 weeks   
  Never drank cola 8 weeks   
  Stopped drinking cola  8 weeks   
  Reduced cola consumption 8 weeks   
  Craved or had more cola 8 weeks   






  Binge drinking  18 weeks Number of life events 18 weeks 
  Binge drinking  32 weeks Reactions to becoming a parent 18 weeks 
  Alcohol consumption per week 32 weeks Social class 32 weeks 
  Total caffeine mg/day  18 weeks Highest education 32 weeks 
  Tea mg/day  18 weeks Activity level compared with other 
pregnant women 
32 weeks 
  Coffee mg/day 18 weeks Image-perception during pregnancy 18 weeks 
  Cola mg/day  18 weeks Image-perception change from 
before to during pregnancy 
18 weeks 
  Total caffeine mg/day  32 weeks   
  Tea mg/day 32 weeks   
  Coffee mg/day  32 weeks   






4.2.2.2 Maternal phenotypes outside of pregnancy 
Maternal phenotypes assessed outside of pregnancy (pre- and post-
pregnancy) are shown in Table 4.2. All phenotypes were assessed using 
self-report. Validated questionnaires were available measuring 
depression, anxiety, life events, personality traits and alcohol use based 
on risk levels.  
 
Depression, anxiety and number of life events were measured with the 
same questionnaire as during pregnancy. Although EPDS was originally 
developed to measure post-natal depression, this instrument has also 
been validated for measuring depression outside of pregnancy (Cox et al., 
1996; Thorpe et al., 1993).  
 
Personality traits were measured using the Karolinska Scale of Personality 
(KSP). This instrument was developed to measure personality traits 
relevant for assessing psychopathology in psychiatry (Gustavsson et al., 
1997). The KSP measures 15 personality traits which are assessed in 
subscales: somatic anxiety, psychic anxiety, muscular tension, 
psychasthenia, inhibition of aggression, irritability, guilt, socialization, 
social desirability, monotony avoidance, impulsivity, verbal aggression, 
indirect aggression, suspicion and detachment. 
 
Although previous studies have found that the KSP is comparable with 
other personality questionnaires, such as the Eysenck Personality 
Questionnaire and “Big Five” personality factors from the International 
Personality Item Pool, it has been also found that individual items in some 
subscales overlap with items included in other subscales (Gustavsson et 
al., 2000; Ortet et al., 2002). Considering this, personality traits included 
in this study were based on a previous study in ALSPAC where latent 
variable analysis was performed to construct the traits distinct from other 
domains (Pearson et al., 2018). These five traits included in the study 
were: monotony avoidance, impulsivity, verbal anger, suspicion and 




associated with neuroticism and given that the neuroticism phenotype 
was already included during pregnancy (hypersensitivity to interpersonal 





Table 4.2. Maternal phenotypes outside of pregnancy 
Mental health Timepoint Substance use Timepoint Non-mental health phenotypes Timepoint 
Binary phenotypes 
Anxiety score 11 years Ever been a smoker 18 weeks Physical activity 18 years 
Depression score 11 years Mother drank before pregnancy 18 weeks   
Ever had bulimia 12 weeks     
Ever had alcoholism 12 weeks     
Ever had drug addiction 12 weeks     
Ever had schizophrenia 12 weeks     
Ever had anorexia nervosa 12 weeks     
Ever had severe depression 12 weeks     
Ever had other psychiatric problem 12 weeks     
Image perception before pregnancy 18 weeks     
Continuous phenotypes 
Image perception before pregnancy 18 weeks Number of cigarettes smoked before 
pregnancy 
18 weeks Number of life events 11 years 
  Number of cigarettes smoked last 2 
weeks 
8 years Impulsivity trait 9 years 
  Total caffeine intake mg/day 8 years Monotony avoidance trait 9 years 
  Caffeine intake from coffee mg/day 8 years Anger trait 9 years 
  Caffeine intake from tea mg/day 8 years Suspicion trait 9 years 
  Caffeine intake from cola mg/day 8 years Detachment trait 9 years 
  Alcohol consumption daily/units  8 years Social class 4 years 
  Binge drinking 5 years Highest education 5 years 
  Alcohol consumption daily/units 4 years BMI before pregnancy 12 weeks 





4.2.2.3 Offspring phenotypes in childhood 
Offspring phenotypes assessed in childhood are shown in Table 4.3. 
Included phenotypes were measured at child age 7 to 10 years. Most of the 
childhood phenotypes were based on maternal report. Only IQ was 
assessed during the clinic visit and based on the Wechsler Intelligence Scale 
(The WISC-III) (Wechsler et al., 1992). The WISC-III consists of 10 subtests: 5 
of these are assessing verbal abilities and other 5 non-verbal (performance) 
abilities.  
 
Validated questionnaires were available for measuring externalising 
disorder and internalising disorder symptoms. ADHD, conduct disorder and 
emotional problems symptoms were assessed with the SDQ instrument. 
Oppositional-defiant disorder (ODD) and anxiety disorder symptoms were 
assessed with the DAWBA instrument. Specific phobia phenotype was 
derived based on DAWBA bands. Both instruments have been described in 
more detail in Chapter 3 (see section 3.2.2. “ADHD assessment in ALSPAC”). 
Depression symptoms were additionally measured with the Short Mood 
and Feelings Questionnaire (SMFQ) (Angold et al., 1995; Messer et al., 
1995). The Life Events Inventory was used to measure number of life events 
a child had experienced.  
 
Autism diagnosis was derived combining DSM criteria from various 
measures reflecting social, communication and repetitive behaviours up to 
age 9 years (Steer et al., 2010).  
 
Handedness was included as a negative control phenotype, as no 







Table 4.3. Offspring phenotypes in childhood 
Mental health Age Substance use Age Non-mental health phenotypes Age 
Binary phenotypes 
Specific phobia diagnosis 9.5 years Daily tea consumption 8 years Problems with sleep initiation 6.7 years 
Autism diagnosis 9 years Daily coffee consumption 8 years Problems with sleep maintenance 6.7 years 
Continuous phenotypes 
ADHD symptoms 6.7 years Total caffeine intake mg/day 8 years Sleep duration in hours 6.7 years 
Conduct disorder symptoms 6.7 years   Number of life events 6.7 years 
Oppositional-defiant disorder 
symptoms 
7.6 years   IQ 8 years 
Depression symptoms 9.5 years   BMI 7 years 
Emotional problems symptoms  6.8 years   Handedness (negative control 
phenotype) 
11 years 
Anxiety symptoms 7.5 years     





4.2.2.4 Offspring phenotypes in adolescence 
Offspring phenotypes assessed in adolescence are shown in Table 4.4.  
Offspring phenotypes in adolescence were based on self-report and 
maternal reports and measured at age 12 to 18 years.  
 
Maternal report was used for externalising and internalising disorder 
phenotypes assessed with the SDQ, DAWBA and SMFQ scales. Post-
traumatic stress-disorder diagnosis was derived using DAWBA bands.  
 
Maternal report was also used for assessing adolescent caffeine 
consumption.  Self-report was used for depression, anxiety and phobia 
symptoms assessed with the revised Clinical Interview Schedule (CIS-R) 
(Lewis et al., 1992). The depression phenotype used in this study was a sum 
of 5 depression symptom scores. Anxiety and phobia phenotypes were 
based on total symptom scores.  
 
Psychosis interview was used to measure negative and positive symptoms 
of psychosis. Additionally, measures of psychosis-like symptoms (PLIKS) 
were used to assess negative symptoms of psychosis which some are based 
on Diagnostic Interview Schedule version IV (DISC-IV) (Zammit et al., 2008). 
Self-harming behaviour phenotype was derived from combining items from 
multiple questionnaires (Easey, Mars, et al., 2019).  
 
Personality traits were assessed with the International Personality Item 
Pool (IPIP) (Goldberg, 1999) which investigates the “Big Five” personalities: 
extraversion, neuroticism, agreeableness, conscientiousness and openness.  
 
Adolescents had to answer about their own smoking and alcohol 
consumption and the Alcohol Use Disorders Identification Test (AUDIT) was 
used to derive total score of problematic alcohol consumption and risk 
levels of alcohol consumption (Liskola et al., 2018; Saunders et al., 1993). 
These risk levels have been grouped to “low risk”, “hazardous”, “harmful” 




Table 4.4. Offspring phenotypes in adolescence 
Mental health Rater Age Substance use Rater Age Non-mental health phenotypes Rater Age 
Binary phenotypes 
Post-traumatic stress disorder self 15 years Ever tried cannabis self 16.5 years GCSE grades A-C self 18 years 
Self-harming behaviour self 15 years Smoked a cigarette self 14 years GCSE grades D-G self 18 years 
Ever treated for eating disorder self 13 years Number of cigarettes smoked self 14 years    
Ever treated for eating disorder self 16 years Smoked a whole cigarette self 18 years    
Continuous phenotypes 
ADHD symptoms maternal 16.6 years AUDIT score (frequency of 
alcohol consumption) 
self 17 years Sleep duration self 15.5 years 
Conduct disorder symptoms maternal 16.6 years AUDIT (risk levels of alcohol 
consumption) 
self 17 years Number of life-events self 16.5 years 
Oppositional-defiant disorder 
symptoms 
maternal 15.5 years Binge drinking self 17 years Extraversion personality trait self 13 years 
Depression symptoms (CIS-R) self 18 years Number of drinks needed to feel 
tipsy 
self 17 years Agreeableness personality trait self 13 years 
Depression symptoms (SMFQ)  maternal  17 years Number of alcoholic drinks 
consumption in a typical day 
self 18 years Conscientiousness personality trait self 13 years 
Depression symptoms (SMFQ)  maternal 14 years AUDIT total score self 18 years Emotional stability (neuroticism) 
personality trait 
self 13 years 
Emotional problems symptoms maternal 16.5 years Number of times had whole 
drink  
self 12 years Intellect (openness) personality 
trait 
self 13 years 
Anxiety symptoms self 17 years Number of drinks had to feel 
different 
self 12 years Sleep maintenance  self 15 years 
Phobia symptoms self 17 years Number of times had 3+ drinks 
in one day 
self 12 years Sleep initiation self 15 years 
Total behavioural difficulties maternal 16.5 years Age when first smoked a 
cigarette 
self 14 years Frequency of doing exercise self 14 years 
Psychosis positive symptoms  self 12 years Age when first smoked whole 
cigarette 




Psychosis negative symptoms  self 16 years Number of cigarettes smoked in 
lifetime  
self 18 years IQ self 15.5 years 
Psychosis positive symptoms  self 18 years Frequency of smoking cannabis  self 16.5 years    
   Total caffeine intake mg/day maternal 13 years    
   Caffeine intake from tea mg/day maternal 13 years    
   Caffeine intake from coffee 
mg/day 
maternal 13 years    
   Caffeine intake from cola 
mg/day 
maternal 13 years    





4.2.3 Polygenic risk scores (PRSs) 
We calculated PRSs for smoking and caffeine for mothers and offspring 
using effect estimates based on summary data from recent GWAS of 
tobacco (Liu et al., 2019) and coffee consumption (Cornelis et al., 2015). We 
used PLINK v1.90 (Purcell et al., 2007) to compute weighted average scores 
and standardized these using z-score transformation.  
4.2.3.1 Smoking PRS 
The GWAS and Sequencing Consortium of Alcohol and Nicotine use 
(GSCAN, N=1.2 million) identified 378 SNPs associated with smoking 
initiation that were conditionally independent at the genome-wide 
significance level of 5×10−8. Smoking initiation was defined as being an 
‘ever’ vs. ‘never smoker’ where an ‘ever smoker’ had to have either smoked 
100 cigarettes in their lifetime and/or smoked regularly every day for at 
least a month (Liu et al., 2019). Of the 378 genome-wide significant SNPs, 
356 were available in ALSPAC.  
4.2.3.2 Caffeine PRS 
The Coffee and Caffeine Genetics Consortium (N=91,462) found 8 SNPs to 
be independently associated with cups of coffee consumed per day at the 
genome-wide level of significance (Cornelis et al., 2015), which were all 
available in ALSPAC. Although the GWAS was conducted only on coffee 
consumption, these SNPs have also been found to be associated with 
overall caffeine use from other caffeinated beverages, such as tea and cola 
but not from cola alone (McMahon et al., 2014; Treur et al., 2016). 
4.2.4 Statistical analysis 
We performed all analyses using Stata v15 (StataCorp, 2017). We 
conducted linear and logistic regression analyses to test associations of the 
smoking and caffeine PRS with 1) exposure phenotypes in mothers during 
and outside of pregnancy and offspring (caffeine consumption in childhood 




age 10 years) for investigating intergenerational effects; 3) phenotypes in 
mothers during and outside of pregnancy and adolescence in offspring to 
disentangle potential causal effects from pleiotropic effects.  
 
We adjusted analyses for age, offspring gender and the first 10 ancestry-
informative principal components. Principal components analysis was used 
to adjust for underlying population structure due to the allele frequency 
differences in different ancestries (Price et al., 2006). Failure to take into 
account ancestry differences can cause biased associations even in more 
homogenous populations (Seldin et al., 2006).  
 
Due to the large number of tests, we accounted for multiple testing by 
using Bonferroni correction and Monte Carlo permutation testing. Since 
Bonferroni correction is over-conservative and does not take into account 
correlations between the phenotypes, we also included permutation 
testing with 1000 repetitions. Both methods have been widely used in 
genetic studies where false positive findings because of large number of 
tests is a persistent problem (Goeman and Solari, 2014). The Bonferroni 
correction p-value is obtained by dividing p<0.05 by the number of 
independent tests performed. Alternatively, permutation testing randomly 
allocates the exposure values between individuals in the sample and 
reanalyses the resulting dataset. In a permutation test, the resulting p-value 
is the number of times the test statistic observed in the randomly shuffled 
data is as, or more extreme than, the test statistic observed in the original 
dataset divided by the number of permutations. Given the correlation 
between the phenotypes, we used permutation testing as the main analysis 
for multiple correction, but considered the strongest evidence for 
associations that also survived Bonferroni correction – the latter being 
more stringent and therefore more conservative.  
4.2.4.1 Sensitivity analyses 
Given the complex nature of smoking behaviour, it is also important to 
consider smoking heaviness and cessation while investigating the effects of 
prenatal smoking on offspring health outcomes. Therefore, we used the 




behaviours beyond initiation. The lifetime smoking instrument is a 
combined measure of four smoking phenotypes: smoking status (current, 
former, never), smoking duration, smoking heaviness (number of cigarettes 
smoked per day) and smoking cessation which is derived from the entire 
population comprising both smokers and non-smokers and therefore is 
more suitable for use in unstratified samples (Wootton et al., 2020). The 
GWAS of lifetime smoking based on UK Biobank (N=462,690) identified 126 
independent SNPs at the genome-wide significant level of which 123 were 
available in ALSPAC. Consistent results between the lifetime smoking 
and smoking initiation instruments would give more confidence that the 
associations were not false positives but rather the result of smoking 
behaviour beyond initiation. 
4.3 RESULTS 
4.3.1 Aim 1: Validation of smoking and caffeine PRSs 
Associations between smoking initiation and lifetime smoking PRSs on 
exposure phenotypes in mothers and adolescence are shown in Tables 4.5 
and Appendix 4.1.  
 
Both, maternal and offspring smoking initiation and lifetime smoking PRS 
predicted smoking in mothers and offspring in adolescence. In pregnancy, 
maternal smoking initiation PRS was not associated with smoking cessation 
phenotype but association with smoking cessation was observed with the 
maternal lifetime smoking PRS (see Appendix 4.1). This is expected as 
lifetime smoking PRS captures also smoking cessation behaviour.  The 
maternal PRSs for smoking initiation and lifetime smoking explained 1-5% 
of variance in smoking phenotypes during and outside of pregnancy. 
 
In adolescence, offspring smoking initiation PRS was not associated with a 
cigarette smoked at age 14, while the offspring lifetime smoking PRS was 
not associated with number of cigarettes smoked in lifetime reported at 
age 14 and 18. This could be explained by the small sample size of these 





The offspring PRSs for smoking initiation and lifetime smoking explained 





Table 4.5. Associations between maternal and offspring smoking initiation PRSs and smoking phenotypes in mothers and adolescence  
Phenotype Effect 
estimate 
Effect size* 95% CI P-value Sample size R2 
Mothers during of pregnancy  
Tobacco smoked in 1st three months of pregnancy OR 1.35 1.226, 1.440 3.0x10-7 7,237 0.05 
Mother cut down smoking OR 1.33 1.248, 1.423 5.89x10-7 7,269 0.03 
Mother stopped smoking during pregnancy OR 0.98 0.876, 1.105 0.771 1,863 0.01 
Mothers outside of pregnancy  
Mother has ever smoked OR 1.40 1.325, 1.476 1.24x10-8 7,194 0.03 
Number of cigarettes smoked before pregnancy Beta 0.15 0.078, 0.220 3.81x10-5 3,426 0.05 
Offspring: Adolescents  
Smoked at age 14 years OR 1.18 1.089, 1.279 6.50x10-4 4,145 0.03 
Smoked more than 20 cigarettes at age 14 OR 1.19 1.027, 1.382 0.024 1,058 0.03 
Age 1st smoked a cigarette (asked at age 14) Beta 0.001 -0.04, 0.042 0.953 1,064 0.01 
Ever smoked a whole cigarette at age 18 OR 1.26 1.147, 1.374 1.09x10-4 2,402 0.02 
Number of cigarettes smoked in lifetime at age 18 Beta 0.19 0.098, 0.278 4.24x10-5 1,144 0.01 
Note: Reflects the average change in the outcome that is associated with a one standard deviation increase in the PRS. For binary outcomes, this will be the odds 
ratio (OR) (e.g., mother’s odds of ever smoking are 1.4 times compared to not smoking), for continuous outcomes it represents the average unit change (e.g., 0.15 




Results testing the associations between caffeine PRS on exposure 
phenotypes in mothers and offspring are shown in Table 4.6.  
 
Maternal caffeine PRS predicted total caffeine consumption and separately 
coffee and tea consumption but not cola consumption in mothers during 
and outside of pregnancy. The maternal caffeine PRS explained 0.2-1% of 
variance in caffeine phenotypes during pregnancy and outside of 
pregnancy.  
 
Offspring caffeine PRS was not associated with total caffeine consumption 
and neither separately with coffee, tea or cola consumption in childhood 
and adolescence. This could be explained by low levels of caffeine 
consumption in childhood and adolescence. The offspring caffeine PRS 
explained 0.1-0.4% of variance in caffeine phenotypes in childhood and 0.4-
2% variance in caffeine phenotypes in adolescence.  
 
Overview of median daily caffeine consumption across generations is 
shown in Figure 4.3.  







Furthermore, mothers who reported smoking during pregnancy drank more 
caffeine (Median18wks = 190mg/day; Interquartile range (IQR) = 116-
282mg/day; Median32wks = 189mg/day; IQR = 108-279mg/day) compared 
with mothers who did not smoke during pregnancy (Median18wks= 
127mg/day; IQR = 73-191mg/day; Median32wks= 114mg/day; IQR = 57-
189mg/day). Similarly, mothers who reported smoking 8 years post-
pregnancy consumed more caffeine (Median = 225mg/day; IQR = 135-
339mg/day) compared with mothers who did not smoke (Median = 




Table 4.6. Associations between maternal and offspring caffeine PRSs and daily caffeine intake in mothers and offspring 
 Daily caffeine intake phenotype  Effect size* (beta) 95% CI P-value Sample size R2 
Mothers during 
pregnancy – 18 weeks 
gestation 
Total (coffee, tea and cola)  5.85 3.092, 8.614 3.28x10-5 7,220 0.004 
Coffee  0.02 0.005, 0.042 0.011 7,198 0.002 
Tea 0.02 0.006, 0.041 0.007 7,189 0.002 
Cola  -0.001 -0.016, 0.014 0.890 7,185 0.002 
Mothers during 
pregnancy – 32 weeks 
gestation 
Total (coffee, tea and cola)  6.32 3.741, 8.892 1.56x10-6 6,767 0.01 
Coffee  0.03 0.007, 0.043 0.006 6,596 0.002 
Tea  3.42 1.795, 5.036 3.65x10-5 6,608 0.004 
Cola  -0.01 -0.028, 0.008 0.278 6,500 0.002 
Mothers outside of 
pregnancy 
Total (coffee, tea and cola) 9.89 6.337, 13.435 4.97x10-8 4,783 0.01 
Coffee 0.03 0.008, 0.055 0.009 4,655 0.003 
Tea 0.07 0.033, 0.099 1.01x10-4 4,632 0.01 
Cola 0.01 -0.012, 0.034 0.332 4,670 0.002 
Offspring: Childhood – 
age 8 years 
Total (coffee, tea and cola) 0.01 -0.012, 0.032 0.377 4,589 0.002 
Coffee 0.01 -0.063,0.077 0.845 254 0.004 
Tea 0.18 -1.517, 1.875 0.836 1,475 0.001 
Cola 0.003 -0.021, 0.026 0.829 4,551 0.002 
Offspring: Adolescence 
– age 13 years 
Total (coffee, tea and cola)  0.01 -0.030, 0.046 0.670 3,405 0.004 
Coffee  0.03 -0.023, 0.081 0.271 467 0.02 
Tea 0.89 -0.353, 2.125 0.161 1,933 0.004 
Cola  -0.02 -0.052, 0.022 0.424 2,411 0.01 
Note: Reflects the average change in the outcome that is associated with a one standard deviation increase in the PRS. In mothers outside of pregnancy, a one 






4.3.2 Aim 2: Maternal and offspring PRS associations on offspring 
phenotypes in childhood 
4.3.2.1 Smoking Initiation PRS 
Maternal smoking initiation PRS: Several associations were observed 
between the maternal smoking initiation PRS and offspring phenotypes in 
childhood. These results are shown in Figure 4.4.  
 
The associations observed with the childhood mental health phenotypes 
were with reduced anxiety symptoms (β8years = -0.03, 95% CI-0.053, -
0.012, Pperm = 0.002) and increased conduct disorder symptoms (β7years = 
0.02, 95% CI 0.004, 0.044, Pperm = 0.021). The strongest associations 
observed with the non-mental health phenotypes were with lower IQ 
(β8years = -0.59, 95% CI -1.049, -0.134, Pperm = 0.016) and higher BMI (β7years = 
0.08, 95% CI 0.018, 0.135, Pperm =0.001). Among the substance use 
phenotypes, an association was observed with higher overall caffeine 
consumption (mg/day; β8years = 0.05, 95% CI 0.021, 0.068, Pperm = <0.001). 
Additionally, an association with higher likelihood of being left-handed 
(OR11years = 1.11, 95% CI 1.012, 1.225, Pperm = 0.012) was observed, despite 
this being included as a negative control phenotype.  
 
After applying Bonferroni correction (P<0.003), we found the strongest 
evidence for offspring anxiety symptoms and caffeine consumption 
phenotypes. 
 
Offspring smoking initiation PRS: Results for the offspring smoking initiation 
PRS on childhood outcomes are shown in Figure 4.4. 
 
Similarly to the maternal smoking initiation PRS analyses, associations were 
observed with reduced anxiety symptoms (β8years = -0.03, 95% CI -0.051,-
0.010, Pperm = 0.002) and increased conduct disorder symptoms (β7years = 
0.03, 95% CI 0.012, 0.049, Pperm = 0.001). Additionally, an association was 




0.034). Offspring smoking initiation PRS showed similar associations with 
the substance use and non-mental health phenotypes as maternal smoking 
initiation PRS: lower IQ (β8years = -0.74, 95% CI-1.183, -0.287, Pperm = <0.001), 
higher BMI (β7years = 0.05, 95% CI-0.0003, 0.101, Pperm=0.048), and higher 
caffeine consumption (mg/day; β8years = 0.03, 95% CI 0.010, 0.055, Pperm = 
0.006). However, an association with left-handedness was not observed for 
the offspring smoking initiation PRS (OR11years = 1.05, 95% CI 0.954, 
1.145, Pperm = 0.291). After applying Bonferroni correction (P<0.003), we 
found the strongest evidence with IQ and conduct disorder symptoms 
phenotypes.  
 
Full results with maternal and offspring smoking initiation PRS on childhood 






Figure 4.4. Comparison of associations between maternal and offspring smoking initiation PRSs on offspring outcomes in childhood 
  





Table 4.7. Associations between maternal and offspring smoking initiation PRSs and offspring phenotypes in childhood 
Note: OR-odds ratio; 95% CI – 95% confidence intervals
 Maternal smoking initiation PRS analyses Offspring smoking initiation PRS analyses 









95% CI P-value 95% CI P-value Sample 
size 
Total caffeine  Beta 0.05 0.021, 0.068 0.0002 <0.001, 0.004 <0.001 4,067 0.03 0.010, 0.055 0.005 0.002, 0.013 0.006 4,589 
Anxiety Beta -0.03 -0.053, -0.012 0.002 <0.001, 0.007 0.002 4,993 -0.03 -0.051, -0.010 0.003 <0.001, 0.007 0.002 5,355 
BMI Beta 0.08 0.018, 0.135 0.010 0.007, 0.022 0.013 5,032 0.05 <0.001, 0.101 0.051 0.036, 0.063 0.048 5,799 
IQ Beta -0.59 -1.049, -0.134 0.011 0.009, 0.026 0.016 4,675 -0.74 -1.183, -0.287 0.001 <0.001, 0.004 <0.001 5,295 
Conduct disorder Beta 0.02 0.004, 0.044 0.019 0.013, 0.032 0.021 5,012 0.03 0.012, 0.049 0.001 <0.001, 0.006 0.001 5,326 
Handedness OR 1.11 1.012, 1.225 0.030 0.006, 0.021 0.012 4,849 1.05 0.954, 1.145 0.315 0.263, 0.320 0.291 5,403 
Specific phobia OR 1.32 0.964, 1.813 0.078 0.042, 0.071 0.055 5,100 1.18 0.881, 1.587 0.241 0.199, 0.252 0.225 5,470 
Emotional problems Beta -0.02 -0.037, 0.004 0.117 0.106, 0.148 0.126 5,139 -0.01 -0.031, 0.009 0.267 0.236, 0.291 0.263 5,459 
ADHD Beta 0.02 -0.013, 0.045 0.277 0.232, 0.287 0.259 4,916 0.03 0.003, 0.058 0.030 0.024, 0.047 0.034 5,219 
Sleep duration Beta -0.01 -0.033, 0.014 0.426 0.392, 0.454 0.423 5,127 -0.02 -0.042, 0.004 0.106 0.107, 0.149 0.127 5,443 
Behavioural difficulties Beta 0.01 -0.021, 0.041 0.522 0.482, 0.544 0.513 5,133 0.02 -0.008, 0.051 0.152 0.130, 0.176 0.152 5,452 
Depression Beta -0.01 -0.027, 0.015 0.557 0.524, 0.586 0.555 4,885 -0.01 -0.027, 0.012 0.466 0.442, 0.504 0.473 5,434 
Sleep maintenance OR 0.98 0.919, 1.051 0.589 0.534, 0.596 0.565 5,127 0.97 0.913, 1.038 0.383 0.313, 0.372 0.342 5,448 
ODD Beta -0.004 -0.024, 0.016 0.700 0.683, 0.740 0.712 4,943 0.02 -0.005, 0.034 0.148 0.146, 0.194 0.169 5,319 
Autism OR 1.03 0.722, 1.460 0.874 0.860, 0.901 0.882 5,975 1.15 0.803, 1.654 0.411 0.380, 0.442 0.411 6,156 
Sleep initiation OR 0.99 0.934, 1.061 0.874 0.827, 0.873 0.851 5,150 0.97 0.913, 1.032 0.309 0.269, 0.326 0.297 5,476 




4.3.2.2 Caffeine PRS 
Maternal caffeine PRS: Results for the maternal caffeine PRS and childhood 
outcomes analyses are shown in Figure 4.5.  
 
Maternal caffeine PRS was associated only with one childhood phenotype, 
which was decreased risk for specific phobias (OR10years = 0.72, 95% CI 0.519, 
1.012, Pperm= 0.028). However, this association did not survive Bonferroni 
correction (P<0.003).  
 
Offspring caffeine PRS: Results for the offspring caffeine PRS analyses 
and childhood outcomes are shown in Figure 4.5. Given that offspring 
caffeine PRS was not associated with caffeine consumption in 
childhood, we were able to use these results as a test for pleiotropy.  
 
Compared to the findings with maternal caffeine PRS, the offspring 
caffeine PRS analyses did not show evidence for association with the 
specific phobia phenotype (OR10years = 1.00, 95% CI 0.723, 1.381, Pperm= 
0.998). However, offspring caffeine PRS was associated with fewer anxiety 
symptoms (β8years = -0.02, 95% CI -0.042, -0.002, Pperm = 0.026) and fewer 
hours of sleep (β7years = -0.03, 95% CI -0.048, -0.004, Pperm = 0.018). However, 
the evidence for these associations was weak as none survived Bonferroni 
correction (P<0.003).  
 
Full results for the maternal and offspring caffeine PRS and childhood 





Figure 4.5. Comparison of associations between maternal and offspring caffeine PRSs on offspring outcomes in childhood 
 
   




Table 4.8. Associations between maternal and offspring caffeine PRSs and offspring phenotypes in childhood 
Note: OR-odds ratio; 95% CI – 95% confidence intervals
 Maternal caffeine PRS analyses Offspring caffeine PRS analyses 









95% CI P-value 95% CI P-value Sample 
size 
Specific phobia OR 0.72 0.519, 1.012 0.057 0.019, 0.040 0.028 5,100 1.00 0.723, 1.381 0.997 0.993, 1.000 0.998 4,900 
Depression Beta -0.02 -0.039, 0.002 0.075 0.056, 0.089 0.071 4,885 -0.02 -0.037, 0.002 0.081 0.055, 0.088 0.070 5,434 
ADHD Beta -0.02 -0.008, 0.050 0.161 0.110, 0.152 0.130 4,916 -0.02 -0.046, 0.010 0.206 0.199, 0.251 0.224 5,219 
Handedness OR 1.06 0.968, 1.169 0.178 0.143, 0.189 0.165 4,849 0.98 0.897, 1.070 0.624 0.548, 0.610 0.579 5,399 
Life events Beta -0.01 -0.007, 0.030 0.228 0.217, 0.271 0.243 5,167 -0.01 -0.027, 0.010 0.366 0.329, 0.390 0.359 5,493 
ODD Beta 0.002 -0.032, 0.008 0.240 0.257, 0.314 0.285 4,943 0.002 -0.018, 0.022 0.829 0.583, 0.644 0.614 5,319 
Sleep initiation OR 0.97 0.913, 1.036 0.352 0.316, 0.375 0.345 5,150 0.95 0.895, 1.010 0.094 0.059, 0.092 0.074 5,476 
Total caffeine Beta 0.01 -0.015, 0.032 0.490 0.444, 0.506 0.475 4,067 0.01 -0.012, 0.032 0.377 0.349, 0.410 0.379 4,589 
BMI Beta 0.03 -0.033, 0.084 0.387 0.364, 0.425 0.394 5,032 0.03 -0.027, 0.077 0.348 0.297, 0.356 0.326 5,799 
Behavioural difficulties Beta -0.02 -0.019, 0.043 0.441 0.369, 0.431 0.400 5,133 -0.02 -0.044, 0.015 0.324 0.294, 0.353 0.323 5,452 
Emotional problems Beta 0.001 -0.014, 0.027 0.538 0.569, 0.631 0.600 5,139 0.001 -0.018, 0.021 0.883 0.881, 0.919 0.901 5,459 
Sleep duration Beta -0.03 -0.030, 0.017 0.577 0.544, 0.606 0.575 5,127 -0.03 -0.048, -0.004 0.018 0.011, 0.028 0.018 5,443 
CD Beta -0.01 -0.024, 0.015 0.624 0.627, 0.686 0.657 5,012 -0.01 -0.024, 0.013 0.563 0.541, 0.603 0.572 5,326 
autism OR 1.05 0.758, 1.461 0.742 0.733, 0.787 0.761 5,975 0.85 0.603, 1.199 0.326 0.307, 0.366 0.336 6,156 
IQ Beta 0.28 -0.521, 0.390 0.778 0.766, 0.817 0.792 4,675 0.28 -0.155, 0.707 0.209 0.183, 0.234 0.208 5,290 
Anxiety Beta -0.02 -0.023, 0.019 0.849 0.805, 0.853 0.830 4,993 -0.02 -0.042, -0.002 0.029 0.017, 0.038 0.026 5,355 




4.3.3 Aim 3: Maternal and offspring PRS associations on their own 
outcomes during and outside of pregnancy and adolescence 
4.3.3.1 Smoking Initiation PRS 
Maternal smoking initiation PRS on maternal outcomes during and outside 
of pregnancy: The associations between maternal smoking initiation PRS 
and maternal outcomes during and outside of pregnancy are shown in 
Figures 4.6 and 4.7 and Appendix 4.2. We found the strongest evidence 
(Bonferroni corrected) for non-mental health phenotypes, such as lower 
education and more negative image perception during and outside of 
pregnancy, higher anger, monotony avoidance and BMI outside of 
pregnancy, higher sensitivity to interpersonal rejection, and lower 
socioeconomic status during pregnancy. Among the substance use 
phenotypes, there was strong evidence for increased alcohol and caffeine 





Figure 4.6. Associations between maternal smoking initiation PRS and 
maternal outcomes during pregnancy 
Note: Red dashed line shows threshold P<0.05 after permutation testing and blue 
dashed line shows threshold P<0.002 after Bonferroni correction 
 
Figure 4.7. Associations between maternal smoking initiation PRS and 
maternal outcomes outside of pregnancy 
Note: Red dashed line shows threshold P<0.05 after permutation testing and blue 




Offspring smoking initiation PRS on offspring outcomes during adolescence:  
All results of the associations between offspring smoking initiation PRS and 
offspring outcomes during adolescence are shown in Figure 4.8 and 
Appendix 4.3. 
 
Similarly to the results in childhood, offspring smoking initiation PRS 
showed the strongest evidence (Bonferroni corrected) for associations with 
mental health phenotypes such as increased conduct disorder symptoms. 
Furthermore, as in childhood, there was strong evidence for association 
with higher BMI in adolescence. Additionally, as in mothers, we observed 
associations for some personality traits in adolescence, such as higher 
extraversion. Among the substance use phenotypes, we observed strongest 





Figure 4.8. Associations between offspring smoking initiation PRS and 
offspring outcomes in adolescence 
Note: Red dashed line shows threshold P<0.05 after permutation testing and blue 






4.3.3.2 Caffeine PRS 
Maternal caffeine PRS on maternal outcomes during and outside of 
pregnancy: The associations between maternal caffeine PRS and maternal 
outcomes are shown in Figures 4.9 and 4.10 and Appendix 4.4. 
 
There was weak evidence for associations between maternal caffeine PRS 
and maternal mental health phenotypes. The only association we observed 
was with decreased likelihood of schizophrenia in mothers outside of 
pregnancy. However, there was some evidence for associations with non-
mental health phenotypes, such as higher socioeconomical status during 
pregnancy. Additionally, among the substance use phenotypes, maternal 
caffeine PRS was associated with decreased binge drinking and higher 
likelihood of decreasing caffeine consumption during pregnancy. However, 




Figure 4.9. Associations between maternal caffeine PRS and maternal 
outcomes during pregnancy 
Note: Red dashed line shows threshold P<0.05 after permutation testing and blue 
dashed line shows threshold P<0.001 after Bonferroni correction 
Figure 4.10. Associations between maternal caffeine PRS and maternal 
outcomes outside of pregnancy 
Note: Red dashed line shows threshold P<0.05 after permutation testing and blue 




Offspring caffeine PRS on offspring outcomes in adolescence: Associations 
between offspring caffeine PRS and offspring outcomes in adolescence are 
shown in Figure 4.11 and Appendix 4.5. The only evidence for an 
association in adolescence was observed for offspring caffeine PRS and 
higher GCSE exam grades, but this association did not survive Bonferroni 
correction. 
Figure 4.11. Associations between offspring caffeine PRS and offspring 
outcomes in adolescence.  
Note: Red dashed line shows threshold P<0.05 after permutation testing and blue 




4.3.4 Sensitivity analyses 
The results using the lifetime smoking PRS were mostly consistent with the 
results using the smoking initiation PRS. After applying Bonferroni 
correction, we found the strongest evidence for IQ in the maternal PRS 
analyses on offspring childhood outcomes, and ODD and total behavioural 
difficulties in the offspring PRS analyses on childhood outcomes. These 
results are shown in Figure 4.12 and Appendix 4.6. 
 
The strongest evidence (Bonferroni corrected) in the maternal analyses 
during and outside pregnancy was observed for lower education during and 
outside of pregnancy, lower social class during pregnancy, increased anger 
and BMI outside of pregnancy, as well as with increased caffeine 
consumption during and outside of pregnancy. These results are shown in 
Figures 4.13 and 4.14 and in Appendix 4.7. 
 
For the adolescence lifetime smoking PRS analysis, we found the strongest 
evidence (Bonferroni corrected) for higher conduct disorder symptoms and 
extraversion, as well as for lower IQ in adolescence. An overview of all the 
other results in adolescence using lifetime smoking PRS is shown in Figure 





Figure 4.12. Comparison of associations between maternal and offspring lifetime smoking PRSs on offspring outcomes in childhood 
  




Figure 4.13. Associations between maternal lifetime smoking PRS and 
maternal outcomes during pregnancy 
 
Note: Red dashed line shows threshold P<0.05 after permutation testing and blue 
dashed line shows threshold P<0.002 after Bonferroni correction 
 
Figure 4.14. Associations between maternal lifetime smoking PRS and 
maternal outcomes outside of pregnancy 
Note: Red dashed line shows threshold P<0.05 after permutation testing and blue 




Figure 4.15. Associations between offspring lifetime smoking PRS and 
offspring outcomes in adolescence 
Note: Red dashed line shows threshold P<0.05 after permutation testing and blue 






The main aim of this study was to investigate possible causal effects of 
maternal smoking and caffeine consumption on offspring mental health 
outcomes. Although the PheWAS design does not allow us to conclude 
directly which of the observed associations may be causally linked with 
mental health outcomes in offspring, by comparing different analyses 
across generations some inferences can be made.  
 
Overall, these results showed that the smoking and caffeine PRS could be 
used as proxies for measuring smoking and caffeine consumption during 
pregnancy. However, caffeine PRS did not predict consumption in 
adolescence. Across generations, we observed several associations 
between smoking PRS and mental health outcomes. We found the 
strongest evidence for associations related to externalising behaviours and 
sensation-seeking traits, such as more behavioural problems in childhood 
and adolescence, more extroverted personality type, and increased alcohol 
consumption in mothers during pregnancy and offspring in adolescence. 
These findings indicate that intergenerational effects observed between 
maternal smoking PRS and offspring behavioural outcomes in childhood are 
likely to be pleiotropic. There was weaker statistical evidence for 
intergenerational effects of maternal caffeine PRS and offspring outcomes 
in childhood.  
 
The literature supports findings of pleiotropic associations between the 
smoking PRS and sensation-seeking type of personality traits. Previous 
studies have found that adolescents who smoke have more externalising 
problems, higher impulsivity and novelty-seeking type of behaviours (Crone 
and Reijneveld, 2007) and that children with lower cognitive abilities have 
more behavioural problems and are more likely to initiate smoking 
themselves (Daly and Egan, 2017; Morin et al., 2017). Furthermore, there is 
evidence for shared genetic factors influencing smoking behaviours, 
externalising problems and novelty seeking type of behaviours (Stephens et 




2018). Some studies argue that the effect from the maternal postnatal 
environment (such as parenting behaviours) and mothers own mental 
health cannot be dismissed even after accounting for genetic effects 
(Eilertsen et al., 2020; Maughan et al., 2004).  
 
The evidence for an association between the maternal smoking PRS and 
maternal depression during and outside of pregnancy may explain the 
association between the maternal smoking PRS and offspring externalising 
problems. However, a study using similar design (Easey et al., 2021) found 
an association between maternal PRS for increased alcohol consumption 
and maternal depression during pregnancy but did not find associations 
with offspring externalising problems. This could further support the 
conclusion that the associations observed between the smoking PRS and 
childhood externalising problems are pleiotropic. Furthermore, findings 
from other studies suggest that the smoking initiation PRS may not only 
capture smoking behaviour but also novelty-seeking and impulsive 
behaviours, even when only using genome-wide significant SNPs (Gage et 
al., 2018; Harrison et al., 2020). In addition, GSCAN summary statistics for 
smoking initiation showed a strong genetic correlation with ADHD and risk 
tolerance behaviour, which could make pleiotropic effects more likely (Liu 
et al., 2019). Given that smoking initiation is capturing more behaviours 
than just smoking, using the smoking initiation instrument in MR studies 
can be therefore problematic (Gage et al., 2020).  
 
Taken together with the existing literature, our findings support the notion 
that the associations observed with the smoking initiation PRS are most 
likely explained by shared genetic liability in mothers and 
offspring. However, considering that a recent study conducted in the 
Norwegian Mother, Father and Child longitudinal birth cohort (MoBa) 
found some evidence for a maternal mental health effect on offspring 
ADHD symptoms even after accounting for genetic transmission, a maternal 
environmental effect cannot be completely ruled out (Eilertsen et al., 
2020). Therefore, follow-up analyses are needed to further disentangle 





The associations observed between the smoking initiation PRS and 
offspring BMI, caffeine consumption, and left-handedness were stronger in 
the maternal PRS analysis than in the offspring PRS analysis, which may 
reflect a causal effect. However, the associations with caffeine consumption 
and left-handedness are likely to be false positives, as these associations 
were not observed with lifetime smoking PRS and they did not survive 
Bonferroni correction. 
 
Several studies have shown an association between maternal prenatal 
smoking and higher BMI in offspring (Magalhaes et al., 2019) which has 
been shown not to be affected by low birth weight (Beyerlein et al., 2011). 
However, findings from animal studies have indicated a negative 
association between prenatal smoke exposure on body weight (Jo et al., 
2002). Further, other studies using negative control study designs have 
concluded that the association between maternal pre- and postnatal 
smoking and later childhood BMI is likely to be due to confounding rather 
than a causal intrauterine effect (Florath et al., 2014; Howe et al., 2012). 
Although a stronger association was observed between maternal smoking 
PRS on childhood BMI compared with offspring smoking PRS, analyses in 
mothers outside of pregnancy and adolescence showed consistently a 
positive association between smoking PRS on their own BMI. As previous 
studies using MR have found evidence for smoking decreasing BMI (Asvold 
et al., 2014; Taylor et al., 2019), it is plausible that findings in this study 
could be confounded through pleiotropic associations of the smoking 
initiation PRS or could be affected by maternal postnatal behaviour.  
 
There was no strong evidence for intergenerational effects between 
maternal caffeine PRS and mental health outcomes in offspring in 
childhood, although we observed some interesting associations with the 
caffeine PRS across generations, such as higher social class in pregnancy, 
less anxiety in childhood and higher GCSE exam grades in adolescence. 
However, another study in secondary school students in the UK found a 
negative association between caffeine intake and school attendance 




association between coffee genetic risk score and socio-economic factors 
(Taylor, Davey Smith, et al., 2018). Therefore, these results should be 
interpreted with caution, as these findings could be false positives or 
unique to the ALSPAC sample. 
 
The major strength of this study is the inter-generational approach, which 
enabled us to disentangle possible causal effects from pleiotropic effects by 
comparing observed associations in different sub-populations in ALSPAC. 
This includes ‘negative control’ approaches, by analysing phenotypes in 
childhood before their own consumption behaviour can influence the 
estimates, and together with other results can provide insights into 
potential causal effects. Furthermore, by using a PheWAS design, it was 
possible to include various mental health phenotypes, as well as other 
phenotypes to explore the complex nature of smoking and caffeine 
behaviour.   
 
However, this study has also some limitations. First, due to the small 
sample size, we may have missed some associations. Second, not all the 
phenotypes were available across generations and therefore the 
comparison (externalising disorders in childhood and adolescence were 
compared with personality traits in adulthood) of phenotypes was not 
similar across sub-populations. Third, mental health phenotypes in 
childhood were mostly based on maternal report, which may not accurately 
reflect offspring’s mental health problems (Gartstein et al., 2009; Najman et 
al., 2001) but instead mothers’ own mental health status (Hennigan et al., 
2006; Ringoot et al., 2015). Fourth, the smoking initiation PRS was derived 
from a GWAS that also included ALSPAC. Due to the sample overlap, the 
true strength of the observed associations might be smaller than we found. 
However, given the relatively small contribution of ALSPAC data to a total 
sample size of 1.2 million, the risk of bias is likely negligible. Fifth, to make 
the smoking PRS specific to exposures we based PRS on genome-wide 
significant SNPs only, but the smoking PRS still showed associations with 
some alcohol phenotypes, although the correlation between the smoking, 




the phenotypic associations with alcohol consumption, we cannot rule out 
that associations observed with the maternal smoking PRS are cofounded 
by maternal alcohol consumption. Still, because we did not find evidence 
for potential causal effects and no associations were observed between 
alcohol PRS and offspring mental health outcomes by Easey and colleagues 
(Easey et al., 2021), this is unlikely to affect observed results. Sixth, 
longitudinal cohort studies like ALSPAC may suffer from selection bias if the 
reasons why some participants drop out is not random (Munafò et al., 
2018; Taylor, Jones, et al., 2018). Given that the dataset included 
phenotypes from later time points, with more missing data, it is possible 
that these findings are more subject to selection bias. Seventh, the 
maternal PRS analyses on offspring outcomes in childhood were based on 
transmitted alleles and therefore an indirect effect of maternal non-
transmitted alleles on offspring behavioural outcomes through genetic 
nurturing cannot be ruled out (Kong et al., 2018).  
 
To conclude, we found associations between maternal smoking PRS and 
externalising disorder symptoms in offspring. Although pleiotropic effects 
seem the more plausible explanation, no definitive conclusion can be 
drawn. Given that the PheWAS design does not allow inferring causality in a 
definitive way and analyses were affected by low statistical power, these 
findings need to be replicated in independent samples, ideally using 
methods robust to pleiotropy, such as MR.   
4.5 CHAPTER SUMMARY 
In this chapter I explained how a PheWAS design can be used to disentangle 
causal maternal environmental effects from pleiotropic effects by using 
data from different sub-populations in ALSPAC.  
 
In the next chapter I will focus specifically on the ADHD phenotype, using 
negative control and MR approach to further examine a possible 
intrauterine effect of maternal prenatal smoking, alcohol and caffeine 
consumption on ADHD risk in offspring. In addition to the ALSPAC sample, I 




Chapter 5  PRENATAL SMOKING, ALCOHOL AND CAFFEINE 
EXPOSURE AND ADHD RISK IN CHILDHOOD: PARENTAL 
COMPARISONS AND POLYGENIC RISK SCORE (PRS) ANALYSES 
This chapter is based on the manuscript “Prenatal smoking, alcohol and 
caffeine exposure and ADHD risk in childhood: parental comparisons and 
polygenic risk score (PRS) analyses.” The preprint of this manuscript is 
available in medRxiv https://doi.org/10.1101/2021.03.25.21254087 
 
Compared to Chapter 4, which examined associations between maternal 
and offspring smoking and caffeine PRS and various mental health 
outcomes, this chapter investigates whether there is a causal effect of 
maternal smoking, alcohol, and caffeine consumption during pregnancy on 
ADHD risk in offspring. I combined observational and genetic analyses and 
investigated whether there are different effects on ADHD hyperactive-
impulsive and inattention symptom domains. In addition to data from 
ALSPAC, I also performed analyses using data from GenR and MoBa 
longitudinal birth cohorts.  
5.1 INTRODUCTION 
Many observational studies have shown that child symptoms and diagnosis 
of attention deficit hyperactivity disorder (ADHD) are associated with 
maternal smoking during pregnancy (He et al., 2020; Huang et al., 2018) 
and mixed findings have been reported for association with prenatal 
alcohol and caffeine exposure (Del-Ponte et al., 2016; Mikkelsen et al., 
2017; Pagnin et al., 2019; Porter et al., 2019). However, inferring causality 
from associations between maternal prenatal substance use and offspring 
ADHD is challenging because the association could be affected by 
unmeasured shared familial factors that contribute to both maternal 
substance use during pregnancy and offspring ADHD. Several studies have 
shown genetic overlap between substance use and ADHD (Wimberley et al., 
2020), and critically maternal genetic risk for ADHD has been found to be 





Negative control designs (such as parental and sibling comparison) have 
been used to investigate potential causal intrauterine effects for a range of 
outcomes (Gage et al., 2016; Taylor et al., 2017). The main principle of the 
negative control approach is to compare the association of interest with 
another related association which is not biologically plausible (Gage et al., 
2016). For example, in parental comparison mothers and fathers share the 
same confounding, but only mothers provide the intrauterine environment. 
If the maternal exposure-child outcome association is stronger, compared 
with the paternal exposure-child outcome association, this would suggest a 
potentially causal intrauterine effect. In contrast, if the magnitude of effect 
is similar, this would argue against a causal intrauterine effect, and instead 
suggest the association is due to confounding. An example where 
comparison of maternal and paternal effects has strengthened causal 
inference for an intrauterine effect is the relation between maternal 
smoking during pregnancy and low infant birth weight. In ALSPAC, a strong 
association was found between maternal smoking during pregnancy and 
infant birth weight, while paternal smoking during pregnancy showed only 
a weak association which almost disappeared when accounting for 
maternal smoking (Davey Smith, 2008).  
 
Similarly, sibling comparison studies have been used to investigate 
potential intrauterine effects. These studies compare outcomes in siblings 
who are differentially exposed to maternal prenatal substance use which 
can account for shared environmental and genetic confounding. However, 
sibling comparison studies rely on the assumption that family environment 
remains stable and there are no other factors that vary between siblings 
and/or are highly correlated with both the exposure and outcome 
(D'Onofrio et al., 2013; Lewis et al., 2013).  
 
Negative control designs have been used in the context of maternal 
substance use during pregnancy and offspring ADHD. A study based on the 
Danish National Birth Cohort and using parental comparison found 




pregnancy on ADHD in offspring (Zhu et al., 2014). However, several other 
studies using negative control and other genetically sensitive designs have 
concluded that the association between maternal prenatal smoking and 
offspring ADHD is likely not causal (Rice et al., 2018; Skoglund et al., 2014). 
Sibling comparison studies on alcohol exposure based on the Norwegian 
Mother, Father and Child Cohort Study (MoBa) have found little evidence 
for a causal effect on ADHD symptoms (Eilertsen et al., 2017; Lund et al., 
2019), although a sibling control analysis (Eilertsen et al) suggested some 
evidence for a potential causal effect on ADHD symptoms as measured by 
the Conner’s Parent Rating Scale (CPRS-R). To my knowledge no negative 
control studies have been published on prenatal caffeine exposure and 
offspring ADHD.  
 
Although published negative control studies investigating intrauterine 
effects have improved our understanding of whether a causal relationship 
exists, they may still be biased because of unmeasured and residual 
confounding. Using genetic variants in Mendelian Randomization (MR) 
analyses is an alternative approach that can strengthen causal inference. 
Genetic variants are randomly and independently assigned at conception 
and should therefore not be associated with factors that normally confound 
the exposure-outcome relationship or be subject to reverse causation, 
these methods could therefore provide stronger support for a potential 
causal effect (Lawlor et al., 2008).  
 
Although in this study I did not use a formal MR approach to estimate the 
size of an effect of exposure on the outcome, I used polygenic risk score 
(PRS) analyses to look at whether a potential causal relationship exists. MR 
relies on three main assumptions: (1) relevance – the genetic variant must 
be robustly associated with the exposure of interest; (2) independence – 
the genetic variant is not confounded with the outcome or related through 
selection bias and (3) exclusion restriction – the genetic variant is not 
associated with the outcome by any other path than through the exposure 
of interest (Davies et al., 2018). These assumptions are relevant also in the 




assumptions is shown in Figure 5.1. Assumptions 2 and 3 cannot be tested 
and, therefore, problems with horizontal pleiotropy – where the same 
genetic variant is directly associated with many phenotypes – confounding 
a genetic variant’s relationship with the outcome or selection bias cannot 
be ruled out (Lawlor et al., 2008). 
 
Figure 5.1. Overview of Mendelian Randomization design and assumptions 
 
Note: Exposure is causally associated with the outcome if: (1) the genetic variant(s) 
is associated with the exposure; (2) the genetic variant is not associated with 
confounders; (3) the genetic variant is not independently associated with the 
outcome. 
 
Combining multiple methodological approaches that rely on different 
assumptions and are subject to different sources of bias – known as 
triangulation – can strengthen causal inference (Munafò and Davey Smith, 
2018). If results from multiple approaches with different sources of bias 
provide convergent results, it is more likely that the observed association 
reflects a causal effect (Lawlor et al., 2016). In this study, I combined the 
conventional multivariable regression approach, a negative control design 
using paternal prenatal substance use as a negative control, and genetic 
analyses using maternal PRS as a proxy for the exposures of interest. My 
aim was to investigate whether there is a causal effect of maternal 
substance use during pregnancy on high risk of offspring ADHD outcomes at 
age 7-8 years, using data from three large prospective birth cohorts. 




Figure 5.2. Overview of study design 
 
Note: a) The red dashed arrow represents the negative control analysis. Assumptions include: the same confounders influence maternal and  
paternal prenatal substance use and offspring ADHD, a causal prenatal (intrauterine) effect only exists for maternal prenatal substance use.  
b) Polygenic risk score analysis was conducted with maternal genetic variants as proxies for prenatal smoking, alcohol, and caffeine consumption  








5.2.1 Study Population 
I used data from three European prospective longitudinal birth cohorts: the 
Avon Longitudinal Study of Parents and Children (ALSPAC), the Generation 
R (GenR) and the Norwegian Mother, Father and Child Cohort Study 
(MoBa). More details about each cohort are given in Chapter 3 (see 
sections 3.2.1; 3.3.1 and 3.4.1) 
5.2.2 Availability of genome-wide data 
In ALSPAC, genome-wide data are available for 8,196 mothers. Maternal 
genetic data was not available for GenR at the time of analyses. In MoBa, 
genetic data are currently available for 14,584 mothers. Detailed 
information about the genotyping in the ALSPAC and MoBa cohorts is 
presented in Chapter 3 (see sections 3.2.2 and 3.4.2)  
 
5.2.3 Exposures 
Maternal smoking, alcohol and caffeine use during pregnancy were 
measured in each pregnancy trimester across all cohorts. Whereas paternal 
substance use was assessed only in the 2nd pregnancy trimester across all 
cohorts. I therefore used data assessed in the 2nd pregnancy trimester 
where information for both maternal and paternal substance use was 
available.  
 
More details about exposure assessment in each cohort is given in Chapter 
3 (see sections 3.2.4; 3.3.4 and 3.4.4). 
 
Overall, exposure assessment was similar across the cohorts, but there 
were some exceptions in GenR. For example, paternal caffeine 
consumption during pregnancy was not measured, and maternal caffeine 




smoking and alcohol use were assessed 2 months prior to their partner’s 
pregnancy.  
 
I categorized parental smoking, alcohol and caffeine consumption (from 
coffee and tea) during pregnancy to examine dose-dependent relationships. 
Smoking was categorized: No smoking; 1-4 cigarettes; 5-9 cigarettes and 
>10 cigarettes per day. Alcohol consumption was categorized: No drinking, 
<1 drink a week and 1-6 drinks a week. Only a small number of mothers 
drank daily, therefore these I combined with the group of weekly drinkers. 
Furthermore, because the measure of alcohol consumption is different in 
each cohort, I conducted a meta-analysis across the cohorts comparing 
drinkers and non-drinkers. However, in ALSPAC and MoBa I was able to 
harmonise weekly alcohol consumption from units to grams to create a 
continuous measure of alcohol consumption by multiplying units with 
corresponding grams. In ALSPAC, alcohol consumption was assessed 
continuously at 8 weeks of gestation. Caffeine consumption from coffee 
and tea was transformed and summed to total caffeine consumption in 




In each cohort ADHD was measured using different questionnaires. Given 
that some studies have found that maternal substance use during 
pregnancy can have a distinct effect on ADHD hyperactive-impulsive and 
inattention symptom domains (Gard et al., 2016; Langley et al., 2007), I 
used questionnaires that measured total ADHD symptoms, as well as 
separately hyperactive-impulsive and inattention symptom domains.  
 
5.2.4.1 Primary outcome measures 
The psychometric scales I used for the main outcome measure at age 7-8 
years were: maternal report of the Development And Well-Being 
Assessment (DAWBA) questionnaire in ALSPAC; maternal report of the 
revised Conner’s Parent Rating Scale (CPRS-R) in GenR; and maternal report 




scales have shown good psychometric properties (Conners et al., 1998; 
Goodman et al., 2000; Silva et al., 2005). More details about these 
questionnaires in each cohort are provided in Chapter 3 (see sections 
3.2.3.1; 3.3.3.1 and 3.4.3.1) 
 
5.2.4.2 Secondary outcome measures 
There is evidence of measurement differences between maternal and 
teacher reported ADHD symptoms in children (Narad et al., 2015), and 
some studies have also found conflicting results depending on the 
questionnaire used (Eilertsen et al., 2017). I therefore also included 
additional questionnaires, such as teacher report of the DAWBA 
questionnaire and maternal and teacher report of the Strengths and 
Difficulties Questionnaire (SDQ) hyperactivity subscale in ALSPAC and 
maternal and teacher report of the Child Behavior Checklist (CBCL) 
attention problems subscale in GenR to further explore if I observe 
different results depending on whether ADHD symptoms were reported by 
mother and/or teacher or which questionnaire was used. Psychometric 
properties of SDQ and CBCL are good (Goodman, 2001; Rishel et al., 2005), 
but these scales are broadband screeners and they do not distinguish ADHD 
symptom domains.  
 
More details about the included secondary outcome measures are given in 
Chapter 3 (see sections 3.2.3.2 and 3.3.3.2)  
 
5.2.5 Polygenic risk scores (PRSs) 
I calculated PRSs using weighted sum of effect alleles based on genome-
wide hits (p<5x10-8). These were weighted by effect estimates as reported 
in the GWAS for tobacco, alcohol (Liu et al., 2019), and caffeine 
consumption (Cornelis et al., 2015) for mothers with genetic data available 
using PLINK v1.90 (Purcell et al., 2007). More details about the phenotypes 
and SNPs discovered in GWAS of smoking heaviness, alcohol and coffee 
consumption can be found in Table 5.1. Independent variants of smoking 




discovery GWAS, and I therefore did not need to conduct further clumping 
or pruning (Choi et al., 2020).  
Table 5.1. Phenotyping in genome-wide association studies 
 GWAS phenotyping SNPs 
Smoking 







Smoking heaviness was defined as number 
of cigarettes individual smoked per day. 
Quantitative measure of cigarettes per day 
was binned to categories: 1-5; 6-15; 16-25; 
26-35 and 36+ cigarettes per day. Studies 
with pre-defined bins were left the same. 
55 SNPs were 
discovered to be 
conditionally 
independently 
associated with smoking 






Alcohol consumption was defined as 
number of drinks per week an individual 
consumed. As reporting of weekly alcohol 
consumption varied across the studies, 
binned response ranges were used (e.g., for 
1-4 drinks per week, a midpoint was used). 
Phenotype was left-anchored at 1 and log-
transformed before performing analysis to 
avoid effect from outliers 
99 SNPs were associated 
with alcohol 









Coffee data was collected categorically. 
Median value of each category was taken 
(e.g., for 2-3 cups per day, a 2.5 cups per 
day) for primary phenotype.  
Additionally, high/infrequent, and non-
coffee consumers were compared 
(“phenotype 2”) 
8 SNPs were 
independently 
associated with cups of 
coffee consumed per 
day at the genome-wide 
level of significance* 
*These SNPs have been also validated in caffeine consumption from other sources 
of caffeine besides coffee (McMahon et al., 2014; Treur et al., 2016) 
 
I calculated PRS for smoking heaviness with 49 SNPs available in ALSPAC 
and 51 SNPs available in MoBa and restricted the sample to smokers 
during pregnancy. I calculated PRS for alcohol consumption with 90 SNPs 
available in ALSPAC and 92 SNPs available in MoBa and I restricted the 
sample to mothers who drank during pregnancy. I calculated PRS for 
caffeine consumption with 8 SNPs available in ALSPAC and 7 SNPs 
available in MoBa. The range of PRS in ALSPAC and MoBa is shown in 




Table 5.2. The range of PRS in ALSPAC and MoBa 
PRS ALSPAC MoBa 
Smoking heaviness -0.57 to 0.39 -0.65 to 0.37 
Alcohol consumption -0.23 to 0.23 -0.05 to 0.52 
Caffeine consumption -0.55 to 0.56 -0.53 to 0.42 
 
There was little overlap between the SNPs included in the PRS for alcohol 
and caffeine, and no overlap between PRS for smoking and alcohol or 
caffeine. The correlation between these PRS were low ranging from -0.009 
to 0.209 in ALSPAC and -0.013 to 0.217 in MoBa (shown in Tables 5.3 and 
5.4). 
 







Smoking heaviness PRS -0.005   
Lifetime smoking PRS 0.029 0.209  
Caffeine PRS 0.121 -0.007 -0.009 
Note: Lifetime smoking PRS was included for sensitivity analyses (see section 
5.2.6.3.2) 
 







Smoking heaviness PRS -0.007   
Lifetime smoking PRS 0.043 0.217  
Caffeine PRS 0.128 -0.013 0.001 
Note: Lifetime smoking PRS was included for sensitivity analyses (see section 
5.2.6.3.2) 
 
5.2.6 Statistical analysis 
I performed all analyses using Stata (v15: ALSPAC, GenR; v16: MoBa), 
(StataCorp, 2017, 2019). Before I performed the analyses, I submitted a pre-
registered protocol to the Open Science Framework 
(https://doi.org/10.17605/OSF.IO/WXU58). I conducted analyses separately 
in each cohort and then I meta-analysed results from primary outcome 
measure (maternal reported ADHD symptoms) across the cohorts using a 
random effects model. Compared to a fixed effects model which assumes 




estimates the mean effect in the range of studies by taking into account 
sample size differences, as well as the variance in the exposure and 
outcome assessment across the cohorts. Heterogeneity (the proportion of 
observed variance) between the cohorts was shown by computing I2 
(Borenstein et al., 2009).  
 
I restricted the sample in each cohort to singletons in ALSPAC and GenR, 
whereas in MoBa I used a robust cluster variance estimator to account for 
the presence of siblings. Furthermore, in ALSPAC and GenR I restricted 
paternal analyses to individuals who were reported as biological fathers to 
optimise the validity of the same confounding structure, although still some 
non-paternity may exist. An overview of the sample used in the analyses for 
each cohort is shown in Chapter 3 (see section 3.5 “Cohorts comparison”).  
 
5.2.6.1 Negative control analyses 
I tested associations between maternal and paternal exposures and 
offspring outcome (dichotomised) using multivariable logistic regression 
analyses. I used three models: unadjusted (without including potential 
confounders); adjusted (for confounders identified a priori: child’s gender, 
ethnicity, parental age, education, depression and anxiety problems, 
financial difficulties, marital status and smoking, alcohol, and caffeine use) 
and mutually adjusted (adjusted for confounders and additionally adjusted 
for partner smoking, alcohol or caffeine use).  
 
As there is evidence that mate selection is influenced by health behaviours 
such as smoking and alcohol use (Grant et al., 2007; Howe et al., 2019; 
Madley-Dowd et al., 2020; Taylor et al., 2017), mutually adjusted models 
are thought to produce the most valid estimates. Failure to account for 
assortative mating can increase bias in effect estimates and affect 
interpretation of study results (Madley-Dowd et al., 2020). A study by 
Madley-Dowd and colleagues showed that when assortative mating is 
increased then the difference in maternal and paternal effect estimates 




effect may still exist. In contrast, effect estimates between maternal and 
paternal exposures are more similar after mutual adjustment.   
 
I selected confounders based on the findings from previous studies (Gilman 
et al., 2008; Kovess et al., 2015; Langley et al., 2012; Russell, Ford, et al., 
2015; Sagiv et al., 2013). In ALSPAC, maternal and paternal depression 
symptoms were measured using Edinburgh Postnatal Depressions Scale 
(EPDS) and anxiety symptoms with the anxiety sub-scale of the Crown-Crisp 
Experiential Index (CCEI). The scores were dichotomized, such as for the 
EPDS a validated cut-off score was ≥13 (Cox et al., 1996) and for the CCEI a 
threshold >85th percentile was used as in previous study in ALSPAC (Heron 
et al., 2004). In GenR, parental depression and anxiety symptoms were 
measured with the Brief Symptom Inventory (BSI). The cut-off score for 
maternal depression was 0.80 and for paternal depression was 0.71. For 
maternal anxiety the cut-off score was 0.71 and for fathers 0.65 (Elbert et 
al., 2017; Silva et al., 2019). In MoBa, parental depression and anxiety 
symptoms were measured with the Hopkins Symptoms Checklist-25 (SCL-
25) and a cut-off score ≥2 was applied (Strand et al., 2003). Other included 
confounders were categorized as shown in Chapter 3 (see section 3.5 
“Cohort comparison”). In MoBa, because of the longer recruitment period, I 
additionally adjusted analyses for birth year.  
 
I meta-analysed results from the mutually adjusted model for smoking and 
alcohol consumption and the adjusted model for caffeine consumption (as 
paternal caffeine consumption was not assessed in GenR) in each of the 
three cohorts.  
 
5.2.6.2 Polygenic risk score analyses 
In ALSPAC and MoBa, I investigated the association between maternal PRSs 
and maternal exposure phenotypes, as well as with ADHD risk in offspring. I 
performed PRS analyses in both cohorts with adjustment for 10 ancestry-
informative principal components. In MoBa, I additionally adjusted PRS 
analyses for birth year and genotyping batch as genotyping in MoBa was 




also tested the association between the PRSs, and each confounder 
included in the negative control analyses.  
 
5.2.6.3 Sensitivity analyses 
5.2.6.3.1 Negative control analyses 
If I observed an association between maternal substance use during 
pregnancy and ADHD risk in offspring, I further tested the hypothesis of a 
potential intrauterine effect by comparing maternal substance use during 
pregnancy with substance use before pregnancy. If there is a stronger 
association found with substance use in pregnancy than before pregnancy, 
this may suggest a potential intrauterine effect.  
 
Furthermore, given that ADHD is highly heritable, it is also plausible that 
any observed associations between maternal PRS and ADHD risk in 
offspring could be explained by genetic transmission. In MoBa, a measure 
of maternal ADHD was available, enabling me to test whether maternal 
ADHD could explain the observed associations between maternal exposures 
and ADHD symptoms in offspring. Maternal ADHD symptoms were 
measured at child age 5 years with the Adult ADHD Self-Report Scale (ASRS 
Screener). I dichotomised maternal ADHD symptoms score by using a 
validated cut-off score ≥13 (Kessler et al., 2007).  
 
Finally, I also performed analyses with complete cases by restricting 
unadjusted and adjusted analyses to the sample in the mutually adjusted 
model for each exposure.  
 
5.2.6.3.2 Polygenic risk score analyses 
As well as weighted PRSs, I calculated unweighted PRSs to test the 
association with each exposure phenotype, given that SNPs selected based 
only on the genome-wide significance level may be biased upwards (the so-
called Winner’s Curse) (Shi et al., 2016). In addition to the PRS for smoking 
heaviness, I also included a PRS for lifetime smoking, which captures 
smoking initiation, duration, heaviness, and cessation, and can be used 




GWAS of lifetime smoking based on UK Biobank (N=462,690) identified 126 
independent SNPs at the genome-wide level of significance (p<5x10-8) 
(Wootton et al., 2020), of which 123 were available in ALSPAC and 121 SNPs 
in MoBa. The range of PRS for lifetime smoking in ALSPAC was -0.57 to 0.25 
and in MoBa -0.52 to 0.36. 
 
Finally, given that longitudinal studies may be subject to selection bias 
(Taylor, Jones, et al., 2018), I tested associations between PRSs for smoking, 
alcohol, and caffeine use and whether mothers returned the questionnaire 






Overall, the negative control analyses comparing maternal and paternal 
substance use associations with offspring ADHD risk showed mixed 
evidence across the cohorts. I observed stronger associations in MoBa, 
where mothers had lower prenatal smoking, alcohol and caffeine 
consumption compared to mothers in ALSPAC and GenR.  
 
The results of meta-analysis across the cohorts are shown in Figure 5.3. The 
pooled estimates of maternal exposures were stronger compared with 
paternal exposures and although I did not formally test the difference 
between maternal and paternal exposures, their confidence intervals 
overlapped.  
 
In contrast to the negative control analyses, my PRS analyses in ALSPAC and 
MoBa did not provide evidence for a causal effect of maternal smoking, 
alcohol, or caffeine consumption during pregnancy on ADHD risk in 
offspring. Furthermore, PRS analyses for lifetime smoking indicated 
pleiotropic associations with socio-demographic and mental health traits, 






















Note: Meta-analysis of smoking (a) and alcohol consumption (b) are based on mutually adjusted model. Meta-analysis of caffeine consumption (c) is based on 








5.3.1.1 Negative control analyses 
The pooled estimate for maternal smoking in the mutually adjusted model 
provided weak evidence of an association with high risk of ADHD total and 
inattention symptoms (ORADHD=1.11, 95%CI 1.00, 1.23; ORINA=1.07, 95%CI 
1.01, 1.14). I observed a wide confidence interval for high risk of 
hyperactivity symptoms (ORHYP=1.09, 95%CI 0.97, 1.23). For paternal 
smoking, unlike for maternal consumption, there was some evidence of an 
association with high risk of hyperactivity symptoms (ORHYP=1.06, 95%CI 
1.00, 1.11), but not with other ADHD outcomes (ORADHD=1.03, 95%CI 0.95, 
1.13; ORINA=1.02, 95%CI 0.93, 1.11). The results showing the dose-
dependent relationship using non-smoking as baseline across unadjusted, 
adjusted and mutually adjusted models in each cohort are shown in Tables 
5.5-5.7.  
 
I observed stronger associations between maternal smoking and high risk of 
total ADHD symptoms in offspring compared with paternal smoking in 
GenR and MoBa; however, maternal and paternal confidence intervals 
overlapped. In ALSPAC, I found evidence of an association between 
paternal smoking and high risk of ADHD total symptoms (ORADHD=1.11, 




Table 5.5. Associations between maternal and paternal prenatal smoking and high risk of maternal reported offspring ADHD symptoms in ALSPAC 
   Unadjusted model   Adjusted model*   Mutually adjusted model** 
 N n OR 95% CI P-value N n OR 95% CI P-value N n OR 95% CI P-value 
Maternal 
ADHD (DAWBA) 7,731 1,114   <0.001 6,675 934   0.034 5,201 709   0.654 
No cigarettes (ref) 6,256 822 - -  5,483 701 - -  4,319 542 - -  
1-4 cigarettes 372 67 1.45 1.104,1.911  314 51 1.03 0.747,1.424  244 38 0.84 0.576,1.232  
5-9 cigarettes 367 68 1.50 1.144,1.976  301 60 1.26 0.922,1.734  228 44 1.07 0.734,1.553  
>10 cigarettes 736 157 1.79 1.481,2.170  577 122 1.27 0.990,1.617  410 85 1.07 0.797,1.449  
Hyperactive 7,751 984   <0.001 6,693 828   0.157 5,211 622   0.839 
No cigarettes (ref) 6,274 726 - -  5,499 628 - -  4,329 486 - -  
1-4 cigarettes 373 59 1.44 1.076,1.916  315 43 0.97 0.689,1.368  245 32 0.84 0.559,1.254  
5-9 cigarettes 366 64 1.62 1.223,2.144  300 54 1.27 0.913,1.754  227 35 0.98 0.652,1.463  
>10 cigarettes 738 135 1.71 1.398,2.094  579 103 1.16 0.896,1.501  410 69 0.98 0.715,1.348  
Inattentive 7,743 1,058   <0.001 6,688 890   0.098 5,208 686   0.651 
No cigarettes (ref) 6,266 810 - -  5,494 690 - -  4,326 541 - -  
1-4 cigarettes 372 54 1.14 0.849,1.541  314 44 0.94 0.670,1.321  243 31 0.73 0.487,1.099  
5-9 cigarettes 368 62 1.37 1.029,1.811  302 52 1.20 0.863,1.670  228 39 1.06 0.721,1.568  
>10 cigarettes 737 132 1.47 1.201,1.799  578 104 1.22 0.947,1.581  411 75 1.09 0.802,1.488  
ADHD (SDQ) 7,994 892   <0.001 6,946 737   0.029 5,405 561   0.159 
No cigarettes (ref) 6,421 639 - -  5,672 545 - -  4,459 415 - -  
1-4 cigarettes 386 57 1.57 1.170,2.101  323 45 1.26 0.899,1.767  249 35 1.17 0.792,1.732  
5-9 cigarettes 380 51 1.40 1.033,1.905  317 38 0.97 0.669,1.397  238 28 0.88 0.568,1.358  







ADHD (DAWBA) 5,841 815   <0.001 4,657 622   0.001 4,647 618   0.005 
No cigarettes (ref) 3,977 474 - -  3,288 382 - -  3,284 381 - -  
1-4 cigarettes 296 47 1.40 1.007,1.933  237 35 1.21 0.825,1.787  235 34 1.18 0.799,1.755  
5-9 cigarettes 254 46 1.63 1.171,2.281  185 29 1.29 0.846,1.978  184 28 1.24 0.803,1.912  
>10 cigarettes 1,314 248 1.72 1.453,2.034  947 176 1.44 1.159,1.790  944 175 1.38 1.097,1.730  
Hyperactive 5,851 711   <0.001 4,666 535   0.042 4,656 532   0.105 
No cigarettes (ref) 3,983 427 - -  3,295 341 - -  3,291 340 - -  
1-4 cigarettes 297 38 1.22 0.857,1.743  237 29 1.16 0.764,1.753  235 28 1.112 0.728,1.700  
5-9 cigarettes 254 29 1.07 0.720,1.601  184 16 0.73 0.427,1.248  183 16 0.727 0.424,1.248  
>10 cigarettes 1,317 217 1.64 1.377,1.961  950 149 1.31 1.043,1.652  947 148 1.262 0.991,1.606  
Inattentive 5,849 478   <0.001 4,666 614   0.065 4,656 610   0.089 
No cigarettes (ref) 3,979 45 - -  3,293 394 - -  3,289 393 - -  
1-4 cigarettes 299 41 1.30 0.932,1.807  239 37 1.24 0.847,1.806  237 36 1.24 0.841,1.817  
5-9 cigarettes 254 215 1.41 0.996,1.996  185 27 1.15 0.743,1.776  184 26 1.13 0.723,1.760  
>10 cigarettes 1,317 779 1.43 1.200,1.702  949 156 1.23 0.981,1.530  946 155 1.22 0.966,1.538  
ADHD (SDQ) 6,030 646   0.099 4,804    0.094 4,793    0.023 
No cigarettes (ref) 4,059 373 - -  3,358 289 - -  3,353 289 - -  
1-4 cigarettes 307 37 1.35 0.945,1.940  241 30 1.42 0.942,2.144  239 29 1.32 0.869,2.013  
5-9 cigarettes 268 32 1.34 0.912,1.968  196 23 1.26 0.795,2.004  195 23 1.22 0.762,1.937  
>10 cigarettes 1,396 204 1.69 1.409,2.030  1,009 145 1.48 1.171,1.868  1,006 144 1.33 1.036,1.699  
Note: DAWBA – Development And Well-Being Assessment; SDQ – Strengths and Difficulties Questionnaire; N – total sample size; n – number of cases; OR – odds 
ratio; 95% CI – 95% confidence intervals; *adjusted for child’s gender, ethnicity, parity, parental age, marital status, education, financial difficulties, depression and 






Table 5.6. Associations between maternal and paternal prenatal smoking and high risk of maternal and teacher reported offspring ADHD symptoms in 
GenR 
   Unadjusted model   Adjusted model*   Mutually adjusted model** 
 N n OR 95% CI P-value N n OR 95% CI P-value N n OR 95% CI P-value 
Maternal 
ADHD (CPRS-R) 3,116 452   <0.001 2,053 282   0.023 1,535 196   0.018 
No cigarettes (ref) 2,471 330 - -  1,623 209 - -  1,219 145 - -  
1-4 cigarettes 358 62 1.36 1.009,1.829  226 32 1.02 0.666,1.548  165 21 1.01 0.592,1.720  
5-9 cigarettes 159 29 1.45 0.952,2.200  113 18 1.13 0.649,1.974  82 13 1.26 0.639,2.484  
>10 cigarettes 128 31 2.07 1.361,3.158  91 23 1.97 1.144,3.375  69 17 2.48 1.293,4.755  
Hyperactive 3,119 345   0.007 2,057 201   0.076 1,536 143   0.217 
No cigarettes (ref) 2,475 260 - -  1,628 152 - -  1,221 107 - -  
1-4 cigarettes 358 41 1.10 0.777,1.563  226 20 0.93 0.560,1.548  165 14 0.77 0.413,1.440  
5-9 cigarettes 158 20 1.24 0.759,1.563  112 12 1.05 0.544,2.014  81 9 0.97 0.445,2.123  
>10 cigarettes 128 24 1.97 1.239,3.121  91 17 1.99 1.079,3.663  69 13 1.99 0.964,4.099  
Inattentive 3,117 391   0.039 2,058 240   0.288 1,537 170   0.143 
No cigarettes (ref) 2,472 298 - -  1,628 188 - -  1,221 133 - -  
1-4 cigarettes 358 49 1.16 0.836,1.601  226 21 0.72 0.444,1.183  165 15 0.81 0.442,1.470  
5-9 cigarettes 159 19 0.99 0.604,1.623  113 10 0.65 0.323,1.293  82 7 0.68 0.292,1.589  
>10 cigarettes 128 25 1.77 1.125,2.787  91 21 2.01 1.154,3.513  69 15 2.49 1.259,4.932  
ADHD (CBCL) 4,168 595   <0.001 2,565 331   0.004 1,835 211   0.031 
No cigarettes (ref) 3,199 396 - -  1,970 217 - -  1,432 140 - -  
1-4 cigarettes 521 99 1.66 1.303,2.117  306 54 1.47 1.040,2.090  211 31 1.22 0.770,1.942  
5-9 cigarettes 255 60 2.18 1.601,2.963  161 31 1.35 0.858,2.132  107 21 1.53 0.863,2.725  
>10 cigarettes 193 40 1.85 1.286,2.662  128 29 1.76 1.086,2.846  85 19 1.80 0.972,3.323  
ADHD (TRF) 3,023    <0.001 1,671 218   0.002 1,148 125   0.059 
No cigarettes (ref) 2,247 307 - -  1,253 142 - -  878 85 - -  
1-4 cigarettes 420 76 1.40 1.059,1840  221 33 1.25 0.802,1.944  141 16 1.01 0.529,1.908  
5-9 cigarettes 207 52 2.12 1.514,2.968  117 25 2.24 1.302,3.849  75 12 1.59 0.737,3.449  





ADHD (CPRS-R) 2,381 333   0.882 2,117 289   0.220 1,930 260   0.237 
No cigarettes (ref) 1,412 197 - -  1,249 170 - -  1,148 149 - -  




























Hyperactive 2,381 241   0.031 2,117 202   0.193 1,930 186   0.448 
No cigarettes (ref) 1,412 130 - -  1,249 104 - -  1,148 98 - -  




























Inattentive 2,382 290   0.661 2,119 256   0.024 1,931 233   0.078 
No cigarettes (ref) 1,412 174 - -  1,250 156 - -  1,149 139 - -  




























ADHD (CBCL) 2,913 366   <0.001 2,541 305   0.025 2,323 275   0.039 
No cigarettes (ref) 1,689 177 - -  1,478 148 - -  1,361 130 - -  




























ADHD (TRF) 1,876 214   0.005 1,570 166   0.230 1,445 151   0.347 
No cigarettes (ref) 1,045 100 - -  883 77 - -  816 68 - -  




























Note: CPRS-R – Revised Conners’ Parent Rating Scale; CBCL – Child Behavior Checklist; TRF – Teacher Report Form; N – sample size; n – number of cases; OR – odds 
ratio; 95% CI – 95% confidence intervals; *adjusted for child’s gender, parity, parental ethnicity, age, education, anxiety and depression symptoms, financial 





Table 5.7. Associations between maternal and paternal prenatal smoking and high risk of maternal reported offspring ADHD symptoms in MoBa 
   Unadjusted model   Adjusted model*   Mutually adjusted model** 
 N n OR 95% CI P-value N n OR 95% CI P-value N n OR 95% CI P-value 
Maternal 
ADHD (RS-DBD) 41,515 5,509   <0.001 34,297 4,415   <0.001 28,055 3,543   0.006 
No cigarettes (ref) 39,162 4,993 - -  32,487 4,035 - -  26,706 3,280 - -  
1-4 cigarettes 1,260 234 1.56 1.350,1.805  951 168 1.13 0.946,1.360  707 111 0.95 0.761,1.182  
5-9 cigarettes 650 158 2.20 1.830,2.640  501 121 1.66 1.326,2.075  383 87 1.49 1.136,1.941  
>10 cigarettes 443 124 2.66 2.159,3.277  358 91 1.50 1.149,1.945  259 65 1.38 1.000,1.893  
Hyperactive 41,508 5,436   <0.001 34,290 4,353   <0.001 28,051 3,507   <0.001 
No cigarettes (ref) 39,158 4,916 - -  32,483 3,971 - -  26,704 3,232 - -  
1-4 cigarettes 1,259 239 1.63 1.414,1.883  950 166 1.16 0.968,1.384  707 117 1.04 0.840,1.286  
5-9 cigarettes 649 159 2.26 1.884,2.712  500 124 1.75 1.409,2.185  382 91 1.60 1.228,2.073  
>10 cigarettes 442 122 2.66 2.152,3.278  357 92 1.57 1.208,2.036  258 67 1.45 1.061,1.991  
Inattentive 41,524 4,824   <0.001 34,302 3,874   0.001 28,058 3,102   0.041 
No cigarettes (ref) 39,170 4,402 - -  32,491 3,551 - -  26,708 2,877 - -  
1-4 cigarettes 1,261 198 1.47 1.259,1.719  952 151 1.14 0.940,1.373  708 101 0.99 0.783,1.243  
5-9 cigarettes 650 131 1.99 1.640,2.423  501 102 1.53 1.208,1.935  383 70 1.32 0.996,1.760  






ADHD (RS-DBD) 33,955 4,397   <0.001 10,804 1,462   0.155 10,738 1,454   0.417 
No cigarettes (ref) 26,918 3,312 - -  9,018 1,198 - -  8,965 1,193 - -  
1-4 cigarettes 3,252 436 1.10 0.991,1.229  1,001 122 0.86 0.702,1.050  998 120 0.83 0.680,1.021  
5-9 cigarettes 870 140 1.37 1.134,1.648  213 41 1.40 0.980,1.994  211 40 1.32 0.919,1.889  
>10 cigarettes 2,915 509 1.51 1.360,1.672  572 101 1.17 0.917,1.484  564 101 1.09 0.846,1.404  
Hyperactive 33,951 4,370   <0.001 10,802 1,432   0.082 10,736 1,424   0.242 
No cigarettes (ref) 26,917 3,284 - -  9,017 1,162 - -  8,964 1,157 - -  
1-4 cigarettes 3,252 434 1.11 0.995,1.234  1,000 134 1.00 0.822,1.217  997 132 0.98 0.801,1.190  
5-9 cigarettes 870 133 1.30 1.073,1.572  213 40 1.41 0.988,2.020  211 39 1.35 0.939,1.945  
>10 cigarettes 2,912 519 1.56 1.408,1.730  572 96 1.14 0.893,1.459  564 96 1.09 0.843,1.411  
Inattentive 33,958 3,851   <0.001 10,806 1,254   0.133 10,740 1,248   0.295 
No cigarettes (ref) 26,923 2,922 - -  9,019 1,023 - -  8,966 1,018 - -  
1-4 cigarettes 3,251 383 1.10 0.979,1.229  1,001 111 0.92 0.741,1.131  998 110 0.90 0.727,1.115  
5-9 cigarettes 869 122 1.34 1.102,1.633  213 31 1.18 0.794,1.746  211 31 1.16 0.784,1.725  
>10 cigarettes 2,915 424 1.40 1.253,1.560  573 89 1.21 0.937,1.560  565 89 1.16 0.887,1.509  
Note: RS-DBD – Rating Scale for Disruptive Behavior Disorders; N – sample size; n – number of cases; OR – odds ratio; 95% CI – 95% confidence intervals; *adjusted 
for child’s gender, birth year, parity, parental age, education, marital status, financial difficulties, depression and anxiety symptoms, prenatal alcohol and caffeine 







5.3.1.1.1 Sensitivity analyses 
In MoBa, additional adjustment for maternal ADHD attenuated the 
association between prenatal smoking and high risk of ADHD inattention 
symptoms in offspring, but there still remained evidence of an association 
with high risk of ADHD total and hyperactive-impulsive symptoms 
(Appendix 5.1). Furthermore, I found evidence of an association between 
maternal smoking before pregnancy and high risk of hyperactive-impulsive 
symptoms, but the estimates were stronger with smoking during pregnancy 
(Appendix 5.2).  
 
Analyses using teacher report of DAWBA and SDQ scales in ALSPAC and TRF 
in GenR found no strong evidence of an association between maternal 
smoking during pregnancy and ADHD risk in offspring (Appendix 5.3). In 
contrast, in GenR I found evidence of an association between maternal 
smoking during pregnancy and high risk of ADHD total symptoms measured 
with CBCL (Table 5.6). I did not observe this association for maternal 
smoking before pregnancy (Appendix 5.4). Results were similar in the 
analyses with complete cases in each cohort (Appendices 5.5-5.7).  
 
5.3.1.2 Polygenic risk score analyses 
In each of the PRS analyses I report the results based on the MR 
assumptions described in the introduction (see section 5.1). 
 
First, the weighted PRS for smoking heaviness and lifetime smoking were 
associated with smoking behaviour in pregnancy in ALSPAC and MoBa (all 
p<0.01). These PRS explained 1-3% of variance in smoking phenotypes in 
ALSPAC and MoBa (Tables 5.8 and 5.9). Associations with unweighted PRS 





Table 5.8. Associations between maternal weighted exposure PRSs and exposure 
phenotypes in ALSPAC 
Exposure Beta 95% CI P-value Sample size R2 
Smoking heaviness 0.52 0.258, 0.788 0.001 1,537 0.015 
Lifetime smoking* 0.67 0.495, 0.837 4.91x10-17 7,107 0.010 
Lifetime smoking** 9.09 4.521, 18.275 6.73x10-10 3,413 0.030 
Alcohol consumption 0.29 0.074, 0.501 0.008 3,962 0.019 
Coffee consumption 53.45 30.651, 76.252 4.51x10-6 7,074 0.004 
Note: *smoking heaviness phenotype; **smoking cessation phenotype (in OR’s); 95% CI – 
95% confidence intervals; adjusted for principal components; R2 – variance explained 
 
Table 5.9. Associations between maternal weighted exposure PRSs and exposure 
phenotypes in MoBa 
Exposure Beta 95% CI P-value Sample size R2 
Smoking heaviness 0.39 0.112, 0.674 0.006 1,029 0.020 
Lifetime smoking* 0.28 0.120, 0.351 1.05x10-12 14,488 0.012 
Lifetime smoking** 3.21 1.544, 6.660 0.002 3,118 0.027 
Alcohol consumption 0.65 -0.757, 2.055 0.365 1,362 NA 
Alcohol consumption*** 1.06 0.258, 1.859 0.010 12,953 0.007 
Coffee consumption 18.80 9.206, 28.402 0.0001 14,583 0.003 
Note: *smoking heaviness phenotype; **smoking cessation phenotype (in OR’s); 95% CI – 
95% confidence intervals; R2 – variance explained; ***alcohol consumption before 
pregnancy; NA – alcohol PRS was not associated with alcohol consumption phenotype; 
adjusted for birth year, genotyping batch and principal components 
 
Second, in ALSPAC, I did not find any strong evidence for an association 
between PRS for smoking heaviness and confounders included in the 
negative control analyses (Table 5.10). However, in MoBa, I found evidence 
of an association between the PRS for smoking heaviness and lower parity 
(=-0.41, 95%CI -0.732, -0.092; Table 5.11). The PRS for lifetime smoking 
was associated with younger maternal age (=-2.64, 95%CI -3.688, -1.586), 
lower education (=-1.00, 95%CI -1.286, -0.711), more financial difficulties 
(=1.12, 95%CI 0.317, 1.912), higher likelihood of being single (OR=0.24, 
95%CI 0.138, 0.415) and having more severe anxiety symptoms (OR=1.98, 
95%CI 1.035, 3.801) in ALSPAC (Table 5.12). Similarly, in MoBa, the PRS for 
lifetime smoking showed evidence of an association with lower maternal 
education (=-0.27, 95%CI -0.356, -0.191) and higher likelihood of having 
more severe depression and anxiety symptoms (OR=1.98, 95%CI 1.052, 





Table 5.10. Associations between maternal smoking heaviness PRS and 
confounders in ALSPAC 
Confounder Effect 
estimate 
Effect size 95% CI P-value Sample size 
Maternal age Beta 0.04 -1.437, 1.524 0.954 1,853 
Maternal education Beta -0.38 -0.782, 0.023 0.065 1,527 
Financial difficulties Beta 0.51 -0.816, 1.826 0.453 1,475 
Marital status OR 1.24 0.662, 2.330 0.500 1,653 
Depress. symptoms OR 0.90 0.395, 2.027 0.791 1,457 
Anxiety symptoms OR 0.99 0.452, 2.162 0.976 1,451 
Parity Beta 0.04 -0.265, 0.341 0.806 1,540 
Note: adjusted for principal components; OR- odds ratio; 95% CI – 95% confidence 
intervals. 
 
Table 5.11. Associations between maternal smoking heaviness PRS and 
confounders in MoBa 
Confounder Effect 
estimate 
Effect size 95% CI P-value Sample size 
Maternal age Beta -0.21 -13.382, 12.96 0.975 1,125 
Maternal education Beta -0.12 -0.330, 0.084 0.242 1,069 
Financial difficulties OR 1.10 0.502, 2.416 0.810 966 
Marital status Beta -0.04 -0.171, 0101 0.611 1,120 
Depress. / anxiety 
symptoms 
OR 1.39 0.489, 3.958 0.535 1,112 
Maternal ADHD OR 0.59 0.061, 5.694 0.649 557 
Parity Beta -0.41 -0.732, -0.092 0.012 1,125 
Note: adjusted for birth year, genotyping batch and principal components; OR – odds ratio; 
95% CI – 95% confidence intervals. 
 




Effect size 95% CI P-value Sample size 
Maternal age Beta -2.64 -3.688, -1.586 <0.001 7,421 
Maternal education Beta -1.00 -1.286, -0.711 <0.001 6,860 
Financial difficulties Beta 1.12 0.317, 1.912 0.006 6,691 
Marital status OR 0.24 0.138, 0.415 <0.001 7,124 
Depress. symptoms OR 1.85 0.910, 3.757 0.089 6,706 
Anxiety symptoms OR 1.98 1.035, 3.801 0.039 6,669 
Parity Beta 0.09 -0.111, 0.282 0.392 7,040 









Effect size 95% CI P-value Sample size 
Maternal age Beta -0.69 -3.095, 1.723 0.577 14,584 
Maternal education Beta -0.27 -0.356, -0.191 <0.001 13,836 
Financial difficulties OR 1.57 0.995, 2.477 0.053 13,484 
Marital status Beta 0.01 -0.027, 0.038 0.718 14,519 
Depress. / anxiety 
symptoms 
OR 1.98 1.052, 3.705 0.034 14,464 
Maternal ADHD OR 1.90 0.562, 6.403 0.302 8,841 
Parity Beta 0.07 -0.065, 0.200 0.319 14,584 
Note: adjusted for birth year, genotyping batch and principal components; OR- odds ratio; 
95% CI – 95% confidence intervals. 
 
Third, in ALSPAC, I did not find strong evidence of an association between 
the PRS for smoking heaviness and high risk of maternal or teacher 
reported ADHD symptoms in offspring (Table 5.14 and Appendix 5.10).  
Similarly, in MoBa, I did not find clear evidence of an association between 
the PRS for smoking heaviness and offspring ADHD risk (Table 5.15). In 
contrast, I found no clear evidence of an association between the PRS for 
lifetime smoking and high risk of maternal reported ADHD symptoms in 
offspring in ALSPAC (Table 5.16), but I did find evidence of an association 
with high risk of teacher reported ADHD total symptoms measured with 
both the DAWBA (ORDAWBA = 2.70, 95%CI 1.026, 7.079) and the SDQ (ORSDQ = 
3.00, 95%CI 1.034, 8.688; Appendix 5.11.). 
 
There was no strong evidence of an association between maternal PRS for 
lifetime smoking and high risk of maternal reported ADHD symptoms in 





Table 5.14. Associations between maternal smoking heaviness PRS and high risk of 
maternal reported offspring ADHD symptoms in ALSPAC 
 Maternal PRS Maternal PRS adj. for PC  
Outcome OR 95% CI P-
value 




ADHD (DAWBA) 1.04 0.377, 2.885 0.936 1.09 0.389, 3.037 0.873 958 
Hyperactive 0.46 0.156, 1.367 0.163 0.45 0.151, 1.362 0.159 959 
Inattentive 0.86 0.289, 2.561 0.787 0.89 0.294, 2.680 0.833 958 
ADHD (SDQ) 0.12 0.038, 0.403 0.001 0.12 0.037, 0.407 0.001 979 
Note: DAWBA – Development And Well-Being Assessment; SDQ – Strengths and Difficulties 
Questionnaire; OR – odds ratio; 95% CI – 95% confidence intervals; PC – principal 
components 
Table 5.15. Associations between maternal smoking heaviness PRS and high risk of 
maternal reported offspring ADHD symptoms in MoBa 
 Maternal PRS Maternal PRS adj. for PC  
Outcome OR 95% CI P-
value 




ADHD (RS-DBD) 1.77 0.423, 7.385 0.435 1.86 0.430, 8.057 0.406 396 
Hyperactive 0.80 0.195, 3.282 0.757 0.88 0.211, 3.693 0.865 394 
Inattentive 2.82 0.608, 13.097 0.186 3.05 0.639, 14.564 0.162 396 
Note: RS-DBD – Rating Scale for Disruptive Behavior Disorders; OR – odds ratio; 95% CI – 
95% confidence intervals; PC – principal components; additionally adjusted for birth year 
and genotyping batch 
Table 5.16. Associations between maternal lifetime smoking PRS and high risk of 
maternal reported offspring ADHD symptoms in ALSPAC 
 Maternal PRS Maternal PRS adj. for PC  
Outcome OR 95% CI P-
value 




ADHD (DAWBA) 0.91 0.421, 1.979 0.818 0.90 0.414, 1.950 0.787 5,005 
Hyperactive 0.86 0.380, 1.927 0.706 0.83 0.369, 1.881 0.661 5,016 
Inattentive 0.99 0.451, 2.168 0.977 0.98 0.445, 2.142 0.952 5,013 
ADHD (SDQ) 1.53 0.641, 3.650 0.338 1.53 0.638, 3.658 0.341 5,103 
Note: DAWBA – Development And Well-Being Assessment; SDQ – Strengths and Difficulties 
Questionnaire; OR – odds ratio; 95% CI – 95% confidence intervals; PC – principal 
components 
 
Table 5.17. Associations between maternal lifetime smoking PRS and high risk of 
maternal reported offspring ADHD symptoms in MoBa  
 Maternal PRS Maternal PRS adj. for PC  
Outcome OR 95% CI P-
value 




ADHD (RS-DBD) 1.02 0.510, 2.036 0.958 1.02 0.510, 2.040 0.957 7,017 
Hyperactive 1.02 0.512, 2.021 0.961 1.02 0.513, 2.025 0.957 7,012 
Inattentive 1.06 0.510, 2.181 0.885 1.07 0.518, 2.216 0.853 7,017 
Note: RS-DBD – Rating Scale for Disruptive Behavior Disorders; OR – odds ratio; 95% CI – 
95% confidence intervals; PC – principal components; additionally adjusted for birth year 






5.3.2.1 Negative control analyses 
The pooled estimate of maternal alcohol consumption in the mutually 
adjusted model showed some evidence of an association with high risk of 
ADHD total and inattention symptoms (ORADHD=1.27, 95%CI 1.08, 1.49; 
ORINA=1.26, 95%CI 1.10, 1.44), but not with high risk of hyperactive-
impulsive symptoms (ORHYP=1.13, 95%CI 0.87,1.47). I observed the 
strongest associations in ALSPAC and MoBa, in GenR the estimates were in 
opposite direction for high risk of hyperactivity symptoms.  
 
Meta-analysis of paternal alcohol consumption did not show evidence of an 
association with any of the ADHD symptom domains in offspring 
(ORADHD=0.83, 95%CI 0.47, 1.48; ORHYP=0.81, 95%CI 0.53,1.23; ORINA=0.81, 
95%CI 0.52,1.27), but there was high heterogeneity and confidence 
intervals were wide. In ALSPAC, paternal alcohol consumption was 
negatively associated with ADHD risk in offspring (ORADHD=0.46, 95%CI 0.31, 
0.70; ORHYP=0.53, 95%CI 0.35, 0.82; ORINA=0.52, 95%CI 0.34 to 0.79). This 
finding was not replicated in GenR and MoBa. The results across 
unadjusted, adjusted and mutually adjusted models in each cohort are 





Table 5.18. Associations between maternal and paternal prenatal alcohol consumption and high risk of maternal reported offspring ADHD symptoms 
in ALSPAC 
   Unadjusted model   Adjusted model*   Mutually adjusted model** 
 N n OR 95% CI P-value N n OR 95% CI P-value N n OR 95% CI P-value 
Maternal 
ADHD (DAWBA) 7,711 1,114   <0.001 6,675 934   0.010 5,384 733   0.002 
None (ref) 3,411 450 - -  2,938 374 - -  2,369 288 - -  
<1 unit a week 3,119 455 1.12 0.977,1.293  2,725 389 1.16 0.993,1.362  2,220 311 1.23 1.026,1.471  
>1 unit a week 1,181 209 1.42 1.183,1.693  1,012 171 1.29 1.045,1.586  795 134 1.44 1.128,1.832  
Hyperactive 7,732 982   0.009 6,693 828   0.048 5,394 642   0.009 
None (ref) 3,426 407 - -  2,951 338 - -  2,378 260 - -  
<1 unit a week 3,124 398 1.08 0.934,1.255  2,729 346 1.15 0.972,1.350  2,221 272 1.20 0.991,1.443  
>1 unit a week 1,182 177 1.31 1.080,1.580  1,013 144 1.21 0.971,1.507  795 110 1.38 1.064,1.781  
Inattentive 7,723 1,057   0.011 6,688 890   0.061 5,392 708   0.004 
None (ref) 3,416 437 - -  2,943 363 - -  2,375 279 - -  
<1 unit a week 3,125 434 1.10 0.953,1.268  2,723 373 1.15 0.980,1.348  2,222 301 1.24 1.031,1.483  
>1 unit a week 1,182 186 1.27 1.057,1.533  1,013 154 1.19 0.964,1.480  795 128 1.41 1.106,1.808  
ADHD (SDQ) 7,983 890   0.003 6,946 737   0.019 5,613 579   0.008 
None (ref) 3,521 356 - -  3,055 291 - -  2,471 222 - -  
<1 unit a week 3,225 373 1.16 0.997,1.356  2,837 317 1.23 1.037,1.464  2,310 257 1.32 1.082,1.603  







ADHD (DAWBA) 6,049 843   0.019 4,657 622   0.201 4,648 622   0.048 
None (ref) 226 49 - -  148 36 - -  148 36 - -  
<1 unit a week 1,404 202 0.61 0.428,0.861  1,054 136 0.49 0.314,0.748  1,053 136 0.45 0.292,0.701  
1-6 units a week 3,164 424 0.56 0.401,0.779  2,471 320 0.53 0.349,0.795  2,465 320 0.47 0.310,0.715  
>1 unit a day 1,255   168 0.56 0.391,0.797  984 130 0.51 0.327,0.787  982 130 0.44 0.279,0.683  
Hyperactive 6,059 735   <0.001 4,666 535   0.018 4,657 535   0.004 
None (ref) 226 43 - -  148 30 - -  148 30 - -  
<1 unit a week 1,410 194 0.68 0.471,0.978  1,060 131 0.60 0.383,0.953  1,059 131 0.56 0.350,0.905  
1-6 units a week 3,170 365 0.55 0.390,0.786  2,476 275 0.58 0.374,0.895  2,470 275 0.54 0.343,0.855  
>1 unit a day 1,253 133 0.51 0.346,0.737  982 99 0.50 0.312,0.796  980 99 0.47 0.288,0.771  
Inattentive 6,058 804   0.217 4,666 614   0.359 4,657 614   0.102 
None (ref) 227 45 - -  148 32 - -  148 32 - -  
<1 unit a week 1,407 192 0.64 0.446,0.916  1,057 141 0.59 0.379,0.922  1,056 141 0.51 0.320,0.796  
1-6 units a week 3,167 390 0.57 0.403,0.800  2,473 304 0.56 0.367,0.859  2,467 304 0.45 0.291,0.699  
>1 unit a day 1,257 177 0.66 0.461,0.953  988 137 0.62 0.396,0.974  986 137 0.49 0.308,0.781  
ADHD (SDQ) 6,264 669   0.040 4,804 487   0.436 4,796 487   0.156 
None (ref) 233 35 - -  160 24 - -  160 24 - -  
<1 unit a week 1,467 172 0.75 0.507,1.113  1,096 114 0.68 0.418,1.110  1,095 114 0.62 0.374,1.027  
1-6 units a week 3,276 327 0.63 0.430,0.915  2,541 245 0.66 0.416,1.061  2,537 245 0.58 0.356,0.941  
>1 unit a day 1,288 135 0.66 0.443,0.989  1,007 104 0.69 0.418,1.127  1,004 104 0.55 0.328,0.928  
Note: DAWBA – Development And Well-Being Assessment; SDQ – Strengths and Difficulties Questionnaire; N – total sample size; n – number of cases; OR – odds 
ratio; 95% CI – 95% confidence intervals; *adjusted for child’s gender, ethnicity, parity, parental age, marital status, education, financial difficulties, depression and 






Table 5.19. Associations between maternal and paternal prenatal alcohol consumption and high risk of maternal and teacher reported offspring ADHD 
symptoms in GenR 
   Unadjusted model   Adjusted model*   Mutually adjusted model** 
 N n OR 95% CI P-value N n OR 95% CI P-value N n OR 95% CI P-value 
Maternal 
ADHD (CPRS-R) 3,030 440   0.414 1,983 274   0.484 1,532 196   0.581 
None (ref) 1,521 210 - -  920 120 - -  630 72 - -  
<1 unit a week 933 145 1.15 0.913,1.445  644 93 1.11 0.809,1.522  507 71 1.25 0.854,1.834  
>1 unit a week 576 85 1.08 0.823,1.419  419 61 1.13 0.781,1.633  395 53 1.12 0.720,1.735  
Hyperactive 3,033 337   0.053 1,987 194   0.198 1,533 144   0.164 
None (ref) 1,523 186 - -  923 98 - -  631 66 - -  
<1 unit a week 933 96 0.82 0.635,1.070  644 60 0.84 0.586,1.210  507 44 0.78 0.509,1.207  
>1 unit a week 577 55 0.76 0.551,1.040  420 36 0.76 0.492,1.180  395 34 0.71 0.433,1.169  
Inattentive 3,032 379   0.656 1,988 230   0.698 1,534 170   0.498 
None (ref) 1,523 182 - -  924 100 - -  632 60 - -  
<1 unit a week 932 127 1.16 0.912,1.482  644 82 1.19 0.851,1.659  507 62 1.28 0.851,1.913  
>1 unit a week 577 70 1.02 0.758,1.365  420 48 1.05 0.702,1.563  395 48 1.16 0.732,1.842  
ADHD (CBCL) 4,075 585   0.002 2,485 321   0.170 1,828 212   0.105 
None (ref) 2,210 347 - -  1,221 167 - -  809 101 - -  
<1 unit a week 1,159 159 0.85 0.697,1.046  769 103 1.04 0.780,1.397  574 67 0.94 0.651,1.356  
>1 unit a week 706 79 0.68 0.521,0.878  495 51 0.73 0.507,1.064  445 44 0.68 0.441,1.062  
ADHD (TRF) 2,970 458   <0.001 1,622 208   0.129 1,148 126   0.178 
None (ref) 1,784 333 - -  849 129 - -  539 72 - -  
<1 unit a week 723 76 0.51 0.392,0.668  469 48 0.71 0.480,1.056  342 28 0.60 0.357,1.013  






ADHD (CPRS-R) 2,373 333   0.266 2,117 289   0.070 1,937 261   0.163 
None (ref) 279 28 - -  221 19 - -  201 19 - -  
<1 unit a week 311 54 1.88 1.156,3.070  266 42 2.03 1.107,3.708  238 35 1.58 0.841,2.948  
1-6 units a week 


























Hyperactive 2,373 242   0.901 2,117 202   0.636 1,937 186   0.401 
None (ref) 279 26 - -  221 17 - -  201 17 - -  
<1 unit a week 311 42 1.52 0.905,2.551  266 35 1.84 0.962,3.519  238 31 1.68 0.866,3.270  
1-6 units a week 


























Inattentive 2,374 290   0.208 2,119 256   0.111 1,939 234   0.144 
None (ref) 279 29 - -  221 19 - -  201 18 - -  
<1 unit a week 311 41 1.31 0.789,2.171  266 36 1.55 0.838,2.884  238 31 1.38 0.719,2.629  
1-6 units a week 


























ADHD (CBCL) 2,898 363   0.320 2,541 305   0.913 2,332 278   0.865 
None (ref) 413 52 - -  319 40 - -  299 39 - -  
<1 unit a week 413 66 1.32 0.892,1.954  350 54 1.41 0.885,2.258  317 48 1.38 0.848,2.251  
1-6 units a week 


























ADHD (TRF) 1,876 216   0.029 1,570 166   0.829 1,452 149   0.680 
None (ref) 325 49 - -  229 31 - -  213 28 - -  
<1 unit a week 261 31 0.76 0.469,1.230  210 19 0.78 0.400,1.536  196 18 0.85 0.411,1.713  
1-6 units a week 


























Note: CPRS-R – Revised Conners’ Parent Rating Scale; CBCL – Child Behavior Checklist; TRF – Teacher Report Form; N – sample size; n – number of cases; OR – odds 
ratio; 95% CI – 95% confidence intervals; *adjusted for child’s gender, parity, parental ethnicity, age, education, anxiety and depression problems, financial 






Table 5.20. Associations between maternal and paternal prenatal alcohol consumption and high risk of maternal reported offspring ADHD symptoms 
in MoBa 
   Unadjusted model   Adjusted model*   Mutually adjusted model** 
 N n OR 95% CI P-value N n OR 95% CI P-value N n OR 95% CI P-value 
Maternal 
ADHD (RS-DBD) 38,134 5,030   <0.001 34,297 4,415   <0.001 10,641 1,395   <0.001 
None (ref) 33,605 4,342 - -  30,216 3,791 - -  9,800 1,247 - -  
<1 unit a week 4,366 663 1.21 1.104,1.319  3,931 601 1.33 1.202,1.466  811 146 1.53 1.260,1.865  
>1 unit a week 163 25 1.22 0.795,1.875  150 23 1.12 0.709,1.781  30 2 0.37 0.085,1.647  
Hyperactive 38,127 4,957   <0.001 34,290 4,353   <0.001 10,638 1,351   0.005 
None (ref) 33,601 4,281 - -  30,211 3,741 - -  9,797 1,214 - -  
<1 unit a week 4,363 653 1.21 1.102,1.319  3,929 591 1.29 1.166,1.421  811 133 1.40 1.139,1.710  
>1 unit a week 163 23 1.13 0.722,1.754  150 21 1.00 0.625,1.597  30 4 0.89 0.283,2.796  
Inattentive 38,140 4,393   <0.001 34,302 3,874   <0.001 10,639 1,210   0.002 
None (ref) 33,610 3,786 - -  30,220 3,326 - -  9,799 1,087 - -  
<1 unit a week 4,367 584 1.22 1.106,1.337  3,932 527 1.31 1.180,1.455  810 120 1.45 1.176,1.793  






ADHD (RS-DBD) 12,820 1,723   0.594 10,804 1,462   0.807 9,861 1,322   0.366 
None (ref) 1,904 255 - -  613 86 - -  586 82 - -  
<1 unit a week 3,405 463 1.02 0.863,1.200  3,192 438 1.00 0.770,1.297  2,945 403 0.97 0.742,1.270  
1-6 units a week 4,684 601 0.95 0.812,1.277  4,360 556 0.89 0.686,1.360  3,971 501 0.85 0.651,1.284  
>1 unit a day 2,827 404 1.08 0.910,1.805  2,639 382 1.04 0.791,1.805  2,359 336 0.97 0.731,1.805  
Hyperactive 12,818 1,684   0.833 10,802 1,432   0.837 9,858 1,294   0.616 
None (ref) 1,904 256 - -  613 89 - -  586 86 - -  
<1 unit a week 3,404 452 0.99 0.834,1.164  3,191 421 0.92 0.711,1.182  2,944 387 0.88 0.676,1.137  
1-6 unit a week 4,683 580 0.91 0.776,1.244  4,359 545 0.85 0.656,1.299  3,969 490 0.79 0.611,1.206  
>1 unit a day 2,827 396 1.05 0.884,1.805  2,639 377 1.00 0.765,1.805  2,359 331 0.92 0.698,1.805  
Inattentive 12,821 1,486   0.802 10,806 1,254   0.660 9,862 1,129   0.293 
None (ref) 1,903 233 - -  613 76 - -  586 72 - -  
<1 unit a week 3,404 396 0.94 0.793,1.123  3,191 375 0.95 0.726,1.252  2,944 345 0.94 0.708,1.244  
1-6 unit a week 4,686 512 0.88 0.744,1.191  4,362 473 0.84 0.639,1.299  3,972 423 0.81 0.607,1.238  
>1 unit a day 2,828 345 1.00 0.833,1.805  2,640 330 0.98 0.736,1.805  2,360 289 0.92 0.684,1.805  
Note: RS-DBD – Rating Scale for Disruptive Behavior Disorders; N – sample size; n – number of cases; OR – odds ratio; 95% CI – 95% confidence intervals;* adjusted 
for child’s gender, birth year, parity, parental age, education, marital status, financial difficulties, depression and anxiety symptoms, prenatal smoking and caffeine 





5.3.2.1.1 Sensitivity analyses 
In MoBa, due to the low number of cases, I was not able to report dose-
dependent results of the association between maternal alcohol 
consumption during pregnancy and high risk of maternal reported ADHD 
symptoms in offspring after adjustment to maternal ADHD (Appendix 5.12). 
However, maternal alcohol consumption before pregnancy was not 
associated with high risk of maternal reported offspring’s ADHD symptoms 
(Appendix 5.13). In ALSPAC I found evidence of an association between 
maternal alcohol consumption before pregnancy and high risk of ADHD 
symptoms measured with the maternal report of DAWBA but not the SDQ 
(Appendix 5.14).  
 
Analyses using teacher reported ADHD symptoms in ALSPAC did not find 
clear evidence of an association with maternal or paternal alcohol 
consumption during pregnancy measured either with the DAWBA or SDQ 
(Appendix 5.15). Additionally, the results in ALSPAC and MoBa where I 
harmonised alcohol units into weekly alcohol consumption in grams did not 
find clear evidence for associations between maternal alcohol consumption 
during pregnancy and high risk of maternal reported ADHD symptoms 
(Appendices 5.16-5.17). The results were similar for the analyses of 
complete cases in each cohort (Appendices 5.18-5.20).  
 
5.3.2.2 Polygenic risk score analyses 
First, in ALSPAC, the PRS for alcohol consumption was associated with 
alcohol consumption during pregnancy (Table 5.8). However, in Moba, the 
PRS for alcohol consumption did not predict alcohol consumption during 
pregnancy (=-0.65, 95%CI -0.757, 2.055), although it was associated with 
alcohol consumption before pregnancy (=1.06, 95%CI 0.258, 1.859) (Table 
5.9). The alcohol PRS explained 2% of variance in alcohol phenotype during 
pregnancy in ALSPAC and 0.7% variance in alcohol phenotype before 





Associations were similar with unweighted PRS (Appendices 5.8 and 5.9). 
 
Second, the PRS for alcohol consumption was associated with higher 
maternal education (=0.52, 95%CI 0.058, 0.983) and with a higher 
likelihood of having more severe depression symptoms (OR=3.42, 95%CI 
1.058, 11.047) in ALSPAC (Table 5.21). However, I found no clear evidence 
for an association between the PRS for alcohol consumption and 
confounders in MoBa (Table 5.22).  
 




Effect size 95% CI P-value Sample size 
Maternal age Beta 0.46 -1.241, 2.165 0.595 6,944 
Maternal education Beta 0.52 0.058, 0.983 0.027 6,438 
Financial difficulties Beta 1.09 -0.186, 2.368 0.094 6,277 
Marital status OR 0.44 0.182, 1.068 0.070 6,660 
Depress. symptoms OR 3.42 1.058, 11.047 0.040 6,262 
Anxiety symptoms OR 1.85 0.639, 5.362 0.257 6,229 
Parity Beta 0.09 -0.228, 0.401 0.590 6,574 
Note: adjusted for principal components; OR – odds ratio; 95% CI – 95% confidence 
intervals and excluding mothers who did not report drinking before pregnancy 
 
Table 5.22. Associations between maternal alcohol PRS and confounders in MoBa 
Confounder Effect 
estimate 
Effect size 95% CI P-value Sample size 
Maternal age Beta -1.77 -4.678, 1.146 0.235 13,216 
Maternal education Beta -0.07 -0.199 0.060 0.292 12,524 
Financial difficulties OR 0.83 0.403, 1.049 0.690 12,228 
Marital status Beta -0.04 -0.097, 0.009 0.102 13,152 
Depress. /Anxiety 
symptoms 
OR 0.62 0.230, 1.652 0.336 13,109 
Maternal ADHD OR 2.32 0.327, 16.477 0.400 7,985 
Parity Beta 0.02 -0.188, 0.222 0.870 13,216 
Note: adjusted for birth year, genotyping batch and principal components; OR – odds ratio; 
95% CI – 95% confidence intervals and excluding mothers who did not report drinking 
before pregnancy 
 
Third, I found no clear evidence of an association between maternal PRS 
for alcohol consumption and either high risk of maternal or teacher 
reported offspring ADHD symptoms in ALSPAC, and with high risk of 
maternal reported ADHD symptoms in MoBa (Table 5.23-5.24 and 




Table 5.23. Associations between maternal alcohol consumption PRS and high risk 
of maternal reported offspring ADHD symptoms in ALSPAC 
 Maternal PRS Maternal PRS adj. for PC  
Outcome OR 95% CI P-
value 




ADHD (DAWBA) 2.01 0.422, 9.542 0.382 2.14 0.449, 10.218 0.339 2,890 
Hyperactive 0.46 0.088, 2.429 0.361 0.49 0.094, 2.609 0.406 2,890 
Inattentive 1.21 0.249, 5.908 0.811 1.27 0.260, 6.182 0.769 2,893 
ADHD (SDQ) 1.53 0.272, 8.566 0.632 1.45 0.259, 8.164 0.671 2,934 
Note: DAWBA – Development And Well-Being Assessment; SDQ – Strengths and Difficulties 
Questionnaire; OR – odds ratio; 95% CI – 95% confidence intervals; PC – principal 
components 
 Table 5.24. Associations between maternal alcohol consumption PRS and high risk 
of maternal reported offspring ADHD symptoms in MoBa 
 Maternal PRS Maternal PRS adj. for PC  
Outcome OR 95% CI P-
value 




ADHD (RS-DBD) 0.66 0.064, 6.837 0.727 0.64 0.060, 6.769 0.710 1,356 
Hyperactive 0.76 0.077, 7.455 0.813 0.83 0.083, 8.374 0.876 1,355 
Inattentive 0.95 0.086, 10.479 0.967 0.99 0.089, 11.048 0.993 1,358 
Note: RS-DBD – Rating Scale for Disruptive Behavior Disorders; OR – odds ratio; 95% CI – 
95% confidence intervals; PC – principal components; additionally adjusted for birth year 
and genotyping batch 
 
5.3.3 Caffeine 
5.3.3.1 Negative control analyses 
The pooled estimate of maternal caffeine consumption in the adjusted 
model showed some evidence of an association only with high risk of ADHD 
total symptoms in offspring (ORADHD=1.05, 95%CI 1.00, 1.11; ORHYP=1.06, 
95%CI 0.98, 1.14; ORINA=1.02, 95%CI 0.98, 1.07), whereas the meta-analysis 
of paternal caffeine consumption in ALSPAC and MoBa did not show 
associations with ADHD risk in offspring (ORADHD=1.02, 95%CI 0.97, 1.07; 
ORHYP=1.00, 95%CI 0.95, 1.06; ORINA=1.03, 95%CI 0.97, 1.09). 
 
I observed stronger associations between maternal caffeine consumption 
during pregnancy and ADHD risk in MoBa, but not in ALSPAC or GenR 






 Table 5.25. Associations between maternal and paternal daily prenatal caffeine consumption and high risk of maternal reported offspring ADHD 
symptoms in ALSPAC 
   Unadjusted model   Adjusted model*   Mutually adjusted model** 
 N n OR 95% CI P-value N n OR 95% CI P-value N n OR 95% CI P-value 
Maternal 
ADHD (DAWBA) 7,680 1,105   <0.001 6,675 934   0.045 5,447 745   0.191 
0-49mg (ref) 1,026 119 - -  895 104 - -  735 84 - -  
50-199mg 3,149 435 1.22 0.984,1.517  2,765 369 1.13 0.888,1.432  2,284 304 1.10 0.840,1.429  
200-299mg 1,871 270 1.29 1.021,1.619  1,638 227 1.15 0.891,1.486  1,354 175 1.02 0.767,1.365  
>300mg 1,634 281 1.58 1.257,1.993  1,377 234 1.31 1.008,1.701  1,074 182 1.26 0.937,1.695  
Hyperactive 7,701 978   0.006 6,693 828   0.269 5,458 653   0.381 
0-49mg (ref) 1,027 105 - -  895 93 - -  735 74 - -  
50-199mg 3,154 400 1.28 1.016,1.601  2,769 339 1.17 0.909,1.495  2,284 273 1.13 0.853,1.489  
200-299mg 1,878 238 1.27 0.999,1.625  1,644 199 1.13 0.866,1.480  1,359 152 1.02 0.755,1.384  
>300mg 1,642 235 1.47 1.148,1.873  1,385 197 1.22 0.930,1.611  1,080 154 1.22 0.896,1.673  
Inattentive 7,692 1,047   0.268 6,688 890   0.948 5,455 722   0.953 
0-49mg (ref) 1,025 132 - -  895 113 - -  735 90 - -  
50-199mg 3,161 424 1.05 0.850,1.292  2,775 363 1.00 0.796,1.266  2,292 302 1.00 0.769,1.293  
200-299mg 1,875 258 1.08 0.862,1.352  1,643 219 1.01 0.786,1.297  1,356 171 0.93 0.701,1.236  
>300mg 1,631 233 1.13 0.896,1.418  1,375 195 0.99 0.763,1.288  1,072 159 1.03 0.769,1.391  
ADHD (SDQ) 7,943 879   0.009 6,946 737   0.710 5,662 586   0.558 
0-49mg (ref) 1,047 113 - -  926 96 - -  766 77 - -  
50-199mg 3,228 333 0.95 0.759,1.192  2,847 288 0.95 0.737,1.212  2,349 229 0.91 0.691,1.206  
200-299mg 1,965 204 0.96 0.751,1.221  1,722 166 0.86 0.658,1.132  1,411 127 0.81 0.596,1.100  







ADHD (DAWBA) 6,124 859   0.325 4,657 622   0.811 4,625 617   0.786 
0-49mg (ref) 220 27 - -  152 18 - -  151 18 - -  
50-199mg 773 102 1.09 0.691,1.710  596 77 1.15 0.655,2.008  593 77 1.11 0.634,1.945  
200-299mg 950 135 1.18 0.761,1.842  733 95 1.09 0.631,1.895  729 94 1.02 0.588,1.773  
>300mg 4,181 595 1.19 0.786,1.791  3,176 432 1.13 0.674,1.890  3,152 428 1.03 0.615,1.734  
Hyperactive 6,135 749   0.411 4,666 535   0.719 4,634 533   0.976 
0-49mg (ref) 219 24 - -  151 18 - -  150 18 - -  
50-199mg 771 88 1.05 0.649,1.689  596 66 0.97 0.550,1.708  593 66 0.94 0.535,1.663  
200-299mg 953 119 1.16 0.728,1.846  736 76 0.86 0.490,1.498  732 76 0.82 0.469,1.438  
>300mg 4,192 518 1.15 0.742,1.768  3,183 375 0.99 0.592,1.662  3,159 373 0.93 0.554,1.567  
Inattentive 6,133 822   0.784 4,666 614   0.518 4,633 609   0.726 
0-49mg (ref) 220 25 - -  152 14 - -  151 14 - -  
50-199mg 777 108 1.26 0.792,2.001  600 78 1.55 0.844,2.860  597 78 1.52 0.827,2.805  
200-299mg 951 127 1.20 0.762,1.897  734 99 1.55 0.850,2.823  730 97 1.46 0.800,2.667  
>300mg 4,185 562 1.21 0.790,1.852  3,180 423 1.52 0.859,2.689  3,155 420 1.44 0.810,2.550  
ADHD (SDQ) 6,323 678   0.346 4,804 487   0.346 4,772 481   0.633 
0-49mg (ref) 216 22 - -  148 12 - -  147 12 - -  
50-199mg 790 76 0.94 0.569,1.548  615 58 1.29 0.667,2.490  612 58 1.26 0.650,2.432  
200-299mg 994 108 1.08 0.662,1.744  757 70 1.18 0.619,2.266  753 68 1.09 0.568,2.090  
>300mg 4,323 472 1.08 0.688,1.697  3,284 347 1.34 0.729,2.471  3,260 343 1.23 0.665,2.271  
Note: DAWBA – Development And Well-Being Assessment; SDQ – Strengths and Difficulties Questionnaire; N – total sample size; n – number of cases; OR – odds 
ratio; 95% CI – 95% confidence intervals; *adjusted for child’s gender, ethnicity, parity, parental age, marital status, education, financial difficulties, depression and 






Table 5.26. Associations between maternal and paternal daily prenatal caffeine consumption and high risk of maternal reported offspring ADHD 
symptoms in MoBa 
   Unadjusted model   Adjusted model*   Mutually adjusted model** 
 N n OR 95% CI P-value N n OR 95% CI P-value N n OR 95% CI P-value 
Maternal 
ADHD (RS-DBD) 42,206 5,607   0.002 34,297 4,415   0.019 12,621 1,686   0.045 
0-49mg (ref) 26,564 3,506 - -  21,616 2,757 - -  7,844 1,021 - -  
50-199mg 12,867 1,651 0.97 0.909,1.031  10,462 1,303 0.99 0.922,1.068  4,133 564 1.07 0.957,1.203  
200-299mg 1,869 282 1.17 1.024,1.334  1,497 215 1.14 0.969,1.329  473 66 1.09 0.820,1.435  
>300 mg 906 168 1.50 1.258,1.782  722 140 1.40 1.142,1.723  171 35 1.61 1.073,2.409  
Hyperactive 42,198 5,538   <0.001 34,290 4,353   <0.001 12,620 1,630   <0.001 
0-49mg (ref) 26,564 3,386 - -  21,615 2,644 - -  7,845 956 - -  
50-199mg 12,861 1,701 1.04 0.980,1.111  10,456 1,348 1.08 1.004,1.162  4,130 573 1.19 1.058,1.332  
200-299mg 1,868 282 1.22 1.067,1.389  1,497 221 1.21 1.031,1.411  474 65 1.17 0.878,1.550  
>300 mg 905 169 1.57 1.322,1.869  722 140 1.44 1.171,1.760  171 36 1.86 1.250,2.758  
Inattentive 42,215 4,913   0.070 34,302 3,874   0.115 12,620 1,448   0.249 
0-49mg (ref) 26,569 3,088 - -  21,619 2,435 - -  7,845 888 - -  
50-199mg 12,872 1,443 0.96 0.898,1.026  10,465 1,135 0.98 0.911,1.064  4,132 474 1.03 0.906,1.159  
200-299mg 1,869 256 1.21 1.051,1.386  1,497 200 1.22 1.038,1.437  473 58 1.09 0.807,1.459  







ADHD (RS-DBD) 15,348 2,085   0.365 10,804 1,462   0.535 10,804 1,462   0.710 
0-49mg (ref) 3,433 511 - -  2,353 344 - -  2,353 344 - -  
50-199mg 5,527 705 0.84 0.739,0.945  3,861 478 0.85 0.731,0.999  3,861 478 0.84 0.720,0.985  
200-299mg 4,518 609 0.89 0.784,1.012  3,231 448 0.99 0.838,1.157  3,231 448 0.97 0.820,1.136  
>300 mg 1,870 260 0.92 0.786,1.085  1,359 192 1.01 0.824,1.227  1,359 192 0.98 0.804,1.199  
Hyperactive 15,349 2,045   0.189 10,802 1,432   0.929 10,802 1,432   0.729 
0-49mg (ref) 3,433 491 - -  2,352 332 - -  2,352 332 - -  
50-199mg 5,530 723 0.90 0.796,1.020  3,862 489 0.91 0.778,1.065  3,862 489 0.89 0.762,1.045  
200-299mg 4,517 582 0.89 0.778,1.009  3,230 428 0.96 0.815,1.132  3,230 428 0.94 0.794,1.104  
>300 mg 1,869 249 0.92 0.781,1.086  1,358 183 0.98 0.798,1.197  1,358 183 0.95 0.775,1.163  
Inattentive 15,350 1,785   0.640 10,806 1,254   0.492 10,806 1,254   0.569 
0-49mg (ref) 3,431 437 - -  2,351 288 - -  2,351 288 - -  
50-199mg 5,532 599 0.83 0.729,0.949  3,866 427 0.93 0.785,1.096  3,866 427 0.92 0.777,1.086  
200-299mg 4,517 518 0.89 0.774,1.017  3,230 368 0.97 0.816,1.158  3,230 368 0.96 0.804,1.143  
>300 mg 1,870 231 0.97 0.814,1.145  1,359 171 1.09 0.877,1.342  1,359 171 1.07 0.862,1.322  
Note: RS-DBD – Rating Scale for Disruptive Behavior Disorders; N – sample size; n – number of cases; OR – odds ratio; 95% CI – 95% confidence intervals; *adjusted 
for child’s gender, birth year, parity, parental age, education, marital status, financial difficulties, mental health, prenatal smoking and alcohol consumption; 






Table 5.27. Associations of maternal daily prenatal caffeine consumption on high risk of maternal/teacher reported offspring ADHD symptoms in GenR 
   Unadjusted model   Adjusted model* 
 N n OR 95% CI P-value N n OR 95% CI P-value 
ADHD (CPRS-R) 2,613 371   0.507 2,053 282   0.438 
0-49mg (ref) 499 83 - -  383 62 - -  
50-199mg  1,251 169 0.78 0.588,1.042  972 125 0.74 0.520,1.039  
200-299mg  443 55 0.71 0.492,1.026  357 43 0.71 0.456,1.106  
>300mg  420 64 0.90 0.632,1.286  341 52 0.83 0.534,1.297  
Hyperactive 2,617 273   0.236 2,057 201   0.387 
0-49mg (ref) 499 65 - -  383 43 - -  
50-199mg  1,255 124 0.73 0.532,1.008  976 94 0.85 0.572,1.266  
200-299mg  444 39 0.64 0.423,0.978  358 29 0.74 0.438,1.235  
>300mg  419 45 0.80 0.536,1.204  340 35 0.84 0.500,1.414  
Inattentive 2,616 312   0.770 2,058 240   0.701 
0-49mg (ref) 499 70 - -  383 53 - -  
50-199mg  1,253 139 0.77 0.562,1.041  976 102 0.69 0.473,0.992  
200-299mg  444 47 0.73 0.489,1.076  358 40 0.77 0.483,1.214  
>300mg  420 56 0.94 0.646,1.376  341 45 0.84 0.526,1.342  
ADHD (CBCL) 3,462 489   0.230 2,565 331   0.285 
0-49mg (ref) 688 109 - -  490 64 - -  
50-199mg  1,648 232 0.87 0.680,1.114  1,216 155 1.09 0.788,1.516  
200-299mg  591 73 0.75 0.544,1.030  445 54 1.12 0.742,1.690  
>300mg  535 75 0.87 0.630,1.191  414 58 1.26 0.824,1.923  
ADHD (TRF) 2,543 402   0.007 1,671 218   0.128 
0-49mg (ref) 565 95 - -  340 48 - -  
50-199mg  1,197 208 1.04 0.797,1.358  777 112 1.17 0.791,1.734  
200-299mg  426 60 0.81 0.571,1.152  296 31 0.87 0.513,1.472  
>300mg  355 39 0.61 0.410,0.910  258 27 0.68 0.383,1.200  
Note: CPRS-R – Revised Conners’ Parent Rating Scale; CBCL – Child Behavior Checklist; TRF – Teacher Report Form; N – sample size; n – number of cases; OR - odds 
ratio; 95% CI – 95% confidence intervals; *adjusted for child’s gender, parity, maternal ethnicity, age, education, anxiety and depression symptoms, financial 





5.3.3.1.1 Sensitivity analyses 
In MoBa, adjustment for maternal ADHD attenuated the association with 
high risk of ADHD total symptoms but the association with high risk of 
hyperactive-impulsive symptoms still remained (Appendix 5.22). 
Furthermore, I also found evidence of an association between maternal 
caffeine consumption before pregnancy and high risk of offspring’s ADHD 
hyperactive-impulsive symptoms (Appendix 5.23). In ALSPAC and GenR, I 
found no strong evidence of an association between maternal caffeine 
consumption during pregnancy and ADHD risk (both maternal and teacher 
reported ADHD symptoms; Table 5.27 and Appendix 5.24). The results were 
similar in the analyses with complete cases in each cohort (Appendices 
5.25-5.27). 
 
5.3.3.2 Polygenic risk score analyses 
First, both the weighted and unweighted PRS for caffeine consumption 
were associated with total caffeine consumption derived from coffee and 
tea in ALSPAC and MoBa. The caffeine PRS explained 0.3-0.4% of variance in 
caffeine phenotype in ALSPAC and MoBa (Tables 5.8 and 5.9 and 
Appendices 5.8 and 5.9).  
 
Second, I found no clear evidence of an association between the PRS for 
caffeine consumption and the confounders in ALSPAC and MoBa (Tables 









Effect size 95% CI P-value Sample size 
Maternal age Beta 0.29 -0.406, 0.988 0.412 7,421 
Maternal education Beta -0.02 -0.211, 0.170 0.832 6,860 
Financial difficulties Beta 0.30 -0.226, 0.829 0.263 6,691 
Marital status OR 0.82 0.569, 1.169 0.267 7,124 
Depress. symptoms OR 0.87 0.540, 1.388 0.550 6,706 
Anxiety symptoms OR 1.14 0.741, 1.756 0.550 6,669 
Parity Beta -0.02 -0.153, 0.107 0.725 7,040 
Note: adjusted for principal components; OR – odds ratio; 95% CI – 95% confidence 
intervals. 
 
Table 5.29. Associations between maternal caffeine PRS and confounders in MoBa  
Confounder Effect 
estimate 
Effect size 95% CI P-value Sample size 
Maternal age Beta -1.43 -3.101, 0.247 0.095 14,584 
Maternal education Beta -0.04 -0.094, 0.021 0.213 13,836 
Financial difficulties OR 0.82 0.593, 1.120 0.207 13,484 
Marital status Beta 0.01 -0.009, 0.036 0.236 14,519 
Depress /Anxiety 
symptoms 
OR 0.80 0.515, 1.238 0.314 14,464 
Maternal ADHD OR 0.75 0.319, 1.757 0.506 8,841 
Parity Beta -0.08 -0.174, 0.011 0.083 14,584 
Note: adjusted for birth year, genotyping batch and principal components; OR -odds ratio; 
95% CI – 95% confidence intervals. 
 
Third, I found no clear evidence of an association between maternal PRS for 
caffeine consumption and either high risk of maternal or teacher reported 
offspring’s ADHD symptoms in ALSPAC and with high risk of maternal 
reported ADHD symptoms in MoBa (Tables 5.30 and 5.31 and Appendix 
5.28).  
 
Table 5.30. Associations between maternal caffeine consumption PRS and high 
risk of maternal reported offspring ADHD symptoms in ALSPAC 
 Maternal PRS Maternal PRS adj. for PC  
Outcome OR 95% CI P-
value 




ADHD (DAWBA) 0.86 0.513, 1.439 0.564 0.87 0.520, 1.460 0.601 5,005 
Hyperactive 0.93 0.540, 1.596 0.787 0.95 0.549, 1.626 0.837 5,016 
Inattentive 0.74 0.436, 1.241 0.250 0.74 0.440, 1.255 0.266 5,013 
ADHD (SDQ) 1.09 0.615, 1.930 0.769 1.11 0.627, 1.969 0.718 5,103 
Note: DAWBA – Development And Well-Being Assessment; SDQ – Strengths and Difficulties 






Table 5.31. Associations between maternal caffeine consumption PRS and high 
risk of maternal reported offspring ADHD symptoms in MoBa 
 Maternal PRS Maternal PRS adj. for PC  
Outcome OR 95% CI P-
value 




ADHD (RS-DBD) 1.16 0.713, 1887 0.549 1.18 0.762, 1.917 0.510 7,017 
Hyperactive 1.40 0.863, 2.262 0.174 1.41 0.870, 2.284 0.163 7,012 
Inattentive 0.91 0.545, 1.511 0.709 0.91 0.545, 1.512 0.709 7,017 
Note: RS-DBD – Rating Scale for Disruptive Behavior Disorders; OR – odds ratio; 95% CI – 
95% confidence intervals; PC – principal components; additionally adjusted for birth year 
and genotyping batch 
 
 
5.3.4 Associations between PRS for substance use and participation at age 
7-8 years 
I found evidence of an association between the PRS for lifetime smoking 
and lower likelihood of returning the questionnaire at age 7-8 years in 
ALSPAC and MoBa (ORALSPAC = 0.49, 95%CI 0.311, 0.757; ORMOBA= 0.59, 
95%CI 0.427, 0.801). Furthermore, in MoBa the PRS for smoking heaviness 
was associated with higher likelihood of returning the questionnaire 
(ORMOBA = 2.10, 95%CI 1.01, 4.359), but I did not observe a similar 
association in ALSPAC (ORALSPAC=0.95, 95% CI 0.561, 1.607) (Tables 5.32 and 
5.33).  
 
Table 5.32. Associations between maternal PRSs and participation in ALSPAC 
PRS OR 95%CI P-value Sample size 
Smoking heaviness 0.95 0.561, 1.607 0.848 2,345 
Lifetime smoking 0.49 0.311, 0.757 0.001 7,915 
Alcohol consumption 0.98 0.398, 2.403 0.961 4,789 
Caffeine consumption 1.28 0.951, 1.714 0.105 7,915 
Note: OR – odds ratio; 95% CI – 95% confidence intervals; adjusted for principal 
components  
 
Table 5.33. Associations between maternal PRSs and participation in MoBa 
PRS OR 95%CI P-value Sample size 
Smoking heaviness 2.10 1.01, 4.359 0.047 1,125 
Lifetime smoking 0.59 0.427, 0.801 0.001 14,584 
Alcohol consumption 0.74 0.237, 2.314 0.605 2,861 
Caffeine consumption 1.07 0.856, 1.324 0.575 14,584 
Note: OR – odds ratio; 95% CI – 95% confidence intervals; adjusted for principal 







In this study I investigated whether maternal smoking, alcohol and caffeine 
use during pregnancy are likely to be causally associated with ADHD risk in 
offspring. I triangulated findings using negative control and polygenic risk 
score analyses and compared results across three longitudinal birth 
cohorts.  
 
Overall, my negative control and PRS analyses did not provide strong 
evidence for a potential causal effect of maternal smoking, alcohol or 
caffeine consumption during pregnancy on ADHD risk in offspring although I 
observed some inconsistencies across the cohorts and questionnaire used 
for ADHD assessment.  
 
My results on smoking did not show strong evidence for a causal effect, 
which is in line with previous findings (Gustavson et al., 2017; Langley et al., 
2012; Roza et al., 2009). Although in GenR and MoBa, I found suggestive 
evidence for a causal effect of maternal smoking during pregnancy on high 
risk of maternal reported ADHD total symptoms, when comparing the 
findings across the cohorts, reporters and questionnaires, the evidence was 
weak and inconsistent. Additionally, my PRS analyses with lifetime smoking 
PRS in ALSPAC and MoBa indicated pleiotropic associations which are 
consistent with my findings in Chapter 4. This is also consistent with the 
large body of evidence showing pleiotropy between smoking PRS, 
impulsivity and sensation-seeking type of personality (Harrison et al., 2020; 
Khouja et al., 2021), which could have confounded observed associations in 
this study. 
 
Similarly, my findings on alcohol exposure do not show evidence of a causal 
effect on ADHD risk in offspring. Although a previous study in MoBa found 
weak evidence for a potential causal effect of maternal alcohol 
consumption during pregnancy when ADHD symptoms were measured with 
CPRS-R (Eilertsen et al., 2017), other studies using alternative analytical 




associations between maternal moderate alcohol consumption during 
pregnancy and ADHD symptoms in offspring may not be causal (D'Onofrio 
et al., 2007; Lund et al., 2019).  
 
My results on caffeine exposure are in line with previous studies which 
have also concluded no causal effect of caffeine consumption during 
pregnancy on ADHD symptoms in offspring (Del-Ponte et al., 2016; 
Loomans et al., 2012). However, previous studies in MoBa have found an 
association between maternal prenatal caffeine intake from soft drinks and 
higher risk for overactivity in 18 months old children (Bekkhus et al., 2010; 
Berglundh et al., 2020). Although a study by Berglundh and colleagues 
further reported that there was no difference in this association between 
caffeinated and non-caffeinated soft drinks and no associations were 
observed between caffeine intake from different sources of caffeine with 
offspring ADHD symptoms at age 8 years. The same study also showed that 
smokers and participants with lower education drank soft drinks more 
often and therefore the association observed with overactivity in their 
study and associations observed in my study are likely to be confounded.  
 
Several studies have reported low to moderate parent-teacher agreement 
on ADHD symptoms assessment (Narad et al., 2015; Sollie et al., 2013). It 
has been suggested that parents and teachers may measure different 
aspects of child’s behaviour as ADHD symptoms may be more visible at 
school which is a more structured environment (Narad et al., 2015). 
Furthermore, it has been also proposed that parent-teacher ratings may 
differ because of the informant’s perception and individual characteristics 
(Amador-Campos et al., 2006). For example, it has been shown that 
mothers with mental health problems and more harsh parenting behaviour 
overestimate their child’s mental health problems (Lavigne et al., 2015; 
Najman et al., 2001). Given that I observed more associations with 
maternal report than with teacher report, it is possible that observed 





Besides reporter-related discrepancies, I also observed different findings 
depending on the scales used for ADHD assessment. Previous studies 
investigating the association between maternal substance use during 
pregnancy and ADHD in offspring have reported inconsistent findings 
depending on which scale was used for ADHD assessment. For example, a 
study using the SDQ scale reported association between maternal smoking 
during pregnancy and ADHD symptoms in children regardless of the 
reporter (Sutin et al., 2017). Another study using maternal and teacher 
reported CPRS-R, as well as CBCL, TRF and combined score of CBCL/TRF 
found some evidence for an association between maternal smoking during 
pregnancy and maternal reported CPRS-R indicating potential causal effect 
and suggesting that this is a more sensitive measure for assessing ADHD 
symptoms (Knopik et al., 2016). Similarly, a study on prenatal alcohol 
exposure found some evidence for a causal effect when ADHD symptoms 
were assessed with maternal reported CPRS-R but not with CBCL (Eilertsen 
et al., 2017).  
 
Although all the scales for the main outcome measure (DAWBA, CPRS-R, RS-
DBD) are based on the Diagnostic and Statistical Manual of Mental 
Disorders (DSM-IV) criteria for ADHD, I observed inconsistent associations 
between maternal prenatal substance use and high risk of ADHD symptoms 
across different scales. More research is needed to better understand if 
these different scales capture the same construct of ADHD symptoms. In 
addition, the observed and unobserved associations could be also affected 
by dichotomised outcome measures as dichotomising influences statistical 
power.  
 
Considering that previous studies have reported inconsistent results, the 
major strength of this study is the triangulation approach using both 
observational and genetic analyses. Further, using data from three 
longitudinal birth cohorts and comparing results across the cohorts helps to 
strengthen evidence towards causal inference. If results are consistent 






However, this study has also several limitations. First, outcome assessment 
varied across the cohorts and although all the questionnaires have good 
psychometric properties, there may still be a risk of measurement error.  
Moreover, dichotomized covariates (such as maternal ADHD symptoms in 
MoBa) may be affected by residual confounding. Second, maternal 
substance use during pregnancy was based on self-reports. Given the 
stigmatization of prenatal substance use, mothers may have underreported 
their prenatal substance use which can affect observed results. Third, I 
calculated PRS for smoking heaviness and alcohol consumption based on 
summary statistics from the latest GWAS which included ALSPAC. However, 
the contribution of ALSPAC sample (~1%) was small and the risk of bias 
because of the sample overlap is likely to be minimal (Burgess et al., 2016). 
Fourth, my PRS analyses were likely underpowered. Compared to the 
variance explained by each PRS reported in GWAS (smoking heaviness PRS 
~4%; alcohol PRS ~2.5%; caffeine PRS 1.3%), in my sample it was much 
smaller. Fifth, the sample size in adjusted models were reduced due to 
missing data in the included confounders which could introduce bias into 
the estimates. However, I performed all analyses restricting to individuals in 
the mutually adjusted models and effect estimates remained consistent.  
 
Sixth, several studies have reported that longitudinal cohort studies may 
suffer from selection bias as socioeconomic and individual characteristics 
may affect initial and continued participation in the study (Launes et al., 
2014; Nohr et al., 2006). A study in MoBa found that bias due to self-
selection and loss to follow-up can influence exposure-outcome 
associations (Biele et al., 2019). Furthermore, a study in ALSPAC also 
showed that common genetic variants of various phenotypes are 
associated with participation in the study and these associations differ in 
the sample with full genetic data and more selected subsamples (Taylor, 
Jones, et al., 2018). Given that attrition in this study sample was more than 
50% and I also observed association between PRS for lifetime smoking and 
decreased likelihood returning the questionnaire at child’s age 7-8 years, it 





5.5 CHAPTER SUMMARY 
In this chapter I combined both observational and genetic analyses using 
data from three longitudinal birth cohorts. I did not find strong support for 
a causal effect of maternal smoking, alcohol or caffeine consumption during 
pregnancy on ADHD risk in offspring. However, I observed somewhat 
different findings between maternal and teacher reported ADHD 
symptoms, as well as between the scales used for ADHD assessment. 
In the next chapter I will focus more on alcohol exposure by using genetic 
variants from alcohol metabolising genes as a proxy for fetal alcohol 




Chapter 6  MATERNAL AND OFFSPRING POLYGENIC RISK SCORE 
(PRS) ANALYSES OF FETAL ALCOHOL EXPOSURE AND ADHD RISK 
IN OFFSPRING 
 
This chapter is based on the manuscript “Maternal and offspring genetic 
risk score (GRS) analyses of fetal alcohol exposure and ADHD risk in 
offspring.” Preprint of this manuscript is available in medRxiv 
https://doi.org/10.1101/2021.03.30.21254492 
 
While Chapter 5 examined all three prenatal substance use exposures, this 
chapter focuses exclusively on prenatal alcohol exposure. In Chapter 5 
alcohol exposure was proxied by SNPs based on GWAS summary statistics 
of alcohol consumption per week and I did not find clear evidence for a 
causal effect. In this chapter I take a different approach, using genetic 
variants in both maternal and fetal alcohol metabolising genes as proxies 
for fetal alcohol exposure. This choice acknowledges that fetal blood 
alcohol levels may depend on maternal and fetal ability to metabolise 
alcohol, and not just maternal alcohol use. Thus, I investigated further 
whether fetal alcohol exposure is causally associated with high risk of 
offspring total ADHD symptoms, as well as separately with hyperactive-
impulsive and inattention symptoms. 
6.1 INTRODUCTION 
It is well documented that alcohol consumption during pregnancy 
negatively affects fetal development. The harmful neurodevelopmental 
effects resulting from prenatal alcohol exposure (PAE) are collectively 
defined as fetal alcohol spectrum disorders (FASD) (Mattson et al., 2019). 
However, as described in Chapter 1 (see section 1.4.3 “Burden of maternal 
prenatal substance use”) there is a substantial overlap between FASD, 
ADHD and other behavioural impairment (Lange et al., 2019; Popova et al., 
2016; Weyrauch et al., 2017), and a lack of clear diagnostic criteria of FASD 




disorders (Burd, 2016). Although ADHD is one of the most common 
neurodevelopmental disorder diagnoses in FASD, little is known about the 
role of PAE in causing ADHD risk specifically in the general population.  
 
Furthermore, the risks of heavier PAE on children’s health outcomes – 
including neurodevelopmental problems – are clear, but evidence is still 
inconsistent regarding the effects of low PAE (Mamluk et al., 2017). A 
systematic review by Easey and colleagues suggested that low and 
moderate alcohol consumption during pregnancy is associated with 
negative mental health outcomes in children, including anxiety/depression, 
total behavioural problems and conduct disorder (Easey, Dyer, et al., 2019). 
However, another recent systematic review and meta-analysis focusing 
specifically on offspring ADHD found little evidence to suggest an increased 
risk of ADHD symptoms in children whose mothers consumed moderate 
amounts of alcohol (up to 70 grams a week) during pregnancy (Porter et al., 
2019). In contrast, low PAE was found to have a protective effect on ADHD 
symptoms in some earlier studies (Kelly et al., 2013; Niclasen et al., 2014). 
However, it is possible that these associations are due to genetic 
confounding or confounding by social factors, as both studies found that 
women who drank low or moderate levels during pregnancy had a higher 
socio-economic position.  
 
As discussed in previous chapters (Chapter 4 and 5) studies using 
conventional observational designs may be biased due to unmeasured and 
residual confounding (Davey Smith and Ebrahim, 2003). One potential 
approach to overcome these limitations is to use genetic variants predictive 
of alcohol consumption or directly involved in alcohol metabolism to 
disentangle effects of PAE on child outcomes. Mendelian Randomization 
(MR) approach, as explained in Chapter 5 offers another useful perspective 
to evaluate the strength of evidence for a causal relationship, as the genetic 
variants used as a proxy for the exposure are generally less affected by 
confounding factors than the self-reported exposure measurements used in 
more conventional epidemiological analyses (Davey Smith and Hemani, 




provides stronger support for a causal influence of the exposure (prenatal 
alcohol consumption) on the outcome (offspring ADHD) (Davey Smith and 
Ebrahim, 2003).  
 
In Chapter 5, I derived the alcohol PRS using SNPs identified from the latest 
GWAS on alcohol consumption per week (Liu et al., 2019). However, the 
alcohol PRS was based on a discovery sample of general population 
individuals, who on average consume more alcohol than pregnant women. 
Therefore, studies examining prenatal exposures may be affected by lower 
power to detect an effect. Moreover, there is evidence that harmful effects 
of alcohol exposure are also affected by maternal and fetal metabolic 
capacity which can lead to different fetal alcohol levels if pregnant women 
drink during pregnancy (Burd et al., 2012). Therefore, analyses based on the 
PRS of alcohol consumption per week could miss biologically important 
effects related to individual differences in the ability to metabolise alcohol.  
 
A large body of research has shown that ethanol metabolism is affected by 
a group of alcohol dehydrogenase (ADH: ADH1A, ADH1B, ADH1C, ADH4, 
ADH5, ADH6, ADH7) and aldehyde dehydrogenase (ALDH: ALDH1A1 and 
ALDH2) genes, and variants in these genes have an impact on how quickly 
alcohol is metabolised, the amount of alcohol consumed and individual 
effects of alcohol consumption (Birley et al., 2009; Birley et al., 2008; 
Edenberg and McClintick, 2018). The majority of ADH genes are expressed 
in the liver with the exception of ADH7 which is expressed in the stomach 
(Edenberg and McClintick, 2018). It has been reported that more than 90% 
of ethanol is metabolised through the liver (Pizon et al., 2007).  
 
Of relevance to this study of intrauterine effects, genetic variants in some 
ADH genes are also expressed in early fetal development. After maternal 
alcohol intake, fetal blood alcohol concentration is nearly equivalent to 
maternal alcohol levels (Burd et al., 2012) and although the fetus is able to 
metabolise some alcohol, the majority of alcohol metabolism acts through 
maternal metabolic pathways (Burd et al., 2012). Therefore, it is possible 




outcomes depends on both fetal and maternal metabolic activity. The 
importance of fetal ADH genetic variants is evidenced by previous studies 
using the ALSPAC sample which have shown that four child ADH genetic 
variants were associated with lower IQ at age 8 and early onset conduct 
problems in children whose mothers drank during pregnancy (Lewis et al., 
2012; Murray et al., 2016). However, these studies used a PRS comprised of 
four ADH genetic variants, and it is still unknown how these four genetic 
variants change metabolic activity. 
 
It remains unclear whether PAE has a causal effect on ADHD risk in 
offspring, through modulations of maternal and fetal alcohol metabolism. 
In this study, I use genetic variants in ADH/ALDH genes as proxies for fetal 
alcohol exposure and investigate their association with high risk of offspring 
ADHD symptoms, as well as separately with hyperactive-impulsive and 





Figure 6.1. Study design 
 
Note: Maternal and offspring genetic variants of alcohol use and metabolism were used as proxies for fetal alcohol exposure (the exposure of interest, 
unmeasured) to investigate associations with ADHD risk in offspring around age 7-8 years (outcome). Dashed arrows represent genetic correlation as a child 
inherits 50% of its genetic make-up from mother and father. In this study I assume that mate selection is not based on confounders but could be affected by 
alcohol behaviour. Adjustment to paternal genetic data will help to overcome potential bias because of the assortment and shared genetics.
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6.2.1 Study Populations 
Similarly to Chapter 5, I used data from three European prospective 
longitudinal birth cohorts: the Avon Longitudinal Study of Parents and 
Children (ALSPAC), the Generation R (GenR) and the Norwegian Mother, 
Father and Child Cohort Study (MoBa). More details about each cohort are 
given in Chapter 3 (see sections 3.2.1; 3.3.1 and 3.4.1) 
6.2.2 Availability of genome-wide data 
In ALSPAC, genome-wide data are available for 8,237 children and 8,196 
mothers. In GenR, genetic data are available for 5,732 children, but 
maternal genetic data was not available at the time of analyses. In MoBa, 
genetic data are currently available for 14,112 children, 13,614 mothers 
and 13,935 fathers. Detailed information about the genotyping in the 




More details about exposure assessment in each cohort is given in Chapter 
3 (see sections 3.2.4; 3.3.4 and 3.4.4).  
 
Compared to Chapter 5, in this study I used a cumulative measure of 
alcohol consumption throughout pregnancy and mothers who reported 
alcohol consumption at any point during the pregnancy were classified as 
drinkers.  
 
6.2.3.1 Genetic variants 
I identified genes responsible for alcohol metabolism expressed in liver and 
brain in mothers and fetus using Expression Atlas (Kapushesky et al., 2010; 
Papatheodorou et al., 2020), as this online tool provides information about 




which provides information about gene expression across different species 
(incl. humans), tissues, cells, as well as about experimental conditions and 
diseases (Papatheodorou et al., 2020). Using this online tool, I identified 
ADH1A, ADH1B, ADH4, ADH5, ADH6, ALDH2, ALDH1A1 and ALDH1B1 that 
were expressed in adults and fetus, and additionally ADH1C and ADH7 
genes which were only expressed in adults. All these genes are located in 
chromosomes 4, 9 and 12. In total I identified 869 single nucleotide 
polymorphisms (SNPs) from these genes available in the genome-wide 
dataset from ALSPAC (shown in Appendices 6.1-6.3). Given the high linkage 
disequilibrium of these SNPs, I used a clumping procedure with a R2 
threshold of 0.01 to identify independent SNPs. A clumping procedure was 
preferred over the pruning method as clumping identifies independent 
SNPs by using an SNP with the lowest p-value as an index SNP, and can 
retain multiple SNPs in the same genomic region, whereas pruning selects 
independent SNPs based on correlations between the SNP pairs which may 
leave genomic region without representative SNP (Choi et al., 2020; Purcell 
et al., 2007).  
 
I used 1000 Genomes as a reference panel for clumping, which was also 
used for genetic imputation in ALSPAC. After clumping, I identified 36 
independent SNPs, these are listed in Table 6.1. Although there is evidence 
that the genetic variant rs1229984 from ADH1B gene has a functional role 
in alcohol metabolism (Zuccolo et al., 2009), this SNP was not included in 
my list after clumping. However, my list included an SNP rs141973904 

























rs168351  9 
rs8187953  9 
rs8187950  9 
rs78094588 9 
rs8187928 9 
rs34878833  9 
rs8187898 9 
rs80105873  9 
rs8187891  9 










In this study I used the same outcome measures as in Chapter 5. More 
details about the questionnaires used in ADHD assessment in each cohort 
are provided in Chapter 3 (see sections 3.2.3.1 and 3.2.3.2; 3.3.3.1 and 
3.3.3.2; and 3.4.3.1). 
 
The psychometric scales used for the primary outcome measure assessed at 
age 7-8 years were: maternal report of the Development And Well-Being 




revised Conner’s Parent Rating Scale (CPRS-R) in GenR; and maternal report 
of the Rating Scale for Disruptive Behavior Disorders (RS-DBD) in MoBa.  
 
The secondary outcome measures were: teacher report of the DAWBA 
questionnaire and maternal and teacher report of the Strengths and 
Difficulties Questionnaire (SDQ) hyperactivity subscale in ALSPAC and 
maternal and teacher report of the Child Behavior Checklist (CBCL) 
attention problems subscale in GenR.  
 
6.2.5 Harmonisation 
Before calculating PRS, I conducted harmonisation to ensure that alleles 
were coded on the same DNA strand (in a positive 5’ to 3’ strand) to reduce 
potential issues with palindromic variants. Genetic variants are called 
palindromic if they are the same in both DNA strands (such as SNPs with 
A/T or G/C alleles) (Anjana et al., 2013). Harmonisation of palindromic 
variants can be problematic if allele frequencies are close to 0.5 as it would 
be difficult to identify which of the alleles is the effect allele in the exposure 
and the outcome GWAS (Hartwig et al., 2016). Harmonisation is essential in 
genetic association studies when multiple independently generated 
datasets are used (Hartwig et al., 2016).  
 
In addition, I also aligned the SNPs so that the effect alleles were all 
positively associated with alcohol consumption in the discovery sample. 
These effect estimates were taken from the summary statistics of the latest 
GWAS on alcohol consumption per week (GSCAN) (Liu et al., 2019). If effect 
alleles in GSCAN were negatively associated with the exposure, then effect 
alleles in the discovery sample were flipped to the other allele to ensure 
that all variants are in the exposure-increasing direction.  
 
The harmonisation procedure in ALSPAC is shown in Table 6.2. All the SNPs 
identified in ALSPAC were also available in GenR and I aligned the SNPs 
similarly as in ALSPAC (Appendix 6.4). However, in MoBa genetic imputation 
was conducted using the Haplotype Reference Consortium (HRC) as a 




in MoBa. I identified proxy for these SNPs using Single Nucleotide 
Polymorphisms Annotator (SNiPA) (Arnold et al., 2015) and also aligned 
these SNPs based on the summary statistics of the latest GWAS on alcohol 





Table 6.2. Harmonisation of SNPs in ALSPAC based on the GSCAN summary statistics 
 GSCAN ALSPAC 
SNP Non-effect 
allele  
Effect allele  Effect allele 
frequency  
Beta Minor allele  Major allele  Minor allele 
frequency 
Effect allele after 
harmonisation 
rs7669660  T C 0.136 0.0086 C T 0.1481 C 
rs116010022 C A 0.00942 -0.0023 A C 0.0131 C 
rs28730582 C T 0.0318 0.0149 T C 0.0294 T 
rs29001207 G C 0.038 -0.0334 C G 0.0512 G 
rs13125262 G C 0.0436 0.0160 C G 0.0498 C 
rs17033 T C 0.0881 -0.0063 C T 0.0880 T 
rs138331988 G A 0.0192 0.0042 A G 0.0180 A 
rs17028839 A G 0.039 0.0031 G A 0.0437 G 
rs138244919 C T 0.0272 0.0052 T C 0.0258 T 
rs141973904 C T 0.0178 -0.1990 T C 0.0120 C 
rs3805329  T C 0.0625 0.0105 C T 0.0650 C 
rs75756595 G A 0.0522 0.0015 A G 0.0499 A 
rs1154465  T A 0.0276 0.0061 A T 0.0248 A 
rs4646769 T C 0.857 -0.0014 T C 0.1372 T 
rs77054814 A G 0.067 0.0017 G A 0.0612 G 
rs12378961 C G 0.0573 0.0068 G C 0.0705 G 
rs10973779 G A 0.0299 -0.0067 A G 0.0312 G 
rs8187999 C G 0.0238 0.0111 G C 0.0265 G 
rs8187996 C T 0.0479 -0.0030 T C 0.0502 C 
rs168351 A G 0.147 -0.0039 G A 0.1564 A 
rs8187953 C G 0.0268 0.0011 G C 0.0308 G 
rs8187950 A G 0.0364 -0.0033 G A 0.0366 A 
rs78094588 G A 0.0233 0.0031 A G 0.0178 A 
rs8187928 C T 0.0253 0.0103 T C 0.0212 T 
rs34878833 G A 0.0231 0.0139 A G 0.0348 A 




rs80105873 G T 0.0289 -0.0029 T G 0.0337 G 
rs8187891 T C 0.0252 0.0002 C T 0.0268 C 
rs17648566 T C 0.0204 -0.0093 C T 0.0205 T 
rs116917518 A T 0.0351 -0.0020 T A 0.0512 A 
rs11143426 A G 0.0127 0.0147 G A 0.0150 G 
rs41287405 T C 0.0238 0.0057 C T 0.0283 C 
rs148620777 A G 0.0177 -0.0048 G A 0.0177 A 
rs2283354 G A 0.174 0.0023 A G 0.1742 A 
rs73205605 G A 0.036 -0.0018 A G 0.0442 G 
rs61941278 A G 0.013 0.0075 G A 0.0260 G 






Table 6.3. Harmonisation of SNPs in MoBa based on the GSCAN summary statistics 
  GSCAN MoBa 
SNP New proxy SNP Non-effect 
allele  








Effect allele after 
harmonisation 
rs7669660   T C 0.136 0.0086 T C 0.1364 C 
rs116010022 rs11724783 C A 0.425 0.0003 C A 0.4252 A 
rs28730582  C T 0.0318 0.0149 C T 0.0318 T 
rs29001207  G C 0.038 -0.0334 G C 0.0380 G 
rs13125262 rs13133633 C G 0.272 0.0061 C G 0.2717 G 
rs17033  T C 0.0881 -0.0063 T C 0.0881 T 
rs138331988  G A 0.0192 0.0042 G A 0.0192 A 
rs17028839  A G 0.039 0.0031 A G 0.0390 G 
rs138244919  C T 0.0272 0.0052 C T 0.0272 T 
rs141973904 rs143502255 C T 0.366 -0.0023 C T 0.3658 C 
rs3805329   T C 0.0625 0.0105 T C 0.0625 C 
rs75756595  G A 0.0522 0.0015 G A 0.0522 A 
rs1154465   T A 0.0276 0.0061 T A 0.0276 A 
rs4646769  T C 0.857 -0.0014 T C 0.8574 T 
rs77054814  A G 0.067 0.0017 A G 0.0670 G 
rs12378961  C G 0.0573 0.0068 C G 0.0573 G 
rs10973779  G A 0.0299 -0.0067 G A 0.0299 G 
rs8187999  C G 0.0238 0.0111 C G 0.0238 G 
rs8187996  C T 0.0479 -0.0030 C T 0.0479 C 
rs168351  A G 0.147 -0.0039 A G 0.1467 A 
rs8187953 rs918836 G C 0.312 0.0002 G C 0.3116 C 
rs8187950 rs8187924 G A 0.501 -0.0010 G A 0.5008 G 
rs78094588  G A 0.0233 0.0031 G A 0.0233 A 
rs8187928  C T 0.0253 0.0103 C T 0.0253 T 
rs34878833  G A 0.0231 0.0139 G A 0.0231 A 




rs80105873 rs7848927 G T 0.559 -0.0004 G T 0.5588 G 
rs8187891  T C 0.0252 0.0002 T C 0.0252 C 
rs17648566 rs7860944 C T 0.604 -0.0026 C T 0.6040 C 
rs116917518  A T 0.0351 -0.0020 A T 0.0351 A 
rs11143426  A G 0.0127 0.0147 A G 0.0127 G 
rs41287405 rs4237253 C T 0.5 -0.0010 C T 0.4995 C 
rs148620777  A G 0.0177 -0.0048 A G 0.0177 A 
rs2283354  G A 0.174 0.0023 G A 0.1738 A 
rs73205605  G A 0.036 -0.0018 G A 0.0360 G 
rs61941278 rs61941274 G A 0.0148 0.0073 G A 0.0148 A 







6.2.6 Polygenic risk scores 
As it is not possible to directly measure the effect of each SNP on fetal 
exposure to alcohol, and therefore to calculate weights, I derived 
unweighted PRS using 36 independent SNPs (Table 6.1). Similarly to 
Chapter 5, I calculated a sum score of SNPs using PLINK v1.90  (Purcell et al., 
2007) for offspring in all the cohorts, for mothers in ALSPAC and MoBa and 
additionally for fathers in MoBa.  
 
6.2.7 Statistical analysis 
I performed all analyses using Stata v15 in ALSPAC and GenR and Stata v16 
in MoBa (StataCorp, 2017, 2019) and restricted to unrelated individuals and 
additionally to European ancestry in GenR (sample size 2,661 children).  
Before I performed the analyses, I submitted the pre-registered protocol to 
the Open Science Framework (https://doi.org/10.17605/OSF.IO/AQRXP). 
I tested associations between maternal and offspring PRS and ADHD risk in 
offspring using logistic regression. I adjusted all analyses for 10 ancestry 
informed principal components and in MoBa additionally for birth year and 
genotyping batch.  
 
6.2.7.1 Primary analysis 
I performed analyses using three models: 1) maternal PRS; 2) maternal PRS 
adjusted for offspring PRS; 3) maternal PRS adjusted for offspring and 
paternal PRS. I performed these analyses in the full sample without 
stratifying based on maternal drinking status, because this could induce 
collider bias thus introducing a spurious association between the PRS and 




Figure 6.2. Collider bias in maternal PRS analyses 
 
Note: Conditioning on maternal drinking status during pregnancy induces a form of 
bias known as collider bias. In practice, this manifests as an artefactual association 
(red dashed arrow) between genetic variants of alcohol use and confounders. This 
may induce a spurious association between the exposure and outcome as genetic 
propensities in women who drink may differ from women who abstain. 
 
Similarly, I used three models for the offspring PRS analyses too: 1) 
offspring PRS; 2) offspring PRS adjusted for maternal PRS; 3) offspring PRS 
adjusted for maternal and paternal PRS. This time, I stratified these 
analyses by maternal drinking status during pregnancy, since fetal alcohol 
exposure cannot affect maternal prenatal alcohol consumption and collider 
bias could not be an issue as in the case of maternal PRS analyses (Figure 
6.3). 
a) Collider bias in maternal GRS analyses 
 
 























Figure 6.3. Collider bias in offspring PRS analyses 
  
 
Note: Conditioning on maternal drinking status during pregnancy in offspring PRS 
analyses does not induce collider bias as offspring genetic variants does not affect 
maternal alcohol use. However, adjustment for maternal PRS is still necessary given 
the shared genetics between child and mother.  
 
As in Chapter 5, I performed analyses separately in each cohort and then 
meta-analysed across the cohorts using a random effects model which 
takes into account variability in the exposure and outcome assessment 
across the cohorts. ALSPAC and MoBa results from model 2 (maternal PRS 
adjusted for offspring PRS) were pooled in meta-analyses, while all three 
cohorts contributed to meta-analyses for model 1 (offspring PRS) results. 
 
6.2.7.2 Sensitivity analyses 
I also checked the influence of each individual SNP on the outcome using a 
leave one out approach. I created 36 additional PRSs for mothers and 
offspring excluding one SNP at a time. Given that there was no deviation in 
effect estimates when leaving out individual SNPs, I was able to use the PRS 
including all 36 SNPs in my analyses. Results from leave-one-out analyses 
are shown in Appendices 6.5-6.15. I also tested the associations between 
maternal PRS and potential confounders as a post hoc check for potential 
pleiotropic effects.  
 
a) Collider bias in offspring GRS analyses 
 
 


























6.2.7.3 Replication analysis of previous ALSPAC studies 
In addition, I used PRS including four offspring ADH genetic variants (ADH1A 
rs975833 and rs2866151, ADH1B rs4147536 and ADH7 rs284779) found to 
be associated with child health outcomes in previous ALSPAC studies (Lewis 




An overview of study sample characteristics used in the analyses and 
stratified by maternal drinking status during pregnancy is shown in Table 
6.4. In all the cohorts, mothers who reported drinking were older and 




Table 6.4. Overview of study sample characteristics  
 ALSPAC GenR MoBa 













Confounders       
Mother’s age in years  
(mean and SD) 








































































Depression symptoms** 9% 10% 8% 5% 
5% 6% 
Anxiety symptoms 12% 14% 10% 6% 





























Mother smoked during 
pregnancy 
15% 17% 17% 25% 5% 7% 
Offspring ADHD 
symptoms above the 85th 
percentile threshold 
13% 14% 13% 15% 12% 12% 
Note: *In ALSPAC, financial difficulties were measured with 5 items questionnaire: 1) 
Difficulty in affording food; 2) Difficulty in affording clothing; 3) Difficulty in affording 
heating 4) Difficulty in affording accommodation 5) Difficulty in affording things for baby. In 
GenR, financial difficulties were assessed with single item question: Difficulty in paying food, 
rent, bills and suchlike. In MoBa, financial difficulties were assessed with single item 
question: Have you experienced financial problems?; **In MoBa, depression and anxiety 
symptoms were assessed together 
 
 
6.3.1 Maternal PRS analysis 
To maximise data available across the cohorts, meta-analysis for maternal PRS 
was conducted using results from model 2 (maternal PRS adjusted for offspring 
PRS).  
The pooled estimate for the association of maternal PRS with high risk of maternal 
reported ADHD symptoms in offspring in model 2 did not show clear evidence for 
an association (ORADHD=0.99, 95%CI 0.97, 1.02; ORHYP=0.99, 95%CI 0.95, 1.03; 
ORINA=1.00, 95%CI 0.97, 1.02) (Figure 6.4). However, in MoBa I found a negative 




hyperactivity symptoms in offspring in model 1 (maternal PRS) and model 3 
(adjusted for offspring and paternal PRS) (Figure 6.5 and Table 6.5). This finding 
was not replicated in ALSPAC using high risk of maternal reported ADHD 
symptoms (Figure 6.5 and Table 6.6). Similarly, the results did not change when I 
used secondary outcome measures in ALSPAC (Appendices 6.16 and 6.17).   
 
Figure 6.4. Meta-analysis of maternal PRS on high risk of maternal reported 
offspring ADHD symptoms in ALSPAC and MoBa 
 






Figure 6.5. Associations between maternal PRS and high risk of maternal reported offspring ADHD symptoms in ALSPAC and MoBa 
 
 
Note: Model 1 – only maternal PRS; Model 2 – maternal PRS adjusted for offspring PRS; Model 3 - maternal PRS adjusted for offspring and paternal  
PRS; All analyses are adjusted for 10 ancestry principal components. In MoBa, also for birth year and genotyping batch; Development And Well-Being  







Table 6.5. Associations between maternal PRS and high risk of maternal reported offspring ADHD symptoms in MoBa (primary analyses) 
 Model 1 Model 2 Model 3 
Outcome OR 95% CI P-value OR 95% CI P-value OR 95% CI P-value Sample size 
ADHD symptoms (RS-DBD) 0.99 0.963, 1.016 0.418 0.99 0.959, 1.020 0.488 0.99 0.956, 1.022 0.494 5,599 
Hyperactivity symptoms 0.97 0.947, 0.999 0.042 0.97 0.943, 1.004 0.082 0.97 0.934, 0.998 0.039 5,595 
Inattention symptoms 1.00 0.974, 1.029 0.940 0.99 0.961, 1.026 0.659 1.00 0.961, 1.031 0.798 5,601 
Note: Model 1 – only maternal PRS; Model 2 – maternal PRS adj. for offspring PRS; Model 3 – maternal PRS adj. for offspring and paternal PRS; all analyses 






Table 6.6. Associations between maternal PRS and high risk of maternal reported offspring ADHD symptoms in ALSPAC  
(primary analyses) 
 Model 1 Model 2 
Outcome OR 95% CI P-value OR 95% CI P-value Sample size 
ADHD symptoms (DAWBA) 0.99 0.938, 1.047 0.746 1.01 0.951, 1.080 0.682 3,698 
Hyperactivity symptoms 1.01 0.950, 1.066 0.827 1.02 0.952, 1.088 0.608 3,706 
Inattention symptoms 0.98 0.926, 1.035 0.452 1.01 0.942, 1.072 0.872 3,708 
ADHD symptoms (SDQ) 0.96 0.897, 1.017 0.148 0.95 0.883, 1.020 0.159 3,736 
Note: Model 1 – only maternal PRS; Model 2 – maternal PRS adj. for offspring PRS; all analyses adjusted also for 10 ancestry principal  







6.3.2 Offspring PRS analysis 
The pooled estimate of the association between offspring PRS and high risk 
of maternal reported ADHD symptoms in offspring using model 1 (offspring 
PRS) found no strong evidence of an association. This remained consistent 
regardless of drinking status during pregnancy (Drinking: ORADHD=0.98, 
95%CI 0.94, 1.02; ORHYP=0.99, 95%CI 0.95, 1.03; ORINA=0.98, 95%CI 0.94, 
1.02; No drinking: ORADHD=0.99, 95%CI 0.97, 1.02; ORHYP=0.99, 95%CI 0.96, 
1.01; ORINA=0.99, 95%CI 0.91, 1.09) (Figure 6.6). These results did not 
change after adjusting for maternal PRS (model 2) or maternal and paternal 
PRS (model 3) in ALSPAC and MoBa (Figure 6.7 and 6.8, Tables 6.7-6.10). 
Similarly, when I used secondary outcome measures in GenR and ALSPAC, I 
found no strong evidence of an association between offspring PRS and 





Figure 6.6. Meta-analysis of offspring PRS on high risk of maternal reported offspring ADHD symptoms across the cohorts 
 
 
Note: Model 1 – only offspring PRS and adjusted for 10 ancestry principal components 
 
 




Figure 6.7. Associations between offspring PRS and high risk of maternal reported offspring ADHD symptoms  




Note: Model 1 – only offspring PRS; Model 2 – offspring PRS adjusted for maternal PRS; all analyses are adjusted for 10 ancestry  









Figure 6.8. Associations between offspring PRS and high risk of maternal reported offspring ADHD symptoms  




Note: Model 1 – only offspring PRS; Model 2 – offspring PRS adjusted for maternal PRS; Model 3 – offspring PRS adjusted for maternal  
and paternal PRS; all analyses are adjusted for 10 ancestry principal components, birth year and genotyping batch; Rating Scale for  
Disruptive Behavior Disorders (RS-DBD) 
 
 




Table 6.7. Associations between offspring PRS and high risk of maternal reported offspring ADHD symptoms in ALSPAC if mother  
drank during pregnancy (primary analyses) 
 Model 1 Model 2 
Outcome OR 95% CI P-value OR 95% CI P-value Sample size 
ADHD symptoms (DAWBA) 0.97 0.907, 1.034 0.341 0.97 0.897, 1.045 0.400 2,573 
Hyperactivity symptoms 0.98 0.913, 1.050 0.552 0.98 0.903, 1.061 0.599 2,576 
Inattention symptoms 0.96 0.901, 1.029 0.266 0.97 0.898, 1.047 0.431 2,582 
ADHD symptoms (SDQ) 0.98 0.912, 1.058 0.643 0.99 0.907, 1.077 0.787 2,606 
Note: Model 1 – only offspring PRS; Model 2 – offspring PRS adj. for maternal PRS; all analyses adjusted also for 10 ancestry principal  





Table 6.8. Associations between offspring PRS and high risk of maternal reported offspring ADHD symptoms in ALSPAC if mother  
did not drink during pregnancy (primary analyses) 
 Model 1 Model 2 
Outcome OR 95% CI P-value OR 95% CI P-value Sample size 
ADHD symptoms (DAWBA) 0.93 0.833, 1.027 0.145 0.91 0.809, 1.031 0.142 1,125 
Hyperactivity symptoms 0.97 0.875, 1.085 0.635 0.96 0.847, 1.085 0.502 1,130 
Inattention symptoms 0.90 0.808, 1.002 0.055 0.89 0.788, 1.009 0.069 1,126 
ADHD symptoms (SDQ) 0.99 0.878, 1.116 0.868 1.07 0.929, 1.227 0.356 1,130 
Note: Model 1 – only offspring PRS; Model 2 – offspring PRS adj. for maternal PRS; all analyses adjusted also for 10 ancestry principal  






Table 6.9. Associations between offspring PRS and high risk of maternal reported offspring ADHD symptoms in MoBa if mother drank during 
pregnancy (primary analyses) 
 Model 1 Model 2 Model 3 
Outcome OR 95% CI P-value OR 95% CI P-value OR 95% CI P-value Sample size 
ADHD symptoms (RS-DBD) 0.98 0.915, 1.043 0.485 0.99 0.917, 1.073 0.842 0.98 0.895, 1.081 0.728 982 
Hyperactivity symptoms 0.99 0.931, 1.055 0.778 1.02 0.944, 1.097 0.656 1.02 0.933, 1.115 0.666 981 
Inattention symptoms 0.99 0.922, 1.055 0.692 0.98 0.898, 1.059 0.548 0.96 0.869, 1.062 0.431 982 
Note: Model 1 – only offspring PRS; Model 2 – offspring PRS adj. for maternal PRS; Model 3 – offspring PRS adj. for maternal and paternal PRS; all analyses adjusted 





Table 6.10. Associations between offspring PRS and high risk of maternal reported offspring ADHD symptoms in MoBa if mother did not drink during 
pregnancy (primary analyses) 
 Model 1 Model 2 Model 3 
Outcome OR 95% CI P-value OR 95% CI P-value OR 95% CI P-value Sample size 
ADHD symptoms (RS-DBD) 1.00 0.969, 1.028 0.904 1.00 0.968, 1.038 0.881 1.01 0.965, 1.050 0.766 4,617 
Hyperactivity symptoms 0.99 0.956, 1.015 0.318 1.00 0.965, 1.035 0.986 1.02 0.973, 1.061 0.479 4,614 
Inattention symptoms 1.02 0.988, 1.051 0.242 1.03 0.988, 1.063 0.193 1.02 0.977, 1.069 0.353 4,619 
Note: Model 1 – only offspring PRS; Model 2 – offspring PRS adj. for maternal PRS; Model 3 – offspring PRS adj. for maternal and paternal PRS; all analyses adjusted 







Figure 6.9. Associations between offspring PRS and high risk of maternal 
and teacher reported offspring ADHD symptoms in GenR stratified by 
maternal drinking status (primary and secondary analyses) 
  
 
Note: Model 1 – only offspring PRS adjusted for 10 ancestry principal components; 
Revised Conner’s Parent Rating Scale (CPRS-R); Child Behavior Checklist (CBCL) – 






Table 6.11. Associations between offspring PRS and high risk of maternal and teacher reported offspring ADHD symptoms in GenR (primary and 
secondary analyses) 
 Mother drank during pregnancy Mother did not drink during pregnancy 
Outcome OR 95% CI P-value Sample size OR 95% CI P-value Sample size 
ADHD symptoms (CPRS-R) 0.99 0.895, 1.083 0.750 1,037 1.01 0.867, 1.176 0.903 418 
Hyperactivity symptoms 1.00 0.896, 1.123 0.958 1,038 1.02 0.872, 1.198 0.790 419 
Inattention symptoms 0.99 0.891, 1.093 0.794 1,038 1.10 0.927, 1.296 0.285 420 
ADHD symptoms (CBCL) 1.04 0.945, 1.152 0.398 1,186 0.92 0.799, 1.069 0.288 510 
ADHD symptoms (TRF) 1.00 0.860, 1.157 0.976 708 1.04 0.857, 1.251 0.719 317 
Note: Model 1 – only offspring PRS adjusted also for 10 ancestry principal components; Revised Conner’s Parent Rating Scale (CPRS-R); Child Behavior Checklist 







6.3.3 Sensitivity analyses 
My sensitivity analyses testing the associations between maternal PRS and 
confounders found an association with higher likelihood of not being 
married in MoBa, but there was no clear evidence for associations in 
ALSPAC (Table 6.12-6.13).  
 
Table 6.12. Associations between maternal PRS and confounders in ALSPAC 
Confounder Effect 
estimate 
Effect size 95% CI P-value Sample size 
Maternal age Beta -0.02 -0.084, 0.042 0.507 7,421 
Maternal education Beta 0.001 -0.017, 0.018 0.951 6,860 
Financial difficulties Beta -0.03 -0.078, 0.018 0.217 6,691 
Marital status OR 0.98 0.949, 1.013 0.227 7,124 
Depression 
symptoms 
OR 1.02 0.982, 1.069 0.264 6,706 
Anxiety symptoms OR 0.98 0.945, 1.022 0.384 6,669 
Parity Beta 0.01 -0.004, 0.020 0.184 7,040 
Maternal smoking in 
pregnancy 
OR 0.90 0.958,1.022 0.528 7,138 
Note: adjusted for 10 ancestry principal components; OR – odds ratio; 95% CI – 95% 
confidence intervals. 
Table 6.13. Associations between maternal PRS and confounders in MoBa  
Confounder Effect 
estimate 
Effect size 95% CI P-value Sample 
size 
Maternal age Beta 0.04 -0.049, 0.129 0.381 13,614 
Maternal education Beta <0.001 -0.003, 0.0003 0.839 12,917 
Financial difficulties OR 1.00 0.980, 1.012 0.650 12,575 
Marital status Beta 0.001 0.0001, 0.002 0.035 13,555 
Depression/Anxiety 
symptoms 
OR 0.99 0.969, 1.014 0.454 13,503 
Parity Beta 0.002 -0.003, 0.007 0.433 13,614 
Maternal ADHD 
symptoms 
OR 1.02 0.976,1.065 0.390 8,231 
Maternal smoking in 
pregnancy 
OR 1.00 0.973, 1.016 0.627 13,540 
Note: adjusted for 10 ancestry principal components; birth year and genotyping batch; OR 
– odds ratio; 95% CI – 95% confidence intervals 
 
6.3.4 Replication analysis of previous ALSPAC studies 
Replication analysis using offspring PRS with 4 ADH SNPs were consistent 
with the main analysis, and provided little evidence for an association 




reported ADHD symptoms in offspring. These results are shown in 
Appendices 6.21-6.31.   
 
6.4 DISCUSSION 
I used maternal and offspring genetic variants in the ADH and ALDH genes 
linked to alcohol consumption and metabolism to investigate whether 
there is a causal effect of fetal alcohol exposure on ADHD risk in offspring. 
Consistent with findings in previous chapters, I did not find strong evidence 
for a causal effect. I observed a protective effect of maternal PRS indicative 
of higher alcohol exposure on high risk of maternal reported offspring 
ADHD hyperactive-impulsive symptoms in MoBa. However, this was not 
replicated in ALSPAC where mothers had more prevalent daily alcohol use 
(16% in ALSPAC and 0.45% in MoBa) and regardless of whether ADHD 
symptoms were reported by mother or teacher. I did not observe 
associations of offspring PRS with high risk of maternal and teacher 
reported childhood ADHD symptoms, in any of the cohorts, or for any of 
the subtypes, with or without adjustment for maternal and paternal PRS 
where this was available, or stratification by maternal alcohol use in 
pregnancy.  
 
My results are somewhat dissimilar from previous findings in ALSPAC, 
which found the risk of early onset conduct problems and decreased IQ to 
be associated with the ADH variants particularly in children whose mothers 
drank during pregnancy (Lewis et al., 2012; Murray et al., 2016). This might 
suggest that there could be some cognitive effects not mediated by 
behavioural factors, although several studies have found opposite effect 
(Schoemaker et al., 2013). Alternatively, these previous findings could be 
false positives, as these studies used a very limited number of offspring 
genetic variants in ADH genes as a proxy for fetal alcohol exposure. In 
addition, these four offspring SNPs were selected based on the association 
with the outcome. The present study was based on larger numbers of 
mother-offspring dyads, and importantly used all available ADH/ALDH 
variants, not just a restricted number of them selected on their effects on 




maternal PAE and behavioural problems in offspring by using quasi-
experimental design to account for shared genetic and environmental 
factors found evidence for a potential causal effect on conduct disorder 
symptoms measured with CBCL at age 4-11 years, somatic complaints and 
emotional reactiveness at age 3 years, but not ADHD symptoms (D'Onofrio 
et al., 2007; Lund et al., 2019). However, a study by Lund and colleagues did 
not observe the association with emotional reactiveness at age 5 years. 
Moreover, another study using a similar design in the MoBa cohort 
observed an association with ADHD symptoms at age 5 years measured 
with CPRS-R, but not with CBCL or when ADHD diagnosis was used 
(Eilertsen et al., 2017). Although these studies used a sibling comparison 
design which enables to account for shared genetic and environmental 
confounds between mothers and offspring, they cannot prove causality. 
The association may be still affected by non-shared individual specific 
factors and measurement error, as well as familial confounding can also 
change over time (D'Onofrio et al., 2014; Frisell et al., 2012). Alternatively, 
the genetic variants used in this study can help to overcome the limitation 
of unmeasured confounding.  
 
Triangulating findings across the studies based on different study designs 
which have a different source of bias can provide more support on whether 
a causal relationship exists. This is why, given that the results are not 
consistent across the studies, I am able to conclude that there are unlikely 
to be large effects of PAE on ADHD.  
 
In addition, a common limitation of previous studies reporting a positive 
association between PAE, conduct disorder and ADHD symptoms (e.g., 
Murray et al. (2016), Lund et al. (2019), D’Onofrio et al. (2007) and Eilertsen 
et al. (2017)) is that they were based on outcomes that were measured 
using maternal report. In Chapter 5 I found inconsistent findings when 
offspring ADHD symptoms were reported by mothers compared to 
teachers. This is not unexpected, as several studies had previously shown 
informant discrepancies in the assessment of child mental health problems 




socioeconomic status (Collishaw et al., 2009; De Los Reyes and Kazdin, 
2005). Differences between findings in previous studies and this study may 
be also related to the scales used for ADHD assessment, as was found by 
Eilertsen and colleagues and I observed in Chapter 5. The child’s age at the 
time of assessment and severity of the ADHD symptoms may also have an 
impact on the observed results. It has been shown that presentation and 
manifestation of ADHD and other behavioural symptoms, and diagnosis 
change from preschool to adolescence (Bunte et al., 2014; Curchack-Lichtin 
et al., 2014; Martel et al., 2017). This may lead to different findings across 
development as ADHD symptoms have been found to decline with age 
(Faraone et al., 2006). It is therefore possible that observed associations in 
previous studies may be influenced by reporter bias, child age and scales 
used for ADHD assessment and methods that do not sufficiently account for 
unmeasured confounds.   
 
6.4.1 Strengths and limitations 
Currently there are few studies which have investigated the effects of fetal 
alcohol exposure on child mental health outcomes by using genetic variants 
associated with alcohol consumption and metabolism as a proxy for fetal 
alcohol exposure. Compared with previous studies in ALSPAC this study 
uses a more comprehensive approach for identifying genetic variants 
affecting alcohol metabolism. I also compared findings across three 
international longitudinal cohorts, of which one cohort includes genetic 
data from both parents and offspring. Having trio genetic data enables to 
properly account for shared genetics and overcome potential biases such as 
dynastic effects and assortative mating (Davies et al., 2019).  
 
Dynastic effects (also known as genetic nurturing effects) are effects 
observed between parent’s genotype on offspring outcomes which are 
mediated via parent’s phenotype (Davies et al., 2019). For example, a study 
using PRS for educational attainment based on parental non-transmitted 
alleles (which are free from genetic transmission between parents and 




that dynastic effects can have an impact on offspring educational 
attainment via parental environmental effects (Kong et al., 2018).  
 
Similarly, assortative mating can have an effect on offspring outcomes as 
partner selection may be based on specific phenotypes, and partners may 
influence each other’s phenotypes (such as alcohol behaviour) (Hartwig et 
al., 2018). It has been shown that similarities in partners alcohol 
consumption are also genetically influenced (Howe et al., 2019) and 
therefore it is important to adjust for both maternal and paternal genotype 
when estimating the effect on offspring outcomes.  
 
However, several limitations should also be considered. First, sample size 
may have been too small to detect a true effect of fetal alcohol exposure on 
offspring ADHD risk. Although MR studies normally require sample sizes 
with tens of thousands of individuals, this can be difficult to gain in the 
context of intergenerational research and in pregnancy substance use 
exposures, as many women reduce/stop using substances when planning 
pregnancy and while being pregnant. Second, although MR and PRS 
analyses are less affected by confounding, as discussed in Chapter 5 (see 
section 5.1 “Introduction”) assumptions 2 and 3 cannot be fully verified, 
and the risk of horizontal pleiotropy where the genetic variant directly 
affects the outcome still remains, even if an effect is observed. 
Furthermore, considering that it is not possible to directly measure the 
level of alcohol that the fetus is exposed to, I could not test assumption 1 
either. Third, it is not possible to measure fetal blood alcohol levels to 
examine whether a dose-response relationship exists. Fourth, maternal 
alcohol consumption during pregnancy was based on self-reports and 
mothers may have underreported their prenatal alcohol use due to social 
desirability bias. This may have caused bias in the offspring PRS analyses 
where I stratified analyses based on maternal drinking status during 
pregnancy. Fifth, it is possible that lack of effects could be also influenced 
by included dichotomized outcome measures as this results in loss of 
statistical power. Very often, the scales used in ADHD assessment (SDQ, 




measures to use in general population studies (Swanson et al., 2012). 
Alternatively, continuous measures associated with ADHD symptoms could 
be more sensitive measures to use for investigating effects of fetal alcohol 
exposure. Research suggests that ADHD symptoms across a population are 
continuously distributed, and ADHD diagnosis is the extreme end of a trait 
(Ahmad and Hinshaw, 2017; Larsson et al., 2012). Furthermore, it has been 
suggested that one approach to investigate causal pathways is to include 
intermediate endophenotypes (such as reaction time, response inhibition 
and working memory) associated with ADHD (Andreou and Kuntsi, 2005; 
Kuntsi et al., 2014; Kuntsi et al., 2010). One such study found that reaction 
time and reaction time variability captured 85% and impaired response 
inhibition 13% of the familial variance of ADHD, suggesting that reaction 
time could be a promising cognitive target for genetic investigations (Kuntsi 
et al., 2010). Additionally, other studies have shown that reaction time and 
omission errors tasks were separately associated with ADHD hyperactive-
impulsive and inattention symptom domains (Kuntsi et al., 2014). 
Furthermore, another study found that  cognitive and brain function 
measures can separate individuals with more persistent ADHD from 
childhood to young adulthood (Michelini et al., 2017). 
 
Sixth, longitudinal birth cohorts may be affected by selection bias if some 
groups are under-represented in the initial recruitment. Selective attrition 
over time can also affect representativeness, which may cause biased 
exposure-outcome associations (Munafò et al., 2018). For example, in 
MoBa women who smoked during pregnancy, lived alone and had two 
previous births were under-represented (Nilsen et al., 2009) and in GenR 
women who continued to participate in the study were older and better 
educated (Kooijman et al., 2016). In addition, analyses restricted to live 
births can be affected by some degree of selection bias, in the form of 
collider bias (Liew et al., 2015), although it has been found that live birth 






6.5 CHAPTER SUMMARY 
In this chapter I investigated whether there is a causal effect of fetal alcohol 
exposure on ADHD risk in offspring by using maternal and offspring genetic 
variants from alcohol metabolising genes. My results did not find strong 
support for a causal effect of fetal alcohol exposure on ADHD risk in 




Chapter 7  DISCUSSION 
In this thesis I investigated whether there is a causal effect of maternal 
smoking, alcohol, and caffeine use during pregnancy on ADHD risk in 
offspring. I used different research methods to triangulate evidence and 
evaluate support for a causal effect. These methods were a systematic 
review (Chapter 2), a Phenome-Wide Association Study (PheWAS) 
(Chapter 4), a negative control (Chapter 5) and polygenic risk scores (PRS) 
analyses (Chapter 5 and 6). As well as using data from ALSPAC, I also 
replicated analyses in GenR and MoBa and meta-analysed the results 
across the cohorts. In this chapter I discuss the main findings from each 
chapter, before combining the overall evidence from my research in the 
light of its strengths and limitations. I will also provide suggestions for 
future research.  
7.1 SUMMARY OF FINDINGS 
7.1.1 Prenatal smoking, alcohol and caffeine exposure and offspring 
externalising disorders: A systematic review 
In Chapter 2, I conducted a systematic review where I aimed to examine 
whether there is evidence for a causal relationship between maternal 
smoking, alcohol and caffeine use during pregnancy, and attention-deficit 
hyperactivity disorder (ADHD), conduct disorder (CD) and oppositional-
defiant disorder (ODD) in offspring by synthesising existing research. Given 
the high comorbidity between ADHD, CD and ODD, I investigated whether 
the associations would differ between these disorders and each exposure, 
as this could provide important aetiological clues.  
 
I found evidence for an association between maternal smoking during 
pregnancy and ADHD in offspring. Based on the characteristics and results 
of included studies, I concluded that the association is unlikely to be causal. 
The majority of studies were on the relationship between smoking and 
ADHD, and studies on alcohol and caffeine exposure and CD and ODD 





I also identified several limitations and gaps in the current research. For 
example, studies varied greatly on the number of confounders adjusted for 
in analyses, which may lead to bias because of residual confounding. Of 
note, none of the studies accounted for partner substance use during 
pregnancy and only a few studies adjusted for maternal mental health 
during pregnancy. In addition, studies differed in terms of assessment of 
exposures and the age of ADHD assessment in offspring. Although several 
studies have shown that childhood ADHD persists into adulthood, other 
studies have also found that ADHD symptoms change across development. 
Therefore, lack of evidence may be influenced by changes at different 
developmental stages.  
 
Many of the included studies were based on binary exposures and assessed 
retrospectively, which may lead to recall bias. The majority of the studies 
on ADHD were based on overall ADHD diagnosis and only a few studies 
investigated ADHD hyperactive-impulsive and inattention symptom 
domains separately, so the evidence was weaker for the individual 
symptoms’ components. Despite the scant evidence base, some studies 
found that maternal prenatal substance use can have a distinct effect on 
ADHD symptom domains.  
7.1.2 Maternal and child genetic liability for smoking and caffeine 
consumption and child mental health: A Phenome-Wide Association 
Study in the ALSPAC cohort. 
In Chapter 4, I used intergenerational PRS analyses to investigate the 
effects of maternal and child genetic liability for smoking and caffeine 
consumption on various child mental health outcomes, in a targeted 
PheWAS approach. This study had three main aims: 1) validate that the PRS 
for smoking (smoking initiation and lifetime smoking) and caffeine 
consumption are associated with consumption of these substances in 
pregnancy and offspring in adolescence; 2) investigate intergenerational 
effects by testing associations between maternal and offspring PRS and 
offspring outcomes in childhood before children are likely to consume 




potential causal effects from pleiotropic effects by testing associations 
between maternal PRS and their own mental health outcomes during and 
outside of pregnancy, as well as between offspring PRS on their own mental 
health outcomes in adolescence.  
 
Results from this study showed that smoking and caffeine PRS could be 
used as proxies for measuring smoking and caffeine consumption during 
pregnancy, but not during adolescence on caffeine consumption. I also 
found evidence for likely pleiotropic effects between maternal smoking PRS 
and socio-economic traits, as well as with externalising disorder symptoms 
in offspring. Evidence was weaker for intergenerational effects between 
maternal caffeine PRS and offspring outcomes in childhood. However, in 
this study I did not investigate ADHD symptom domains separately and 
given the limitations of the PheWAS design, which is meant to generate 
rather than test hypotheses, no strong conclusions regarding causality can 
be drawn.  
7.1.3 Prenatal smoking, alcohol and caffeine exposure and ADHD risk in 
childhood: parental comparisons and polygenic risk score (PRS) 
analyses 
In Chapter 5, I combined a negative control design and an PRS approach to 
investigate whether there is a causal effect of maternal smoking, alcohol, 
and caffeine use during pregnancy on high risk of offspring total ADHD, as 
well as separately for hyperactive-impulsive and inattention symptoms. 
Considering that negative control analyses may still be biased because of 
unmeasured and residual confounding, I also used genetic variants as 
proxies for maternal prenatal substance use to gain stronger support for 
causal inference. As well as using data from ALSPAC, I also conducted the 
same analyses in GenR and MoBa cohorts and then meta-analysed results 
across the cohorts, to increase statistical power.  
 
In this study, I did not find strong support for a causal effect between 
maternal smoking, alcohol, or caffeine consumption during pregnancy and 




reported in Chapter 4, results with smoking PRS showed pleiotropic effects 
with socio-economic and mental health traits. However, I observed 
somewhat different findings between maternal and teacher reported ADHD 
symptoms, as well as between the different scales used for ADHD 
assessment. Therefore, future research should further investigate whether 
different scales are measuring the same construct of ADHD. 
7.1.4 Maternal and offspring polygenic risk score (PRS) analyses of fetal 
alcohol exposure and ADHD risk in offspring 
In Chapter 6, I used maternal and offspring genetic variants from alcohol 
metabolising genes (ADH and ALDH) as proxies for fetal alcohol exposure to 
investigate their association with high risk of offspring total ADHD, as well 
as hyperactive-impulsive and inattention symptoms. As in Chapter 5, I used 
data from three longitudinal birth cohorts: ALSPAC, GenR and MoBa.  
 
I tested the association between maternal PRS and ADHD outcomes using 
three models: 1) only maternal PRS; 2) maternal PRS adjusted for offspring 
PRS; and 3) maternal PRS adjusted for offspring and paternal PRS. I ran 
maternal analyses in the full sample as stratifying on maternal prenatal 
drinking status may induce a collider bias.  
 
I used three models also in offspring PRS analyses: 1) only offspring PRS; 2) 
offspring PRS adjusted for maternal PRS; and 3) offspring PRS adjusted for 
maternal and paternal PRS. These analyses were stratified based on 
maternal drinking status during pregnancy as compared to maternal PRS 
analyses there was no risk for a collider bias in offspring PRS analyses. 
However, given differences in availability of genetic data across the cohorts, 
I was able to conduct analyses in all three models only in MoBa.  
 
Similarly to the findings reported in Chapter 5, I did not find strong support 
for a causal effect of fetal alcohol exposure on offspring ADHD risk. 
However, lack of evidence for effects may be influenced by low statistical 
power due to the small sample size and dichotomised outcome measures. 




measures for ADHD might be necessary to detect potential causal effects. In 
general, my findings are in line with other studies which have concluded 
that low level of alcohol consumption during pregnancy do not have a 
substantial effect on offspring mental health outcomes.  
7.2 OVERALL FINDINGS 
This thesis aimed to investigate whether there is a causal effect of maternal 
smoking, alcohol and caffeine consumption during pregnancy on offspring 
ADHD risk. The observed associations could be explained by several 
scenarios: 
1. There is a true causal effect of maternal prenatal substance use on ADHD 
risk in offspring. 
2. There is no causal effect and the association between maternal prenatal 
substance use and ADHD risk in offspring is explained by confounding. 
3. The effect is observed by chance. 
4. The effect is observed as a result of the bias in applied method. 
5. The effect could be causal, but the current effect estimates are biased by 
environmental and genetic confounding. 
 
In this thesis I did not find strong support for a causal effect of maternal 
prenatal smoking, alcohol or caffeine use on offspring ADHD risk (Chapter 4, 
5 and 6). The associations observed in the negative control analyses were 
inconsistent across the cohorts, and sensitivity analyses did not find 
evidence for a causal effect of alcohol and caffeine exposure. However, 
some suggestive evidence was found in support of a causal effect between 
prenatal smoking exposure and only offspring maternal-reported ADHD 
symptoms in GenR and MoBa, (Chapter 5). Still, the evidence was weak and 
inconsistent across different scales and reporters used in ADHD 
assessment. Therefore, these observed associations are likely to be affected 
by genetic confounding.  
 
Furthermore, findings using genetic analyses which are less affected by 




observed associations between maternal smoking PRS and offspring 
externalising disorder symptoms, as well as with ADHD symptoms are likely 
explained by shared genetics between mother and offspring. Similarly, 
maternal smoking PRS analyses in Chapter 5 observed pleiotropic effects 
with multiple socio-economic traits. Additionally, findings from the 
systematic review (Chapter 2) where I included various study designs of 
which some accounted for environmental and genetic confounders 
suggested that the association between maternal smoking during 
pregnancy and ADHD in offspring is confounded. Therefore, taken together 
results from multiple methods, my findings do not support a causal effect 
of maternal prenatal smoking on offspring ADHD risk.  
 
Moreover, it is also possible that some associations of prenatal alcohol 
exposure observed in MoBa were because of chance, as these were not 
replicated in other cohorts (Chapter 6). In addition, as stated above, 
associations of smoking exposure found in the negative control analyses in 
GenR and MoBa could be a result of unmeasured confounding (Chapter 5), 
as PheWAS and PRS analyses did not confirm potential causal effects 
(Chapter 4 and 5).  
 
Nevertheless, considering the limitations in my studies and methods, I 
cannot completely rule out the possibility that there still may be a causal 
maternal environmental (pre- and postnatal) effect, as well as the 
association could be explained by genetic transmission from mother to 
offspring.  
 
A summary of causal inference approaches, including biases, limitations and 




Table 7.1 Summary of causal inference approaches 
Causal inference 
approach 
Bias addressed Limitations of 
approach 





Low power and 
horizontal 
pleiotropy 
- Positive association between maternal smoking PRS and externalising disorder 
symptoms in offspring in childhood 
- Positive association between offspring smoking PRS and externalising disorder 
symptoms in childhood 
- The magnitude of effect estimates of maternal and offspring smoking PRS on 
externalising disorder symptoms in childhood was similar 
- Positive association between maternal smoking PRS and sensation type of personality 
traits outside of pregnancy 
- Positive association between offspring smoking PRS and externalising disorder 
symptoms, as well as extroverted personality traits in adolescence 
- No strong evidence for intergenerational effects of maternal caffeine PRS on offspring 











- Suggestive causal effect of maternal prenatal smoking on high risk of offspring maternal 
reported ADHD symptoms in GenR and MoBa 
- No strong support for a causal effect between maternal prenatal alcohol and caffeine 
consumption and ADHD risk in offspring in any of the cohorts 
PRS analyses  





Low power and 
horizontal 
pleiotropy 
- Pleiotropic associations observed with maternal lifetime smoking PRS and socio-
economic and mental health traits in ALSPAC and MoBa 
- No associations observed between maternal alcohol and caffeine PRS and high risk of 
ADHD symptoms in offspring 
- No support for a causal effect between fetal alcohol exposure (PRS for alcohol 







7.3 STRENGTHS AND IMPLICATIONS 
7.3.1 Triangulation 
The major strength of this thesis is the triangulation of evidence through 
the use of different research methods, each with different strengths, 
weaknesses and sources of potential bias. Applying various approaches for 
the same research question enables me to draw stronger conclusions on 
causal effects. Given that each method has different source of biases, it is 
unlikely that all these methods are biased in the same way. Therefore, 
methods used in this thesis enable me to account for both environmental 
and genetic confounding that can affect the association between maternal 
prenatal substance use and ADHD risk in offspring. Furthermore, I used 
both negative control and PRS analyses to investigate causal effects of 
maternal prenatal substance use on ADHD symptom domains. In addition 
to ALSPAC, I used data from GenR and MoBa cohorts to increase statistical 
power and replicate findings which can also provide more credibility to 
observed results. 
As mentioned above, the main principle of using triangulation is to apply 
multiple approaches which address the same causal question but rely on 
different assumptions and will be subject to different sources and direction 
of bias. If consistent results are observed using these methods and across 
the different study populations then stronger conclusions on causal effects 
can be made, as it would be unlikely that the results are explained by the 
different biases affecting each type of study (often in opposite directions or 
unequal in size). It has previously been noted that when investigating 
prenatal effects, researchers should consider multiple approaches (Lawlor 
et al., 2017). For example, it is recommended that Mendelian 
Randomization (MR) studies should be integrated with other methods, as 
very often MR studies on pregnancy exposures may be underpowered and 
assumptions could be violated (Lawlor et al., 2017). Therefore, negative 
control studies (such as parental and sibling comparison or cross-cohort 
comparison) provide an opportunity to address the same research question 





As described in section 7.2 (“Overall findings”) my findings across cohorts 
and different methods did not find evidence for a causal effect of maternal 
prenatal substance use and ADHD risk in offspring. Use of both 
observational (Chapter 5) and genetic analyses (Chapter 4, 5 and 6) show 
how we can triangulate evidence to example causal relationship.   
7.3.2 Multiple measures of ADHD 
Currently there are few studies that have investigated ADHD symptom 
domains separately, and many studies in the published research have 
mostly relied on maternal report. My findings in Chapter 5 showed that 
results varied depending on whether ADHD symptoms were reported by 
mothers or teachers and which questionnaire was used for the ADHD 
assessment. This further highlights the need to focus more on the 
phenotyping of ADHD, as this could be also one of the reasons why I did not 
find strong evidence for an effect. Alternatively, more refined phenotyping 
may show that there is no effect of maternal prenatal substance use on 
offspring ADHD risk.  
7.3.3 Public health and clinical implications 
Considering the high economic and societal burden of ADHD, it is crucial to 
improve current knowledge about the risk factors that may have a causal 
effect on ADHD risk. The Developmental origins of Health and Disease 
(DoHaD) hypothesis suggests that maternal health behaviours during 
pregnancy can have a causal effect on child health outcomes (Swanson and 
Wadhwa, 2008). Therefore, if maternal smoking, alcohol, and caffeine 
consumption during pregnancy have a causal effect on ADHD risk in 
offspring, these harmful behaviours could be potential targets for public 
health interventions, or this evidence could be used to further strengthen 
existing interventions. Evidence do not suggest a causal effect of prenatal 
smoking and caffeine use on offspring ADHD, but there may be potential 
causal effects of alcohol and public health interventions could focus on this 
risk factor in relation to offspring ADHD. Furthermore, considering that 




smoke during pregnancy may pass on genes to their children that increase 
the risk for ADHD. This knowledge can help to detect children at risk for 
ADHD. For example, children at risk for ADHD could benefit from 
interventions that can help them to cope better with their symptoms and 
therefore also reduce later negative outcomes. 
7.4 LIMITATIONS 
In each chapter I have discussed potential limitations that may have 
influenced my results. Here I describe the main challenges that were 
common across multiple chapters. 
7.4.1 Attrition in cohort studies 
A common limitation of longitudinal birth cohorts is attrition over time. 
Missing data due to loss to follow up or irregular response rate may lead to 
selection bias and also affect effect estimates in exposure-outcome 
associations (Biele et al., 2019; Mostafa and Wiggins, 2015). Furthermore, 
loss to follow up can also weaken the representativeness of the study 
population as people with certain socio-demographic characteristics are 
more likely to drop out (Mostafa and Wiggins, 2015). Considering that in my 
analyses attrition was around 50% in all the cohorts by the time children 
were aged around 7-8 years, it is possible that observed results may be 
affected by selection bias. This may lead to either over or under estimation 
of the association between exposure and outcome (Hernan et al., 2004).  
 
Multiple imputation has been used to increase sample size and account for 
missing data, but findings have not differed substantially between imputed 
and non-imputed datasets in previous studies (Easey et al., 2020; 
Gustavson et al., 2017). Although I did not perform multiple imputation, I 
restricted negative control analyses to complete data (Chapter 5) and 
results remained similar. Inverse participation-probability weighting (IPPW) 
has also been suggested as one potential method to reduce selection bias 
due to participation factors, such as education which may predict 
participation in the study (Biele et al., 2019). However, it is also noted that 




outcome association is affected by unmeasured confounders, as may be the 
case between maternal prenatal smoking and offspring ADHD (Biele et al., 
2019).  
7.4.2 Selection bias 
My findings could have also been affected by selection bias related to 
selection on becoming pregnant and live births. For example, women who 
agreed to participate in the study had a “successful” pregnancy, but there is 
evidence that maternal substance use before pregnancy may increase the 
risk for spontaneous abortion and difficulties to conceive (Lassi et al., 2014; 
Sharma et al., 2013), as well as substance use during pregnancy may affect 
women’s ability to carry pregnancy to term. A recent systematic review and 
meta-analysis on prenatal alcohol use and miscarriage found a dose-
dependent association between alcohol consumption during pregnancy and 
increased risk of miscarriage (Sundermann et al., 2019).  
 
Similarly, studies on prenatal smoking and caffeine exposure have found 
evidence of increased risk for spontaneous abortion, miscarriage and 
stillbirth (Greenwood et al., 2014; Pineles et al., 2014). Therefore, it is 
possible that women with greater prenatal substance use were not eligible 
to participate in the cohorts because of early fetal loss and this could also 
affect observed findings in my studies. As described in Chapter 6 
conditioning on live birth may induce collider bias and open another 
pathway via unmeasured common cause between exposure, live birth and 
outcome, but it has been shown that live birth bias is unlikely to cause bias 
in studies investigating perinatal factors (Heinke et al., 2020; Liew et al., 
2015; Neophytou et al., 2020).  
7.4.3 Assessment of exposures 
7.4.3.1 Self-reported exposures 
In all the included cohorts, maternal substance use during pregnancy was 
measured with maternal self-reported questionnaires. Given the 
stigmatisation of prenatal substance use, mothers may have underreported 




sensitive questions the bias is stronger for in-person data collection than 
for self-reported questionnaires (Bowling, 2005), mothers may still have 
responded in the way which is seen as more favourable and underreporting 
is still plausible. However, using genetic variants as proxies for maternal 
prenatal exposures can help to overcome the limitation of social desirability 
bias.  
 
Alternatively, biomarkers associated with smoking and alcohol 
consumption could be used as potential measures for prenatal smoking and 
alcohol use. For example, ethyl glucuronide (EtG) is a biomarker of fetal 
ethanol exposure that can be measured in newborns and could be used to 
detect alcohol consumption in late pregnancy (Eichler et al., 2016). This 
measure has been found to be more precise than retrospectively self-
reported prenatal alcohol consumption (Eichler et al., 2016).  
 
For prenatal smoking exposure, measuring cotinine (the primary metabolite 
of nicotine, and therefore a useful biomarker) has been suggested. Cotinine 
could be measured in urine or blood, as well as in newborns at birth. 
However, cotinine could be used as a marker for recent smoking, and it may 
still be affected by maternal metabolic variability and may not be precise 
enough (Dukic et al., 2007).  
 
Although a biochemical verification of prenatal substance use may provide 
more accurate information, these measures could be too costly for 
longitudinal cohort studies, and will still be as affected by confounding as 
the behavioural self-reported measures. 
7.4.3.2 Time-variation in exposures 
My negative control analyses were performed using exposure data from the 
first pregnancy trimester, where both maternal and paternal exposure data 
were available. However it is possible that the effect of exposures on 
outcomes can differ between the trimesters and the effect may also 
depend on whether the exposure was present throughout pregnancy or not 
(Neophytou et al., 2020). However, one previous study on alcohol exposure 




offspring conduct disorder in the first pregnancy trimester than in the third 
pregnancy trimester indicating that prenatal substance use may have more 
harmful effects on offspring health outcomes in the first pregnancy 
trimester (Larkby et al., 2011). However, considering that many women 
reduce or stop their substance use once they become aware of their 
pregnancy, then the effects of later substance use may be harder to detect.   
 
Similarly, my PRS analyses were based on the assumption that genetic 
effects on exposure remains constant throughout pregnancy. A potential 
bias because of time-varying exposures has been pointed out in MR studies 
where the goal is to estimate a lifetime effect (Labrecque and Swanson, 
2019). Therefore, it is also possible that my results may be subject to bias if 
duration and intensity of maternal prenatal smoking, alcohol and caffeine 
consumption, as well as the genetic effects on these exposures change over 
the course of the pregnancy.  
7.4.4 Assessment of ADHD 
Although all the included scales for ADHD assessment had good 
psychometric properties, different scales were used in all the cohorts, 
which may have caused measurement error when combining them 
together. Furthermore, ADHD symptom scores in the analyses were 
dichotomised due to the skewed distribution. This may have had an impact 
on power to detect an effect in PRS analyses (Fedorov et al., 2009). In 
addition, studies on prenatal alcohol exposure have indicated shared 
characteristics and symptom overlap between ADHD and FASD which may 
lead to misclassification of ADHD (Mattson and Riley, 2011). Therefore, 
more clear phenotyping of ADHD is needed for future studies which could 
help to distinguish ADHD from FASD.  
 
Furthermore, some studies have shown that prenatal substance use may 
have a somewhat different effect on ADHD symptom domains, as well as 
heritability has been found to be stronger for ADHD hyperactive-impulsive 
symptoms. My findings did not indicate that prenatal substance use had 




domains. However, lack of evidence may be also affected by scales used for 
distinguishing ADHD symptom domains, which also needs further 
investigation. 
7.5 FUTURE DIRECTION 
7.5.1 Phenotyping of ADHD 
Several studies have shown that ADHD symptoms across a population are 
continuously presented (Larsson et al., 2012), but a large number of studies 
are still using binary measures to overcome methodological limitations 
because of skewed distributions in general population-based studies 
(Burton et al., 2019; Swanson et al., 2012). The Strengths and Weaknesses 
of ADHD Symptoms and Normal Behaviour Rating Scale (SWAN) has been 
suggested as a more suitable scale to measure ADHD dimensionally where 
the scores produce a normal distribution (Swanson et al., 2012). SWAN has 
been shown to be a good measure also in molecular genetics research for 
capturing genetic variation across the continuum of ADHD traits, and SWAN 
enables differentiation of ADHD hyperactive-impulsive and inattention 
symptom domains (Burton et al., 2019; Greven et al., 2016). Considering 
that it is possible that prenatal substance use may have somewhat different 
effects on ADHD hyperactive-impulsive and inattention symptoms, SWAN 
could be a better scale to further investigate the effects of prenatal 
substance use on offspring ADHD symptom domains.  
 
Moreover, as discussed in Chapter 6, more detailed phenotyping of ADHD 
using endophenotypes could be one solution to distinguish ADHD from 
FASD diagnoses. Several studies have found that executive function deficits 
are somewhat different in children with ADHD and FASD (Kingdon et al., 
2016). One such a study found that children with ADHD and FASD have 
different sustained attention and inhibition profiles (Kooistra et al., 2010). 
Another study using neuroimaging techniques found some white-matter 
pathology in prenatally alcohol exposed children with ADHD compared to 





Other aspects to consider in ADHD phenotyping are the change in 
symptoms across developmental periods, and high comorbidity with other 
mental health disorders which can also change in different developmental 
periods (Franke et al., 2018). A study in ALSPAC found 4-class trajectories of 
ADHD at age 4 to 17 years: low; intermediate; childhood-limited and 
persistent where the highest genetic loading and comorbidity was observed 
in the persistent trajectory (Riglin et al., 2016). Another study also 
identified an ADHD late-onset trajectory that begins in adolescence 
(Manfro et al., 2019). However, there is an ongoing debate whether late-
onset ADHD exists and to what extent it differs from childhood ADHD 
(Asherson and Agnew-Blais, 2019). Currently, there are few studies which 
have investigated whether prenatal substance use has different effects on 
ADHD with comorbid disorders. One such study found that the strongest 
effect of maternal prenatal smoking was observed on ADHD with comorbid 
ODD (Joelsson et al., 2016).  
 
In order to gain clarity in these areas, more longitudinal studies with 
repeated measures which investigate ADHD symptoms with and without 
comorbidities over the life course, are needed.  
7.5.2 Establishing stronger causal inference 
Although a combination of negative control and PRS analyses can provide 
stronger evidence for a causal effect, my PRS analyses were affected by low 
power. Both PRS analyses (Chapter 5 and 6) and the PheWAS approach 
(Chapter 4) do not formally estimate the causal effect. Therefore, future 
studies should use more sophisticated methods in bigger samples to further 
investigate whether a true causal effect exists.  
7.5.2.1 Natural experiments and quasi-experimental designs 
Quasi-experimental designs, such as negative control, sibling comparison, 
as well as twin and other genetically sensitive designs can all contribute to a 





Also, natural experiments are useful approaches in general population 
studies. For example, universal experiences could be applied to caffeine 
exposure. The current guidelines in the UK advise pregnant women to limit 
their caffeine intake during pregnancy to less than 200mg a day. However, 
before 2008 the upper limit of caffeine intake in pregnancy was advised as 
300mg a day (Miles and Foxen, 2009). This change over time could provide 
an opportunity to investigate whether children born to mothers who could 
consume more caffeine during pregnancy experienced more developmental 
difficulties compared to children whose mothers were recommended to 
drink less caffeine. Although this type of experiment will not solve the 
problem of unmeasured confounding, it can still provide a hypothesis for a 
potential causal effect.  
 
Another example of how quasi-experimental designs could be useful to 
disentangle maternal prenatal substance use effects from postnatal effects, 
is to use genetically sensitive designs. For instance, a study on cocaine 
exposure conducted in children reared by their biological mothers and 
adoptive parents concluded that children raised by adoptive parents or 
biological mothers did not differ substantially in their mean IQ indicating 
that observed lower IQ is because of the actual prenatal cocaine exposure 
and not due to the postnatal environment (Singer et al., 2004). This type of 
study design could also be used to disentangle prenatal effects from 
postnatal effects on offspring ADHD symptoms in other substances. 
Although given the high comorbidity between smoking, alcohol and 
caffeine use, it may still be difficult to separate specific effects of each 
substance on the outcome.   
7.5.2.2 Two-Sample Mendelian Randomization (MR) 
Two-sample MR could be used to estimate the causal effect of prenatal 
exposures on offspring health outcomes. Two-sample MR has been 
established to overcome limitations due to the Winner’s curse in one-
sample MR and increase power to detect a potential causal effect. The main 
principle of two-sample MR is that the SNP-exposure association is 
measured in one sample and the SNP-outcome association is measured in 




tested in two-sample MR either, methods have been developed to test for 
pleiotropy. For example, the inverse variance weighted method assumes 
that all genetic variants are valid instruments and there is no pleiotropy. 
Alternatively, MR Egger allows all genetic variants to violate MR 
assumptions and the weighted median assumes that majority of the genetic 
variants satisfy MR assumptions (Bowden et al., 2017; Burgess and 
Thompson, 2017; Slob and Burgess, 2020).  
 
However, to increase the power to detect a potential causal effect 
establishment of large-scale consortia are needed to perform two-sample 
MR studies in the context of prenatal exposures and intergenerational 
research (Evans et al., 2019).  
7.5.2.3 Multivariable MR 
As an extension of the one- and two-sample MR approaches, multivariable 
MR enables the use of multiple genetic variants associated with several risk 
factors simultaneously to estimate the causal effect on the outcome 
(Sanderson et al., 2019). Considering high comorbidity between smoking, 
alcohol and caffeine use, multivariable MR would enable researchers to 
estimate direct causal effects of each exposure on the outcome 
independent of the others. Multivariable MR can be used with individual 
level data as well as in two sample settings. Similarly to two-sample MR, 
sensitivity analyses can be performed to test for pleiotropy (Rees et al., 
2017), but also bigger sample sizes are needed than currently available to 
use this method in intergenerational research and on prenatal exposures.  
7.5.2.4 Transmitted and Non-Transmitted Alleles 
Alternatively, in the situation where the impact of genetic transmission on 
the child health outcomes is likely and paternal genetic data is limited, it is 
also possible to investigate causal effects by separating maternal 
transmitted and non-transmitted alleles.  Conducting MR analyses using 
maternal non-transmitted alleles will reduce collider bias if paternal genetic 
data is not available and can provide more evidence for a causal effect 
(Lawlor et al., 2017). One such a study investigating offspring adiposity 




when maternal non-transmitted alleles were used in MR analysis 
(Richmond et al., 2017).  
However, similarly to other MR approaches, large sample sizes are needed 
to be sufficiently powered to detect a potential causal effect when using 
non-transmitted alleles.  
 
Furthermore, non-transmitted alleles could be used to examine genetic 
nurturing effects. For example, it has been found that PRS for educational 
attainment based on non-transmitted alleles was not associated with 
children’s ADHD symptoms indicating that genetic nurturing related to 
parental educational characteristics was not relevant in ADHD (de Zeeuw et 
al., 2020). However, genetic nurturing effects may differ when using 
parental non-transmitted alleles based on substance use behaviours. A 
recent study based on MoBa did not find evidence for genetic nurturing 
effects between maternal prenatal smoking and child ADHD symptoms, but 
more research is needed for other exposures (Pingault et al., 2021). 
7.5.2.5 Structural Equation Models (SEM) 
Additionally, structural equation models (SEM) have been developed to 
investigate intergenerational associations by taking into account both 
genetic and environmental influences, as well as genetic transmission 
between parents and offspring (Hannigan et al., 2018; McAdams et al., 
2018). A study in MoBa using SEM have found some evidence that maternal 
prenatal depression can have a direct effect on offspring ADHD symptoms 
after accounting for genetic transmission (Eilertsen et al., 2020). This model 
could be also applied to further investigate whether maternal prenatal 
substance use can have a direct effect on offspring ADHD after accounting 
for genetic confounding. 
7.5.3 Evocative effects 
It has been suggested that offspring externalising problems may be a result 
of gene-environment correlations where parental behaviour is a response 
to children’s genetically influenced behaviour (evocative effects) indicating 




externalising problems is bidirectional (Marceau et al., 2013). Furthermore, 
it has been found that children who were genetically predisposed to ADHD 
related impulsive behaviour experienced more hostile parenting by their 
genetically unrelated mothers which also predicted child ADHD symptoms 
at later age (Harold et al., 2013). Another study that examined evocative 
effects by using PRS to control for passive gene-environment correlation 
between parents and offspring found that children’s genetic predisposition 
for behavioural difficulties was associated with poorer parental monitoring 
via children’s impulsivity which also contributed to affiliation with 
substance-using peers in adolescence (Elam et al., 2017). Therefore, it is 
plausible that offspring ADHD symptoms may have an effect on maternal 
substance use which also influences offspring ADHD via parenting 
behaviour.  
7.6 THESIS CONCLUSIONS 
The main aim of this thesis was to investigate whether there is a causal 
effect of maternal smoking, alcohol, or caffeine consumption during 
pregnancy on ADHD risk in offspring. I used both observational and genetic 
analyses and triangulated my findings across different methods applied in 
this thesis. Taken together, I did not find strong evidence to support a 
causal effect of maternal prenatal substance use on offspring ADHD risk.  
My findings on prenatal smoking and caffeine exposure suggest that a 
causal effect of these exposures on offspring ADHD is unlikely, in line with 
previous studies on these substances. The results do not differ according to 
method of ADHD assessment (i.e., based on diagnosis or symptom score). 
My findings on prenatal alcohol exposure are less conclusive, when 
considered in the context of the wider literature. While my analyses do not 
support a causal effect, other studies have found some evidence for a 
causal effect of prenatal alcohol exposure on offspring ADHD, but there 
remains the possibility that ADHD characteristics/behaviours that overlap 
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Appendix 2.1. Search performed in Medline (Ovid platform) including relevant 
MeSH Terms 
1. disruptive, impulse control, and conduct disorders"/ or "attention deficit and 
disruptive behavior disorders"/ or attention deficit disorder with hyperactivity/ or 
conduct disorder/ or child behavior disorders/ - MeSH Terms  
2. Child Behavior Disorders/ - MeSH Terms  
3. Impulsive Behavior/ - MeSH Terms  
4. Problem Behavior/ - MeSH Terms  
5. attention deficit disorder.tw   
6. hyperactiv*.tw   
7. impulsiv*.tw  
8. ADHD.tw  
9. attention deficit hyperactivity.tw  
10. externali?ing.tw  
11. conduct disorder.tw  
12. behavio* disorders.tw  
13. behavio* problem*.tw  
14. disruptive behavio*.tw  
15. oppositional defiant disorder.tw  
16. ALCOHOLS/ - MeSH Terms  
17. DRINKING BEHAVIOR/ or ALCOHOL DRINKING/ or DRINKING/ or BINGE 
DRINKING/ - MeSH Terms  
18. TOBACCO USE"/ or TOBACCO/ or TOBACCO SMOKING – MeSH Terms  
19. CAFFEINE/ - MeSH Terms  
20. COFFEE/ - MeSH Terms  
21. TEA/ - MeSH Terms  
22. Energy Drinks/ - MeSH Terms  
23. Ethanol – MeSH Terms  
24. Taurine – MeSH Terms  
25. alcohol*.tw  
26. tobacco.tw  
27. caffein*.tw  
28. drink*.tw  
29. ethanol.tw  
30. smoking.tw  
31. cigarette*.tw  
32. nicotine.tw  
33. coffee.tw  
34. tea.tw  
35. energy.drink*.tw  
36. taurine.tw  
37. Pregnancy trimesters – MeSH Terms  
38. Pregnancy – MeSH Terms  
39. PREGNANCY TRIMESTER, SECOND/ or PREGNANCY TRIMESTER, FIRST/ or PREGNANCY 
TRIMESTER, THIRD/ - MeSH Terms  
40. Pregnan*.tw  
41. Perinatal*.tw  




43. Intrauterine*.tw  
44. Utero.tw  
45. F?etal.tw  
46. Gestation.tw  




Appendix 2.2. Risk of bias assessment 
Newcastle Ottawa Scale for cohort studies 
Item Points 
Selection 
1) Representativeness of the 
exposed cohort 
1 point – cohort is representative of the average 
pregnant woman in the community 
0 points – cohort is based on selected group or 
not representative or no description of the 
cohort of interest  
2) Selection of the non-exposed 
cohort 
1 point – drawn from the same community as 
exposed cohort 
0 points – drawn from a different source or no 
description provided 
3) Ascertainment of exposure 1 point – exposure assessed prospectively or 
assigned from the medical record 
0 points – retrospective assessment or may be 
at risk for recall bias or no description 
4) Demonstration that outcome 
of interest was not present at 
start of study 
1 point – yes 
0 points – no 
Comparability 
5) Comparability of cohorts on 
the basis of the design or 
analysis 
1 point – study controls for potential 
confounder other than sociodemographic 
factors (such as social class, education, 
maternal age and ethnicity, child gender) 
2 points – study controls for any other 
additional factor 
0 points – no confounders included, or study 
does not control for sociodemographic factors 
Outcome 
6) Assessment of outcome 1 point – record linkage or assessment based on 
multiple sources and/or evaluation by clinician 
0 points - self-report or no reference to records 
or no assessment by clinician 
7) Was follow-up long enough for 
outcome to occur 
1 point – child age at least 6-7 years or 50% of 
the sample is older than 6 years 
0 points – child age less than 6 years or >50% of 
the sample is younger than 6 years 
8) Adequacy of follow up of 
cohorts 
1 point – complete follow up or loss to follow-
up is <50% 
0 points - >50% of the sample lost to follow up 




Newcastle Ottawa Scale for case-control studies 
Item Points 
Selection 
1) Is the case definition adequate? 1 point – independent validation (record linkage or 
using multiple sources and clinical assessment) 
0 points – based on self-reports with no clinical 
validation or no description  
2) Representativeness of the cases 1 point – eligible cases over a defined period of 
time, in a defined catchment area or clearly defined 
group 
0 points – potential for selection bias or not stated 
3) Selection of controls 1 point – same community as cases 
0 points – hospital controls or not representing 
controls without mental health problems 
4) Definition of controls 1 point – no history of disease (endpoint) 
0 points – not meeting criteria for endpoint or no 
description 
Comparability 
5) Comparability of cases and 
controls on the basis of the 
design or analysis 
1 point – study controls for potential confounder 
other than sociodemographic factors (such as social 
class, education, maternal age and ethnicity, child 
gender) 
2 points – study controls for any other additional 
factor 
0 points – no confounders included, or study does 
not control for sociodemographic factors 
Exposure 
6) Ascertainment of exposure 1 point – secure record, prospective measure or 
structured interview blind to case/control status 
0 points – assessment not blinded to case/control 
status or retrospective self-report or may be at risk 
for recall bias 
7) Same method of ascertainment 
for cases and controls 
1 point – yes 
0 points – no 
8) Non-response rate 1 point – same rate for both groups 






Appendix 2.3. Risk of bias assessment scores based on NOS scale of cohort, 
longitudinal and cross-sectional studies 
Study Item1 Item2 Item3 Item4 Item5 Item6 Item7 Item8 Total 
Smoking 
Ball et al., 2010 1 1 0 1 1 0 1 0 5 
Gustavson et al., 
2017 
1 1 1 1 2 1 1 1 9 
Langley et al., 2012 1 1 1 1 1 0 1 0 6 
Obel et al., 2011 1 1 1 1 1 1 1 1 8 
Obel et al., 2016 1 1 1 1 0 1 1 1 7 
Skoglund et al., 2014 1 1 1 1 0 1 1 1 7 
Zhu et al., 2014 1 1 1 1 2 1 1 1 9 
Lehn et al., 2007* 1 1 1 1 1 0 1 1 7 
Lindblad et al., 2010 1 1 1 1 2 1 1 1 9 
Braun et al., 2006 1 1 0 0 1 0 1 0 4 
Wakschlag et al., 
1997 
0 1 0 0 2 1 1 1 6 
Talati et al., 2016* 0 1 0 0 0 1 1 1 4 
Braun et al., 2008 1 1 0 0 0 0 1 1 4 
Ellis et al., 2012 1 1 0 0 2 0 0 1 5 
Nigg et al., 2007 1 1 0 0 1 0 1 1 5 
Talati et al., 2017 0 1 0 1 0 1 1 1 5 
Weissman et al., 
1999 
0 1 0 0 0 1 1 1 4 
Nomura et al., 2010 0 0 0 0 2 1 0 0 3 
Neuman et al., 2007 1 1 0 1 2 0 1 0 6 
Koshy et al., 2011 0 1 0 0 0 0 1 0 2 
Sciberras et al., 2011 1 1 0 0 1 0 1 1 5 
Froehlich et al., 2009 1 1 0 0 1 0 1 0 4 
Knopik et al., 2006 1 1 0 0 0 1 1 0 4 
Alcohol 
Eilertsen et al., 2017 1 1 1 1 1 1 0 0 6 
Larkby et al., 2011 1 1 1 1 2 0 1 1 8 
Caffeine 
Del-Ponte et al., 
2016 
1 1 0 1 2 1 1 1 8 
Linnet et al., 2008 1 1 1 1 2 1 1 1 9 
Smoking and Alcohol 
Fergusson et al., 
1998 
1 1 1 1 2 0 1 1 8 
Pohlabeln et al., 
2017 
0 1 0 0 2 0 1 1 5 
Sagiv et al., 2013 1 1 1 1 2 1 1 1 9 
Schmitt et al., 2012 1 1 0 0 2 0 1 0 5 
Whitbeck et al., 
2009 
0 1 0 0 0 0 1 0 2 
Knopik et al., 2005 1 1 0 0 1 0 1 1 5 
Smoking, alcohol and caffeine 




Appendix 2.4. Risk of bias assessment scores based on NOS scale of case-control 
studies 
Study Item1 Item2 Item3 Item4 Item5 Item6 Item7 Item8 Total 
Smoking 
Biederman et al., 
2009 
1 1 0 1 2 0 1 0 6 
Gard et al., 2010 0 0 0 0 1 0 1 0 2 
Gustaffson and 
Kallen, 2010 
1 1 1 1 0 1 1 1 7 
Joelsson et al., 
2016 
1 1 1 1 2 1 1 1 9 
Linnet et al., 2005 1 1 1 1 2 1 1 1 9 
Milberger et al., 
1996 
1 1 0 1 1 0 1 0 5 
Milberger et al., 
1998 
1 1 0 1 1 0 1 0 5 
Motlagh et al., 
2010 
1 1 1 1 0 0 0 0 4 
Schmitz et al., 
2006 
1 1 1 1 2 0 1 1 8 
Silva et al., 2014 1 1 1 1 2 0 1 1 8 
Todd et al., 2007 0 1 1 1 1 0 1 0 5 
Yoshimasu et al., 
2009 
1 1 0 1 2 0 1 1 7 
Altink et al., 2009 1 1 1 1 2 0 1 0 7 
Altink et al., 2008 1 1 1 1 0 0 1 0 5 
Arnold et al., 2005 1 1 1 1 2 0 1 0 7 
Biederman et al., 
2017 
1 1 0 1 0 0 1 0 4 
Oerlemans et al., 
2016 
1 1 1 1 0 0 1 0 5 
Smoking and Alcohol 
Ketzer et al., 2012 1 1 1 1 1 0 1 0 6 
Mick et al., 2002 1 1 0 1 1 0 1 0 5 
Pineda et al., 2007 1 1 1 1 0 0 1 1 6 
Wiggs et al., 2016 1 1 1 1 1 0 1 0 6 
Alcohol and caffeine 




Appendix 2.5. List of studies excluded 
 Author Year Title Exclusion reason 
1. Brookes et al. 2006 A common haplotype of the 
dopamine transporter gene 
associated with attention-
deficit/hyperactivity disorder and 
interacting with maternal use of 
alcohol during pregnancy 
no comparison/control 
group 
2. Freitag et al. 2012 Biological and psychosocial 
environmental risk factors 
influence symptom severity and 




3. Brookes et al. 2006 Association of Fatty Acid 




4. Langley et al. 2007 Effects of low birth weight, 
maternal smoking in pregnancy and 
social class on the phenotypic 
manifestation of Attention Deficit 
Hyperactivity Disorder and 
associated antisocial behaviour: 
investigation in a clinical sample 
no comparison/control 
group 
5. Langley et al. 2008 Testing for gene x environment 
interaction effects in attention 
deficit hyperactivity disorder and 
associated antisocial behavior 
no comparison/control 
group 
6. Thakur et al. 2012 Comprehensive 
Phenotype/Genotype Analyses of 
the Norepinephrine Transporter 
Gene (SLC6A2) in ADHD: Relation 




7. Thakur et al. 2013 Maternal smoking during 
pregnancy and ADHD: A 




8. Biederman et 
al.  
2012 Does exposure to maternal 
smoking during pregnancy affect 
the clinical features of ADHD? 
Results from a controlled study 
no comparison/control 
group 
9. Bhatara et al. 2006 Association of attention deficit 
hyperactivity disorder and 




10. Xu et al. 2010 Racial differences in the effects of 
postnatal environmental tobacco 
smoke on neurodevelopment 
wrong exposure 
11. Mulligan et al. 2013 Home environment: association 
with hyperactivity/impulsivity in 






12. Naeye and 
Peters 
1984 Mental development of children 
whose mothers smoked during 
pregnancy 
wrong outcome 
13. Holz et al. 2014 Effect of Prenatal Exposure to 
Tobacco Smoke on Inhibitory 
Control Neuroimaging Results from 
a 25-Year Prospective Study 
wrong outcome 
14. Martel and 
Roberts 
2014 Prenatal testosterone increases 
sensitivity to prenatal stressors in 





2001 Clinical significance and correlates 
of disruptive behavior in 
environmentally at-risk 
preschoolers 
don' t meet outcome 
criteria  
(maternal reported 
conduct disorder and 
ADHD symptoms) 
16. Sengupta et 
al. 
2015 Parental psychopathology in 
families of children with attention-
deficit/hyperactivity disorder and 
exposed to maternal smoking 
during pregnancy 
wrong outcome 




18. Grabell and 
Olson 
2010 Executive functioning as a 
mediating factor of prenatal 
alcohol exposure and externalizing 
problems in preschool children 
conference/meeting 
abstract 
19. Schmitz et al. 2017 Pre- and perinatal risk factors in 
autism spectrum disorder and 
attention deficit/hyperactivity 
disorder 
not English language 
20. Willoughby et 
al. 
2012 Parent-Reported Attention 
Deficit/Hyperactivity 
Symptomatology in Preschool-Aged 
Children: Factor Structure, 




21. Wiliams et al. 1998 Maternal cigarette smoking and 
child psychiatric morbidity: a 
longitudinal study 
wrong outcome 
22. Whitaker et 
al. 
2011 Serial pediatric symptom checklist 
screening in children with prenatal 
drug exposure 
wrong exposure 
23. Whitaker et 
al. 
2006 Food insecurity and the risks of 
depression and anxiety in mothers 
and behavior problems in their 
preschool-aged children 
wrong exposure 
24. Way and 
Rojahn 
2012 Psycho-social characteristics of 
children with prenatal alcohol 
exposure, compared to children 






25. Twardella et 
al. 
2010 Exposure to secondhand tobacco 
smoke and child behaviour - results 
from a cross-sectional study among 
preschool children in Bavaria 
wrong exposure 
26. Vuijk et al. 2006 Prenatal smoking predicts non-
responsiveness to an intervention 
targeting attention-
deficit/hyperactivity symptoms in 
elementary schoolchildren 
retracted 
27. Van Den Berg 
and Marcoen 
2004 High antenatal maternal anxiety is 
related to ADHD symptoms, 
externalizing problems, and anxiety 
in 8- and 9-year-olds 
wrong exposure 
28. Todd and 
Neuman 
2007 Gene-environment interactions in 
the development of combined type 
ADHD: evidence for a synapse-
based model 
duplicate 
29. Tiesler and 
Heinrich 
2014 Prenatal nicotine exposure and 
child behavioural problems 
review  
30. Teramoto et 
al. 
2005 Problematic behaviours of 3-year-
old children in Japan: Relationship 




31. Tearne et al. 2015 The association between prenatal 
environment and children's mental 




32. Höök et al. 2006 Prenatal and postnatal maternal 
smoking as risk factors for 
preschool children's mental health 
externalising disorder 
not specified 
33. Schonfeld et 
al. 
2005 Moral maturity and delinquency 
after prenatal alcohol exposure 
FAS sample 
34. Roza et al. 2009 Maternal smoking during 
pregnancy and child behaviour 
problems: the Generation R Study 
externalising disorder 
not specified 
35. Schlotz et al. 2010 Lower maternal folate status in 
early pregnancy is associated with 
childhood hyperactivity and peer 
problems in offspring 
wrong exposure 
36. Salom et al. 2015 Familial factors associated with 
development of alcohol and mental 
health comorbidity 
wrong exposure 
(not measured during 
pregnancy) 
37. Salom et al. 2016 Predictors of comorbid 
polysubstance use and mental 
health disorders in young adults-a 
latent class analysis 
wrong outcome 
38. Ruchkin et al. 2008 Developmental pathway modeling 
in considering behavior problems 






39. Pauli-Rott et 
al. 
2017 Psychosocial risk factors underlie 
the link between attention deficit 
hyperactivity symptoms and 
overweight at school entry 
wrong exposure 
40. Paley et al. 2005 Prenatal Alcohol Exposure, Child 




41. Oulhote and 
Bouchard 
2013 Urinary metabolites of 
organophosphate and pyrethroid 
pesticides and behavioral problems 
in Canadian children 
wrong exposure 
42. Olson et al. 1992 Prenatal exposure to alcohol and 
school problems in late childhood: 
A longitudinal prospective study 
externalising disorder 
not specified 
43. Robinson et 
al. 
2010 Low-moderate prenatal alcohol 
exposure and risk to child 
behavioural development: A 
prospective cohort study 
externalising disorder 
not specified 
44. Robinson et 
al. 
2008 Pre- and postnatal influences on 
preschool mental health: A large-
scale cohort study 
externalising disorder 
not specified 
45. Robinson et 
al. 
2010 Smoking cessation in pregnancy 
and the risk of child behavioural 
problems: A longitudinal 
prospective cohort study 
externalising disorder 
not specified 
46. Pineda et al. 2003 Perinatal factors associated with 
attention deficit/hyperactivity 
diagnosis in Colombian Paisa 
children] 
not English language 
47. Pfinder et al. 2014 Impact of Moderate Prenatal 
Alcohol Exposure on Problem 
Behaviors in Preschool and School 
Children 
duplicate 
48. Petkovsek et 
al. 
2014 Prenatal smoking and genetic risk: 
Examining the childhood origins of 
externalizing behavioral problems 
externalising disorder 
not specified 
49. Oćallaghan et 
al. 
1997 Obstetric and perinatal factors as 




50. O'Brien et al. 2013 Do dopamine gene variants and 
prenatal smoking interactively 




51. Niemela et al. 2016 Maternal smoking during 
pregnancy and offpsring's 
psychiatric morbidity in early 
adulthood. Findings from the 




52. Niclasen et al. 2012 Prenatal exposure to alcohol and 




53. Najman et al.  2000 Preschool children and behaviour 






54. Glass et al. 2014 Correspondence of parent report 
and laboratory measures of 
inattention and hyperactivity in 
children with heavy prenatal 
alcohol exposure 
FAS sample 
55. Fryer et al. 2007 Evaluation of psychopathological 
conditions in children with heavy 
prenatal alcohol exposure 
FAS sample 
56. Mina et al. 2017 Prenatal exposure to very severe 
maternal obesity is associated with 
adverse neuropsychiatric outcomes 
in children 
wrong exposure 
57. Melchior et al. 2012 Food Insecurity and Children's 
Mental Health: A Prospective Birth 
Cohort Study 
wrong exposure 
58. Mullen et al. 2017 Effects of prenatal alcohol 
exposure on child behaviour 
outcomes at age five: Lifeways 





2011 Prenatal smoking exposure and the 
risk of behavioral problems and 




60. Minnes et al. 2010 The effects of prenatal cocaine 
exposure on problem behavior in 
children 4-10 years 
wrong exposure 
61. Momany et al. 2017 Sex moderates the impact of birth 
weight on child externalizing 
psychopathology 
wrong exposure 
62. Milberger et 
al. 
1996 Is maternal smoking during 
pregnancy a risk factor for 
attention deficit hyperactivity 
disorder in children? 
duplicate 
63. MacKinnon et 
al. 
2018 The Association Between Prenatal 
Stress and Externalizing Symptoms 
in Childhood: Evidence From the 
Avon Longitudinal Study of Parents 
and Children 
wrong exposure 
64. Lukkari et al. 2012 Exposure to Obstetric 
Complications in Relation to 
Subsequent Psychiatric Disorders 
of Adolescent Inpatients: Specific 
Focus on Gender Differences 
wrong exposure 
65. McLaughlin et 
al. 
2011 Caregiver and self-report of mental 
health symptoms in 9-year old 
children with prenatal cocaine 
exposure 
wrong exposure 
66. McCrory et al. 2012 Prenatal exposure to maternal 
smoking and childhood behavioural 







67. Maughan et 
al. 
2004 Prenatal smoking and early 
childhood conduct problems: 
Testing genetic and environmental 
explanations of the association 
don't meet outcome 
criteria  
(maternal and teacher 
reported measure of 
conduct disorder and 
delinquent behaviour 
symptoms) 
68. Marceau et al. 2018 Within-Family Effects of Smoking 
during Pregnancy on ADHD: the 
Importance of Phenotype 




69. Linnet et al. 2003 Maternal Lifestyle Factors in 
Pregnancy Risk of Attention Deficit 
Hyperactivity Disorder and 
Associated Behaviors: Review of 
the Current Evidence 
review  
70. Langley et al. 2005 Maternal smoking during 
pregnancy as an environmental risk 
factor for attention deficit 
hyperactivity disorder behaviour. A 
review 
review  
71. Coles et al. 1997 A comparison of children affected 
by prenatal alcohol exposure and 
attention deficit, hyperactivity 
disorder 
FAS sample 
72. Walthall et al. 2008 A comparison of psychopathology 
in children with and without 
prenatal alcohol exposure 
FAS sample 
73. Neiderhiser et 
al. 
2016 Estimating the Roles of Genetic 
Risk, Perinatal Risk, and Marital 
Hostility on Early Childhood 




74. Max et al. 2013 Attention deficit hyperactivity 
disorder among children exposed 
to secondhand smoke: A logistic 




Mendez et al. 
2015 Environmental factors associated 
with suspected ADHD in 
preschoolers using a screening tool 
(ADHD-RS-IV-P) 
wrong exposure  
(not measured in 
pregnancy) 
76. Maat et al. 2017 Attention-deficit hyperactivity 
disorder (adhd) symptoms in 
children adopted from poland and 
their atypical association patterns: 
A bayesian approach 
no exposure-outcome 
association measured 
77. Linnet al. 2006 Gestational age, birth weight, and 





78. LaGasse et al. 2012 Prenatal methamphetamine 
exposure and childhood behavior 
problems at 3 and 5 years of age 
wrong exposure 
79. Lewis et al. 2016 Prospective Memory Impairment in 
Children with Prenatal Alcohol 
Exposure 
FAS sample 
80. Lahti et al. 2006 Small body size at birth and 
behavioural symptoms of ADHD in 
children aged five to six years 
wrong exposure 
81. Maatta et al. 2017 Maternal Smoking During 
Pregnancy Is Associated With 
Offspring's Musculoskeletal Pain in 
Adolescence: Structural Equation 
Modeling 
wrong outcome 
82. Li et al. 1996 Study of child's behavior problem 
in logistic regression analysis 
not English language 
83. Langley et al. 2010 Maternal and paternal smoking 
during pregnancy and risk for child 




84. Kukla et al. 2006 Smoking of mothers during 
pregnancy in relation to mental 
and motoric development 
disorders in 4- and 5-year-old 
children. The elspac study results 
not English language 
85. Wakschlag et 
al. 
2006 Elucidating early mechanisms of 
developmental psychopathology: 
The case of prenatal smoking and 
disruptive behavior 
wrong outcome 
86. Leung et al. 2015 Early second-hand smoke exposure 
and child and adolescent mental 
health: Evidence from Hong Kong's 
'Children of 1997' birth cohort 
wrong exposure 
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269. Batstra et al. 2003 Effect of antenatal exposure to 
maternal smoking on behavioural 
problems and academic 
achievement in childhood: 
Prospective evidence from a Dutch 
birth cohort 




270. Arruda et al. 2015 ADHD and mental health status in 
Brazilian school-age children 
only unadjusted 
analyses 
271. Anselmi et al.  2010 Early determinants of attention 
and hyperactivity problems in 
adolescents: the 11-year follow-up 







272. Agrawal et al. 2010 The effects of maternal smoking 
during pregnancy on offspring 
outcomes 
don't meet outcome 
criteria  
(maternal reported 
conduct disorder and 
ADHD symptoms) 
273. Sayal et al. 2007 Prenatal alcohol exposure and 
gender differences in childhood 
mental health problems: A 
longitudinal population-based 
study 
don't meet outcome 
criteria  
(maternal and teacher 
reported conduct 
disorder and ADHD 
symptoms) 
274. Sayal et al. 2009 Binge pattern of alcohol 
consumption during pregnancy and 
childhood mental health outcomes: 
longitudinal population-based 
study 
don't meet outcome 
criteria  
(maternal reported 
conduct disorder and 
ADHD symptoms) 
275. Sayal et al. 2014 Prenatal exposure to binge pattern 
of alcohol consumption: mental 
health and learning outcomes at 
age 11 
don't meet outcome 
criteria  
(maternal and teacher 
reported conduct 
disorder and ADHD 
symptoms) 
276. Salationo-
Oliveira et al. 
2016 COMT and prenatal maternal 
smoking in associations with 
conduct problems and crime: the 
Pelotas 1993 birth cohort study 





277. Rodriguez et 
al. 
2009 Is prenatal alcohol exposure 
related to inattention and 
hyperactivity symptoms in 
children? Disentangling the effects 
of social adversity 
don't meet outcome 
criteria  
(maternal and teacher 
reported ADHD 
symptoms) 
278. Rodriguez and 
Bohlin 
2005 Are maternal smoking and stress 
during pregnancy related to ADHD 
symptoms in children? 




279. Pourcain et al. 2011 Links between co-occurring social-
communication and hyperactive-
inattentive trait trajectories 







280. Piper et al. 2012 Maternal smoking cessation and 
reduced academic and behavioral 
problems in offspring 




281. Pfinder et al. 2014 Impact of moderate prenatal 
alcohol exposure on problem 
behaviors in preschool and school 
children stronger effects in 
disadvantaged populations? 
Results from the KiGGS study 
don't meet outcome 
criteria  
(maternal reported 
conduct disorder and 
ADHD symptoms) 
282. Parker et al. 2016 Prenatal smoking and childhood 
behavior problems: is the 
association mediated by birth 
weight? 
don't meet outcome 
criteria  
(maternal reported 
conduct disorder and 
ADHD symptoms) 
283. Park et al. 2014 Mediating role of stress reactivity 
in the effects of prenatal tobacco 
exposure on childhood mental 
health outcomes 
don't meet outcome 
criteria  
(maternal and teacher 
reported conduct 
disorder and ADHD 
symptoms) 
284. Palmer et al. 2016 Effects of Maternal Smoking during 
Pregnancy on Offspring 
Externalizing Problems: Contextual 
Effects in a Sample of Female Twins 
don't meet outcome 
criteria  
(child's and maternal 
reported conduct 
disorder and ADHD 
symptoms) 
285. Palili et al. 2011 Inattention, hyperactivity, 
impulsivity--epidemiology and 
correlations: a nationwide greek 
study from birth to 18 years 




286. Orlebeke et 
al. 
1999 Child behavior problems increased 
by maternal smoking during 
pregnancy 
don't meet outcome 
criteria  
(maternal reported 
conduct disorder and 
ADHD symptoms) 
287. Orlebeke et 
al. 
1997 Increase in child behavior problems 
resulting from maternal smoking 
during pregnancy 
don't meet outcome 
criteria  
(maternal reported 





288. Obel et al. 2009 Smoking during pregnancy and 
hyperactivity-inattention in the 
offspring - Comparing results from 
three Nordic cohorts 




289. O'Leary et al. 2010 Evidence of a complex association 
between dose, pattern and timing 
of prenatal alcohol exposure and 
child behaviour problems 
don't meet outcome 
criteria  
(maternal reported 




2017 Risk factors for comorbid 





291. Niclasen et al. 2014 Prenatal exposure to alcohol, and 
gender differences on child mental 
health at age seven year 
don't meet outcome 
criteria  
(maternal reported 
conduct disorder and 
ADHD symptoms) 
292. Niclasen et al. 2014 Is alcohol binge drinking in early 
and late pregnancy associated with 
behavioural and emotional 
development at age 7 years? 
don't meet outcome 
criteria  
(maternal reported 
conduct disorder and 
ADHD symptoms) 
293. Murray et al. 2010 Very early predictors of conduct 
problems and crime: results from a 
national cohort study 





294. Murray et al. 2016 Moderate alcohol drinking in 
pregnancy increases risk for 
children's persistent conduct 
problems: causal effects in a 
Mendelian randomisation study 





295.  Hill et al. 2000 Maternal smoking and drinking 
during pregnancy and the risk for 
child and adolescent psychiatric 
disorders” - did not any adjusted 
results on tobacco and alcohol 
exposure and ADHD, CD and ODD 




Appendix 2.6. List of studies not reporting all the results 
Author/Year Title Country Study design Exposure Outcome Missing data 
Talati et al., 
2016 
Brain derived neurotrophic factor moderates 
associations between maternal smoking 






Results not reported on 
ADHD due to the low 
number of cases 
Talati et al., 
2017 
Prenatal tobacco exposure, birthweight, and 
offspring psychopathology” – did not report 






Results not reported on 
ADHD due to the low 
number of cases 
Whitbeck et 
al., 2009 
Gestational risks and psychiatric disorders 
among indigenous adolescents” – did not 
report results on tobacco exposure and 
ADHD 




Results on smoking 
exposure not reported 
Hill et al., 2000 Maternal smoking and drinking during 
pregnancy and the risk for child and 
adolescent psychiatric disorders” – did not 
any adjusted results on tobacco and alcohol 









Adjusted results not 
reported 
Kim et al., 
2009 
Perinatal and Familial Risk Factors Are 
Associated with Full Syndrome and 
Subthreshold Attention-Deficit Hyperactivity 
Disorder in a Korean Community Sample 
Korea Case-control Smoking 
Alcohol 
Caffeine 
ADHD Results not reported on 
smoking exposure due to 
the low prevalence of 
smoking in the sample 
Knopik et al., 
2006 
Maternal alcohol use disorder and offspring 
ADHD: disentangling genetic and 
environmental effects using a children-of-
twins design 




ADHD Only unadjusted results 





Appendix 2.7. Study characteristics and results of cohort, longitudinal and cross-sectional studies 
Author/Year Country Study sample 
Cases/total 







exposure Outcome Outcome assessment Follow up time Confounders 
Results (as reported in the 
study) 
Smoking             








(CPP), the new 
England Family Study 
(NEFS) and 
Providence cohort 
219/2024 Both 37.2 years Prospective self-
report during all 
the pregnancy 
trimesters 
No smoking (ref); 
<half pack per day; 







1, 4, 7 years 
and adulthood 
Ascertainment source, family 
psychopathology, maternal education, 
offspring gender 
OR (95% CI)  
No smoking (ref)  
<half pack per day:  
1.2 (0.81, 1.7)  
>half pack to <full pack:  
1.1 (0.75, 1.6)  





cohort study in 
general population 
(the Norwegian 
Mother, Father and 
Child Cohort study 
(MoBa)) 
2035/104,846 Both 5 years Prospective self-
report during the 
2nd and 3rd 
pregnancy 
trimester 
Binary (Yes/No) ADHD ADHD diagnosis 
obtained from the 
Norwegian Patient 
Registry (NPR) 
6, 18 months, 
3, 5, 7, 8 and 13 
years (ongoing 
study) 
Parental age, education, parental 
ADHD symptoms; maternal (pre-
pregnancy) and paternal BMI; 
maternal alcohol consumption during 
pregnancy; maternal parity; child’s 
birth year; geographical residential 
region 
Hazard ratio (HR) (95% CI), p-
value  
1.48 (1.3, 1.68), <0.001  
 
*the magnitude of the effect 
size was similar in all negative 
controls (paternal smoking, 
grandmother’s smoking when 
pregnant with the mother, and 






cohort study in 
general population 
(the Avon 
Longitudinal Study of 
Parents and Children 
(ALSPAC)) 
121/5637 Both 7.6 years Prospective self-
report during the 
2nd and 3rd 
pregnancy 
trimester 
No smoking (ref);  




ADHD the Development and 
Well-Being 
Assessment (DAWBA) 
and diagnosis were 
generated based on 
maternal and teacher 
reports 
From birth to 
adulthood 
(ongoing study) 
child’s sex, ethnicity, multiple births 
(twins), maternal prenatal alcohol use, 
social class 
OR (95% CI), p-value  
1.72 (1.14, 2.61), <0.05  
 
*the magnitude of the effect 
estimates were similar with 
paternal smoking  
Obel et al., 
2011 
Finland Population based 
cohort and registry 
study 
7023/868,449 







15 years Information 
collected during 
the routine visit 
to midwives in 









Only 1st trimester; 
After first trimester  
Hyperkinetic 
disorder  
the Finnish Hospital 
Discharge Register 
(FHDR) 
15 years child age, birth year, child sex, 
gestational age at birth, parity, 
maternal age, SES 
HR (95% CI), p-value  
Total sample: 2.01 (1.9, 2.12)  
Boys: 1.96 (1.85, 2.08)  
Girls: 2.28 (1.99, 2.63)  
Total sample:  
Overall:  
1.92 (1.69, 2.18)  
1-9 cigarettes:  
1.77 (1.47, 2.12)  
10+ cigarettes:  
2.03 (1.74, 2.37)  
Boys:  
Overall: 1.88 (1.64, 2.15)  
1-9 cigarettes:  
1.75 (1.43, 2.13)  




1.97 (1.67, 2.33)  
Girls:  
Overall: 2.23 (1.56, 3.18)  
1-9 cigarettes:  
1.93 (1.15, 3.23)  
10+ cigarettes:  
2.46 (1.59, 3.81)  
Total sample:  
Overall: 1.92 (1.80, 2.04)  
Only 1st trimester:  
1.34 (1.11, 1.62)  
After 1st trimester:  
1.98 (1.86, 2.12)  
Boys:  
Overall: 1.88 (1.75, 2.01)  
Only 1st trimester:  
1.34 (1.09, 1.64)  
After 1st trimester:  
1.94 (1.81, 2.08)  
Girls:  
Overall: 2.13 (1.82, 2.49)  
Only 1st trimester:  
1.35 (0.82, 2.22)  
After 1st trimester:  
2.21 (1.88, 2.60)  
 
*no difference in effect 
estimates in sibling 
comparison analyses 
Obel et al., 
2016 
Denmark Population based 










9 years Information 
collected during 









during 1st trimester; 
Continued smoking 
Non-smokers (ref);  
1-10cigarettes/day; 




obtained from the 
ICD-10 registration 
system and ADHD 
medication obtained 




up time 9 years 
birth year, child sex, maternal age, and 
parity 
HR (95% CI)  
Total sample :  
2.01 (1.94, 2.07)  
Boys : 1.98 (1.91, 2.05)  
Girls: 2.12 (1.99, 2.27)  
No smoking (ref)  
Quitted smoking during 1st 
trimester: 
 1.61 (1.39, 1.88)  
Continued smoking:  
2.19 (2.09, 2.29)  
No smoking (ref)  
1-10 cigarettes:  
1.92 (1.81, 2.02)  
10+ cigarettes:  
2.77 (2.60, 2.95)  




Sweden Population based 
registry study 
19,891/768,227 Both ~9 years Antenatal visit 
during the 1st 
pregnancy 
trimester 
No smoking (ref); 
Moderate (1-9 
cigarettes);  
High (>10 cigarettes) 
ADHD Diagnosis and 
medication use of 
ADHD were identified 
from the Patient 
Up to 9 years child sex, birth year, parity, maternal 
age at child’s birth, cohabitation with 
the child’s father, maternal education, 
mother’s country of birth 
HR (95% CI)  
Moderate: 1.62 (1.56, 1.69) 





Register and the 
Swedish Prescribed 
Drug register 
*no association in sibling and 
cousin analyses 
Zhu et al., 
2014 
Denmark Population based 
longitudinal and 
registry study 
(Danish Birth Cohort 
Study) 







replacement user;  
Smoking quitter 









Up to 8 to 14 
years 
maternal age at birth of the child, 
alcohol intake during pregnancy, 
parental socio-occupational status, 
parental psychopathology, parity and 
child’s gender 
HR (95% CI)  
Smoking (both parents):  
1.83 (1.60, 2.10)  
Smoking (father non-smoker): 
1.63 (1.36, 1.94)  
 
*stronger association with 
maternal smoking and nicotine 




Sweden Population based 
registry study 
6141/927,007 Both 6-19 years Visit to the 
midwives during 
the 1st pregnancy 
trimester 
No smoking in any 
pregnancy (ref);  
No smoking at least 
in one pregnancy;  
1-9 cigarettes/day; 
10+ cigarettes/day 
ADHD ADHD medication use 




from 6 up to 19 
years 
maternal age and year of birth, child 
sex, and parity. Marital status, 
maternal education, social assistance, 
parental psychiatric disorders and 
substance use, child’s indicator of 
small for gestational age (gestational 
age and Apgar score) 
OR (95% CI)  
No smoking at least in one 
pregnancy: 1.43 (1.26, 1.61)  
1-9 cigarettes:  
1.59 (1.49, 1.70)  
10+ cigarettes:  
1.89 (1.75, 2.04)  
 
*no association within-mother 
between pregnancy analyses 
Braun et al.., 
2006 
USA population based 
cross-sectional study 









4-15 years Not specified Binary (Yes/No) ADHD Combination of 
parent report 
whether child has 
diagnosed for ADHD 
and stimulant 
medication use based 
on National Drug 
Codes 
NA child’s age, sex, race, socioeconomic 
status as measured by poverty-to-
income ratio (PIR), mother’s age at 
child’s birth, national insurance 
coverage, preschool attendance and 
perinatal distress (birth weight and 
admission to neonatal intensive care 
unit) 
OR (95% CI), p-value  
Total sample:  
2.5 (1.2, 5.2), 0.02  
Boys: 2.1 (0.9, 4.7), 0.07  
Girls: 4.6 (1.7, 12.4)  
Wakschlag et 
al., 1997 
USA longitudinal study 
(clinic referred 
sample) 





No and occasional 





CD A diagnosis was 
derived by combining 
parent, teacher and 
child report of the 
National Institute of 
Mental Health 
Diagnostic Interview 




(starting age 7 
years) and 5th 
assessment in 2 
years 
SES and ethnicity, parental 
psychopathologic conditions (paternal 
antisocial personality disorder, 
maternal MMPI antisocial index, and 
maternal and paternal depression and 
substance abuse), other pregnancy 
risk factors (maternal age at child’s 
birth, use of illicit drugs and alcohol 
during pregnancy, pregnancy and birth 
complications, low birth weight, and 
prematurity), and family and 
parenting risk factors (number of 
children in the household, marital 
status, poor communication, little 
supervision, and ineffective and harsh 
discipline 
OR (95% CI), p-value Smoked 
<half pack/day:  
1.6 (0.53, 5.11), 0.39  
Smoked >half pack/day:  
3.3 (1.2, 9.07), 0.02 
Talati et al., 
2016 
USA longitudinal family 
study (clinical sample 










Six waves up to 
30 years 
age, gender, and maternal depression 
and substance use history 
Effect estimate (SE), p-value 













trained mental health 
professional 
Smoking and child genotype 
interaction:  
1.92 (0.81), 0.017  
Braun et al., 
2008 
USA population based 
cross-sectional study 









Binary (Yes/No) CD the Diagnostic 
Interview Schedule 
for Children (DISC) 
based on DSM-IV 
criteria 
NA child’s age, sex, race, socioeconomic 
status as measured by poverty-to-
income ratio (PIR), and mother’s age 
at child’s birth 
OR (95% CI)  
3.00 (1.36, 6.63)  
Ellis et al., 
2012 




Secure Study (TESS)) 
995  
34 ADHD cases 
57 ODD cases 
both 4 years retrospective 
interview 
(assessed in each 
pregnancy 
trimester) 
Binary (Yes/No) ADHD 
ODD 
Structured interview 
with mothers using 
the Preschool Age 
Psychiatric 
Assessment (PAPA – 




Personality traits of narcissistic, 
histrionic, borderline, schizotypal, 
paranoid, avoidant, dependent, 
obsessive-compulsive personality, 
parental alcohol use, parental anxiety, 
depression, prenatal stress, 
depression, alcohol use, planned 
pregnancy, parental feelings about 
pregnancy, mothers’ feelings in the 
first month after birth, parental 
experience of mental breakdown, 
parent requested medical treatment, 
parent ever been arrested, parent 
ever been indicted by police, parental 
ability to pay family expenses, parent 
received medical treatment for 
psychological disorder, and parental 
admission to a mental health 
institution. Maternal age and SES  
OR (95% CI), p-value  
ADHD: 2.17 (1.3, 3.61), 0.003  
ODD: 2.46 (1.66, 3.63), 0.001  
 
*propensity score analyses 
Nigg et al., 
2007 
USA longitudinal cohort 
study 
798 95  
ADHD cases  
46 CD cases 
 89 ODD cases 
both 11 years in 
ADHD  
17 years in 











for Children (DISC; 
version 2.1) 
3 assessments: 
at age 6, 11 and 
17 years 
low birth weight, maternal substance 
use disorders, maternal education, 
home environment (urban vs 
suburban) 
OR (95% CI), p-value  
ADHD: 1.19 (0.79, 1.8)  
CD: 2.32 (1.05, 5.15), <0.05 
ODD: 2.31 (1.24, 4.31), <0.05  
 
*low birth weight did not 
mediate the association with 
ADHD. Independent effect of 
low birth weight was observed 
on ADHD but not on CD or 
ODD 
Talati et al., 
2017 
USA longitudinal family 




21 ADHD cases 











Binary (whether or 
not mother smoked 
>10 cigarettes/day) 






trained mental health 
professional 
6 waves (age 1, 




Familial risk for depression, offspring 
age at final interview, and sex (except 
in the sex-specific models). Further 
covariates included lifetime diagnosis 
of nicotine dependence in either 
parent and any parental mental health 
diagnosis 
OR (95% CI), p-value  
Total sample:  
1.75 (0.94, 3.23), <0.07  
Boys: 2.63 (1.05, 6.49), <0.05  
Girls: 1.08 (0.41, 2.82)  
 







USA longitudinal family 

















Parent and offspring 







in 10 years: 
baseline 6 to 23 
years 
history of maternal depression, 
offspring age and divorce 
Relative Risk (RR) (95% CI)  
CD 13-17 years:  
Boys: 1.70 (0.48, 5.96)  
Girls: 1.00 (0.35, 2.86)  
ADHD <13 years:  
Boys: 0.44 (0.09, 2.09)  
Girls: 2.16 (0.14, 34.71) 
Nomura et 
al., 2010 
USA longitudinal study 209 65 ADHD 
cases 6 ODD 
cases 
both 4.3 years retrospective 
self-report 









Child’s age, gender, SES, birth weight, 
and ethnicity, self-report of maternal 
and paternal ADHD symptoms, and 
maternal alcohol use during 
pregnancy 
OR (95% CI), p-value  
ADHD: 4 (1.36, 11.12), 0.012  
ODD: 3.37 (0.22, 38.46), 0.34  
 
*stronger association with 
maternal smoking compared 
to paternal smoking in ADHD 
Fergusson et 
al., 1998 










No smoking;  




CD the Composite 
International 
Diagnostic Interview 
and the Self-Report 
Delinquency 
Inventory. DSM-IV 
criteria were used for 
constructing 
diagnosis 
At birth, 4 
months, annual 
assessment up 
to 16 years and 
18 years 
Maternal education, age, family SES, 
pregnancy planning, prenatal alcohol 
and illicit drug use, maternal child-
rearing practices, parental separation, 
parental conflict, parental history of 
alcohol problems, criminal offending 
and illicit drug use 
OR (95% CI), SE, p-value  
1.27 (0.9, 1.78), 0.17, 0.172  
 
*exposure treated in 
continuous scale 
Koshy et al., 
2011 
UK cross-sectional study 
(preselected areas of 
lower socio-
economic status) 










ADHD Parent report 
whether child has 
been diagnosed for 
ADHD by a doctor 
NA child obesity and overweight, doctor-
diagnosed asthma, preterm birth, 
household member smoking during 
pregnancy, low birthweight 
OR (95% CI), p-value  
Total smoking:  
2.20 (1.08, 9.49), 0.04  
Light: 2.89 (0.38, 22.09)  












study in general 
population (the 
European IDEFICS 
study – Identification 
and prevention of 
dietary- and lifestyle-
induced health 
effects in children 
and infants) 





Never (ref);  
<1 a month;  
Several occasions a 
week/daily 
ADHD Maternal report – 
“Has the child ever 






child’s sex, age, country, maternal age, 
SES and further for gestational 
hypertension, proteinuria, sugar in 
urine (glycosuria), and gestational 
diabetes, weight and height of the 
child at birth, potential health 
problems (respiratory adjustment 
disorders or infections), the duration 
of breastfeeding (exclusive and in 
combination with other types of 
feeding), and, in case of preterm birth, 
the number of weeks the child was 
born before the estimated date of 
birth.  
OR (95% CI), p-value  
Several occasions week/daily: 
1.74 (1.13, 2.67), 0.02  
 
*adjusted results reported only 
for heavier smoking  
Sagiv et al., 
2013 
USA prospective cohort 
study in general 
population (the New 
Bedford Cohort 
study) 





No smoking (ref);  
1-10 cigarettes/day 
>10 cigarettes/day 
ADHD Diagnosis were 
obtained from the 
paediatric medical 
records and parents 
were asked to report 
whether the child 
8 years maternal age at offspring birth and 
education, paternal education, annual 
household income, marital status, 
prenatal substance use, maternal IQ, 
maternal depression (postnatal), 
HOME score, child age, gestational 
RR (risk ratio) (95% CI), p-
value  
1-10 cigarettes:  
0.9 (0.4, 1.8), 0.68  
>10 cigarettes:  




was regularly taking 
ADHD medications 
age, sex, ethnicity, breast feeding, 
school type, number of siblings 
Schmitt et 
al., 2012 
Germany cross-sectional study 
in general population 
(the German Health 
Interview and 
Examination Survey 
for Children and 
Adolescents (KIGGS) 
660/13,488 both 9.9 years not specified Binary (Yes/No) ADHD lifetime diagnosis of 







conducted by trained 
interviewers  
NA child gender, age, SES (based on 
parental education, professional 
qualification, family income), maternal 
gestational diabetes, perinatal health 
problems, breastfeeding, atopic 
eczema 
OR (95% CI)  






Study of Australian 
Children (LSAC) 





No smoking (ref); 
Occasionally;  
Most days 
ADHD Primary caregiver 
report – “Does the 





maternal age, education, marital 
status, number of people in the 
household, child gender, household 
income, child’s birth weight, maternal 
postnatal depression, intensive care at 
birth 
OR (95% CI), p-value 
Occasionally:  
0.62 (0.17, 2.26)  
Most days:  
3.31 (1.49, 7.39), 0.004 

















age 1, 2, 3, 5, 7, 
10 and 12 years 
Discordant and concordant pairs were 
matched on gender, zygosity, date of 
birth, maternal age, and parental SES. 
In wave II matching criteria was 
gender, date of birth, zygosity, 
handedness, and SES 
*prenatal maternal smoking 
was more common in MZ pairs 
concordant for Aps/ADHD than 
in the other groups, providing 
at least secondary evidence 
that smoking, in addition to a 
common genetic risk, leads to 
increased rates of ADHD in 
offspring 
Russell et al., 
2015 
USA cross-sectional study 












More than 20 
cigarettes per day;  
11 to 20 cigarettes 
per day;  
1 to 10 cigarettes per 
day;  
Fewer than 1 
cigarette per day;  
None (ref) 
ODD Structured diagnostic 






NA offspring age OR (95% CI)  
Total sample: 1.06 (0.8, 1.3) 
Boys: 1.00 (0.7, 1.4)  
Girls: 1.11 (0.8, 1.5) 
Froehlich et 
al., 2009 
USA Cross-sectional study 
(household survey in 
general population) 





Binary (Yes/No) ADHD Diagnostic Interview 
Schedule for Children 
(DISC) 
NA child age, ethnicity and gender, 
household income/poverty ratio, 
mother’s age at child’s birth, birth 
weight, NICU admission, postnatal 
secondhand smoke exposure, 
preschool attendance, health 
insurance status 
OR (95% CI), p-value 
2.4 (1.5, 3.7), 0.001 
Knopik et al., 
2005 
USA Longitudinal twin 
study (the Missouri 
Adolescent Female 
Twin Study) 


















over 2 years – 
13, 15, 17 and 
19 years 
zygosity, prenatal and parental 
predictors – low birth weight, 
maternal alcohol abuse/dependence, 
paternal alcohol dependence, 
frequent heavy drinking during 
pregnancy 
OR (95%CI) 
First trimester: 0.97 (0.5, 1.86) 
1-10 cigarettes/day:  
1.05 (0.48, 2.37) 
11-19 cigarettes/day:  
0.42 (0.11, 1.63) 








1.40 (0.48, 4.07) 
 
Beyond first trimester:  
1.50 (0.86, 2.63) 
1-10 cigarettes/day:  
1.24 (0.61, 2.52) 
11-19 cigarettes/day:  
1.83 (0.89, 3.76) 
>20 cigarettes/day:  
1.79 (0.79, 4.07) 
Knopik et al., 
2006 
Australia Longitudinal twin 
study 







Regular smoker, not 
during pregnancy;  











Not specified child gender and age, paternal history 
of alcohol problems and paternal 
conduct disorder/antisociality history 
OR (95% CI), p-value 
Never smoked (ref) 
Regular smoker, not during 
pregnancy: 0.72 (0.23, 2.22) 
1st trimester only:  
1.88 (0.45, 7.81) 
Beyond 1st trimester, 1–15 
cigarettes/day:  
0.54 (0.16, 1.83) 
Beyond 1st trimester, 16+ 
cigarettes/day:  
3.83 (1.09, 13.45), <0.005 
Alcohol 
            
Fergusson et 
al., 1998 










No drinking (ref);  
1-3 drinks/week;  
4-6 drinks/week;  
7+ drinks/week 
CD the Composite 
International 
Diagnostic Interview 
and the Self-Report 
Delinquency 
Inventory. DSM-IV 
criteria were used for 
constructing 
diagnosis 
At birth, 4 
months, annual 
assessment up 
to 16 years and 
18 years 
Maternal education, age, family SES, 
pregnancy planning, prenatal smoking 
and illicit drug use, maternal child-
rearing practices, parental separation, 
parental conflict, parental history of 
alcohol problems, criminal offending 
and illicit drug use 
OR (95% CI), SE, p-value  
1.32 (0.93, 1.88), 0.18, 0.126  
 
*exposure treated in 
continuous scale 
Larkby et al., 
2011 
USA longitudinal birth 
cohort study 
67/487 both 16.8 years Prospective self-
report in each 
pregnancy 
trimester (focus 




based on average 
daily volume (ADV)  
No drinking (ref); 
Light (ADV <0.4); 
Moderate (0.4-0.89); 
Heavy (>0.89) 
CD the Diagnostic 
Interview Schedule-
IV (DIS-IV). 
At delivery, 8 
and 18 months, 
3, 6, 10, 14, 16 
and 22 years 
prenatal exposure to marijuana, 
cocaine, and other illicit drugs, 
income, child’s race, age and gender, 
parenting style, life events, home 
environment, family history of alcohol 
problems, and maternal lifetime 
psychopathology 
OR (95% CI)  
First trimester:  
Heavy: 2.47 (1.3, 4.7)  
 
*Results not reported for other 












study in general 
population (the 
European IDEFICS 
study – Identification 
and prevention of 
dietary- and lifestyle-
induced health 
effects in children 
and infants) 






 <1 a month;  
Several occasions a 
month/week 
ADHD Maternal report – 
“Has the child ever 






child’s sex, age, country, maternal age, 
SES and further for gestational 
hypertension, proteinuria, sugar in 
urine (glycosuria), and gestational 
diabetes, weight and height of the 
child at birth, potential health 
problems (respiratory adjustment 
disorders or infections), the duration 
of breastfeeding (exclusive and in 
combination with other types of 
feeding), and, in case of preterm birth, 
OR (95% CI), p-value  
Several occasions 
month/week:  
0.76 (0.23, 2.48), 0.65  
 
*adjusted results reported only 




the number of weeks the child was 
born before the estimated date of 
birth.  
Sagiv et al., 
2013 
USA prospective cohort 
study in general 
population 
(the New Bedford 
Cohort study) 
75/604 both 8 years prospective self-
report 2 weeks 








ADHD Diagnosis were 
obtained from the 
paediatric medical 
records and parents 
were asked to report 
whether the child 
was regularly taking 
ADHD medications 
8 years maternal age at offspring birth and 
education, paternal education, annual 
household income, marital status, 
prenatal substance use, maternal IQ, 
maternal depression (postnatal), 
HOME score, child age, gestational 
age, sex, ethnicity, breast feeding, 
school type, number of siblings 
RR (95% CI), p-value 
1-2 servings: 2.5 (0.8, 7.2), 0.1 
>2 servings: 0.8 (0.3, 2.1), 0.71 
Schmitt et 
al., 2012 
Germany cross-sectional study 
in general population  
(the German Health 
Interview and 
Examination Survey 
for Children and 
Adolescents (KIGGS) 
660/13,488 both 9.9 years not specified Binary (Yes/No) ADHD lifetime diagnosis of 







conducted by trained 
interviewers   
NA child gender, age, SES (based on 
parental education, professional 
qualification, family income), maternal 
gestational diabetes, perinatal health 
problems, breastfeeding, atopic 
eczema 
OR (95% CI) 
1.02 (0.79, 1.33) 
Whitbeck et 
al., 2009 
USA cohort study (lagged 
sequential) 
(population based on 
indigenous culture) 















child age, gender, marital status, 
income, parenting behaviour 
(maternal warmth, support and 
maternal approval) 
OR, p-value 
Binge drinking: 3.29, <0.01 
Russell et al., 
2015 
USA cross-sectional study 
(household survey in 
general population) 











3 to 5 times per 
week;  
1 to 2 times per 
week;  
1 to 3 times per 
month;  
Less than once per 
month; 
Never (ref) 
ODD Structured diagnostic 






NA child age OR (95% CI) 
Total sample: 0.56 (0.3, 1.1) 
Boys: 0.56 (0.2, 1.5) 





cohort study  
(MoBa) 
220/34,283 both 5 years prospective self-
report (assessed 
during the 1st 
pregnancy 
trimester) 
continuous score of 
AUDIT scale 
ADHD Diagnosis of 
hyperkinetic disorder 
obtained from the 
National Patient 
Registry 
6, 18 months, 
3, 5, 7, 8 and 13 
years (ongoing 
study) 
parental education and income, 
maternal smoking during pregnancy, 
children’s birth order and children’s 
gender 
OR (95% CI) 
0.97 (0.93, 1.01) 
Knopik et al., 
2005 
USA Longitudinal twin 
study (the Missouri 
Adolescent Female 
Twin Study) 






1-10 days;  
11-35 days; 
>35 days 










over 2 years - 
13, 15, 17 and 
19 years 
zygosity, prenatal and parental 
predictors - low birth weight, maternal 
alcohol abuse/dependence, paternal 
alcohol dependence 
OR (95% CI) 
1-10 days: 1.11 (0.72, 1.71) 
11-35 days: 0.97 (0.26, 3.64) 
>35 days: 3.31 (0.83, 13.12) 
Some heavy alcohol use:  
2.20 (0.95, 5.09) 
Frequent heavy alcohol use: 




Caffeine                         
Del-Ponte et 
al., 2016 
Brazil population based 
longitudinal cohort 
study 
(Pelotas birth cohort 
study) 












<100 mg/day (ref); 
100-299 mg/day; 
>300 mg/day 
ADHD The Development 
and Well-Being 
Assessment Scale 
(DAWBA) reported by 
mothers and 
diagnosis by a child 
psychiatrist 
3, 12, 24 and 48 
months, 6 and 
11 years 
(ongoing study) 
National Economic Index mother’s and 
father’s education levels, evaluated as 
years of study; maternal age, mother 
living with or without partner; number 
of cigarettes smoked per day by the 
mother during pregnancy; number of 
cigarettes smoked per day by the 
father in the mother’s presence during 
pregnancy; alcohol consumption by 
the mother during pregnancy; number 
of antenatal care consultations; mood 
symptoms during pregnancy; maternal 
nutritional state before  pregnancy, 
evaluated according to the body mass 
index (BMI); the child gestational age 
at birth; birth weight and sex 
OR (95% CI) 
1st trimester 
total sample  
100-299 mg/day:  
1.04 (0.62, 1.73) 
>300 mg/day:  
0.93 (0.55, 1.60) 
Boys 
100-299 mg/day:  
1.06 (0.57, 1.98) 
>300 mg/day:  
1.06 (0.57, 1.96) 
Girls 
100-299 mg/day:  
1.13 (0.44, 2.90) 
>300 mg/day:  
0.68 (0.21, 2.17) 
2nd trimester 
total sample  
100-299 mg/day:  
1.03 (0.61, 1.74) 
>300 mg/day:  
0.95 (0.55, 1.63) 
Boys 
100-299 mg/day:  
1.03 (0.55, 1.94) 
>300 mg/day:  
1.09 (0.58, 2.03) 
Girls 
100-299 mg/day:  
1.24 (0.48, 3.22) 
>300 mg/day:  
0.75 (0.24, 2.38) 
3rd trimester 
total sample  
100-299 mg/day:  
0.96 (0.55, 1.68) 
>300 mg/day:  
1.05 (0.61, 1.81) 
Boys 
100-299 mg/day:  
0.82 (0.40, 1.68) 
>300 mg/day:  
1.07 (0.57, 2.02) 
Girls 
100-299 mg/day:  
1.68 (0.64, 4.40) 
>300 mg/day:  





total sample  
100-299 mg/day:  
1.12 (0.68, 1.84) 
>300 mg/day:  
0.90 (0.51, 1.59) 
Boys 
100-299 mg/day:  
1.05 (0.57, 1.92) 
>300 mg/day:  
1.01 (0.52, 1.95) 
Girls 
100-299 mg/day:  
1.46 (0.58, 3.68) 
>300 mg/day:  
0.82 (0.25, 2.65) 





(the Aarhus Birth 
Cohort) 
88/24,068 both 7 years prospective self-
report (assessed 
during the 2nd 
pregnancy 
trimester) 




ADHD Diagnosis was 
obtained from the 
Danish Psychiatric 
Case Register 
up to age 12 
years 
prenatal smoking and alcohol use, 
maternal age, gender of the child, 
parental years of schooling after basic 
school, employment status, 
cohabitant status and parental and 
siblings’ psychiatric hospitalisations or 
contacts in outpatient clinics 
OR (95% CI) 
1-3 cups: 0.9 (0.5, 1.6) 
4-9 cups: 1.3 (0.7, 2.3) 
10+ cups: 2.3 (0.9, 5.9) 
Russell et al., 
2015 
USA cross-sectional study 
(household survey in 
general population) 










None to less than 
one cup per day; 
One or more cups 
per day 
ODD Structured diagnostic 






NA child age OR (95% CI) 
Total sample: 0.86 (0.7, 1.0) 
Boys: 0.98 (0.8, 1.3) 
Girls: 0.75 (0.6, 1.0), p=<0.05* 
 
*coding unclear (authors are 
reporting increasing effect on 




Appendix 2.8. Study characteristics and results of case-control studies 







exposure Outcome Outcome assessment Follow up time Confounders 
Results (as reported in the 
study) 
Smoking 
            
Biederman 











Binary (Yes/No) ADHD 
CD 
Clinical interview (K-SADS-E and 
SCID) with mothers and offspring, 
diagnosis confirmed by a 
psychiatrist  
Assessments at 
baseline, 4 and 
10 years for 
boys and in 5 
years in girls. 
Age range at 
baseline 5 – 37 
years (mean 
13.4 years) 
maternal age at offspring 
birth, social class, offspring 
age at baseline, offspring 
gender, parental lifetime 
history of ADHD, parental 
lifetime history of CD, 
prenatal exposure to 
maternal alcohol or illicit 
drugs, study of origin (Boys 
ADHD, Girls ADHD), referral 
status, number of 
assessments (ADHD 
analyses were adjusted for 
CD and vice versa) 
OR (95% CI), p-value  
ADHD: 2.5 (1.39, 4.51), 0.002  
CD: 3.3 (1.23, 8.88)  
 
*the association with CD was 
only among siblings from 
control families. No 
association was observed 
among siblings of ADHD 
families 

















Diagnostic interview (DISC-IV) 
with mothers as well as maternal 
and self-report on ADHD 
symptom domains (diagnosis 
based on DSM-IV criteria) 
2 waves – 5 
(mean age 14 
years) and 10 
years (mean age 
20 years) 
SES, maternal education, 
income, maternal ADHD, 
participant ODD symptoms 
and substance use  
*cases and controls 
matched by age and 
ethnicity 
Beta, p-value  
Maternal report:  
HYP: 0.16, 0.03  
INA: 0.10  
Self-report:  















No smoking;  
<10 cigarettes/day; 
>10 cigarettes/day 
ADHD Diagnosis derived from the 
hospital database (the 
department of child and 
adolescent psychiatry in Malmo) 
from 5 up to 17 
years 
birth year, maternal age, 
birthplace, preterm birth, 
Apgar score, gestational 
age, child gender 
OR (95% CI), p-value  
















Smoking only 1st 
trimester;  








the Finnish Hospital Discharge 
Register (FHDR) 
not specified maternal and paternal 
psychiatric history, 
maternal history of any 
substance use, maternal 
and paternal age at birth of 
offspring, maternal and 
paternal immigrant status, 
maternal socioeconomic 
status (SES), birth weight 
for gestational age, Apgar 
scores at 1 min, number of 
previous births and 
gestational age  
*cases and controls 
matched by date of birth, 
sex and residence in Finland 
OR (95% CI)  
















Binary (Yes/No) Hyperkinetic 
disorder 
Diagnosis were obtained from the 
Danish Psychiatric Central 
Register 




socioeconomic factors, and 
maternal age  
*cases and control subjects 
were matched for age, 
gender, and calendar time 
Relative Risk (RR) (95% CI)  












Binary (Yes/No) ADHD Structured interviews with 
mothers and offspring’s using the 
childhood version of the Schedule 
for Affective Disorders and 
Schizophrenia for School-Age 
Children – Epidemiologic Version 
(K-SADS-E). Diagnosis were 
confirmed by the psychiatrist 
not specified socioeconomic status, 
parental ADHD status, and 
parental IQ  
*cases and controls 
matched by ethnicity, 
gender and age 
OR (SE), (95% CI), p-value  
















Binary (Yes/No) ADHD Structured interviews with 
mothers and offspring’s using the 
childhood version of the Schedule 
for Affective Disorders and 
Schizophrenia for School-Age 
Children – Epidemiologic Version 
(K-SADS-E). Diagnosis were 
confirmed by the psychiatrist 
not specified socioeconomic status, 
parental ADHD status, and 
parental IQ  
*cases and controls 
matched by ethnicity, 
gender and age 
OR (SE), (95% CI), p-value 4.4 
(2.8), (1.2, 15.5), 0.02  
Schmitz et 
al., 2006 











3 stage process: The first stage 
was a semi-structured interview 
(Schedule for Affective Disorders 
and Schizophrenia for School-Age 
Children, Epidemiological Version 
[K-SADS-E] administered to the 
parents. In stage 2, each diagnosis 
derived from the K-SADS-E was 
discussed in a clinical committee 
chaired by an experienced child 
and adolescent psychiatrist. For 
the third stage, a clinical 
evaluation of ADHD-I and 
comorbid conditions using DSM-
IV criteria was conducted by a 
child and adolescent psychiatrist 
who previously received the 
results of the K-SADS-E and 
conducted interviews with the 
parents and the child or 
adolescent.  
NA maternal age, SES, maternal 
ADHD, child ODD, alcohol 
use in pregnancy, birth 
weight  
*cases and controls 
matched by gender and age 
OR (95% CI), p-value  
No smoking (ref)  
1-9 cigarettes:  
1.09 (0.32, 3.66), 0.89 
 >10 cigarettes:  
3.44 (1.17, 10.06), 0.02 
















Binary (Yes/No) ADHD stimulant medication for ADHD 
identified through the Monitoring 
of Drugs of Dependence System 
(MODDS). Controls were selected 
from the Midwives Notification 
up to 25 years marital status, parity, 
pregnancy complications, 
onset of labour, 
complications of labour, 
type of delivery, child 
OR (95% CI)  
Boys: 1.86 (1.53, 2.27)  






System (MNS) and matched by 
birth year, gender and SES 
gestational age, birth 
weight *cases and controls 
matched by year of birth, 
gender and SES 
















Parents interview using the 
Missouri Assessment of Genetics 
Interview for Children (MAGIC) to 
obtain DSM-IV diagnoses and 
individual symptom information. 
NA child gender, negative 
expressed emotion in the 
family and DSM-IV 
diagnoses of oppositional 
defiant disorder (ODD) and 
conduct disorder (CD) 
OR (95% CI)  
ADHDcombined: 3.9 (1.2, 13.1)  
 
*the association was observed 
between prenatal smoking and 
child genotype at the 
rs1044396 C allele (CHRNA4 
gene) **Association was also 
observed between prenatal 
smoking and two genes 
(CHRNA4 and DAT1) - 













smokers (ref);  
Former smokers; 
Stopped smoking 
when aware of 
pregnancy; 
Continued smoking 
ADHD experienced psychiatrists or 
paediatricians diagnosed ADHD 
according to the diagnostic 
criteria of DSM-IV, with full 
consideration of both parents’ 
and teachers’ evaluations. 
NA children’s gender, family 
income, maternal drinking 
during pregnancy, 
pregnancy-induced 
hypertension, birth weight, 
and children’s iron intake, 
maternal tendency of 
ADHD, parental history of 
mental disorders and 
maternal mental stress 
during pregnancy  
*cases and controls 
matched by age 
OR (95% CI)  
Lifetime non-smokers (ref) 
Former smokers:  
0.8 (0.3, 2.5)  
Stopped smoking:  
1.3 (0.5, 3.6)  
Continued smoking:  
1.3 (0.5, 3.6) 
















Binary (Yes/No) ADHD All probands were included after 
completing clinical evaluations by 
a paediatrician or child 
psychiatrist prior to the study. 
The clinical diagnosis of the ADHD 
probands and siblings was 
verified with the Parental 
Account of Childhood Symptoms 
(PACS) by a trained interviewer  
NA Child age, gender, IQ, birth 
weight, oppositional and 
anxious-shy symptoms of a 
child, total maternal or 
paternal ADHD symptoms, 
maternal age and socio-
economic status 
OR (95% CI), p-value 
*association between 
maternal prenatal smoking 
and ADHD status  
3.29 (1.48, 7.30), 0.003  
This relationship was partly 
mediated by the performance 
on attentional control:  
OR=2.42, 95%CI 1.04, 5.61), 
p=<0.001  
*no effect was found between 
prenatal smoking and child 
genotype on attentional 
control in children with ADHD  
 
*paternal risk genes (DRD4, 
DAT1) mediated paternal 
smoking and effect on 























Binary (Yes/No) ADHD All probands were included after 
completing clinical evaluations by 
a paediatrician or child 
psychiatrist prior to the study. 
The clinical diagnosis of the ADHD 
probands and siblings was 
verified with the Parental 
Account of Childhood Symptoms 
(PACS) by a trained interviewer  
NA child gender, age and birth 
weight 
OR (95% CI), p-value 
*association between prenatal 
smoking and ADHD status:  
1.76 (1.09, 2.85), 0.021  
 
*no interaction effect was 
found between DRD4 gene and 
prenatal smoking  


















1st stage - screening interview 
2nd stage - diagnostic interview 
completed by parents (the 
Missouri Assessment of Genetics 
Interview for Children (MAGIC), a 
modified version of the 
Diagnostic Interview for Children 
and Adolescents) 
NA Child’s gender, negative 
home environment, ODD 
and CD diagnosis 
OR (95% CI)  
Any ADHD: 1.58 (1.03, 2.43) 
ADHD combined:  
1.91 (0.97, 3.76)  
ADHD inattention:  
1.52 (0.89, 2.58)  
 
*The odds for a diagnosis of 
DSM-IV ADHD was 1.8 times 
greater in twins whose 
genotype at the DAT3= VNTR 
contained the 440 allele and 
whose mother smoked during 
pregnancy than for twins who 
had neither risk factor. 
Similarly, the risk for a 
diagnosis of DSM-IV ADHD was 
significantly elevated in twins 
with prenatal smoke exposure 
and the DRD4 seven-repeat 
allele. There were no 
significant interactions for the 
DSM-IV ADHD phenotype 
between prenatal smoking and 
the DAT1 480 allele  














Binary (Yes/No) ADHD  diagnosed prior to the study by 
the clinician 
14 months Child sex, mother’s 
educational level, public 
assistance, single parent 
status, prenatal drinking, 
family history of ADHD and 
CD 
p-value  
*prenatal smoking predicted 
ADHD status ADHD with 
comorbid CD/ODD: 0.024 
ADHD without comorbidities: 
0.096  
 
*No moderating effect was 
found between prenatal smoke 
exposure and ADHD treatment 
outcome 
Biederman 








115 CD cases 
211 ODD 
cases" 





Binary (Yes/No) CD 
ODD 
The assessment had 3 stages: 
referral; telephone questionnaire 
with mother; diagnostic interview 
(DISC) 
10 years for 
boys and 11 
years for girls 
SES, child ADHD *cases and 
controls matched by gender 
and age 
OR (95% CI), p-value  
CD: 1.51 (0.66, 1.96), 0.13 




Ketzer et al., 
2012 





Binary (Yes/No) ADHD 
inattention 
subtype 
3 stage assessment: 1st stage – a 
semi-structured interview 
(Schedule for Affective Disorders 
and Schizophrenia for School-Age 
Children) modified to assess 
DSM-IV criteria and administered 
to the parents by trained research 
assistants 2nd stage - each 
diagnosis derived from the K-
SADS-E was discussed in a clinical 
committee chaired by an 
experienced child and adolescent 
psychiatrist 3rd stage - a clinical 
evaluation of ADHD-I and 
comorbid conditions were 
performed according to DSM-IV 
criteria by a child and adolescent 
psychiatrist who previously had 
access to K-SADS-E results. 
NA generalised anxiety 
disorder, ODD, 
agoraphobia, maternal 
ADHD. *Cases and controls 
were matched by age and 
gender 
OR (95% CI), SE, p-value  
1 (0.9, 1.1), 0.03, 0.2 











Binary (Yes/No) ADHD structured diagnostic interview 
(the Schedule for Affective 
Disorders and Schizophrenia for 
School-Age Children-
Epidemiologic version (K-SADS-E). 
All assessments were made by 
raters who were blind to the 
child’s diagnosis (ADHD or non-
ADHD control) and ascertainment 
site 
NA maternal age at child’s 
birth, indicators of social 
adversity (low social class, 
large family size, severe 
marital discord), parental 
history of ADHD, parental 
history of CD/ASPD, and 
comorbid CD in cases and 
controls *cases and 
controls matched by gender 
and age 
OR (95% CI), p-value  
2.1 (1.1, 4.1), 0.02 
Pineda et al., 
2007 










ADHD psychiatric Diagnostic Interview 
for Children and Adolescents—
parent revised Spanish version 
(DICA-PR). DSM-IV-ADHD-
symptoms questionnaire, 
Behavioural Assessment System 
for Children (BASC) - parent and 
teacher report. All psychiatric, 
medical, neurological, 
neuropsychological, and 
psychological records of the 
ADHD children were reviewed by 
neurologists and neuro- 
psychologists. Parents provided 
information about the current 
clinical condition of their children 
and filled out the ADHD 
retrospective structured risk 
factor survey. 
NA gender and school grades 
*cases and controls 
matched by age, SES and 
school level 
OR (95% CI), p-value  
High: 8.9 (1.0, 78.4), <0.05 
Motlagh et 
al., 2010 




ADHD Semi-structured interview using 
the Schedule for Affective 
NA gender, severe psychosocial 
stress and limited coping 
OR (95% CI), p-value  







Disorders and Schizophrenia for 
School-Age Children-Present and 
Lifetime Version (SADS-PLV) and a 
‘‘best estimate’’ consensus 
procedure in which expert 
clinicians considered all available 
clinical and diagnostic 
information 
abilities during pregnancy, 
more than one pregnancy 
complication, and antibiotic 
use *cases and controls 
matched by age and ZIP 
code 















Schedule for Affective Disorders 
and Schizophrenia-E for each 
child with a trained master’s level 
clinical interviewer. Clinical data 
were reviewed, and a best 
estimate diagnostic procedure 
was implemented by a board-
certified child psychiatrist and a 
licensed child clinical psychologist 
NA child sex, age, ethnicity, 
income, parental ADHD 
symptoms and externalizing 
disorder status, and 
maternal and paternal age 
at birth 
Beta(β), 95% CI, p-value  
Direct effect of prenatal 
tobacco exposure  
INA: 0.05 (-0.01, 0.11), 0.19 
HYP: 0.03 (-0.05, 0.11), 0.56 
CD: 0.02 (-0.08, 0.12), 0.76 
ODD: 0.04 (-0.06, 0.14), 0.19  
 
*Indirect effect of prenatal 
tobacco exposure via 
neuropsychological functioning  
INA: 0.08 (0.02, 0.14), 0.02 
specifically via memory span 
β=.03, (0.005, 0.06], p=. 039  
*indirect effects were observed 
also for CD  
β=.04, (0.005, 0.07], p=.060 
and ODD β=.04, (0.00, 0.07], 
p=.08  
Oerlemans 















Binary (Yes/No) ADHD Conners rating scale; Parental 
Account of Childhood Symptoms 
ADHD subversion and diagnostic 
interview 
NA Family size, parity, child 
gender 
OR (95% CI), p-value  
2.12 (1.52, 4.48), 0.005  
 
*single and multiple ADHD 
incidence stratification showed 
that prenatal smoking was a 
shared familial risk between 
affected and unaffected ADHD 
children 
Alcohol 
            
Ketzer et al., 
2012 





Binary (Yes/No) ADHD 
inattention 
subtype 
3 stage assessment: 1st stage – a 
semi-structured interview 
(Schedule for Affective Disorders 
and Schizophrenia for School-Age 
Children) modified to assess 
DSM-IV criteria and administered 
to the parents by trained research 
assistants 2nd stage - each 
diagnosis derived from the K-
SADS-E was discussed in a clinical 
committee chaired by an 
experienced child and adolescent 
psychiatrist 3rd stage - a clinical 
evaluation of ADHD-I and 
NA social phobia, ODD, 
maternal ADHD, IQ, 
tobacco use in pregnancy  
*cases and controls 
matched by age and 
gender" 
OR (95% CI), SE, p-value  




comorbid conditions were 
performed according to DSM-IV 
criteria by a child and adolescent 
psychiatrist who previously had 
access to K-SADS-E results. 











Binary (Yes/No) ADHD structured diagnostic interview 
(the Schedule for Affective 
Disorders and Schizophrenia for 
School-Age Children-
Epidemiologic version (K-SADS-E). 
All assessments were made by 
raters who were blind to the 
child’s diagnosis (ADHD or non-
ADHD control) and ascertainment 
site 
NA maternal age at child’s 
birth, indicators of social 
adversity (low social class, 
large family size, severe 
marital discord), parental 
history of ADHD, parental 
history of CD/ASPD, and 
comorbid CD in cases and 
controls 
OR (95% CI), p-value  
2.5 (1.1, 5.5), 0.03 
Pineda et al., 
2007 









during the first 2 
months 
ADHD psychiatric Diagnostic Interview 
for Children and Adolescents—
parent revised Spanish version 
(DICA-PR). DSM-IV-ADHD-
symptoms questionnaire, 
Behavioural Assessment System 
for Children (BASC) - parent and 
teacher report. All psychiatric, 
medical, neurological, 
neuropsychological, and 
psychological records of the 
ADHD children were reviewed by 
neurologists and neuro- 
psychologists. Parents provided 
information about the current 
clinical condition of their children 
and filled out the ADHD 
retrospective structured risk 
factor survey. 
NA gender and school grades  
*cases and controls 
matched by age, SES and 
school level. 
OR (95% CI), p-value  
High: 11.7 (1.5, 94.1), 0.02 
Kim et al., 
2009 





Binary (Yes/No) ADHD Psychiatric disorders were 
assessed, according to the 
Diagnostic and Statistical Manual 
of Mental Disorders 4th version 
(DSM-IV), with the Korean version 
of the DISC-IV and with parental 
interview 
NA age, gender, SES (by 
income) 
OR (95% CI)  
3.31 (1.59, 6.91) 
Caffeine 
            
Kim et al., 
2009 





Binary (Yes/No) ADHD Psychiatric disorders were 
assessed, according to the 
Diagnostic and Statistical Manual 
of Mental Disorders 4th version 
(DSM-IV), with the Korean version 
of the DISC-IV and with parental 
interview 
NA age, gender, SES (by 
income) 
OR (95% CI)  




Appendix 2.9. Confounders included in the cohort, longitudinal and cross-sectional 
studies 
Number of studies adjusted for this confounder  






Offspring gender  21 (75%) 7 (78%) 2 (67%) 
Offspring age  18 (64%) 6 (67%) 1 
Offspring ethnicity  9 (32%) 4 (44%) - 
Offspring comorbid externalising disorders  - - - 
Parity and/or number of siblings  9 (32%) 2 (22%) 
 
Maternal age at offspring birth  17 (61%) 3 (33%) 2 (67%) 
Parental socio-economic characteristics (social 
class, education, income, marital status)  
21 (75%) 7 (78%) 2 (67%) 
Parenting behaviour and/or home environment  5 (18%) 4 (44%) - 
Parental externalising disorder symptoms 
(ADHD, antisocial personality)  
3 (11%) - - 
Other parental psychopathology and substance 
use disorders  
13 (46%) 4 (44%) 1 1 
Maternal mental health during pregnancy  2 (7%) - 1 
Maternal other substance use during pregnancy  10 (36%) 4 (44%)  2 (67%) 
Household member substance use during 
pregnancy  
1 (4%) - - 
Perinatal factors (birth weight, gestational age, 
birth complications)  





Appendix 2.10. Confounders included in the case-control studies 
Number of studies adjusted for this confounder  






Offspring gender  21 (95%) 3 (75%) 1 
Offspring age  17 (77%) 3 (75%) 1 
Offspring ethnicity  5 (23%) - - 
Offspring comorbid externalising disorders  9 (41%) 2 (50%) 
 
Parity and/or number of siblings  3 (14%) - - 
Maternal age at offspring birth  8 (36%) 1 
 
Parental socio-economic characteristics (social 
class, education, income, marital status)  
15 (68%) 4 (100%) 1 
Parenting behaviour and/or home environment  2 (9%) - - 
Parental externalising disorder symptoms (ADHD, 
antisocial personality)  
11 (50%) 2 (50%) - 
Other parental psychopathology, and substance 
use disorders  
3 (14%) - - 
Maternal mental health during pregnancy  2 (9%) - - 
Maternal other substance use during pregnancy  5 (23%) 1 
 
Partner’s substance use during pregnancy  - - - 
Perinatal factors (birth weight, gestational age, 
birth and pregnancy complications)  




Appendix 3.1. Maternal and paternal daily smoking during the 1st pregnancy 




Appendix 3.2. Maternal and paternal alcohol consumption during the 1st 





Appendix 3.3. Maternal and paternal daily caffeine consumption during 






Appendix 3.4. Maternal and paternal daily smoking during the 1st pregnancy 




Appendix 3.5. Maternal and paternal alcohol consumption during the 1st 




Appendix 3.6. Maternal and paternal daily smoking during the 1st 




Appendix 3.7. Maternal and paternal alcohol consumption during the 1st 





Appendix 3.8. Maternal and paternal daily caffeine consumption during the 





Appendix 4.1. Associations between maternal and offspring lifetime smoking PRSs and smoking phenotypes in mothers and adolescence 
Phenotype Effect estimate Effect size* 95% CI P-value Sample size R2 
Mothers during pregnancy  
Tobacco smoked in 1st three months of pregnancy OR 1.24 1.159, 1.315 9.41x10-6 7,237 0.04 
Mother cut down tobacco consumption OR 1.17 1.097, 1.244 <0.001 7,269 0.02 
Mother stopped smoking during pregnancy OR 0.87 0.775, 0.979 0.024 1,863 0.01 
Mothers outside of pregnancy  
Mother has ever smoked OR 1.15 1.089, 1.209 <0.001 7,194 0.01 
Number of cigarettes mother smoked before pregnancy Beta 0.19 0.124, 0.264 5.27x10-8 3,426 0.05 
Number of cigarettes smoked last 2weeks Beta 0.76 0.191, 1.318 0.011 845  
Offspring: Adolescents  
Smoked age 14 years OR 1.12 1.033, 1.208 0.009 4,145 0.03 
Smoked more than 20 cigarettes age 14 OR 1.16 0.995, 1.342 0.057 1,058 0.01 
Age 1st smoked a cigarette (asked age 14) Beta -0.05 -0.096, -0.009 0.019 1,064 0.01 
Ever smoked a whole cigarette age 18 OR 1.13 1.035, 1.233 0.010 2,402 0.01 
Number of cigarettes smoked in lifetime age 18 Beta 0.08 -0.004, 0.171 0.061 1,144 0.002 
Note: *Reflects the average change in the outcome that is associated with a one standard deviation increase in the PRS. For binary outcomes, this will be the odds ratio (OR) 
(eg Mother’s odds of ever smoking are 1.2 times compared to not smoking), for continuous outcomes it represents the average unit change (eg 0.2 cigarettes smoked); 95% 




Appendix 4.2. Associations between maternal smoking initiation PRS and maternal outcomes during and outside of pregnancy 
  Regression analyses Permutation testing 
Phenotype Effect 
estimate 
Effect size 95% CI P-value 95% CI P-value Sample size 
Mothers during pregnancy 
Mental health  
Depression (18wks) OR 1.12 1.028, 1.211 0.013 0.001, 0.010 0.004 6,734 
Depression (32wks) OR 1.12 1.039, 1.216 0.007 <0.001, 0.006 0.001 6,751 
Anxiety OR 1.00 0.915, 1.091 0.991 0.979, 0.994 0.988 6,645 
Hypersensitivity to interpersonal rejection Beta -0.47 -0.846, -0.102 0.012 0.003, 0.016 0.008 7,167 
Feelings becoming a parent Beta -0.003 -0.025, 0.018 0.752 0.724, 0.778 0.752 7,165 
Substance use 
Caffeine 
Total caffeine (18wks) Beta 7.35 4.748, 9.957 3.25x10-8 <0.001, 0.004 <0.001 7,220 
Total caffeine (32wks) Beta 6.28 3.693, 8.872 2.02x10-6 <0.001, 0.004 <0.001 6,767 
Alcohol 
Binge drinking (18wks) Beta 0.04 0.024, 0.061 8.07x10-6 <0.001, 0.004 <0.001 7,171 
Binge drinking (32wks) Beta 0.03 0.014, 0.054 0.001 <0.001, 0.004 <0.001 5,324 
Weekly alcohol units (32wks) Beta 0.16 0.033, 0.286 0.013 0.003, 0.014 0.007 4,294 
Other substances 
Cannabis use in pregnancy OR 1.17 0.977, 1.389 0.082 0.046, 0.077 0.060 6,918 
Hard drug use in pregnancy OR 0.99 0.568, 1.726 0.971 0.947, 0.972 0.961 7,147 
Non-mental health 
Education Beta -0.10 -0.128, -0.071 1.01x10-11 <0.001, 0.004 <0.001 6,954 
Social class Beta 0.05 0.023, 0.078 3.19x10-4 <0.001, 0.004 <0.001 5,854 
Life events in pregnancy Beta 0.05 0.018, 0.074 0.001 <0.001, 0.004 <0.001 6,744 
Image perception in pregnancy Beta 0.15 0.045, 0.245 0.005 0.004, 0.017 0.009 6,699 
Image perception change Beta 0.08 -0.011, 0.166 0.087 0.079, 0.117 0.097 6,549 
Activity level compared with other pregnant 
women 
Beta 0.01 -0.008, 0.029 0.262 0.226, 0.281 0.253 6,611 




Vomiting in first three months of pregnancy OR 0.98 0.927, 1.034 0.418 0.367, 0.428 0.397 6,797 
Sleep problems (18wks)  Beta 0.02 0.001, 0.036 0.036 0.015, 0.036 0.005 6,742 
Sleep problems (32wks) Beta 0.03 0.009, 0.046  0.003 <0.001, 0.004 <0.001 6,743 
Mothers outside of pregnancy 
Mental health         
Depression symptoms OR 1.07 0.969, 1.182 0.161 0.117, 0.161 0.138 4,725 
Anxiety symptoms OR 1.03 0.934, 1.131 0.542 0.515, 0.577 0.546 4,740 
Bulimia OR 1.08 0.926, 1.261 0.295 0.319, 0.379 0.349 6,799 
Drug addiction OR 0.94 0.594, 1.480 0.764 0.748, 0.801 0.775 6,799 
Alcoholism OR 1.24 0.903, 1.711 0.163 0.118, 0.162 0.139 6,799 
Schizophrenia OR 0.84 0.386, 1.825 0.632 0.585, 0.646 0.616 6,799 
Anorexia nervosa OR 1.06 0.886, 1.272 0.484 0.429, 0.491 0.460 6,799 
Severe depression OR 1.18 1.064, 1.303 0.004 <0.001, 0.004 <0.001 6,799 
Other psychological problem OR 1.15 0.941, 1.396 0.157 0.103, 0.145 0.123 6,799 
Substance use         
Alcohol        
Alcohol drinking before pregnancy OR 1.13 1.017, 1.253 0.026 0.006, 0.020 0.011 7,199 
Binge drinking Beta 0.05 0.020, 0.080 0.001 <0.001, 0.004 <0.001 4,866 
Daily alcohol units at child age 4 Beta 0.02 0.003, 0.044 0.027 0.018, 0.039 0.027 5,680 
Daily alcohol units at child age 8 Beta -0.003 -0.033, 0.027 0.838 0.799, 0.847 0.824 2,707 
AUDIT score Beta 0.02 0.002, 0.045 0.036 0.034, 0.061 0.046 2,424 
Caffeine        
Total caffeine consumption Beta 8.57 4.948, 12.187 <0.001 <0.001, 0.004 <0.001 4,783 
Non-mental health        
Life events Beta 0.02 -0.012, 0.055 0.212 0.222, 0.277 0.249 4,219 
Sleep duration Beta -0.02 -0.049, 0.004 0.099 0.088, 0.127 0.106 1,867 
Impulsivity personality trait Beta 0.07 -0.034, 0.177 0.183 0.147, 0.195 0.170 4,847 
Monotony avoidance personality trait Beta 0.24 0.099, 0.386 0.001 <0.001, 0.006 0.001 4,794 
Anger personality trait Beta 0.34 0.207, 0.475 <0.001 <0.001, 0.004 <0.001 4,769 
Suspicion personality trait Beta 0.13 0.016, 0.234 0.024 0.012, 0.031 0.020 4,856 
Detachment personality trait Beta -0.06 -0.169, 0.053 0.304 0.293, 0.352 0.322 4,753 




Social class Beta 0.02 -0.024, 0.064 0.379 0.422, 0.484 0.453 2,906 
Education Beta -0.09 -0.124, -0.060 2.19 x 10-8 <0.001, 0.004 <0.001 4,919 
BMI before pregnancy Beta 0.21 0.117, 0.302 9.67 x 10-6 <0.001, 0.004 <0.001 6,398 
Image perception before pregnancy Beta 0.06 0.029, 0.082 3.26x10-5 <0.001, 0.004 <0.001 6,623 





Appendix 4.3. Associations between offspring smoking initiation PRS and offspring outcomes in adolescence 
  Regression analyses Permutation testing 
Phenotype Effect 
estimate 
Effect size 95% CI P-value 95% CI P-value Sample size 
Offspring: Adolescents 
Mental health  
Conduct disorder symptoms Beta 0.04 0.015, 0.066 0.002 <0.001, 0.006 0.001 3,834 
ADHD symptoms Beta 0.05 0.016, 0.085 0.004 0.001, 0.010 0.004 3,852 
Oppositional-defiant disorder symptoms Beta 0.04 0.011, 0.060 0.004 <0.001, 0.006 0.001 3,436 
Psychosis positive symptoms age 12 Beta 0.02 <0.001, 0.029 0.046 0.034, 0.061 0.046 4,974 
Psychosis negative symptoms age 16 Beta -0.02 -0.059, 0.015 0.251 0.230, 0.285 0.257 3,511 
Psychosis positive symptoms age 18 Beta 0.01 -0.004, 0.028 0.134 0.089, 0.129 0.134 3,403 
PTSD disorder Beta 0.01 -0.002, 0.028 0.085 0.042, 0.071 0.055 4,008 
Depression score age 17 (MFQ) Beta 0.01 -0.004, 0.020 0.178 0.164, 0.214 0.188 3,212 
Depression symptom score age 18 (CIS-R) Beta 0.02 -0.010, 0.041 0.236 0.210, 0.264 0.236 3,303 
Eating disorder age 16 Beta -0.002 -0.007, 0.002 0.281 0.247, 0.303 0.274 3,543 
Eating disorder age 13 Beta -0.001 -0.003, 0.001 0.395 0.452, 0.514 0.483 4,256 
Specific phobia symptoms Beta 0.01 -0.008, 0.028 0.298 0.269,0.326 0.297 3,293 
Emotional problems symptoms Beta -0.01 -0.032, 0.014 0.422 0.410, 0.472 0.441 4,073 
Self-harming behaviour OR 0.96 0.810, 1.135 0.596 0.562, 0.624 0.593 2,576 
Depression symptoms score age 14 (MFQ) Beta -0.002 -0.016, 0.013 0.821 0.808, 0.856 0.833 4,574 
Anxiety score Beta 0.002 -0.023, 0.027 0.848 0.830, 0.874 0.853 3,293 
Total behavioural difficulties score Beta 0.04 -0.001, 0.073 0.055 0.035, 0.062 0.047 4,055 
Substance use  
Cannabis use OR 1.23 1.127, 1.330 <0.001 <0.001, 0.004 <0.001 3,571 
AUDIT risk score age 18 Beta 0.04 0.018, 0.064 0.001 <0.001, 0.004 <0.001 3,008 
Binge drinking age 18 Beta 0.07 0.025, 0.114 0.002 0.001, 0.010 0.004 2,829 
AUDIT total score age 18 Beta 0.07 0.029, 0.109 6.58x10-4 <0.001, 0.004 <0.001 3,008 
Number of alcoholic drinks on a typical day Beta 0.07 0.022, 0.111 0.003 <0.001, 0.007 0.002 2,826 




Number of drinks to feel different after first 
five times drinking 
Beta 0.1 -0.016, 0.211 0.093 0.073, 0.109 0.090 299 
Binge drinking age 13 Beta 0.04 -0.065, 0.142 0.461 0.421, 0.483 0.452 464 
Frequency of having alcoholic drinks Beta 0.01 -0.024, 0.039 0.641 0.586, 0.647 0.617 3,626 
Number of times had whole drink age 13 Beta 0.01 -0.066, 0.079 0.860 0.838, 0.882 0.861 1,103 
Frequency of cannabis smoking Beta -0.02 -0.092, 0.060 0.676 0.625, 0.684 0.655 1,035 
Total caffeine age 13 Beta 0.01 -0.030, 0.046 0.680 0.639, 0.698 0.669 3,405 
Non-mental health 
BMI Beta 0.24 0.104, 0.373 0.001 <0.001, 0.004 <0.001 3,606 
IQ Beta -0.58 -1.006, -0.159 0.007 0.003, 0.016 0.008 3,720 
GCSE grades D-G OR 1.09 0.988, 1.193 0.083 0.040, 0.069 0.053 2,182 
GCSE grades A-C OR 0.82 0.651, 1.032 0.085 0.063, 0.097 0.079 2,360 
Extraversion personality trait Beta 0.36 0.155, 0.569 0.001 <0.001, 0.006 0.001 4,354 
Conscientiousness personality trait Beta -0.22 -0.403, -0.031 0.022 0.006, 0.021 0.012 4,162 
Emotional Stability personality trait Beta -0.07 -0.263, 0.117 0.449 0.436, 0.498 0.467 4,224 
Intellect personality trait Beta -0.05 -0.226, 0.119 0.545 0.491, 0.553 0.522 4,263 
Agreeableness personality trait Beta -0.04 -0.188, 0.113 0.628 0.610, 0.671 0.641 4,279 
Sleep maintenance Beta 0.03 <0.001, 0.051 0.051 0.039, 0.068 0.052 3,418 
Sleep initiation (time to fall asleep) Beta 0.01 -0.027, 0.043 0.641 0.616, 0.677 0.647 3,626 
Sleep duration (hours of sleep) Beta 0.02 -0.017, 0.047 0.360 0.304, 0.363 0.333 3,726 
Frequency of doing exercise Beta -0.004 -0.027, 0.020 0.762 0.736, 0.790 0.764 4,270 
Life events  Beta -0.01 -0.043, 0.031 0.756 0.762, 0.814 0.789 3,376 




Appendix 4.4. Associations between maternal caffeine PRS and maternal outcomes during and outside of pregnancy 
  Regression analyses Permutation testing 
Phenotype Effect 
estimate 
Effect size 95% CI P-value 95% CI P-value Sample size 
Mothers during pregnancy 
Mental health  
Depression symptoms (18 wks) OR 0.98 0.905, 1.067 0.647 0.616, 0.677 0.647 6,734 
Depression symptoms (32 wks) OR 0.99 0.920, 1.074 0.870 0.823, 0.869 0.847 6,751 
Anxiety symptoms OR 1.01 0.919, 1.099 0.910 0.891, 0.927 0.910 6,645 
Hypersensitivity to interpersonal rejection Beta -0.04 -0.412, 0.322 0.833 0.838, 0.882 0.861 7,167 
Feelings becoming a parent Beta 0.01 -0.015, 0.030 0.528 0.496, 0.558 0.527 7,165 
Substance use   
Tobacco 
Ever smoked in pregnancy OR 1.01 0.947, 1.070 0.813 0.783, 0.833 0.809 6,718 
Smoking first three months in pregnancy OR 1.03 0.966, 1.097 0.343 0.275, 0.333 0.303 7,237 
Caffeine 
Reduced caffeine consumption during pregnancy OR 1.05 1.001, 1.111 0.046 0.017, 0.038 0.026 7,269 
Reduced coffee consumption during pregnancy OR 1.06 1.008, 1.117 0.028 0.006, 0.021 0.012 7,269 
Stopped drinking cola during pregnancy OR 1.09 0.991, 1.208 0.072 0.034, 0.061 0.046 4,570 
Never drank coffee OR 1.06 0.988, 1.146 0.093 0.059, 0.092 0.074 6,782 
Never drank cola OR 1.00 0.946, 1.062 0.933 0.915, 0.947 0.932 6,744 
Stopped drinking coffee during pregnancy OR 1.04 0.981, 1.100 0.175 0.104, 0.146 0.124 5,809 
Never has been drinking caffeine OR 0.97 0.918, 1.018 0.179 0.126, 0.170 0.147 7,269 
Stopped drinking tea during pregnancy OR 1.04 0.973, 1.109 0.226 0.184, 0.236 0.209 6,082 
Reduced cola consumption during pregnancy OR 1.04 0.967, 1.116 0.272 0.244, 0.300 0.271 7,269 
Never drank tea OR 1.04 0.950, 1.141 0.353 0.269, 0.326 0.297 6,754 
Reduced tea consumption during pregnancy OR 1.03 0.970, 1.085 0.333 0.290, 0.349 0.319 7,269 
Consumed more caffeine during pregnancy OR 1.04 0.948, 1.137 0.384 0.333, 0.394 0.363 7,269 
No change in caffeine consumption during 
pregnancy 
OR 0.99 0.934, 1.041 0.580 0.532, 0.594 0.563 7,269 




Craved or had more coffee during pregnancy OR 0.98 0.824, 1.160 0.774 0.700, 0.756 0.729 6,782 
Craved or had more tea during pregnancy OR 1.01 0.927, 1.108 0.750 0.718, 0.773 0.746 6,754 
Alcohol 
Binge drinking (32wks) Beta -0.02 -0.04, -0.003 0.026 0.031, 0.057 0.043 5,324 
Binge drinking (18wks) Beta -0.01 -0.03, 0.306 0.268 0.249, 0.306 0.277 7,171 
Weekly alcohol units (32wks) Beta -0.06 -0.167, 0.056 0.329 0.314, 0.373 0.343 4,294 
Craved or had more alcohol during pregnancy OR 0.95 0.569, 1.584 0.828 0.826, 0.872 0.850 6,771 
Other substances 
Cannabis use in first three months during 
pregnancy 
OR 1.12 0.952, 1.328 0.151 0.134, 0.180 0.156 6,918 
Hard drugs during pregnancy OR 1.00 0.664, 1.491 0.980 0.968, 0.987 0.979 7,147 
Non-mental health 
Life events during pregnancy Beta 0.001 -0.028, 0.023 0.944 0.154, 0.202 0.177 6,930 
Activity level compared with other pregnant 
women 
Beta 0.01 -0.007, 0.029 0.234 0.227, 0.282 0.254 6,611 
Image perception during pregnancy Beta -0.03 -0.029, 0.023 0.540 0.517, 0.579 0.548 6,699 
Physical activity Beta -0.003 -0.021, 0.016 0.780 0.754, 0.806 0.781 6,767 
Social class Beta 0.03 0.001, 0.054 0.043 0.035, 0.062 0.047 6,954 
Image perception change Beta 0.02 -0.070, 0.108 0.678 0.394, 0.456 0.425 3,741 
Education Beta -0.01 -0.034, 0.023 0.709 0.658, 0.717 0.688 6,954 
Vomiting in first three months during pregnancy OR 1.00 0.950, 1.059 0.903 0.871, 0.911 0.892 6,797 
Sleeping problems (18 wks) Beta 0.002 -0.015, 0.019 0.825 0.797, 0.845 0.822 6,742 
Sleeping problems (32 wks) Beta -0.003 -0.022, 0.015 0.733 0.726, 0.780 0.754 6,743 
Mothers outside of pregnancy  
Mental health         
Depression symptoms OR 1.04 0.943, 1.148 0.398 0.507, 0.569 0.538 4,725 
Anxiety symptoms OR 0.98 0.890, 1.077 0.641 0.340, 0.401 0.370 4,740 
Bulimia OR 1.11 0.932, 1.309 0.225 0.180, 0.231 0.205 6,799 
Drug addiction OR 0.99 0.657, 1.481 0.943 0.941, 0.968 0.956 6,799 
Alcoholism OR 0.95 0.697, 1.287 0.706 0.697, 0.753 0.726 6,799 
Schizophrenia OR 0.43 0.244, 0.772 0.008 0.021, 0.044 0.031 6,799 




Severe depression OR 1.05 0.953, 1.166 0.277 0.218, 0.272 0.244 6,799 
Other psychiatric problem OR 1.05 0.867, 1.266 0.601 0.529, 0.591 0.560 6,799 
Substance use         
Tobacco        
Ever smoking OR 1.01 0.959, 1.064 0.679 0.626. 0.685 0.656 7,194 
Number of cigarettes smoked past 2 weeks Beta 0.30 -0.271, 0.879 0.300 0.270, 0.327 0.298 845 
Number of cigarettes smoked before pregnancy Beta 0.04 -0.028, 0.111 0.245 0.224, 0.279 0.251 3,426 
Alcohol        
Alcohol drinking before pregnancy OR 0.97 0.876, 1.078 0.558 0.016, 0.514 0.545 7,199 
Binge drinking Beta 0.004 -0.024, 0.032 0.786 0.752, 0.804 0.779 4,867 
Daily alcohol units at child age 4 Beta 0.01 -0.013, 0.027 0.518 0.467, 0.529 0.498 5,680 
Daily alcohol units at child age 8 Beta 0.01 -0.016, 0.044 0.347 0.354, 0.415 0.384 2,707 
AUDIT score Beta 0.01 -0.013, 0.028 0.473 0.450, 0.512 0.481 2,424 
Non-mental health        
Life events Beta -0.03 -0.059, 0.008 0.141 0.115, 0.159 0.136 4,219 
Sleep duration Beta -0.01 -0.034, 0.019 0.588 0.535, 0.597 0.588 1,867 
Impulsivity personality trait Beta 0.04 -0.063, 0.146 0.436 0.397, 0.459 0.428 4,847 
Monotony avoidance personality trait Beta -0.11 -0.251, 0.037 0.144 0.131, 0.177 0.153 4,794 
Anger personality trait Beta 0.01 -0.115, 0.144 0.830 0.784, 0.834 0.810 4,769 
Suspicion personality trait Beta -0.02 -0.128, 0.095 0.772 0.718, 0.773 0.746 4,856 
Detachment personality trait Beta 0.01 -0.102, 0.125 0.841 0.815, 0.861 0.839 4,753 
Physical activity OR 0.97 0.890, 1.050 0.387 0.015, 0.340 0.370 2,787 
Social class Beta -0.01 -0.053, 0.035 0.696 0.680, 0.737 0.709 2,906 
Education Beta 0.002 -0.030, 0.035 0.889 0.882, 0.920 0.902 4,919 
BMI before pregnancy Beta 0.08 -0.008, 0.174 0.075 0.058, 0.091 0.073 6,398 
Image perception before pregnancy Beta -0.003 -0.029, 0.023 0.820 0.796, 0.844 0.821 6,623 





Appendix 4.5. Associations between offspring caffeine PRS and offspring outcomes in adolescence 
  Regression analyses Permutation testing 
Phenotype Effect 
estimate 
Effect size 95% CI P-value 95% CI P-value Sample size 
Offspring: Adolescence 
Mental health  
Conduct disorder symptoms Beta 0.01 -0.014, 0.039 0.362 0.332, 0.393 0.362 3,834 
Depression symptoms score age 18 Beta 0.01 -0.013, 0.039 0.314 0.288, 0.347 0.317 3,303 
Specific phobia symptoms Beta 0.001 -0.019, 0.020 0.937 0.935, 0.963 0.950 3,293 
Emotional problems score Beta -0.02 -0.047, 0.002 0.072 0.063, 0.097 0.079 3,593 
Anxiety symptoms Beta 0.001 -0.024, 0.026 0.913 0.899, 0.934 0.918 3,293 
Eating disorder age 13 Beta -0.001 -0.003, 0.001 0.289 0.346, 0.407 0.376 4,256 
Eating disorder age 16 Beta 0.003 -0.001, 0.007 0.184 0.166, 0.216 0.190 3,543 
ADHD symptoms Beta -0.03 -0.065, 0.010 0.146 0.142, 0.188 0.164 3,435 
Depression score age 14 (MFQ) Beta -0.002 -0.016, 0.013 0.835 0.817, 0.863 0.841 4,574 
Depression score age 17 (MFQ) Beta -0.003 -0.015, 0.010 0.685 0.647, 0.706 0.677 3,212 
Psychosis negative symptoms age 16 Beta <0.001 -0.037, 0.036 0.996 0.993, 1.000 0.998 3,511 
Total behavioural difficulties Beta -0.02 -0.056, 0.022 0.397 0.364, 0.425 0.394 3,603 
Psychosis positive symptoms age 12 Beta 0.01 -0.006, 0.024 0.230 0.198, 0.250 0.223 4,974 
Psychosis positive symptoms age 18 Beta 0.01 -0.006, 0.027 0.200 0.097, 0.137 0.116 3,403 
PTSD disorder symptoms Beta -0.01 -0.027, 0.002 0.091 0.052, 0.084 0.067 4,008 
Self-harming behaviour OR 0.99 0.811, 1.196 0.869 0.836, 0.880 0.859 2,576 
Oppositional-defiant disorder symptoms age 15 Beta -0.01 -0.036, 0.013 0.367 0.561, 0.623 0.592 3,436 
Substance use  
Tobacco  
Age when first smoked a cigarette Beta -0.01 -0.056, 0.030 0.553 0.535, 0.597 0.566 1,064 
Has smoked a cigarette OR 1.05 0.927, 1.179 0.443 0.384, 0.446 0.415 2,089 
Total number of cigarettes smoked age 14 OR 0.99 0.767, 1.277 0.931 0.900, 0.935 0.919 461 
Total number of cigarettes smoked age 18 Beta 0.07 -0.023, 0.162 0.142 0.114, 0.158 0.135 1,144 
Alcohol        




Binge drinking age 13 Beta 0.01 -0.094, 0.113 0.854 0.834, 0.878 0.857 464 
Number of times had whole drink age 13 Beta 0.01 -0.059, 0.083 0.748 0.700, 0.756 0.729 1,103 
Number of alcoholic drinks on a typical day Beta -0.01 -0.058, 0.034 0.609 0.580, 0.641 0.611 2,826 
Binge drinking age 18 Beta 0.01 -0.036, 0.056 0.670 0.632, 0.691 0.662 2,829 
Frequency having alcoholic drinks Beta 0.01 -0.020, 0.042 0.485 0.462, 0.524 0.493 2,886 
AUDIT risk score age 18 Beta -0.01 -0.030, 0.017 0.562 0.539, 0.601 0.570 3,008 
AUDIT total score age 18 Beta 0.01 -0.031, 0.050 0.647 0.986, 0.997 0.993 3,008 
Number of drinks needed to feel tipsy Beta -0.02 -0.059, 0.029 0.500 0.461, 0.523 0.492 2,391 
Other substances        
Cannabis use OR 0.98 0.900, 1.060 0.551 0.494, 0.556 0.525 3,571 
Frequency of cannabis use Beta 0.02 -0.057, 0.093 0.636 0.613, 0.674 0.644 1,035 
Non-mental health 
BMI Beta 0.03 -0.100, 0.161 0.645 0.612, 0.673 0.643 3,606 
Agreeableness personality trait Beta 0.07 -0.080, 0.211 0.376 0.368, 0.430 0.399 4,279 
Conscientiousness personality trait Beta -0.04 -0.218, 0.130 0.617 0.600, 0.661 0.631 4,162 
Intellect personality trait Beta 0.10 -0.069, 0.269 0.245 0.223, 0.278 0.250 4,263 
Emotional stability personality trait Beta -0.07 -0.263, 0.130 0.506 0.472, 0.534 0.503 4,224 
Extraversion personality trait Beta -0.04 -0.243, 0.159 0.682 0.657, 0.716 0.687 4,354 
Frequency of doing exercise Beta -0.01 -0.032, 0.014 0.450 0.443, 0.505 0.474 4,270 
Sleep duration (hours of sleep) Beta -0.02 -0.047, 0.014 0.294 0.260, 0.317 0.288 3,726 
GCSE grades A-C OR 1.47 1.146, 1.877 0.005 0.000, 0.004 <0.001 2,360 
GCSE grades D-G OR 1.01 0.914, 1.109 0.876 0.846, 0.889 0.869 2,182 
IQ Beta 0.14 -0.293, 0.569 0.531 0.497, 0.559 0.528 3,720 
Sleep initiation Beta 0.02 -0.019, 0.050 0.385 0.353, 0.414 0.383 3,626 
Sleep maintenance Beta -0.003 -0.028, 0.022 0.804 0.813, 0.859 0.837 3,418 
Life events Beta -0.01 -0.045, 0.031 0.733 0.690, 0.747 0.719 3,376 




Appendix 4.6. Associations between maternal and offspring lifetime smoking PRSs and offspring phenotypes in childhood 
Note: OR - odds ratio; 95% CI – 95% confidence intervals 
 Maternal lifetime smoking PRS analyses Offspring lifetime smoking PRS analyses 









95% CI P-value 95% CI P-value Sample 
size 
IQ Beta -0.74 -1.202, -0.282 0.002 <0.001, 0.007 0.002 4,675 -0.93 -1.371, -0.488 3.73x10-5 <0.001, 0.004 <0.001 5,290 
Conduct disorder Beta 0.03 0.007, 0.045 0.009 0.003, 0.014 0.007 5,012 0.03 0.010, 0.048 0.003 0.001, 0.009 0.003 5,326 
BMI Beta 0.06 0.007, 0.119 0.029 0.020, 0.043 0.030 5,032 0.03 -0.025, 0.076 0.316 0.282, 0.341 0.311 5,799 
Total caffeine Beta 0.02 -0.003, 0.045 0.079 0.063, 0.097 0.079 4,067 0.02 -0.007, 0.038 0.187 0.170, 0.220 0.194 4,589 
Sleep initiation OR 0.95 0.892, 1.012 0.104 0.064, 0.099 0.080 5,150 0.97 0.911, 1.029 0.273 0.203, 0.256 0.229 5,476 
Behavioural difficulties Beta 0.03 -0.005, 0.056 0.107 0.089, 0.129 0.108 5,133 0.05 0.016, 0.075 0.003 <0.001, 0.007 0.002 5,452 
ADHD Beta 0.02 -0.006, 0.052 0.117 0.098, 0.139 0.117 4,916 0.04 0.009, 0.065 0.009 0.006, 0.020 0.011 5,219 
Specific phobia OR 1.22 0.916, 1.631 0.156 0.179, 0.230 0.204 5,100 0.82 0.628, 1.083 0.150 0.169, 0.219 0.193 5,470 
Anxiety Beta -0.01 -0.033, 0.009 0.256 0.229, 0.284 0.256 4,993 -0.01 -0.034, 0.007 0.189 0.150, 0.198 0.173 5,355 
Sleep duration Beta -0.01 -0.036, 0.010 0.259 0.243, 0.299 0.270 5,127 0.002 -0.021, 0.024 0.878 0.851, 0.893 0.873 5,443 
Sleep maintenance OR 1.02 0.952, 1.090 0.559 0.503, 0.565 0.534 5,127 0.98 0.924, 1.048 0.594 0.556, 0.618 0.587 5,448 
Autism OR 1.10 0.768, 1.589 0.563 0.512, 0.574 0.543 5,975 1.26 0.838, 1.891 0.243 0.163, 0.213 0.187 6,156 
ODD Beta 0.01 -0.014, 0.026 0.574 0.557, 0.619 0.588 4,943 0.03 0.012, 0.051 0.002 <0.001, 0.004 <0.001 5,319 
Emotional problems Beta -0.01 -0.025, 0.016 0.656 0.630, 0.689 0.660 5,139 -0.01 -0.031, 0.008 0.248 0.210, 0.264 0.236 5,459 
Depression Beta -0.003 -0.023, 0.018 0.809 0.783, 0.833 0.809 4,885 0.01 -0.010, 0.030 0.323 0.300, 0.359 0.329 5,434 
Handedness OR 1.01 0.914, 1.114 0.846 0.790, 0.839 0.815 4,849 1.01 0.924, 1.096 0.876 0.866, 0.906 0.887 5,399 




Appendix 4.7. Associations between maternal lifetime smoking PRS and maternal outcomes during and outside of pregnancy 
  Regression analyses Permutation testing 
Phenotype Effect 
estimate 
Effect size 95% CI P-value 95% CI P-value Sample size 
Mothers during pregnancy 
Mental health  
Depression (18wks) OR 1.08 0.997, 1.163 0.060 0.034, 0.061 0.046 6,734 
Depression (32wks) OR 1.08 0.999, 1.164 0.053 0.015, 0.036 0.024 6,751 
Anxiety (18 wks) OR 1.06 0.980, 1.155 0.127 0.087, 0.126 0.105 6,645 
Hypersensitivity to interpersonal rejection Beta -0.30 -0.657, 0.065 0.108 0.097, 0.137 0.116 7,167 
Feelings becoming a parent Beta -0.01 -0.034, 0.009 0.266 0.236, 0.291 0.263 7,165 
Substance use  
Caffeine 
Total caffeine (18wks) Beta 6.76 4.239, 9.280 <0.001 <0.001, 0.004 <0.001 7,220 
Total caffeine (32wks) Beta 5.33 2.776, 7.874 <0.001 <0.001, 0.004 <0.001 6,767 
Alcohol 
Binge drinking (18wks) Beta 0.02 0.005, 0.042 0.012 0.003, 0.016 0.008 7,171 
Binge drinking (32wks) Beta 0.02 0.001, 0.039 0.044 0.049, 0.080 0.063 5,324 
Weekly alcohol units (32wks) Beta 0.13 0.034, 0.233 0.009 0.008, 0.025 0.015 4,294 
Other substances 
Cannabis use during pregnancy OR 1.11 0.942, 1.299 0.197 0.175, 0.225 0.199 6,918 
Hard drugs  OR 1.05 0.670, 1.653 0.809 0.779, 0.829 0.805 7,147 
Non-mental health 
Education Beta -0.09 -0.122, -0.065 <0.001 <0.001, 0.004 <0.001 6,954 
Social class Beta 0.06 0.037, 0.091 <0.001 <0.001, 0.004 <0.001 5,854 
Life events during pregnancy Beta 0.02 -0.010, 0.045 0.214 0.196, 0.248 0.221 6,744 
Image perception during pregnancy Beta 0.12 0.023, 0.219 0.016 0.011, 0.028 0.018 6,699 
Image perception change Beta 0.004 -0.087, 0.095 0.931 0.906, 0.940 0.924 6,549 
Activity level compared with other pregnant 
women 
Beta -0.001 -0.019, 0.017 0.911 0.892, 0.928 0.911 6,611 




Vomited first three months in pregnancy OR 0.98 0.928, 1.033 0.412 0.373, 0.435 0.404 6,797 
Sleep (18 wks) Beta 0.01 -0.003, 0.032 0.108 0.089, 0.129 0.108 6,742 
Sleep (32 wks) Beta 0.03 0.016, 0.052 <0.001 <0.001, 0.004 <0.001 6,743 
Mothers outside of pregnancy 
Mental health         
Depression symptoms OR 1.01 0.913, 1.109 0.886 0.876, 0.915 0.897 4,725 
Anxiety symptoms OR 1.01 0.915, 1.105 0.904 0.880, 0.918 0.900 4,740 
Bulimia OR 1.14 0.964, 1.349 0.114 0.083, 0.121 0.101 6,799 
Drug addiction OR 0.98 0.596, 1.620 0.941 0.912, 0.945 0.930 6,799 
Alcoholism OR 1.27 0.968, 1.667 0.079 0.101, 0.143 0.121 6,799 
Schizophrenia OR 1.59 0.870, 2.889 0.120 0.197, 0.249 0.222 6,799 
Anorexia Nervosa OR 1.15 0.932, 1.419 0.174 0.096, 0.136 0.115 6,799 
Severe depression OR 1.16 1.049, 1.280 0.007 0.001, 0.010 0.004 6,799 
Other psychiatric problem OR 1.16 0.949, 1.408 0.134 0.079, 0.117 0.097 6,799 
Substance use        
Alcohol        
Alcohol drinking before pregnancy OR 1.01 0.910, 1.122 0.833 0.816, 0.862 0.840 7,199 
Binge drinking Beta 0.04 0.009, 0.068 0.010 <0.001, 0.004 <0.001 4,867 
Daily alcohol units at child age 4 Beta 0.03 0.007, 0.049 0.008 0.006, 0.020 0.011 5,680 
Daily alcohol units at child age 8 Beta -0.01 -0.039, 0.021 0.559 0.564, 0.626 0.595 2,707 
AUDIT score Beta 0.01 -0.007, 0.035 0.181 0.174, 0.224 0.198 2,424 
Caffeine        
Total caffeine consumption Beta 8.70 5.083, 12.313 2.46 x 10-6 <0.001, 0.004 <0.001 4,783 
Non-mental health        
Life events Beta 0.03 -0.009, 0.060 0.142 0.117, 0.161 0.138 4,219 
Sleep duration Beta -0.02 -0.046, 0.009 0.183 0.163, 0.213 0.187 1,867 
Impulsivity personality trait Beta 0.11 0.006, 0.217  0.039 0.033, 0.060 0.045 4,847 
Monotony avoidance personality trait Beta 0.18 0.037, 0.332 0.014 0.008, 0.025 0.015 4,794 
Anger personality trait Beta 0.25 0.115, 0.377 2.34x10-4 <0.001, 0.004 <0.001 4,769 
Suspicion personality trait Beta 0.16 0.057, 0.272 0.003 0.003, 0.016 0.008 4,856 
Detachment personality trait Beta -0.06 -0.175, 0.054 0.301 0.258, 0.315 0.286 4,753 




Social class Beta 0.03 -0.015, 0.072 0.204 0.185, 0.237 0.210 2,906 
Education Beta -0.08 -0.115, -0.051 4.33 x 10-7 <0.001, 0.004 <0.001 4,919 
BMI before pregnancy Beta 0.16 0.065, 0.254 0.001 0.001, 0.010 0.004 6,398 
Image perception before pregnancy Beta 0.03 0.002, 0.054 0.037 0.029, 0.054 0.040 6,623 





Appendix 4.8. Associations between offspring lifetime smoking PRS and offspring outcomes in adolescence 
  Regression analyses Permutation testing 
Phenotype Effect 
estimate 
Effect size 95% CI P-value 95% CI P-value Sample size 
Offspring: Adolescence  
Mental health 
Conduct disorder symptoms Beta 0.06 0.031, 0.082 <0.001 <0.001, 0.004 <0.001 3,834 
Psychosis positive symptoms age 12 Beta 0.02 0.010, 0.018 0.001 <0.001, 0.004 <0.001 4,974 
Depression symptoms age 17 (MFQ) Beta 0.02 0.007, 0.036 0.002 <0.001, 0.006 0.001 3,212 
Total behavioural difficulties  Beta 0.06 0.019, 0.091 0.003 0.001, 0.009 0.003 4,055 
Psychosis positive symptoms age 18 Beta 0.02 0.004, 0.018 0.014 0.004, 0.017 0.009 3,403 
ADHD symptoms Beta 0.03 -0.003, 0.030 0.075 0.078, 0.116 0.096 3,852 
Eating disorder age 16 Beta 0.003 -0.001, 0.041 0.146 0.138, 0.184 0.160 3,543 
Depression symptoms score age 17 Beta 0.02 -0.010, 0.039 0.228 0.218, 0.272 0.244 3,303 
Specific phobia symptoms Beta 0.01 -0.009, 0.031 0.301 0.261, 0.318 0.289 3,293 
PTSD symptoms Beta 0.01 -0.007, 0.027 0.360 0.340, 0.401 0.370 4,008 
Oppositional defiant disorder Beta 0.01 -0.013, 0.169 0.374 0.342, 0.403 0.372 3,436 
Anxiety symptoms score Beta 0.01 -0.015, 0.066 0.387 0.345, 0.406 0.375 3,293 
Eating disorder age 13 Beta 0.001 -0.001, 0.007 0.475 0.454, 0.516 0.485 4,256 
Depression symptoms age 14 (MFQ) Beta 0.004 -0.010, 0.019 0.573 0.568, 0.630 0.599 4,574 
Emotional problems symptoms Beta 0.004 -0.018, 0.036 0.700 0.655, 0.714 0.685 4,073 
Psychosis negative symptoms age 16 Beta 0.002 -0.034, 0.038 0.922 0.892, 0.928 0.911 3,511 
Self-harming behaviour OR  0.99 0.834, 1.185 0.944 0.927, 0.957 0.943 2,576 
Substance use  
Alcohol 
Number of drinks needed to feel different Beta 0.10 -0.020, 0.218 0.103 0.101, 0.143 0.121 299 
Binge drinking age 13 Beta 0.09 -0.017, 0.197 0.099 0.073, 0.109 0.090 464 
Number of times had a whole drink past 6 
months 
Beta -0.01 -0.076, 0.062 0.840 0.825, 0.871 0.849 1,103 
Number of alcoholic drinks on a typical day Beta 0.04 -0.005, 0.082 0.083 0.058, 0.091 0.073 2,826 




Frequency of having alcoholic drinks Beta -0.002 -0.032, 0.027 0.876 0.833, 0.877 0.856 2,886 
AUDIT risk score age 18 Beta 0.04 0.014, 0.061 0.002 <0.001, 0.006 0.001 3,008 
AUDIT total score age 18 Beta 0.04 -0.004, 0.075 0.082 0.088, 0.127 0.106 3,008 
Number of drinks needed to feel tipsy Beta 0.05 0.004, 0.089 0.032 0.030, 0.055 0.041 2,391 
Tobacco  
Cannabis use OR 1.07 0.990, 1.164 0.082 0.040, 0.069 0.053 3,571 
Frequency of cannabis use Beta 0.04 -0.031, 0.115 0.261 0.248, 0.305 0.276 1,035 
Caffeine 
Total caffeine consumption Beta 0.02 -0.019, 0.055 0.348 0.342, 0.403 0.372 3,405 
Non-mental health  
Extraversion personality trait Beta 0.45 0.244, 0.646 <0.001 <0.001, 0.004 <0.001 4,354 
Conscientiousness personality trait Beta -0.19 -0.367, -0.008 0.041 0.030, 0.056 0.042 4,162 
Agreeableness personality trait Beta 0.01 -0.132, 0.151 0.893 0.896, 0.932 0.915 4,279 
Intellect personality trait Beta -0.01 -0.174, 0.156 0.918 0.900, 0.935 0.919 4,263 
Emotional stability personality trait Beta -0.07 -0.253, 0.124 0.501 0.489, 0.551 0.520 4,224 
IQ Beta -0.74 -1.163, -0.320 0.001 <0.001, 0.004 <0.001 3,720 
BMI Beta 0.21 0.078, 0.331 0.001 0.001, 0.010 0.004 3,606 
Sleep maintenance Beta 0.03 0.008, 0.059 0.011 0.005, 0.018 0.010 3,418 
GCSE grades D-G OR 1.11 1.008, 1.213 0.036 0.011, 0.028 0.018 2,182 
Frequency of doing exercise Beta -0.03 -0.048, -0.001 0.039 0.032, 0.059 0.044 4,270 
Sleep duration (hours of sleep) Beta -0.03 -0.055, 0.005 0.097 0.088, 0.127 0.106 3,726 
Sleep initiation (time to fall asleep) Beta 0.03 -0.009, 0.060 0.150 0.127, 0.173 0.149 3,626 
GCSE grades A-C OR 0.84 0.652, 1.082 0.160 0.101, 0.142 0.120 2,360 
Life events Beta 0.01 -0.026, 0.047 0.570 0.583, 0.644 0.614 3,376 









Caffeine PRS Alcohol PRS 
Smoking 
initiation PRS 
- 0.35 0.01 0.08 
 Lifetime 
smoking PRS 
- -0.01 0.02 
  Caffeine PRS - 0.12 




Appendix 5.1. Associations between maternal prenatal smoking and high risk of maternal reported offspring ADHD symptoms in MoBa (adjusted for 
maternal ADHD) 
   Unadjusted model   Adjusted model*   Mutually adjusted model** 
 N n OR 95% CI P-value N n OR 95% CI P-value N n OR 95% CI P-value 
ADHD (RS-DBD) 41,515 5,509   <0.001 28,507 3,655   <0.001 23,491 2,954   0.026 
No cigarettes (ref) 39,162 4,993 - -  27,093 3,360 - -  22,430 2,748 - -  
1-4 cigarettes 1260 234 1.56 1.350,1.805  764 138 1.19 0.969,1.450  572 94 1.04 0.813,1.318  
5-9 cigarettes 650 158 2.20 1.830,2.640  371 91 1.64 1.266,2.121  285 64 1.46 1.071,1.994  
>10 cigarettes 443 124 2.66 2.159,3.277  279 66 1.32 0.961,1.799  204 48 1.28 0.875,1.861  
Hyperactive 41,508 5,436   <0.001 28,504 3,600   <0.001 23,489 2,933   0.010 
No cigarettes (ref) 39,158 4,916 - -  27,092 3,308 - -  22,429 2,719 - -  
1-4 cigarettes 1,259 239 1.63 1.414,1.883  763 136 1.19 0.974,1.448  572 99 1.10 0.873,1.394  
5-9 cigarettes 649 159 2.26 1.884,2.712  371 90 1.63 1.263,2.094  285 64 1.43 1.055,1.939  
>10 cigarettes 442 122 2.66 2.152,3.278  278 66 1.34 0.982,1.836  203 51 1.36 0.938,1.970  
Inattentive 41,524 4,824   <0.001 28,512 3,186   0.030 23,494 2,571   0.195 
No cigarettes (ref) 39,170 4,402 - -  27,098 2,940 - -  22,433 2,398 - -  
1-4 cigarettes 1,261 198 1.47 1.259,1.719  764 119 1.14 0.924,1.416  572 81 1.00 0.776,1.299  
5-9 cigarettes 650 131 1.99 1.640,2.423  371 80 1.61 1.234,2.112  285 55 1.41 1.015,1.947  
>10 cigarettes 443 93 2.10 1.663,2.648  279 47 1.00 0.698,1.427  204 37 1.08 0.711,1.631  
Note: RS-DBD – Rating Scale for Disruptive Behavior Disorders; N – sample size; n – number of cases; OR – odds ratio; 95% CI – 95% confidence intervals;*adjusted for child’s 
gender, birth year, parity, maternal age, education, marital status, financial difficulties, depression, anxiety and ADHD symptoms, prenatal alcohol and caffeine 





Appendix 5.2. Associations between maternal smoking before pregnancy and high risk of maternal reported offspring ADHD symptoms in MoBa 
   Unadjusted model   Adjusted model*   Mutually adjusted model** 
 N n OR 95% CI P-value N n OR 95% CI P-value N n OR 95% CI P-value 
ADHD (RS-DBD) 41,263 5,471   <0.001 36,636 4,750   <0.001 30,013 3,807   0.051 
No cigarettes (ref) 31,691 3,880 - -  28,375 3,417 - -  23,448 2,788 - -  
1-4 cigarettes 4,364 574 1.09 0.988,1.193  3,837 497 0.97 0.871,1.075  3,117 395 0.94 0.830,1.054  
5-9 cigarettes 1,619 258 1.36 1.184,1.560  1,395 217 1.09 0.927,1.269  1,095 161 0.99 0.819,1.187  
>10 cigarettes 3,589 759 1.92 1.762,2.098  3,029 619 1.32 1.184,1.470  2,353 463 1.18 1.036,1.350  
Hyperactive 41,254 5,390   <0.001 36,626 4,693   <0.001 30,007 3,792   <0.001 
No cigarettes (ref) 31,686 3,787 - -  28,369 3,343 - -  23,445 2,730 - --  
1-4 cigarettes 4,364 597 1.17 1.064,1.282  3,837 523 1.06 0.958,1.179  3,117 427 1.07 0.952,1.203  
5-9 cigarettes 1,617 261 1.42 1.236,1.627  1,393 213 1.10 0.941,1.289  1,094 164 1.06 0.879,1.271  
>10 cigarettes 3,587 745 1.93 1.769,2.109  3,027 614 1.37 1.227,1.521  2,351 471 1.28 1.122,1.457  
Inattentive 41,271 4,791   <0.001 36,642 4,169   0.002 30,015 3,331   0.112 
No cigarettes (ref) 31,694 3,432 - -  28,375 3,022 - -  23,446 2,464 - -  
1-4 cigarettes 4,364 485 1.03 0.930,1.140  3,838 422 0.92 0.824,1.032  3,118 328 0.89 0.778,1.007  
5-9 cigarettes 1,620 230 1.36 1.181,1.573  1,396 193 1.08 0.917,1.274  1,095 141 1.00 0.825,1.218  
>10 cigarettes 3,593 644 1.80 1.638,1.974  3,033 532 1.24 1.101,1.387  2,356 398 1.17 1.012,1.341  
Note: RS-DBD – Rating Scale for Disruptive Behavior Disorders; N – sample size; n – number of cases; OR – odds ratio; 95% CI – 95% confidence intervals;*adjusted for child’s 
gender, birth year, parity, maternal age, education, marital status, financial difficulties, depression and anxiety symptoms, prenatal alcohol and caffeine consumption;  





Appendix 5.3. Associations between maternal and paternal prenatal smoking and high risk of teacher reported offspring ADHD symptoms in ALSPAC 
   Unadjusted model   Adjusted model*   Mutually adjusted model** 
 N n OR 95% CI P-value N n OR 95% CI P-value N n OR 95% CI P-value 
Maternal 
ADHD (DAWBA) 5,767 808   <0.001 4,584 576   0.087 3,452 396   0.331 
No cigarettes (ref) 4,433 530 - -  3,648 404 - -  2,792 286 - -  
1-4 cigarettes 296 63 1.99 1.486,2.668  226 46 1.67 1.157,2.404  164 30 1.63 1.041,2.554  
5-9 cigarettes 314 47 1.30 0.938,1.791  230 31 0.92 0.604,1.405  163 20 0.82 0.481,1.396  
>10 cigarettes 724 168 2.23 1.831,2.704  480 95 1.32 0.984,1.762  333 60 1.24 0.863,1.782  
Hyperactive 5,766 726   <0.001 4,584 520   0.253 3,452 357   0.419 
No cigarettes (ref) 4,432 489 - -  3,648 372 - -  2,792 263 - -  
1-4 cigarettes 296 57 1.92 1.419,2.606  226 42 1.68 1.155,2.451  164 28 1.76 1.110,2.795  
5-9 cigarettes 314 44 1.31 0.943,1.832  230 32 1.17 0.769,1.777  163 22 1.26 0.748,2.107  
>10 cigarettes 724 136 1.87 1.514,2.298  480 74 1.15 0.836,1.567  333 44 1.10 0.736,1.639  
Inattentive 5,767 713   <0.001 4,583 508   0.503 3,450 358   0.822 
No cigarettes (ref) 4,433 476 - -  3,648 365 - -  2,791 266 - -  
1-4 cigarettes 297 53 1.81 1.322,2.467  226 41 1.60 1.094,2.337  164 26 1.40 0.875,2.236  
5-9 cigarettes 313 39 1.18 0.835,1.677  229 23 0.73 0.454,1.165  162 14 0.59 0.322,1.080  
>10 cigarettes 724 145 2.08 1.695,2.556  480 79 1.17 0.859,1.591  333 52 1.13 0.777,1.656  
ADHD (SDQ) 5,764 633   <0.001 4,587 444   0.025 3,455    0.102 
No cigarettes (ref) 4,430 405 - -  3,650 303 - -  2,795 217 - -  
1-4 cigarettes 296 46 1.83 1.314,2.545  226 34 1.56 1.034,2.345  164 24 1.65 1.009,2.682  
5-9 cigarettes 314 40 1.45 1.025,2.053  230 27 1.08 0.687,1.689  162 21 1.29 0.756,2.185  






ADHD (DAWBA) 4,081 509   <0.001 3,075 334   0.173 3,067 332   0.454 
No cigarettes (ref) 2,648 287 - -  2,100 200 - -  2,097 200 - -  
1-4 cigarettes 218 26 1.11 0.726,1.708  162 18 1.07 0.633,1.822  161 18 1.04 0.608,1.769  
5-9 cigarettes 186 24 1.22 0.780,1.903  132 15 0.98 0.547,1.753  132 15 0.96 0.535,1.734  
>10 cigarettes 1,029 172 1.65 1.346,2.026  681 101 1.24 0.926,1.653  677 99 1.14 0.834,1.545  
Hyperactive 4,081 462   0.004 3,075 313   0.802 3,067 310   0.413 
No cigarettes (ref) 2,648 276 - -  2,100 203 - -  2,097 202 - -  
1-4 cigarettes 218 24 1.06 0.683,1.654  162 17 1.03 0.601,1.777  161 17 0.99 0.573,1.716  
5-9 cigarettes 186 18 0.92 0.557,1.521  132 11 0.70 0.361,1.344  132 11 0.67 0.346,1.296  
>10 cigarettes 1,029 144 1.40 1.127,1.735  681 82 0.99 0.727,1.349  677 80 0.90 0.646,1.248  
Inattentive 4,079 456   <0.001 3,073 307   0.196 3,065 306   0.215 
No cigarettes (ref) 2,647 250 - -  2,099 178 - -  2,096 178 - -  
1-4 cigarettes 218 31 1.59 1.064,2.375  162 23 1.63 1.005,2.643  161 23 1.63 0.999,2.652  
5-9 cigarettes 186 20 1.16 0.713,1.870  132 13 0.94 0.507,1.729  132 13 0.96 0.519,1.790  
>10 cigarettes 1,028 155 1.70 1.373,2.110  680 93 1.23 0.914,1.664  676 92 1.23 0.900,1.694  
ADHD (SDQ) 4,079 401   <0.001 3,079    0.124 3,071 258   0.782 
No cigarettes (ref) 2,645 219 - -  2,101 151 - -  2,098 151 - -  
1-4 cigarettes 218 25 1.44 0.925,2.226  162 18 1.45 0.847,2.478  161 18 1.39 0.805,2.384  
5-9 cigarettes 186 16 1.04 0.613,1.773  132 9 0.76 0.369,1.559  132 9 0.69 0.334,1.440  
>10 cigarettes 1,030 141 1.76 1.403,2.201  684 83 1.32 0.961,1.817  680 80 1.08 0.766,1.520  
Note: DAWBA – Development And Well-Being Assessment; SDQ – Strengths and Difficulties Questionnaire; N – total sample size; n – number of cases; OR – odds ratio; 95% 
CI – 95% confidence intervals; *adjusted for child’s gender, ethnicity, parity, parental age, marital status, education, financial difficulties, depression and anxiety symptoms, 






Appendix 5.4. Associations between maternal smoking before pregnancy and high risk of maternal and teacher reported offspring ADHD symptoms in 
GenR 
   Unadjusted model   Adjusted model*   Mutually adjusted model** 
 N n OR 95% CI P-value N n OR 95% CI P-value N n OR 95% CI P-value 
ADHD (CPRS-R) 3,028 444   0.001 1,979 277   0.100 1,481 194   0.080 
No cigarettes (ref) 1,883 248 - -  1,226 159 - -  928 110 - -  




























Hyperactive 3,031 336   0.004 1,983 194   0.059 1,482 138   0.111 
No cigarettes (ref) 1,888 187 - -  1,231 105 - -  930 72 - -  




























Inattentive 3,030 380   0.079 1,985 231   0.715 1,484 165   0.192 
No cigarettes (ref) 1,887 224 - -  1,232 142 - -  931 99 - -  




























ADHD (CBCL) 4,076 596   <0.001 2,484 332   0.006 1,778 214   0.083 









































ADHD (TRF) 2,997 464   <0.001 1,633 213   0.002 1,119 123   0.019 
No cigarettes (ref) 1,791 252 - -  970 108 - -  675 65 - -  




























Note: CPRS-R – Revised Conners’ Parent Rating Scale; CBCL – Child Behavior Checklist; TRF – Teacher Report Form; N – sample size; n – number of cases; OR – odds ratio; 
95% CI – 95% confidence intervals; *adjusted for child’s gender, parity, maternal ethnicity, age, education, anxiety and depression symptoms, financial difficulties, alcohol 




Appendix 5.5. Associations between maternal and paternal prenatal smoking and high risk of maternal reported offspring ADHD symptoms in 
ALSPAC (complete cases) 
       Unadjusted model    Adjusted model*  Mutually adjusted model** 
 N n OR 95% CI P-value OR 95% CI P-value OR 95% CI P-value 
Maternal 
ADHD (DAWBA) 5,201 709   <0.001   0.130   0.654 
No cigarettes (ref) 4,319 542 - -  - -  - -  
1-4 cigarettes 244 38 1.29 0.899,1.838  0.96 0.663,1.400  0.84 0.576,1.232  
5-9 cigarettes 228 44 1.67 1.185,2.344  1.22 0.846,1.767  1.07 0.734,1.553  
>10 cigarettes 410 85 1.82 1.412,2.352  1.23 0.916,1.637  1.07 0.797,1.449  
Hyperactive 5,211 622   <0.001   0.669   0.839 
No cigarettes (ref) 4,329 486 - -  - -  - -  
1-4 cigarettes 245 32 1.19 0.810,1.743  0.91 0.615,1.360  0.84 0.559,1.254  
5-9 cigarettes 227 35 1.44 0.993,2.092  1.05 0.704,1.555  0.98 0.652,1.463  
>10 cigarettes 410 69 1.60 1.215,2.107  1.08 0.790,1.465  0.98 0.715,1.348  
Inattentive 5,208 686   <0.001   0.246   0.651 
No cigarettes (ref) 4,326 541 - -  - -  - -  
1-4 cigarettes 243 31 1.02 0.694,1.507  0.80 0.538,1.199  0.73 0.487,1.099  
5-9 cigarettes 228 39 1.44 1.011,2.062  1.16 0.792,1.702  1.06 0.721,1.568  
>10 cigarettes 411 75 1.56 1.197,2.038  1.20 0.889,1.622  1.09 0.802,1.488  
ADHD (SDQ)  5,405 561   <0.001   0.030   0.159 
No cigarettes (ref) 4,459 415 - -  - -  - -  
1-4 cigarettes 249 35 1.59 1.099,2.310  1.29 0.880,1.892  1.17 0.792,1.732  
5-9 cigarettes 238 28 1.30 0.865,1.952  0.95 0.619,1.461  0.88 0.568,1.358  





ADHD (DAWBA) 4,647 618   <0.001   0.001   0.005 
No cigarettes (ref) 3,284 381 - -  - -  - -  
1-4 cigarettes 235 34 1.29 0.882,1.882  1.19 0.804,1.758  1.18 0.799,1.755  
5-9 cigarettes 184 28 1.37 0.902,2.074  1.25 0.816,1.930  1.24 0.803,1.912  
>10 cigarettes 944 175 1.73 1.426,2.109  1.44 1.155,1.784  1.38 1.097,1.730  
Hyperactive 4,656 532   <0.001   0.045   0.105 
No cigarettes (ref) 3,291 340 - -  - -  - -  
1-4 cigarettes 235 28 1.17 0.779,1.770  1.12 0.737,1.711  1.11 0.728,1.700  
5-9 cigarettes 183 16 0.83 0.492,1.406  0.74 0.431,1.263  0.73 0.424,1.248  
>10 cigarettes 947 148 1.61 1.305,1.980  1.31 1.040,1.648  1.26 0.991,1.606  
Inattentive 4,656 610   <0.001   0.076   0.089 
No cigarettes (ref) 3,289 393 - -  - -  - -  
1-4 cigarettes 237 36 1.32 0.912,1.911  1.21 0.828,1.780  1.24 0.841,1.817  
5-9 cigarettes 184 26 1.21 0.790,1.860  1.11 0.715,1.729  1.13 0.723,1.760  
>10 cigarettes 946 155 1.44 1.180,1.767  1.22 0.976,1.525  1.22 0.966,1.538  
ADHD (SDQ)  4,793    <0.001   0.001   0.023 
No cigarettes (ref) 3,353 289 - -  - -  - -  
1-4 cigarettes 239 29 1.46 0.975,2.199  1.38 0.909,2.091  1.32 0.869,2.013  
5-9 cigarettes 195 23 1.42 0.903,2.227  1.27 0.802,2.022  1.22 0.762,1.937  
>10 cigarettes 1,006 144 1.77 1.430,2.193  1.4 1.163,1.857  1.33 1.036,1.699  
Note: DAWBA – Development And Well-Being Assessment; SDQ – Strengths and Difficulties Questionnaire; N – total sample size; n – number of cases; OR – odds ratio; 95% 
CI – 95% confidence intervals; *adjusted for child’s gender, ethnicity, parity, parental age, marital status, education, financial difficulties, depression and anxiety symptoms, 






Appendix 5.6. Associations between maternal and paternal prenatal smoking and high risk of maternal reported offspring ADHD symptoms in 
GenR (complete cases) 
   Unadjusted model Adjusted model* Mutually adjusted model** 
 N n OR 95% CI P-value OR 95% CI P-value OR 95% CI P-value 
Maternal 
ADHD (CPRS-R) 1,535 196   0.004   0.013   0.018 
No cigarettes (ref) 1,219 145 - -  - -  - -  




















Hyperactive 1,536 143   0.017   0.034   0.217 
No cigarettes (ref) 1,221 107 - -  - -  - -  




















Inattentive 1,537 170   0.125   0.244   0.143 
No cigarettes (ref) 1,221 133 - -  - -  - -  




















ADHD (CBCL) 1,835 211   <0.001   <0.001   0.031 
No cigarettes (ref) 1,432 140 - -  - -  - -  




















ADHD (TRF) 1,148 125   0.002   0.017   0.059 
No cigarettes (ref) 878 85 - -  - -  - -  
























ADHD (CPRS-R) 1,930 260   0.316   0.605   0.237 
No cigarettes (ref) 1,148 149 - -  - -  - -  




















Hyperactive 1,930 186   0.013   0.330   0.448 
No cigarettes (ref) 1,148 98 - -  - -  - -  




















Inattentive 1,931 233   0.843   0.082   0.078 
No cigarettes (ref) 1,149 139 - -  - -  - -  




















ADHD (CBCL) 2,323 275   <0.001   0.003   0.039 
No cigarettes (ref) 1,361 130 - -  - -  - -  




















ADHD (TRF) 1,445 151   0.005   0.211   0.347 
No cigarettes (ref) 816 68 - -  - -  - -  




















Note: CPRS-R – Revised Conners’ Parent Rating Scale; CBCL – Child Behavior Checklist; TRF – Teacher Report Form; N – sample size; n – number of cases;  
OR – odds ratio; 95% CI – 95% confidence intervals; *adjusted for child’s gender, parity, parental ethnicity, age, education, anxiety and depression symptoms, 




Appendix 5.7. Associations between maternal and paternal prenatal smoking and high risk of maternal reported offspring ADHD symptoms in 
MoBa (complete cases) 
   Unadjusted model Adjusted model* Mutually adjusted model** 
 N n OR 95% CI P-value OR 95% CI P-value OR 95% CI P-value 
Maternal 
ADHD (RS-DBD) 28,055 3,543   <0.001   0.001   0.006 
No cigarettes (ref) 26,706 3,280 - -  - -  - -  
1-4 cigarettes 707 111 1.33 1.082,1.635  0.98 0.788,1.219  0.95 0.761,1.182  
5-9 cigarettes 383 87 2.10 1.645,2.679  1.56 1.201,2.038  1.49 1.136,1.941  
>10 cigarettes 259 65 2.39 1.810,3.163  1.47 1.078,2.008  1.38 1.000,1.893  
Hyperactive 28,051 3,507   <0.001   <0.001   <0.001 
No cigarettes (ref) 26,704 3,232 - -  - -  - -  
1-4 cigarettes 707 117 1.44 1.177,1.763  1.08 0.871,1.329  1.04 0.840,1.286  
5-9 cigarettes 382 91 2.27 1.789,2.884  1.68 1.300,2.170  1.60 1.228,2.073  
>10 cigarettes 258 67 2.55 1.924,3.373  1.57 1.152,2.127  1.45 1.061,1.991  
Inattentive 28,058 3,102   <0.001   0.014   0.041 
No cigarettes (ref) 26,708 2,877 - -  - -  - -  
1-4 cigarettes 708 101 1.38 1.110,1.711  1.01 0.800,1.265  0.99 0.783,1.243  
5-9 cigarettes 383 70 1.85 1.423,2.412  1.37 1.032,1.815  1.32 0.996,1.760  





ADHD (RS-DBD) 10,738 1,454   0.002   0.142   0.417 
No cigarettes (ref) 8,965 1,193 - -  - -  - -  
1-4 cigarettes 998 120 0.89 0.729,1.088  0.85 0.690,1.035  0.83 0.680,1.021  
5-9 cigarettes 211 40 1.52 1.074,2.162  1.38 0.960,1.969  1.32 0.919,1.889  
>10 cigarettes 564 101 1.42 1.136,1.777  1.19 0.933,1.511  1.09 0.846,1.404  
Hyperactive 10,736 1,424   0.001   0.075   0.242 
No cigarettes (ref) 8,964 1,157 - -  - -  - -  
1-4 cigarettes 997 132 1.03 0.849,1.249  0.99 0.809,1.201  0.98 0.801,1.190  
5-9 cigarettes 211 39 1.53 1.075,2.178  1.39 0.967,1.995  1.35 0.939,1.945  
>10 cigarettes 564 96 1.38 1.100,1.742  1.16 0.909,1.485  1.09 0.843,1.411  
Inattentive 10,740 1,248   0.002   0.117   0.295 
No cigarettes (ref) 8,966 1,018 - -  - -  - -  
1-4 cigarettes 998 110 0.97 0.785,1.191  0.91 0.734,1.123  0.90 0.727,1.115  
5-9 cigarettes 211 31 1.35 0.913,1.980  1.19 0.803,1.767  1.16 0.784,1.725  
>10 cigarettes 565 89 1.46 1.154,1.847  1.22 0.948,1.579  1.16 0.887,1.509  
Note: RS-DBD – Rating Scale for Disruptive Behavior Disorders; N – sample size; n – number of cases; OR – odds ratio; 95% CI – 95% confidence intervals;*adjusted 
for child’s gender, birth year, parity, parental age, education, marital status, financial difficulties, depression and anxiety symptoms, prenatal alcohol and caffeine 







Appendix 5.8. Associations between maternal unweighted PRSs and maternal 
exposure phenotypes in ALSPAC  
Exposure Beta 95% CI P-value Sample size 
Smoking heaviness 0.02 0.008, 0.023 <0.001 1,537 
Lifetime smoking* 0.01 0.007, 0.124 <0.001 7,107 
Lifetime smoking** 1.03 1.022, 1.044 <0.001 3,413 
Alcohol consumption 0.004 0.002, 0.007 <0.001 3,962 
Coffee consumption 3.49 1.477, 5.511 <0.001 7,074 
Note: *smoking heaviness phenotype; **smoking cessation phenotype (in OR’s);  
95% CI – 95% confidence intervals; adjusted for principal components 
 
 
Appendix 5.9. Associations between maternal unweighted PRSs and maternal 
exposure phenotypes in MoBa 
Exposure Beta 95% CI P-value Sample size 
Smoking heaviness 0.01 0.002, 0.180 0.021 1,029 
Lifetime smoking* 0.004 0.003, 0.005 <0.001 14,488 
Lifetime smoking** 1.02 1.005, 1.027 0.004 3,118 
Alcohol consumption 0.001 -0.016, 0.018 0.911 1,362 
Alcohol consumption*** 1.06 0.258, 1.859 0.010 12,953 
Coffee consumption 1.14 0.279, 2.008 0.010 14,583 
Note: *smoking heaviness phenotype; **smoking cessation phenotype (in OR’s);  
95% CI – 95% confidence intervals; ***alcohol consumption before pregnancy; adjusted for 




Appendix 5.10. Associations between maternal smoking heaviness PRS and high risk of teacher reported  
offspring ADHD symptoms in ALSPAC 
 Maternal PRS Maternal PRS adj. for PC  
Outcome OR 95% CI P-value OR 95% CI P-value Sample size 
ADHD (DAWBA) 2.51 0.816, 7.735 0.108 2.40 0.764, 7.510 0.134 833 
Hyperactive 2.30 0.736, 7.180 0.152 2.19 0.688, 6.947 0.185 833 
Inattentive 3.00 0.888, 10.122 0.077 2.68 0.781, 9.198 0.117 833 
ADHD (SDQ) 1.38 0.419, 4.560 0.595 1.31 0.390, 4.364 0.666 834 
Note: DAWBA – Development And Well-Being Assessment; SDQ – Strengths and Difficulties Questionnaire; OR – odds ratio;  
95% CI – 95% confidence intervals; PC – principal components 
 
 
Appendix 5.11. Associations between maternal lifetime smoking PRS and high risk of teacher reported  
offspring ADHD symptoms in ALSPAC 
 Maternal PRS Maternal PRS adj. for PC  
Outcome OR 95% CI P-value OR 95% CI P-value Sample size 
ADHD (DAWBA) 2.68 1.025, 7.022 0.044 2.70 1.026, 7.079 0.044 3,486 
Hyperactive 2.39 0.883, 6.478 0.086 2.43 0.893, 6.603 0.082 3,485 
Inattentive 1.91 0.685, 5.321 0.216 1.91 0.682, 5.332 0.219 3,487 
ADHD (SDQ) 2.97 1.029, 8.548 0.044 3.00 1.034, 8.688 0.043 3,486 
Note: DAWBA – Development And Well-Being Assessment; SDQ – Strengths and Difficulties Questionnaire; OR – odds ratio;  





Appendix 5.12. Associations between maternal prenatal alcohol consumption and high risk of maternal reported offspring ADHD symptoms in MoBa 
(adjusted for maternal ADHD) 
   Unadjusted model   Adjusted model*   Mutually adjusted model** 
 N n OR 95% CI P-value N n OR 95% CI P-value N n OR 95% CI P-value 
ADHD RS-DBD) 38,134 5,030   <0.001 28,507 3,655   <0.001 9,031 1,187   0.001 
None (ref) 33,605 4,342 - -  25,110 3,140 - -  8,317 1,059 - -  
<1 unit a week 4,366 663 1.21 1.104,1.319  3,271 500 1.33 1.197,1.488  691 126 1.53 1.238,1.891  
>1 unit a week 163 25 1.22 0.795,1.875  126 15 0.85 0.476,1.516  NA NA NA NA  
Hyperactive 38,127 4,957   <0.001 28,504 3,600   <0.001 9,030 1,149   0.007 
None (ref) 33,601 4,281 - -  25,109 3,097 - -  8,316 1,031 - -  
<1 unit a week 4,363 653 1.21 1.102,1.319  3,269 489 1.29 1.154,1.435  691 114 1.38 1.105,1.716  
>1 unit a week 163 23 1.13 0.722,1.754  126 14 0.78 0.436,1.395  NA NA NA NA  
Inattentive  38,140 4,393   <0.001 28,512 3,186   <0.001 9,031 1,026   0.009 
None (ref) 33,610 3,786 - -  25,113 2,747 - -  8,317 922 - -  
<1 unit a week 4,367 584 1.22 1.106,1.337  3,273 426 1.28 1.142,1.440  691 103 1.46 1.162,1.833  
>1 unit a week 163 23 1.29 0.833,2.011  126 13 0.87 0.474,1.583  NA NA NA NA  
Note: RS-DBD – Rating Scale for Disruptive Behavior Disorders; N – sample size; n – number of cases; OR – odds ratio; 95% CI – 95% confidence intervals;*adjusted for child’s 
gender, birth year, parity, maternal age, education, marital status, financial difficulties, depression and anxiety symptoms, prenatal smoking and caffeine consumption; 





Appendix 5.13. Associations between maternal alcohol consumption before pregnancy and high risk of maternal reported offspring ADHD symptoms 
in MoBa 
   Unadjusted model   Adjusted model*   Mutually adjusted model** 
 N n OR 95% CI P-value N n OR 95% CI P-value N n OR 95% CI P-value 
ADHD (RS-DBD) 41,020 5,455   <0.001 36,636 4,750   0.002 11,302 1,500   0.217 
None (ref) 4,363 537 - -  3,882 462 - -  1,608 194 - -  
<1 unit a week 15,062 1,825 0.98 0.886,1.089  13,551 1,595 1.01 0.901,1.133  3,808 487 1.09 0.877,1.348  
1-6 units a week 18,790 2,602 1.15 1.036,1.728  16,733 2,273 1.08 0.964,1.500  4,922 654 1.06 0.844,1.755  
>1 unit per day 2,805 491 1.51 1.322,1.805  2,470 420 1.28 1.099,1.805  964 165 1.31 0.981,1.805  
Hyperactive 41,011 5,381   <0.001 36,626 4,693   0.004 11,301 1,458   0.069 
None (ref) 4,363 552 - -  3,882 477 - -  1,609 194 - -  
<1 unit a week 15,059 1,768 0.92 0.828,1.018  13,548 1,552 0.94 0.840,1.053  3,808 464 1.03 0.829,1.279  
1-6 units a week 18,785 2,589 1.10 0.999,1.598  16,728 2,255 1.04 0.927,1.419  4,921 635 1.05 0.836,1.867  
>1 unit per day 2,804 472 1.40 1.222,1.805  2,468 409 1.22 1.040,1.805  963 165 1.39 1.041,1.805  
Inattentive 41,029 4,775   <0.001 36,642 4,169   0.115 11,302 1,307   0.629 
None (ref) 4,363 476 - -  3,881 415 - -  1,607 171 - -  
<1 unit a week 15,065 1,604 0.97 0.873,1.085  13,554 1,407 0.99 0.875,1.111  3,808 421 1.09 0.866,1.376  
1-6 units a week 18,790 2,288 1.13 1.019,1.594  16,731 2,001 1.05 0.929,1.180  4,922 591 1.11 0.869,1.472  
>1 unit per day 2,811 407 1.38 1.199,1.805  2,476 346 1.22 1.040,1.805  965 124 1.07 0.783,1.805  
Note: RS-DBD – Rating Scale for Disruptive Behavior Disorders; N – sample size; n – number of cases; OR – odds ratio; 95% CI – 95% confidence intervals;*adjusted for child’s 
gender, birth year, parity, maternal age, education, marital status, financial difficulties, depression and anxiety symptoms, smoking and caffeine consumption before 




Appendix 5.14. Associations between maternal alcohol consumption before pregnancy and high risk of maternal reported offspring ADHD symptoms 
in ALSPAC 
   Unadjusted model   Adjusted model*   Mutually adjusted model** 
 N n OR 95% CI P-value N n OR 95% CI P-value N n OR 95% CI P-value 
ADHD (DAWBA) 7,722 1,117   0.177 6,639 931   0.087 5,410 738   0.002 
None (ref) 483 91 - -  397 67 - -  297 46 - -  
<1 unit a week 2,897 385 0.66 0.513,0.849  2,484 317 0.76 0.562,1.024  2,027 249 0.87 0.603,1.260  
1-6 units a week 3,446 471 0.68 0.532,0.874  3,012 413 0.85 0.629,1.143  2,486 340 1.12 0.769,1.628  
>1 unit a week 896 170 1.01 0.760,1.338  746 134 1.08 0.764,1.525  600 103 1.45 0.937,2.243  
Hyperactive 7,743 984   0.664 6,656 824   0.632 5,420 645   0.023 
None (ref) 485 86 - -  398 65 - -  298 41 - -  
<1 unit a week 2,905 355 0.65 0.499,0.836  2,491 299 0.75 0.555,1.016  2,031 237 0.95 0.649,1.391  
1-6 units a week 3,454 404 0.62 0.476,0.793  3,018 347 0.76 0.558,1.023  2,490 280 1.07 0.727,1.587  
>1 unit a week 899 139 0.85 0.632,1.140  749 113 1.00 0.699,1.420  601 87 1.52 0.964,2.401  
Inattentive 7,734 1,060   0.213 6,653 885   0.168 5,418 714   0.004 
None (ref) 484 85 - -  397 63 - -  297 45 - -  
<1 unit a week 2,900 367 0.68 0.525,0.881  2,491 302 0.76 0.559,1.029  2,032 236 0.85 0.583,1.225  
1-6 units a week 3,459 450 0.70 0.544,0.905  3,023 393 0.82 0.603,1.106  2,492 331 1.08 0.740,1.576  
>1 unit a week 891 158 1.01 0.757,1.353  742 127 1.05 0.736,1.486  597 102 1.41 0.908,2.184  
ADHD (SDQ) 7,990 893   0.815 6,907 733   0.846 5,627 580   0.530 
None (ref) 515 65 - -  419 49 - -  319 31 - -  
<1 unit a week 2,987 343 0.90 0.677,1.192  2,588 286 1.03 0.737,1.433  2,115 234 1.34 0.878,2.031  
1-6 units a week 3,566 363 0.79 0.592,1.040  3,130 306 0.93 0.666,1.299  2,572 241 1.19 0.777,1.831  
>1 unit a week 922 122 1.06 0.765, 1457  770 92 1.09 0.738, 1.611  621 74 1.49 0.906, 2.439  
Note: DAWBA – Development And Well-Being Assessment; SDQ – Strengths and Difficulties Questionnaire; N – total sample size; n – number of cases; OR – odds ratio; 95% 
CI – 95% confidence intervals; *adjusted for child’s gender, ethnicity, parity, maternal age, marital status, education, financial difficulties, depression and anxiety symptoms, 





Appendix 5.15. Associations between maternal and paternal prenatal alcohol consumption and high risk of teacher reported offspring ADHD 
symptoms in ALSPAC 
   Unadjusted model   Adjusted model*   Mutually adjusted model** 
 N n OR 95% CI P-value N n OR 95% CI P-value N n OR 95% CI P-value 
Maternal 
ADHD (DAWBA) 5,736 806   0.353 4,584 576   0.753 3,565 420   0.941 
None (ref) 2,572 350 - -  2,044 256 - -  1,615 184 - -  
<1 unit a week 2,262 323 1.06 0.898,1.245  1,844 234 1.07 0.875,1.307  1,433 178 1.15 0.910,1.449  
>1 unit a week 902 133 1.10 0.885,1.362  696 86 0.89 0.675,1.182  517 58 0.90 0.638,1.259  
Hyperactive 5,735 725   0.053 4,584 520   0.261 3,565 376   0.228 
None (ref) 2,572 313 - -  2,044 225 - -  1,615 160 - -  
<1 unit a week 2,261 275 1.00 0.841,1.188  1,844 203 1.03 0.835,1.274  1,433 155 1.13 0.885,1.448  
>1 unit a week 902 137 1.29 1.041,1.606  696 92 1.18 0.890,1.553  517 61 1.16 0.824,1.630  
Inattentive 5,736 710   0.974 4,583 508   0.312 3,563 370   0.543 
None (ref) 2,571 321 - -  2,043 232 - -  1,614 167 - -  
<1 unit a week 2,263 274 0.97 0.813,1.147  1,844 205 1.02 0.829,1.259  1,432 154 1.07 0.842,1.370  
>1 unit a week 902 115 1.02 0.815,1.286  696 71 0.80 0.593,1.078  517 49 0.81 0.563,1.156  
ADHD (SDQ) 5,733 634   0.241 4,587 444   0.915 3,567 321   0.512 
None (ref) 2,576 272 - -  2,048 192 - -  1,618 130 - -  
<1 unit a week 2,255 255 1.08 0.901,1.294  1,843 190 1.21 0.965,1.507  1,432 147 1.37 1.053,1.776  





ADHD (DAWBA) 4,212 538   0.103 3,075 334   0.854 3,067 334   0.787 
None (ref) 155 22 - -  84 11 - -  84 11 - -  
<1 unit a week 1,022 143 0.98 0.606,1.597  724 81 0.96 0.472,1.954  722 81 0.91 0.442,1.852  
1-6 units a week 2,231 280 0.87 0.543,1.386  1,661 181 1.07 0.537,2.136  1,658 181 1.00 0.499,2.019  
>1 unit a day 804 93 0.79 0.480,1.304  606 61 0.91 0.438,1.875  603 61 0.85 0.408,1.784  
Hyperactive 4,211 483   0.353 3,075 334   0.506 3,067 313   0.341 
None (ref) 155 16 - -  84 11 - -  84 9 - -  
<1 unit a week 1,022 129 1.26 0.725,2.174  724 81 1.20 0.556,2.569  722 81 1.13 0.526,2.447  
1-6 units a week 2,230 252 1.11 0.649,1.887  1,661 181 1.15 0.546,2.432  1,658 166 1.07 0.502,2.272  
>1 unit a day 804 86 1.04 0.592,1.828  606 61 1.00 0.456,2.183  603 57 0.91 0.409,2.000  
Inattentive 4,210 471   0.442 3,073 307   0.529 3,065 307   0.562 
None (ref) 155 22 - -  84 10 - -  84 10 - -  
<1 unit a week 1,022 124 0.84 0.512,1.361  724 76 1.01 0.485,2.085  722 76 0.95 0.457,1.986  
1-6 units a week 2,230 228 0.69 0.430,1.103  1,660 151 0.95 0.464,1.925  1,657 151 0.89 0.435,1.833  
>1 unit a day 803 97 0.83 0.505,1.367  605 70 1.16 0.552,2.421  602 70 1.10 0.520,2.329  
ADHD (SDQ) 4,209 416   0.190 3,079 261   0.991 3,071 261   0.793 
None (ref) 155 18    84 9    84 9    
<1 unit a week 1,021 109 0.91 0.535,1.545  725 63 0.93 0.432,2.021  723 63 0.82 0.378,1.797  
1-6 units a week 2,227 215 0.81 0.488,1.356  1,662 137 0.99 0.469,2.097  1,659 137 0.86 0.401,1.836  
>1 unit a day 806 74 0.77 0.445,1.329  608 52 0.94 0.426,2.056  605 52 0.81 0.363,1.799  
Note: DAWBA – Development And Well-Being Assessment; SDQ – Strengths and Difficulties Questionnaire; N – total sample size; n – number of cases; OR – odds ratio; 95% 
CI – 95% confidence intervals; *adjusted for child’s gender, ethnicity, parity, parental age, marital status, education, financial difficulties, depression and anxiety symptoms, 






Appendix 5.16. Associations between maternal prenatal weekly alcohol consumption in grams and high risk of maternal reported offspring ADHD 
symptoms in ALSPAC 
   Unadjusted model   Adjusted model*   Mutually adjusted model** 
 N n OR 95% CI P-value N n OR 95% CI P-value N n OR 95% CI P-value 
ADHD (DAWBA) 7,180 1029 1.00 1.000,1.004 0.003 6,671 933 1.00 0.999,1.003 0.263 5,381 732 1.00 0.999,1.003 0.352 
Hyperactive 7,200 911 1.00 1.000,1.004 0.007 6,689 828 1.00 0.999,1.003 0.170 5,391 642 1.00 0.999,1.004 0.240 
Inattentive 7,192 987 1.00 1.001,1.004 0.004 6,684 889 1.00 0.999,1.003 0.168 5,389 707 1.00 0.999,1.004 0.126 
ADHD (SDQ) 7,442 809 1.00 0.999,1.003 0.325 6,942 737 1.00 0.997,1.002 0.669 5,610 579 1.00 0.997,1.002 0.804 
Note: DAWBA – Development And Well-Being Assessment; SDQ – Strengths and Difficulties Questionnaire; N – total sample size; n – number of cases; OR – odds ratio; 95% 
CI – 95% confidence intervals; *adjusted for child’s gender, ethnicity, parity, parental age, marital status, education, financial difficulties, depression and anxiety symptoms, 
prenatal smoking and caffeine consumption; **additionally adjusted for partner’s prenatal alcohol consumption 
 
Appendix 5.17. Associations between maternal prenatal weekly alcohol consumption in grams and high risk of maternal reported offspring ADHD 
symptoms in MoBa 
   Unadjusted model   Adjusted model*   Mutually adjusted model** 
 N n OR 95% CI P-value N n OR 95% CI P-value N n OR 95% CI P-value 
ADHD (RS-DBD) 38,134 5,030 1.01 1.000,1.021 0.041 34,297 4,415 1.01 0.999,1.020 0.085 10,641 1,395 1.00 0.989,1.015 0.789 
Hyperactive 38,127 4,957 1.01 0.999,1.019 0.074 34,290 4,353 1.01 0.996,1.015 0.231 10,638 1,351 1.00 0.985,1.014 0.969 
Inattentive 38,140 4,393 1.01 1.001,1.021 0.038 34,302 3,874 1.01 0.999,1.019 0.091 10,639 1,210 1.00 0.987,1.015 0.920 
Note: RS-DBD – Rating Scale for Disruptive Behavior Disorders; N – sample size; n – number of cases; OR – odds ratio; 95% CI – 95% confidence intervals; *adjusted for 
child’s gender, birth year, parity, maternal age, education, marital status, financial difficulties, depression and anxiety symptoms, prenatal smoking and caffeine 





Appendix 5.18. Associations between maternal and paternal prenatal alcohol consumption and high risk of maternal reported offspring ADHD 
symptoms in ALSPAC (complete cases) 
   Unadjusted model Adjusted model* Mutually adjusted model** 
 N n OR 95% CI P-value OR 95% CI P-value OR 95% CI P-value 
Maternal 
ADHD (DAWBA) 5,384 733   0.001   0.006   0.002 
None (ref) 2,369 288 - -  - -  - -  
<1 unit a week 2,220 311 1.18 0.991,1.398  1.30 1.002,1.432  1.23 1.026,1.471  
>1 unit a week 795 134 1.47 1.172,1.830  1.37 1.079,1.733  1.44 1.128,1.832  
Hyperactive 5,394 642   0.023   0.045   0.009 
None (ref) 2,378 260 - -  - -  - -  
<1 unit a week 2,221 272 1.14 0.949,1.362  1.16 0.961,1.394  1.20 0.991,1.443  
>1 unit a week 795 110 1.31 1.030,1.661  1.26 0.981,1.620  1.38 1.064,1.781  
Inattentive 5,392 708   0.001   0.007   0.004 
None (ref) 2,375 279 - -  - -  - -  
<1 unit a week 2,222 301 1.18 0.989,1.401  1.21 1.007,1.444  1.20 0.991,1.443  
>1 unit a week 795 128 1.44 1.149,1.808  1.37 1.075,1.736  1.38 1.064,1.781  
ADHD (SDQ) 5,613 579   0.004   0.020   0.008 
None (ref) 2,471 222 - -  - -  - -  
<1 unit a week 2,310 257 1.29 1.049,1.532  1.29 1.062,1.568  1.20 0.991,1.443  





ADHD (DAWBA) 4,648 622   0.096   0.204   0.048 
None (ref) 148 36 - -  - -  - -  
<1 unit a week 1,053 136 0.46 0.304,0.700  0.49 0.314,0.749  0.45 0.292,0.701  
1-6 units a week 2,465 320 0.46 0.313,0.688  0.53 0.350,0.798  0.47 0.310,0.715  
>1 unit a day 982 130 0.48 0.312,0.721  0.51 0.327,0.788  0.44 0.279,0.683  
Hyperactive 4,657 535   0.003   0.018   0.004 
None (ref) 148 30 - -  - -  - -  
<1 unit a week 1,059 131 0.56 0.357,0.863  0.61 0.384,0.954  0.56 0.350,0.905  
1-6 units a week 2,470 275 0.49 0.324,0.750  0.58 0.376,0.898  0.54 0.343,0.855  
>1 unit a day 980 99 0.44 0.281,0.694  0.50 0.312,0.798  0.47 0.288,0.771  
Inattentive 4,657 614   0.253   0.363   0.102 
None (ref) 148 32 - -  - -  - -  
<1 unit a week 1,056 141 0.56 0.364,0.858  0.59 0.379,0.923  0.51 0.320,0.796  
1-6 units a week 2,467 304 0.51 0.338,0.767  0.56 0.368,0.862  0.45 0.291,0.699  
>1 unit a day 986 137 0.59 0.380,0.900  0.62 0.397,0.975  0.49 0.308,0.781  
ADHD (SDQ) 4,796 487   0.300   0.447   0.156 
None (ref) 160 24 - -  - -  - -  
<1 glass a week 1,095 114 0.66 0.409,1.059  0.68 0.418,1.111  0.62 0.374,1.027  
1-6 units a week 2,537 245 0.61 0.385,0.953  0.67 0.417,1.064  0.58 0.356,0.941  
>1 unit a day 1,004 104 0.66 0.406,1.057  0.69 0.419,1.131  0.55 0.328,0.928  
Note: DAWBA – Development And Well-Being Assessment; SDQ – Strengths and Difficulties Questionnaire; N – total sample size; n – number of cases; OR – odds ratio; 95% 
CI – 95% confidence intervals; *adjusted for child’s gender, ethnicity, parity, parental age, marital status, education, financial difficulties, depression and anxiety symptoms, 






Appendix 5.19. Associations between maternal and paternal prenatal alcohol consumption and high risk of maternal and teacher reported 
offspring ADHD symptoms in GenR (complete cases) 
   Unadjusted model Adjusted model* Mutually adjusted model** 
 N n OR 95% CI P-value OR 95% CI P-value OR 95% CI P-value 
Maternal 
ADHD (CPRS-R) 1,532 196   0.292   0.353   0.581 
None (ref) 630 72 - -  - -  - -  
<1 unit a week 507 71 1.26 0.889,1.793  1.31 0.898,1.902  1.25 0.854,1.834  
>1 unit a week 395 53 1.20 0.822,1.755  1.20 0.788,1.831  1.12 0.720,1.735  
Hyperactive 1,533 144   0.285 -  0.284   0.164 
None (ref) 631 66 - -   -  - -  
<1 unit a week 507 44 0.81 0.545,1.215  0.83 0.541,1.265  0.78 0.509,1.207  
>1 unit a week 395 34 0.81 0.522,1.245  0.78 0.483,1.257  0.71 0.433,1.169  
Inattentive 1,534 170   0.149 - - 0.242 - - 0.498 
None (ref) 632 60 - -        
<1 unit a week 507 62 1.33 0.912,1.934  1.35 0.909,2.016  1.28 0.851,1.913  
>1 unit a week 395 48 1.32 0.882,1.972  1.29 0.824,2.003  1.16 0.732,1.842  
ADHD (CBCL) 1,828 212   0.180 - - 0.166 - - 0.105 
None (ref) 809 101 - -        
<1 unit a week 574 67 0.93 0.667,1.288  0.98 0.685,1.400  0.94 0.651,1.356  
>1 unit a week 445 44 0.77 0.529,1.119  0.73 0.476,1.108  0.68 0.441,1.062  
ADHD (TRF) 1,148 126   0.059 - - 0.267 - - 0.178 
None (ref) 539 72 - -        
<1 unit a week 342 28 0.58 0.365,0.916  0.64 0.387,1.068  0.60 0.357,1.013  







ADHD (CPRS-R) 1,937 261   0.188   0.114   0.163 
None (ref) 201 19 - -  - -  - -  
<1 unit a week 238 35 1.65 0.913,2.989  1.64 0.881,3.061  1.58 0.841,2.948  
1-6 units a week 


















Hyperactive 1,937 186   0.869   0.748   0.401 
None (ref) 201 17 - -  - -  - -  
<1 unit a week 238 31 1.62 0.869,3.025  1.62 0.835,3.130  1.68 0.866,3.270  
1-6 units a week 


















Inattentive 1,939 234   0.125   0.120   0.144 
None (ref) 201 18 - -  - -  - -  
<1 unit a week 238 31 1.52 0.824,2.813  1.42 0.743,2.693  1.38 0.719,2.629  
1-6 units a week 


















ADHD (CBCL) 2,332 278   0.158   0.637   0.865 
None (ref) 299 39 - -  - -  - -  
<1 unit a week 317 48 1.19 0.754,1.876  1.31 0.810,2.129  1.38 0.848,2.251  
1-6 units a week 


















ADHD (TRF) 1,452 149   0.247   0.977   0.680 
None (ref) 213 28 - -  - -  - -  
<1 unit a week 196 18 0.67 0.357,1.251  0.79 0.392,1.576  0.85 0.422,1.713  
1-6 units a week 


















Note: CPRS-R – Revised Conners’ Parent Rating Scale; CBCL – Child Behavior Checklist; TRF – Teacher Report Form; N – sample size; n – number of cases;  
OR – odds ratio; 95% CI – 95% confidence intervals. *adjusted for child’s gender, parity, parental ethnicity, age, education, anxiety and depression problems, 






Appendix 5.20. Associations between maternal and paternal prenatal alcohol consumption and high risk of maternal reported offspring ADHD 
symptoms in MoBa (complete cases) 
   Unadjusted model Adjusted model* Mutually adjusted model** 
 N n OR 95% CI P-value OR 95% CI P-value OR 95% CI P-value 
Maternal 
ADHD (RS-DBD) 10,641 1,395   <0.001   <0.001   <0.001 
None (ref) 9,800 1,247 - -  - -  - -  
<1 unit a week 811 146 1.51 1.246,1.820  1.53 1.258,1.857  1.53 1.260,1.865  
>1 unit a week 30 2 0.49 0.117,2.059  0.38 0.087,1.633  0.37 0.085,1.647  
Hyperactive 10,638 1,351   0.002   0.006   0.005 
None (ref) 9,797 1,214 - -  - -  - -  
<1 unit a week 811 133 1.39 1.138,1.690  1.38 1.129,1.690  1.40 1.139,1.710  
>1 unit a week 30 4 1.09 0.379,3.122  0.89 0.285,2.759  0.89 0.283,2.796  
Inattentive 10,639 1,210   0.003   0.003   0.002 
None (ref) 9,799 1,087 - -  - -  - -  
<1 unit a week 810 120 1.39 1.138,1.708  1.44 1.166,1.771  1.45 1.176,1.793  





ADHD (RS-DBD) 9,861 1,322   0.875   0.666   0.366 
None (ref) 586 82 - -  - -  - -  
<1 unit a week 2,945 403 0.97 0.753,1.261  1.00 0.761,1.301  0.97 0.742,1.270  
1-6 units a week 3,971 501 0.89 0.689,1.327  0.88 0.674,1.354  0.85 0.651,1.284  
>1 unit per day 2,359 336 1.02 0.786,1.509  1.02 0.773,1.509  0.97 0.731,1.509  
Hyperactive 9,858 1,294   0.929   0.950   0.616 
None (ref) 586 86 - -  - -  - -  
<1 unit a week 2,944 387 0.88 0.684,1.132  0.90 0.691,1.163  0.88 0.676,1.137  
1-6 units a week 3,969 490 0.82 0.640,1.226  0.82 0.632,1.268  0.79 0.611,1.206  
>1 unit per day 2,359 331 0.95 0.735,1.509  0.97 0.736,1.509  0.92 0.698,1.509  
Inattentive 9,862 1,129   0.971   0.524   0.293 
None (ref) 586 72 - -  - -  - -  
<1 unit a week 2,944 345 0.95 0.721,1.245  0.96 0.724,1.272  0.94 0.708,1.244  
1-6 units a week 3,972 423 0.85 0.651,1.314  0.83 0.628,1.303  0.81 0.607,1.238  
>1 unit per day 2,360 289 1.00 0.755,1.509  0.97 0.722,1.509  0.92 0.684,1.509  
Note: RS-DBD – Rating Scale for Disruptive Behavior Disorders; N – sample size; n – number of cases; OR – odds ratio; 95% CI – 95% confidence intervals; 
*adjusted for child’s gender, birth year, parity, parental age, education, marital status, financial difficulties, depression and anxiety symptoms, prenatal 







Appendix 5.21. Associations between maternal alcohol consumption PRS and high risk of teacher reported  
offspring ADHD symptoms in ALSPAC 
 Maternal PRS Maternal PRS adj. for PC  
Outcome OR 95% CI P-value OR 95% CI P-value Sample size 
ADHD (DAWBA) 1.41 0.197, 10.082 0.732 1.61 0.222, 11.715 0.636 2,022 
Hyperactive 2.14 0.284, 16.174 0.460 2.44 0.316, 18.910 0.392 2,021 
Inattentive 1.37 0.165, 11.347 0.772 1.67 0.197, 14.125 0.640 2,023 
ADHD (SDQ) 2.22 0.259, 19.033 0.467 2.63 0.300, 22.989 0.383 2,018 
Note: DAWBA – Development And Well-Being Assessment; SDQ – Strengths and Difficulties Questionnaire; OR – odds ratio;  





Appendix 5.22. Associations between maternal daily prenatal caffeine consumption and high risk of maternal reported offspring ADHD symptoms in 
MoBa (adjusted for maternal ADHD) 
   Unadjusted model   Adjusted model*   Mutually adjusted model** 
 N n OR 95% CI P-value N n OR 95% CI P-value N n OR 95% CI P-value 
ADHD (RS-DBD) 42,206 5,607   0.002 28,507 3,655   0.025 10,649 1,441   0.099 
0-49mg (ref) 26,564 3,506 - -  18,128 2,294 - -  6,695 880 - -  
50-199mg 12,867 1,651 0.97 0.909,1.031  8,590 1,078 1.00 0.925,1.087  3,423 477 1.07 0.943,1.211  
200-299mg 1,869 282 1.17 1.024,1.334  1,206 175 1.15 0.964,1.368  387 55 1.05 0.767,1.424  
>300 mg 906 168 1.50 1.258,1.782  583 108 1.38 1.092,1.738  144 29 1.56 0.997,2.434  
Hyperactive 42,198 5,538   <0.001 28,504 3,600   <0.001 10,649 1,390   0.001 
0-49mg (ref) 26,564 3,386 - -  18,129 2,208 - -  6,697 825 - -  
50-199mg 12,861 1,701 1.04 0.980,1.111  8,586 1,102 1.08 0.993,1.166  3,421 480 1.18 1.038,1.334  
200-299mg 1,868 282 1.22 1.067,1.389  1,206 192 1.25 1.048,1.480  387 57 1.23 0.903,1.664  
>300 mg 905 169 1.57 1.322,1.869  583 108 1.42 1.127,1.788  144 28 1.71 1.093,2.660  
Inattentive 42,215 4,913   0.070 28,512 3,186   0.271 10,649 1,230   0.473 
0-49mg (ref) 26,569 3,088 - -  18,130 2,031 - -  6,696 766 - -  
50-199mg 12,872 1,443 0.96 0.898,1.026  8,594 916 0.97 0.886,1.052  3,423 394 1.01 0.882,1.154  
200-299mg 1,869 256 1.21 1.051,1.386  1,206 158 1.19 0.995,1.431  387 47 1.03 0.740,1.432  
>300 mg 905 126 1.23 1.014,1.492  582 81 1.15 0.895,1.489  143 23 1.39 0.868,2.215  
Note: RS-DBD – Rating Scale for Disruptive Behavior Disorders; N – sample size; n – number of cases; OR – odds ratio; 95% CI – 95% confidence intervals; *adjusted for 
child’s gender, birth year, parity, parental age, education, marital status, financial difficulties, depression and anxiety symptoms, prenatal smoking and alcohol 





Appendix 5.23. Associations between maternal daily caffeine consumption before pregnancy and high risk of maternal reported offspring ADHD 
symptoms in MoBa 
   Unadjusted model   Adjusted model*   Mutually adjusted model** 
 N n OR 95% CI P-value N n OR 95% CI P-value N n OR 95% CI P-value 
ADHD (RS-DBD) 42,206 5,607   0.057 36,636 4,750   0.373 13,573 1,819   0.276 
0-49mg (ref) 17,079 2,297 - -  14,480 1,905 - -  5,105 672 - -  
50-199mg 12,139 1,500 0.91 0.846,0.974  10,711 1,306 0.97 0.898,1.051  4,251 562 1.06 0.933,1.197  
200-299mg 6,351 836 0.98 0.896,1.062  5,606 703 0.99 0.898,1.091  2,198 300 1.11 0.948,1.290  
>300 mg 6,637 974 1.11 1.020,1.201  5,839 836 1.06 0.962,1.162  2,019 285 1.07 0.913,1.257  
Hyperactive 42,198 5,357   0.004 36,626 4,693   0.050 13,572 1,775   0.035 
0-49mg (ref) 17,079 2,257 - -  14,479 1,857 - -  5,105 636 - -  
50-199mg 12,136 1,452 0.89 0.831,0.958  10,707 1,264 0.96 0.890,1.042  4,250 557 1.11 0.982,1.264  
200-299mg 6,348 842 1.00 0.922,1.094  5,603 718 1.04 0.940,1.140  2,197 287 1.11 0.946,1.295  
>300 mg 6,635 986 1.15 1.056,1.244  5,837 854 1.10 1.004,1.211  2,020 295 1.18 1.008,1.385  
Inattentive 42,215 4,913   0.115 36,642 4,169   0.179 13,573 1,564   0.206 
0-49mg (ref) 17,078 2,007 - -  14,479 1,661 - -  5,104 577 - -  
50-199mg 12,148 1,320 0.92 0.850,0.986  10,717 1,159 1.00 0.924,1.091  4,254 477 1.05 0.918,1.200  
200-299mg 6,352 753 1.01 0.923,1.105  5,607 626 1.04 0.938,1.151  2,198 265 1.16 0.982,1.364  
>300 mg 6,637 833 1.08 0.988,1.176  5,839 723 1.07 0.971,1.186  2,017 245 1.08 0.915,1.286  
Note: RS-DBD – Rating Scale of Disruptive Behavior Disorders; N – sample size; n – number of cases; OR – odds ratio; 95% CI – 95% confidence intervals; *adjusted for child’s 
gender, birth year, parity, maternal age, education, marital status, financial difficulties, depression and anxiety symptoms, smoking and alcohol consumption before 




Appendix 5.24. Associations between maternal and paternal daily prenatal caffeine consumption and high risk of teacher reported offspring ADHD 
symptoms in ALSPAC 
   Unadjusted model   Adjusted model*   Mutually adjusted model** 
 N n OR 95% CI P-value N n OR 95% CI P-value N n OR 95% CI P-value 
Maternal 
ADHD (DAWBA) 5,726 806   0.008 4,584 576   0.596 3,611 428   0.247 
0-49mg (ref) 728 95 - -  576 66 - -  463 47 - -  
50-199mg 2,259 293 0.99 0.775,1.273  1,855 215 1.08 0.793,1.462  1,483 155 1.08 0.752,1.537  
200-299mg 1,402 201 1.12 0.858,1.450  1,143 154 1.22 0.881,1.680  904 124 1.42 0.979,2.068  
>300mg 1,337 217 1.29 0.995,1.674  1,010 141 1.07 0.765,1.494  761 102 1.14 0.767,1.683  
Hyperactive  5,725 721   0.049 4,584 520   0.757 3,611 384   0.339 
0-49mg (ref) 728 87 - -  576 62 - -  463 44 - -  
50-199mg 2,259 265 0.98 0.756,1.267  1,855 194 1.00 0.731,1.370  1,483 143 1.05 0.728,1.523  
200-299mg 1,401 181 1.09 0.832,1.436  1,143 140 1.16 0.832,1.614  904 107 1.30 0.882,1.919  
>300mg 1,337 188 1.21 0.919,1.582  1,010 124 1.00 0.707,1.410  761 90 1.12 0.746,1.686  
Inattentive 5,726 710   0.014 4,583 508   0.874 3,609 374   0.610 
0-49mg (ref) 727 79 - -  575 56 - -  462 38 - -  
50-199mg 2,259 263 1.08 0.828,1.411  1,854 200 1.21 0.873,1.666  1,482 147 1.30 0.883,1.904  
200-299mg 1,402 181 1.22 0.918,1.610  1,143 133 1.24 0.879,1.746  904 104 1.44 0.959,2.156  
>300mg 1,338 187 1.33 1.007,1.763  1,011 119 1.09 0.765,1.560  761 85 1.16 0.761,1.779  
ADHD (SDQ) 5,723 633   0.014 4,587 444   0.830 3,613 328   0.309 
0-49mg (ref) 727 74 - -  577 52 - -  464 35 - -  
50-199mg 2,261 231 1.00 0.762,1.324  1,858 165 1.04 0.740,1.459  1,485 117 1.06 0.705,1.589  
200-299mg 1,400 155 1.10 0.820,1.472  1,142 116 1.13 0.790,1.623  904 94 1.37 0.894,2.084  







ADHD (DAWBA) 4,268 551   0.760 3,075 334   0.309 3,053 330   0.240 
0-49mg (ref) 134 20 - -  98 13 - -  97 13 - -  
50-199mg 511 64 0.82 0.474,1.404  367 39 0.87 0.430,1.746  366 38 0.81 0.403,1.638  
200-299mg 648 85 0.86 0.508,1.458  465 51 0.80 0.403,1.578  461 51 0.77 0.389,1.522  
>300mg 2,975 382 0.84 0.516,1.367  2,145 231 0.76 0.406,1.425  2,129 228 0.71 0.378,1.336  
Hyperactive 4,267 494   0.349 3,075 313   0.071 3,053 306   0.086 
0-49mg (ref) 134 21 - -  98 15 - -  97 14 - -  
50-199mg 511 57 0.68 0.393,1.161  367 39 0.76 0.386,1.482  366 38 0.78 0.390,1.546  
200-299mg 648 79 0.75 0.443,1.259  465 47 0.63 0.327,1.222  461 47 0.67 0.343,1.320  
>300mg 2,974 337 0.69 0.426,1.111  2,145 212 0.60 0.331,1.096  2,129 207 0.62 0.335,1.153  
Inattentive 4,266 480   0.289 3,073 307   0.937 3,051 303   0.942 
0-49mg (ref) 134 17 - -  98 12 - -  97 12 - -  
50-199mg 511 53 0.80 0.445,1.426  367 33 0.75 0.363,1.541  366 33 0.73 0.355,1.510  
200-299mg 647 58 0.68 0.381,1.205  464 37 0.58 0.284,1.184  460 37 0.57 0.280,1.168  
>300mg 2,974 352 0.92 0.549,1.555  2,144 225 0.77 0.407,1.469  2,128 221 0.75 0.391,1.422  
ADHD (SDQ) 4,265 426   0.425 3,079 261   0.679 3,057 258   0.483 
0-49mg (ref) 134 15 - -  98 11 - -  97 11 - -  
50-199mg 511 44 0.75 0.402,1.389  368 26 0.65 0.302,1.413  367 26 0.63 0.291,1.361  
200-299mg 647 61 0.83 0.454,1.502  466 39 0.68 0.326,1.429  462 39 0.66 0.314,1.374  
>300mg 2,973 306 0.91 0.525,1.577  2,147 185 0.69 0.353,1.361  2,131 182 0.64 0.325,1.265  
Note: DAWBA – Development And Well-Being Assessment; SDQ – Strengths and Difficulties Questionnaire; N – total sample size; n – number of cases; OR – odds ratio; 95% 
CI – 95% confidence intervals. *adjusted for child’s gender, ethnicity, parity, parental age, marital status, education, financial difficulties, depression and anxiety symptoms, 






Appendix 5.25. Associations between maternal and paternal daily prenatal caffeine consumption and high risk of maternal reported offspring 
ADHD symptoms in ALSPAC (complete cases) 
   Unadjusted model Adjusted model* Mutually adjusted model** 
 N n OR 95% CI P-value OR 95% CI P-value OR 95% CI P-value 
Maternal 
ADHD (DAWBA) 5,447 745   0.002   0.131   0.191 
0-49mg (ref) 735 84 - -  - -  - -  
50-199mg 2,284 304 1.19 0.920,1.539  1.11 0.851,1.446  1.10 0.840,1.429  
200-299mg 1,354 175 1.15 0.872,1.518  1.04 0.784,1.390  1.02 0.767,1.365  
>300mg 1,074 182 1.58 1.198,2.087  1.29 0.965,1.732  1.26 0.937,1.695  
Hyperactive 5,458 653   0.021   0.299   0.381 
0-49mg (ref) 735 74 - -  - -  - -  
50-199mg 2,284 273 1.21 0.924,1.591  1.14 0.863,1.504  1.13 0.853,1.489  
200-299mg 1,359 152 1.13 0.839,1.509  1.04 0.769,1.405  1.02 0.755,1.384  
>300mg 1,080 154 1.49 1.106,1.995  1.25 0.919,1.702  1.22 0.896,1.673  
Inattentive 5,455 722   0.167   0.850   0.953 
0-49mg (ref) 735 90 - -  - -  -- -  
50-199mg 2,292 302 1.09 0.846,1.399  1.01 0.781,1.310  1.00 0.769,1.293  
200-299mg 1,356 171 1.03 0.787,1.358  0.95 0.716,1.256  0.93 0.701,1.236  
>300mg 1,072 159 1.25 0.946,1.647  1.06 0.789,1.415  1.03 0.769,1.391  
ADHD (SDQ) 5,662 586   0.014   0.499   0.558 
0-49mg (ref) 766 77 - -  - -  - -  
50-199mg 2,349 229 0.97 0.736,1.269  0.91 0.693,1.206  0.91 0.691,1.206  
200-299mg 1,411 127 0.89 0.657,1.192  0.81 0.601,1.104  0.81 0.596,1.100  





ADHD (DAWBA) 4,625 617   0.473   0.874   0.786 
0-49mg (ref) 151 18 - -  - -  - -  
50-199mg 593 77 1.10 0.638,1.906  1.14 0.648,1.986  1.11 0.634,1.945  
200-299mg 729 94 1.09 0.639,1.873  1.07 0.616,1.853  1.02 0.588,1.773  
>300mg 3,152 428 1.16 0.702,1.919  1.11 0.661,1.853  1.03 0.615,1.734  
Hyperactive 4,634 533   0.568   0.750   0.976 
0-49mg (ref) 150 18 - -  - -  - -  
50-199mg 593 66 0.92 0.527,1.600  0.96 0.543,1.688  0.94 0.535,1.663  
200-299mg 732 76 0.85 0.492,1.468  0.85 0.485,1.482  0.82 0.469,1.438  
>300mg 3,159 373 0.98 0.593,1.626  0.98 0.583,1.640  0.93 0.554,1.567  
Inattentive  4,633 609   0.366   0.530   0.726 
0-49mg (ref) 151 14 - -  - -  - -  
50-199mg 597 78 1.47 0.808,2.678  1.55 0.839,2.845  1.52 0.827,2.805  
200-299mg 730 97 1.50 0.831,2.705  1.50 0.824,2.742  1.46 0.800,2.667  
>300mg 3,155 420 1.50 0.859,2.629  1.50 0.849,2.658  1.44 0.810,2.550  
ADHD (SDQ) 4,772 481   0.170   0.376   0.633 
0-49mg (ref) 147 12 - -  - -  - -  
50-199mg 612 58 1.18 0.615,2.255  1.28 0.664,2.481  1.26 0.650,2.432  
200-299mg 753 68 1.12 0.588,2.120  1.14 0.594,2.179  1.09 0.568,2.090  
>300mg 3,260 343 1.32 0.725,2.413  1.32 0.716,2.429  1.23 0.665,2.271  
Note: DAWBA – Development And Well-Being Assessment; SDQ – Strengths and Difficulties Questionnaire; N – total sample size; n – number of cases; OR – odds ratio; 95% 
CI – 95% confidence intervals; *adjusted for child’s gender, ethnicity, parity, parental age, marital status, education, financial difficulties, depression and anxiety symptoms, 







Appendix 5.26. Associations between maternal daily prenatal caffeine consumption and high risk of maternal and teacher reported 
offspring ADHD symptoms in GenR (complete cases) 
   Unadjusted model Adjusted model* 
 N n OR 95% CI P-value OR 95% CI P-value 
ADHD (CPRS-R) 2,053 282   0.733   0.438 
0-49mg (ref) 383 62 - -  - -  
50-199mg  972 125 0.76 0.549,1.063  0.74 0.520,1.039  
200-299mg  357 43 0.71 0.466,1.078  0.71 0.456,1.106  
>300mg  341 52 0.93 0.624,1.392  0.83 0.534,1.297  
Hyperactive 2,057 201   0536   0.387 
0-49mg (ref) 383 43 - -  - -  
50-199mg  976 94 0.84 0.575,1.235  0.85 0.572,1.266  
200-299mg  358 29 0.70 0.425,1.143  0.74 0.438,1.235  
>300mg  340 35 0.91 0.566,1.455  0.84 0.500,1.414  
Inattentive 2,058 240   0.978   0.701 
0-49mg (ref) 383 53 - -  - -  
50-199mg  976 102 0.73 0.509,1.037  0.69 0.473,0.992  
200-299mg  358 40 0.78 0.505,1.214  0.77 0.483,1.214  
>300mg  341 45 0.95 0.618,1.451  0.84 0.526,1.342  
ADHD (CBCL) 2,565 331   0.760   0.285 
0-49mg (ref) 490 64 - -  - -  
50-199mg  1,216 155 0.97 0.712,1.329  1.09 0.788,1.516  
200-299mg  445 54 0.92 0.624,1.354  1.12 0.742,1.690  
>300mg  414 58 1.08 0.740,1.589  1.26 0.824,1.923  
ADHD (TRF) 1,671 218   0.063   0.128 
0-49mg (ref) 340 48 - -  - -  
50-199mg  777 112 1.03 0.711,1.476  1.17 0.791,1.734  
200-299mg  296 31 0.71 0.440,1.151  0.87 0.513,1.472  
>300mg  258 27 0.71 0.430,1.175  0.68 0.383,1.200  
Note: CPRS-R–Revised Conners’ Parent Rating Scale; CBCL–Child Behavior Checklist; TRF–Teacher Report Form; N–sample size; n–number. of cases; OR–odds ratio; 




Appendix 5.27. Associations between maternal and paternal daily prenatal caffeine consumption and high risk of maternal reported offspring ADHD 
symptoms in MoBa (complete cases) 
   Unadjusted model Adjusted model* Mutually adjusted model** 
 N n OR 95% CI P-value OR 95% CI P-value OR 95% CI P-value 
Maternal 
ADHD (RS-DBD) 12,621 1,686   0.030   0.053   0.045 
0-49mg (ref) 7,844 1,021 - -  - -  - -  
50-199mg 4,133 564 1.06 0.946,1.179  1.06 0.950,1.192  1.07 0.957,1.203  
200-299mg 473 66 1.08 0.829,1.417  1.08 0.815,1.425  1.09 0.820,1.435  
>300 mg 171 35 1.72 1.172,2.524  1.60 1.066,2.387  1.61 1.073,2.409  
Hyperactive 12,620 1,630   <0.001   <0.001   <0.001 
0-49mg (ref) 7,845 956 - -  - -  - -  
50-199mg 4,130 573 1.16 1.039,1.298  1.18 1.050,1.320  1.19 1.058,1.332  
200-299mg 474 65 1.15 0.871,1.506  1.15 0.867,1.532  1.17 0.878,1.550  
>300 mg 171 36 1.92 1.314,2.809  1.84 1.240,2.735  1.86 1.250,2.758  
Inattentive 12,620 1,448   0.156   0.228   0.249 
0-49mg (ref) 7,845 888 - -  - -  - -  
50-199mg 4,132 474 1.02 0.902,1.143  1.02 0.904,1.154  1.03 0.906,1.159  
200-299mg 473 58 1.10 0.824,1.454  1.09 0.810,1.463  1.09 0.807,1.459  





ADHD (RS-DBD) 10,804 1,462   0.968   0.535   0.710 
0-49mg (ref) 2,353 344 - -  - -  - -  
50-199mg 3,861 478 0.83 0.711,0.958  0.85 0.731,0.999  0.84 0.720,0.985  
200-299mg 3,231 448 0.94 0.808,1.094  0.99 0.838,1.157  0.97 0.820,1.136  
>300 mg 1,359 192 0.96 0.794,1.162  1.01 0.824,1.227  0.98 0.804,1.199  
Hyperactive 10,802 1,432   0.672   0.929   0.729 
0-49mg (ref) 2,352 332 - -  - -  - -  
50-199mg 3,862 489 0.88 0.759,1.025  0.91 0.778,1.065  0.89 0.762,1.045  
200-299mg 3,230 428 0.93 0.796,1.084  0.96 0.815,1.132  0.94 0.794,1.104  
>300 mg 1,358 183 0.95 0.780,1.152  0.98 0.798,1.197  0.95 0.775,1.163  
Inattentive 10,806 1,254   0.888   0.492   0.569 
0-49mg (ref) 2,351 288 - -  - -  - -  
50-199mg 3,866 427 0.89 0.758,1.043  0.93 0.785,1.096  0.92 0.777,1.086  
200-299mg 3,230 368 0.92 0.781,1.086  0.97 0.816,1.158  0.96 0.804,1.143  
>300 mg 1,359 171 1.03 0.842,1.262  1.09 0.877,1.342  1.07 0.862,1.322  
Note: RS-DBD – Rating Scale for Disruptive Behavior Disorders; N – sample size; n – number of cases; OR – odds ratio; 95% CI – 95% confidence intervals; *adjusted 
for child’s gender, birth year, parity, parental age, education, marital status, financial difficulties, depression and anxiety symptoms, prenatal smoking and alcohol 







Appendix 5.28. Associations between maternal caffeine consumption PRS and high risk of teacher reported  
offspring ADHD symptoms in ALSPAC 
 Maternal PRS Maternal PRS adj. for PC  
Outcome OR 95% CI P-value OR 95% CI P-value Sample size 
ADHD (DAWBA) 0.68 0.355, 1.295 0.239 0.66 0.342, 1.253 0.201 3,486 
Hyperactive 0.54 0.277, 1.060 0.074 0.52 0.268, 1.027 0.060 3,485 
Inattentive 0.98 0.492, 1.951 0.954 0.95 0.476, 1.890 0.880 3,487 
ADHD (SDQ) 0.59 0.287, 1.195 0.141 0.57 0.277, 1.155 0.118 3,486 
Note: DAWBA – Development And Well-Being Assessment; SDQ – Strengths and Difficulties Questionnaire; OR – odds ratio;  





Appendix 6.1. SNPs positioned in chromosome 4 before clumping 
 





Appendix 6.2. SNPs positioned in chromosome 9 before clumping 
 
Note: 280 SNPs were identified from ALDH1B1 and ALDH1A1 genes 
 
Appendix 6.3. SNPs positioned in chromosome 12 before clumping 
 




Appendix 6.4. Harmonisation of SNPs in GenR based on the GSCAN summary statistics 
 GSCAN GenR 
SNP Non-effect 
allele  
Effect allele  Effect allele 
frequency  
Beta Minor allele  Major allele  Major allele 
frequency 
Effect allele after 
harmonisation 
rs7669660  T C 0.136 0.0086 C T 0.8480 C 
rs116010022 C A 0.00942 -0.0023 A C 0.9921 C 
rs28730582 C T 0.0318 0.0149 T C 0.9707 T 
rs29001207 G C 0.038 -0.0334 C G 0.9554 G 
rs13125262 G C 0.0436 0.0160 C G 0.9471 C 
rs17033 T C 0.0881 -0.0063 C T 0.9137 T 
rs138331988 G A 0.0192 0.0042 A G 0.9826 A 
rs17028839 A G 0.039 0.0031 G A 0.9570 G 
rs138244919 C T 0.0272 0.0052 T C 0.9821 T 
rs141973904 C T 0.0178 -0.1990 T C 0.9809 C 
rs3805329  T C 0.0625 0.0105 C T 0.9486 C 
rs75756595 G A 0.0522 0.0015 A G 0.9599 A 
rs1154465  T A 0.0276 0.0061 A T 0.9838 A 
rs4646769 T C 0.857 -0.0014 T C 0.8085 T 
rs77054814 A G 0.067 0.0017 G A 0.9521 G 
rs12378961 C G 0.0573 0.0068 G C 0.9491 G 
rs10973779 G A 0.0299 -0.0067 A G 0.9441 G 
rs8187999 C G 0.0238 0.0111 G C 0.9740 G 
rs8187996 C T 0.0479 -0.0030 T C 0.9525 C 
rs168351 A G 0.147 -0.0039 G A 0.8714 A 
rs8187953 C G 0.0268 0.0011 G C 0.9736 G 
rs8187950 A G 0.0364 -0.0033 G A 0.9634 A 
rs78094588 G A 0.0233 0.0031 A G 0.9793 A 
rs8187928 C T 0.0253 0.0103 T C 0.9686 T 
rs34878833 G A 0.0231 0.0139 A G 0.9708 A 




rs80105873 G T 0.0289 -0.0029 T G 0.9783 G 
rs8187891 T C 0.0252 0.0002 C T 0.9781 C 
rs17648566 T C 0.0204 -0.0093 C T 0.9747 T 
rs116917518 A T 0.0351 -0.0020 T A 0.9596 A 
rs11143426 A G 0.0127 0.0147 G A 0.9899 G 
rs41287405 T C 0.0238 0.0057 C T 0.9729 C 
rs148620777 A G 0.0177 -0.0048 G A 0.9839 A 
rs2283354 G A 0.174 0.0023 A G 0.8045 A 
rs73205605 G A 0.036 -0.0018 A G 0.9578 G 
rs61941278 A G 0.013 0.0075 G A 0.9856 G 




Appendix 6.5. Leave-one-out analyses in ALSPAC between maternal PRS and high 
risk of maternal reported offspring ADHD symptoms 
 







Appendix 6.6. Leave-one-out analyses in ALSPAC between maternal PRS and 
high risk of teacher reported offspring ADHD symptoms 
 








Appendix 6.7. Leave-one-out analyses in ALSPAC between offspring PRS and high 
risk of maternal reported offspring ADHD symptoms if mother drank during 
pregnancy 
 








Appendix 6.8. Leave-one-out analyses in ALSPAC between offspring PRS and high 
risk of maternal reported offspring ADHD symptoms if mother did not drink during 
pregnancy 
 








Appendix 6.9. Leave-one-out analyses in ALSPAC between offspring PRS and high 
risk of teacher reported offspring ADHD symptoms if mother drank during 
pregnancy 
 







Appendix 6.10. Leave-one-out analyses in ALSPAC between offspring PRS and high 
risk of teacher reported offspring ADHD symptoms if mother did not drink during 
pregnancy 
 







Appendix 6.11. Leave-one-out analyses in GenR between offspring PRS and high 
risk of maternal and teacher reported offspring ADHD symptoms if mother drank 
during pregnancy 
 
Note: Revised Conner’s Parent Rating Scale (CPRS-R); Child Behavior Checklist (CBCL); 







Appendix 6.12. Leave-one-out analyses in GenR between offspring PRS and high 
risk of maternal and teacher reported offspring ADHD symptoms if mother did not 
drink during pregnancy 
 
Note: Revised Conner’s Parent Rating Scale (CPRS-R); Child Behavior Checklist (CBCL); 







Appendix 6.13. Leave-one-out analyses in MoBa between maternal PRS and 
maternal reported offspring ADHD symptoms 
 






Appendix 6.14. Leave-one-out analyses in MoBa between offspring PRS and 
high risk of maternal reported offspring ADHD symptoms if mother drank 
during pregnancy 
 






Appendix 6.15. Leave-one-out analyses in MoBa between offspring PRS and high 
risk of maternal reported offspring ADHD symptoms if mother did not drink during 
pregnancy 
 








Appendix 6.16. Associations between maternal PRS and high risk of teacher 
reported offspring ADHD symptoms in ALSPAC 
 
Note: Model 1 – only maternal PRS; Model 2 – maternal PRS adjusted for offspring 
PRS; All analyses are adjusted for 10 ancestry principal components; Development 






Appendix 6.17. Associations between maternal PRS and high risk of teacher reported offspring ADHD symptoms in ALSPAC 
 Model 1 Model 2 
Outcome OR 95% CI P-value OR 95% CI P-value Sample size 
ADHD symptoms (DAWBA) 0.99 0.915, 1.066 0.750 0.98 0.897, 1.070 0.649 2,310 
Hyperactivity symptoms 1.05 0.968, 1.132 0.252 1.02 0.936, 1.121 0.599 2,309 
Inattention symptoms 1.01 0.925, 1.094 0.889 1.01 0.919, 1.115 0.803 2,311 
ADHD symptoms (SDQ) 1.07 0.978, 1.160 0.148 1.06 0.957, 1.166 0.277 2,312 
Note: Model 1 – only maternal PRS; Model 2 – maternal PRS adj. for offspring PRS; All analyses adjusted also for 10 ancestry principal components; 





Appendix 6.18. Associations between offspring PRS and high risk of teacher reported offspring ADHD symptoms in ALSPAC stratified by 




Note: Model 1 – only offspring PRS; Model 2 – offspring PRS adjusted for maternal PRS; All analyses are adjusted for 10 ancestry principal  
components; Development And Well-Being Assessment (DAWBA); Strengths and Difficulties Questionnaire (SDQ) 
 
 





Appendix 6.19. Associations between offspring PRS and high risk of teacher reported offspring ADHD symptoms in ALSPAC if mother  
drank during pregnancy 
 Model 1 Model 2 
Outcome OR 95% CI P-value OR 95% CI P-value Sample size 
ADHD symptoms (DAWBA) 0.98 0.895, 1.078 0.706 0.98 0.878, 1.087 0.666 1,602 
Hyperactivity symptoms 1.02 0.923, 1.116 0.755 0.99 0.887, 1.102 0.832 1,601 
Inattention symptoms 0.99 0.892, 1.098 0.843 0.98 0.873, 1.107 0.780 1,603 
ADHD symptoms (SDQ) 1.02 0.919, 1.134 0.701 0.98 0.864, 1.102 0.691 1,603 
Note: Model 1 – only offspring PRS; Model 2 – offspring PRS adj. for maternal PRS; All analyses adjusted also for 10 ancestry principal components;  





Appendix 6.20. Associations between offspring PRS and high risk of teacher reported offspring ADHD symptoms in ALSPAC if  
mother did not drink during pregnancy 
 Model 1 Model 2 
Outcome OR 95% CI P-value OR 95% CI P-value Sample size 
ADHD symptoms (DAWBA) 1.07 0.937, 1.216 0.329 1.11 0.949, 1.295 0.192 708 
Hyperactivity symptoms 1.17 1.019, 1.338 0.025 1.21 1.026, 1.419 0.023 708 
Inattention symptoms 1.02 0.880, 1.175 0.822 1.00 0.843, 1.191 0.985 708 
ADHD symptoms (SDQ) 1.11 0.965, 1.286 0.142 1.10 0.927, 1.305 0.277 709 
Note: Model 1 – only offspring PRS; Model 2 – offspring PRS adj. for maternal PRS; All analyses adjusted also for 10 ancestry principal  




Appendix 6.21. Associations between offspring PRS and high risk of maternal and 
teacher reported offspring ADHD symptoms in GenR stratified by maternal 
drinking status 
 
Note: Model 1 – only offspring PRS adjusted for 10 ancestry principal components; 
offspring PRS of 4 SNPs (rs2866151, rs975833, rs4147536, rs284779); Revised Conner’s 
Parent Rating Scale (CPRS-R); Child Behavior Checklist (CBCL); Teacher Report Form (TRF); 





Appendix 6.22. Associations between offspring PRS and high risk of maternal reported offspring ADHD symptoms in ALSPAC stratified by 




Note: Model 1 – only offspring PRS; Model 2 – offspring PRS adjusted for maternal PRS; All analyses are adjusted for 10 ancestry principal components; 
offspring PRS of 4 SNPs (rs2866151, rs975833, rs4147536, rs284779); Development And Well-Being Assessment (DAWBA); Strengths and Difficulties 
Questionnaire (SDQ) – secondary measure 




Appendix 6.23. Associations between offspring PRS and high risk of teacher reported offspring ADHD symptoms in ALSPAC stratified by 




Note: Model 1 – only offspring PRS; Model 2 – offspring PRS adjusted for maternal PRS; All analyses are adjusted for 10 ancestry principal components; 
offspring PRS of 4 SNPs (rs2866151, rs975833, rs4147536, rs284779); Development And Well-Being Assessment (DAWBA); Strengths and Difficulties 
Questionnaire (SDQ) – secondary measure 
 




Appendix 6.24. Associations between offspring PRS and high risk of maternal reported offspring ADHD symptoms in MoBa stratified by 




Note: Model 1 – only offspring PRS; Model 2 – offspring PRS adjusted for maternal PRS; Model 3 – offspring PRS adjusted for maternal and paternal PRS; All 
analyses are adjusted for 10 ancestry principal components, birth year and genotyping batch; offspring PRS of 4 SNPs (rs2866151, rs975833, rs4147536, 
rs284779); ADHD symptoms measured with Rating Scale for Disruptive Behavior Disorders (RS-DBD) 
 




Appendix 6.25. Associations between offspring PRS and high risk of maternal and teacher reported offspring ADHD symptoms in GenR 
 Mother drink during pregnancy Mother did not drink during pregnancy 
Outcome OR 95% CI P-value Sample size OR 95% CI P-value Sample size 
ADHD symptoms (CPRS-R) 0.99 0.868, 1.135 0.915 1,037 0.94 0.744, 1.180 0.581 418 
Hyperactivity symptoms 0.97 0.824, 1.136 0.687 1,038 1.08 0.857, 1.364 0.512 419 
Inattention symptoms 1.00 0.868, 1.155 0.990 1,038 0.90 0.696, 1.165 0.426 420 
ADHD symptoms (CBCL) 1.02 0.888, 1.168 0.793 1,186 0.99 0.801, 1.211 0.884 510 
ADHD symptoms (TRF) 1.05 0.863, 1.270 0.639 708 0.96 0.728, 1.265 0.770 317 
Note: Model 1 – only offspring PRS adjusted also for 10 ancestry principal components; offspring PRS of 4 SNPs (rs2866151, rs975833, rs4147536, rs284779); 





Appendix 6.26. Associations between offspring PRS and high risk of maternal reported offspring ADHD symptoms in ALSPAC if  
mother drank during pregnancy 
 Model 1 Model 2 
Outcome OR 95% CI P-value OR 95% CI P-value Sample size 
ADHD symptoms (DAWBA) 0.95 0.864, 1.034 0.218 0.93 0.842, 1.033 0.181 2,573 
Hyperactivity symptoms 0.95 0.868, 1.049 0.328 0.95 0.848, 1.053 0.307 2,576 
Inattention symptoms 0.93 0.852, 1.022 0.134 0.94 0.842, 1.037 0.201 2,582 
ADHD symptoms (SDQ) 1.03 0.934, 1.139 0.544 0.98 0.870, 1.094 0.672 2,606 
Note: Model 1 – only offspring PRS; Model 2 – offspring PRS adj. for maternal PRS; All analyses adjusted also for 10 ancestry principal  
components; offspring PRS of 4 SNPs (rs2866151, rs975833, rs4147536, rs284779); Development And Well-Being Assessment (DAWBA);  




Appendix 6.27. Associations between offspring PRS and high risk of maternal reported offspring ADHD symptoms in ALSPAC if  
mother did not drink during pregnancy 
 Model 1 Model 2 
Outcome OR 95% CI P-value OR 95% CI P-value Sample size 
ADHD symptoms (DAWBA) 1.05 0.912, 1.207 0.504 1.06 0.899, 1.238 0.514 1,125 
Hyperactivity symptoms 1.03 0.893, 1.196 0.660 1.09 0.920, 1.283 0.330 1,130 
Inattention symptoms 0.98 0.849, 1.137 0.808 0.97 0.820, 1.144 0.708 1,126 
ADHD symptoms (SDQ) 1.00 0.851, 1.176 0.996 1.03 0.852, 1.234 0.790 1,130 
Note: Model 1 – only offspring PRS; Model 2 – offspring PRS adj. for maternal PRS; All analyses adjusted also for 10 ancestry principal components;  
offspring PRS of 4 SNPs (rs2866151, rs975833, rs4147536, rs284779); Development And Well-Being Assessment (DAWBA); Strengths and Difficulties 





Appendix 6.28. Associations between offspring PRS and high risk of teacher reported offspring ADHD symptoms in ALSPAC if mother  
drank during pregnancy 
 Model 1 Model 2 
Outcome OR 95% CI P-value OR 95% CI P-value Sample size 
ADHD symptoms (DAWBA) 0.99 0.870, 1.126 0.876 0.93 0.801, 1.080 0.344 1,602 
Hyperactivity symptoms 1.06 0.927, 1.202 0.416 1.01 0.865, 1.170 0.940 1,601 
Inattention symptoms 0.91 0.786, 1.053 0.206 0.87 0.730, 1.024 0.092 1,603 
ADHD symptoms (SDQ) 0.94 0.810, 1.090 0.413 0.93 0.781, 1.103 0.398 1,603 
Note: Model 1 – only offspring PRS; Model 2 – offspring PRS adj. for maternal PRS; All analyses adjusted also for 10 ancestry principal components;  
offspring PRS of 4 SNPs (rs2866151, rs975833, rs4147536, rs284779); Development And Well-Being Assessment (DAWBA); Strengths and Difficulties 




Appendix 6.29. Associations between offspring PRS and high risk of teacher reported offspring ADHD symptoms in ALSPAC if mother  
did not drink during pregnancy 
 Model 1 Model 2 
Outcome OR 95% CI P-value OR 95% CI P-value Sample size 
ADHD symptoms (DAWBA) 0.98 0.809, 1.186 0.830 1.00 0.807, 1.241 0.998 708 
Hyperactivity symptoms 1.04 0.852, 1.261 0.723 1.08 0.865, 1.342 0.504 708 
Inattention symptoms 0.89 0.713, 1.108 0.293 0.91 0.707, 1.159 0.429 708 
ADHD symptoms (SDQ) 1.15 0.934, 1.408 0.191 1.13 0.898, 1.430 0.292 709 
Note: Model 1 – only offspring PRS; Model 2 – offspring PRS adj. for maternal PRS; All analyses adjusted also for 10 ancestry principal components;  
offspring PRS of 4 SNPs (rs2866151, rs975833, rs4147536, rs284779); Development And Well-Being Assessment (DAWBA); Strengths and Difficulties 





Appendix 6.30. Associations between offspring PRS and high risk of maternal reported offspring ADHD symptoms in MoBa if mother drank during 
pregnancy 
 Model 1 Model 2 Model 3 
Outcome OR 95% CI P-value OR 95% CI P-value OR 95% CI P-value Sample size 
ADHD symptoms (RS-DBD) 0.98 0.841, 1.134 0.757 0.95 0.796, 1.127 0.538 0.93 0.752, 1.150 0.503 982 
Hyperactivity symptoms 1.08 0.941, 1.248 0.263 1.05 0.892, 1.239 0.553 1.08 0.875, 1.318 0.494 981 
Inattention symptoms 0.96 0.820, 1.122 0.606 0.94 0.781, 1.128 0.498 0.90 0.721, 1.127 0.362 982 
Note: Model 1 – only offspring PRS; Model 2 – offspring PRS adj. for maternal PRS; Model 3 – offspring PRS adj. for maternal and paternal PRS; all analyses adjusted 
also for 10 ancestry principal components, birth year and genotyping batch; offspring PRS of 4 SNPs (rs2866151, rs975833, rs4147536, rs284779); Rating Scale for 
Disruptive Behavior Disorders (RS-DBD) 
 
Appendix 6.31. Associations between offspring PRS and high risk of maternal reported offspring ADHD symptoms in MoBa if mother did not drink 
during pregnancy 
 Model 1 Model 2 Model 3 
Outcome OR 95% CI P-value OR 95% CI P-value OR 95% CI P-value Sample size 
ADHD symptoms (RS-DBD) 1.02 0.952, 1.089 0.605 1.01 0.936, 1.091 0.793 1.04 0.945, 1.142 0.427 4,617 
Hyperactivity symptoms 1.01 0.941, 1.079 0.823 0.99 0.913, 1.068 0.750 0.99 0.899, 1.088 0.821 4,614 
Inattention symptoms 0.95 0.884, 1.022 0.168 0.96 0.884, 1.042 0.329 1.01 0.914, 1.120 0.820 4,619 
Note: Model 1 – only offspring PRS; Model 2 – offspring PRS adj. for maternal PRS; Model 3 – offspring PRS adj. for maternal and paternal PRS; all analyses adjusted 
also for 10 ancestry principal components, birth year and genotyping batch; offspring PRS of 4 SNPs (rs2866151, rs975833, rs4147536, rs284779); Rating Scale for 
Disruptive Behavior Disorders (RS-DBD) 
 
